##fileformat=VCFv4.2
##hailversion=0.2.122-be9d88a80695
##FILTER=<ID=AC0,Description="Allele count is zero after filtering out low-confidence genotypes (GQ < 20; DP < 10; and AB < 0.2 for het calls)">
##FILTER=<ID=AS_VQSR,Description="Failed VQSR filtering thresholds of -2.502 for SNPs and -0.7156 for indels">
##FILTER=<ID=InbreedingCoeff,Description="Inbreeding coefficient < -0.3">
##FILTER=<ID=PASS,Description="Passed all variant filters">
##INFO=<ID=AC,Number=A,Type=Integer,Description="Alternate allele count">
##INFO=<ID=AN,Number=1,Type=Integer,Description="Total number of alleles">
##INFO=<ID=AF,Number=A,Type=Float,Description="Alternate allele frequency">
##INFO=<ID=grpmax,Number=A,Type=String,Description="Genetic ancestry group with the maximum allele frequency">
##INFO=<ID=fafmax_faf95_max,Number=A,Type=Float,Description="Maximum filtering allele frequency (using Poisson 95% CI) across genetic ancestry groups">
##INFO=<ID=fafmax_faf95_max_gen_anc,Number=A,Type=String,Description="Genetic ancestry group with maximum filtering allele frequency (using Poisson 95% CI)">
##INFO=<ID=AC_XX,Number=A,Type=Integer,Description="Alternate allele count for XX samples">
##INFO=<ID=AF_XX,Number=A,Type=Float,Description="Alternate allele frequency in XX samples">
##INFO=<ID=AN_XX,Number=1,Type=Integer,Description="Total number of alleles in XX samples">
##INFO=<ID=nhomalt_XX,Number=A,Type=Integer,Description="Count of homozygous individuals in XX samples">
##INFO=<ID=AC_XY,Number=A,Type=Integer,Description="Alternate allele count for XY samples">
##INFO=<ID=AF_XY,Number=A,Type=Float,Description="Alternate allele frequency in XY samples">
##INFO=<ID=AN_XY,Number=1,Type=Integer,Description="Total number of alleles in XY samples">
##INFO=<ID=nhomalt_XY,Number=A,Type=Integer,Description="Count of homozygous individuals in XY samples">
##INFO=<ID=nhomalt,Number=A,Type=Integer,Description="Count of homozygous individuals">
##INFO=<ID=AC_afr_XX,Number=A,Type=Integer,Description="Alternate allele count for XX samples in the African/African-American genetic ancestry group">
##INFO=<ID=AF_afr_XX,Number=A,Type=Float,Description="Alternate allele frequency in XX samples in the African/African-American genetic ancestry group">
##INFO=<ID=AN_afr_XX,Number=1,Type=Integer,Description="Total number of alleles in XX samples in the African/African-American genetic ancestry group">
##INFO=<ID=nhomalt_afr_XX,Number=A,Type=Integer,Description="Count of homozygous individuals in XX samples in the African/African-American genetic ancestry group">
##INFO=<ID=AC_afr_XY,Number=A,Type=Integer,Description="Alternate allele count for XY samples in the African/African-American genetic ancestry group">
##INFO=<ID=AF_afr_XY,Number=A,Type=Float,Description="Alternate allele frequency in XY samples in the African/African-American genetic ancestry group">
##INFO=<ID=AN_afr_XY,Number=1,Type=Integer,Description="Total number of alleles in XY samples in the African/African-American genetic ancestry group">
##INFO=<ID=nhomalt_afr_XY,Number=A,Type=Integer,Description="Count of homozygous individuals in XY samples in the African/African-American genetic ancestry group">
##INFO=<ID=AC_afr,Number=A,Type=Integer,Description="Alternate allele count for samples in the African/African-American genetic ancestry group">
##INFO=<ID=AF_afr,Number=A,Type=Float,Description="Alternate allele frequency in samples in the African/African-American genetic ancestry group">
##INFO=<ID=AN_afr,Number=1,Type=Integer,Description="Total number of alleles in samples in the African/African-American genetic ancestry group">
##INFO=<ID=nhomalt_afr,Number=A,Type=Integer,Description="Count of homozygous individuals in samples in the African/African-American genetic ancestry group">
##INFO=<ID=AC_ami_XX,Number=A,Type=Integer,Description="Alternate allele count for XX samples in the Amish genetic ancestry group">
##INFO=<ID=AF_ami_XX,Number=A,Type=Float,Description="Alternate allele frequency in XX samples in the Amish genetic ancestry group">
##INFO=<ID=AN_ami_XX,Number=1,Type=Integer,Description="Total number of alleles in XX samples in the Amish genetic ancestry group">
##INFO=<ID=nhomalt_ami_XX,Number=A,Type=Integer,Description="Count of homozygous individuals in XX samples in the Amish genetic ancestry group">
##INFO=<ID=AC_ami_XY,Number=A,Type=Integer,Description="Alternate allele count for XY samples in the Amish genetic ancestry group">
##INFO=<ID=AF_ami_XY,Number=A,Type=Float,Description="Alternate allele frequency in XY samples in the Amish genetic ancestry group">
##INFO=<ID=AN_ami_XY,Number=1,Type=Integer,Description="Total number of alleles in XY samples in the Amish genetic ancestry group">
##INFO=<ID=nhomalt_ami_XY,Number=A,Type=Integer,Description="Count of homozygous individuals in XY samples in the Amish genetic ancestry group">
##INFO=<ID=AC_ami,Number=A,Type=Integer,Description="Alternate allele count for samples in the Amish genetic ancestry group">
##INFO=<ID=AF_ami,Number=A,Type=Float,Description="Alternate allele frequency in samples in the Amish genetic ancestry group">
##INFO=<ID=AN_ami,Number=1,Type=Integer,Description="Total number of alleles in samples in the Amish genetic ancestry group">
##INFO=<ID=nhomalt_ami,Number=A,Type=Integer,Description="Count of homozygous individuals in samples in the Amish genetic ancestry group">
##INFO=<ID=AC_amr_XX,Number=A,Type=Integer,Description="Alternate allele count for XX samples in the Admixed American genetic ancestry group">
##INFO=<ID=AF_amr_XX,Number=A,Type=Float,Description="Alternate allele frequency in XX samples in the Admixed American genetic ancestry group">
##INFO=<ID=AN_amr_XX,Number=1,Type=Integer,Description="Total number of alleles in XX samples in the Admixed American genetic ancestry group">
##INFO=<ID=nhomalt_amr_XX,Number=A,Type=Integer,Description="Count of homozygous individuals in XX samples in the Admixed American genetic ancestry group">
##INFO=<ID=AC_amr_XY,Number=A,Type=Integer,Description="Alternate allele count for XY samples in the Admixed American genetic ancestry group">
##INFO=<ID=AF_amr_XY,Number=A,Type=Float,Description="Alternate allele frequency in XY samples in the Admixed American genetic ancestry group">
##INFO=<ID=AN_amr_XY,Number=1,Type=Integer,Description="Total number of alleles in XY samples in the Admixed American genetic ancestry group">
##INFO=<ID=nhomalt_amr_XY,Number=A,Type=Integer,Description="Count of homozygous individuals in XY samples in the Admixed American genetic ancestry group">
##INFO=<ID=AC_amr,Number=A,Type=Integer,Description="Alternate allele count for samples in the Admixed American genetic ancestry group">
##INFO=<ID=AF_amr,Number=A,Type=Float,Description="Alternate allele frequency in samples in the Admixed American genetic ancestry group">
##INFO=<ID=AN_amr,Number=1,Type=Integer,Description="Total number of alleles in samples in the Admixed American genetic ancestry group">
##INFO=<ID=nhomalt_amr,Number=A,Type=Integer,Description="Count of homozygous individuals in samples in the Admixed American genetic ancestry group">
##INFO=<ID=AC_asj_XX,Number=A,Type=Integer,Description="Alternate allele count for XX samples in the Ashkenazi Jewish genetic ancestry group">
##INFO=<ID=AF_asj_XX,Number=A,Type=Float,Description="Alternate allele frequency in XX samples in the Ashkenazi Jewish genetic ancestry group">
##INFO=<ID=AN_asj_XX,Number=1,Type=Integer,Description="Total number of alleles in XX samples in the Ashkenazi Jewish genetic ancestry group">
##INFO=<ID=nhomalt_asj_XX,Number=A,Type=Integer,Description="Count of homozygous individuals in XX samples in the Ashkenazi Jewish genetic ancestry group">
##INFO=<ID=AC_asj_XY,Number=A,Type=Integer,Description="Alternate allele count for XY samples in the Ashkenazi Jewish genetic ancestry group">
##INFO=<ID=AF_asj_XY,Number=A,Type=Float,Description="Alternate allele frequency in XY samples in the Ashkenazi Jewish genetic ancestry group">
##INFO=<ID=AN_asj_XY,Number=1,Type=Integer,Description="Total number of alleles in XY samples in the Ashkenazi Jewish genetic ancestry group">
##INFO=<ID=nhomalt_asj_XY,Number=A,Type=Integer,Description="Count of homozygous individuals in XY samples in the Ashkenazi Jewish genetic ancestry group">
##INFO=<ID=AC_asj,Number=A,Type=Integer,Description="Alternate allele count for samples in the Ashkenazi Jewish genetic ancestry group">
##INFO=<ID=AF_asj,Number=A,Type=Float,Description="Alternate allele frequency in samples in the Ashkenazi Jewish genetic ancestry group">
##INFO=<ID=AN_asj,Number=1,Type=Integer,Description="Total number of alleles in samples in the Ashkenazi Jewish genetic ancestry group">
##INFO=<ID=nhomalt_asj,Number=A,Type=Integer,Description="Count of homozygous individuals in samples in the Ashkenazi Jewish genetic ancestry group">
##INFO=<ID=AC_eas_XX,Number=A,Type=Integer,Description="Alternate allele count for XX samples in the East Asian genetic ancestry group">
##INFO=<ID=AF_eas_XX,Number=A,Type=Float,Description="Alternate allele frequency in XX samples in the East Asian genetic ancestry group">
##INFO=<ID=AN_eas_XX,Number=1,Type=Integer,Description="Total number of alleles in XX samples in the East Asian genetic ancestry group">
##INFO=<ID=nhomalt_eas_XX,Number=A,Type=Integer,Description="Count of homozygous individuals in XX samples in the East Asian genetic ancestry group">
##INFO=<ID=AC_eas_XY,Number=A,Type=Integer,Description="Alternate allele count for XY samples in the East Asian genetic ancestry group">
##INFO=<ID=AF_eas_XY,Number=A,Type=Float,Description="Alternate allele frequency in XY samples in the East Asian genetic ancestry group">
##INFO=<ID=AN_eas_XY,Number=1,Type=Integer,Description="Total number of alleles in XY samples in the East Asian genetic ancestry group">
##INFO=<ID=nhomalt_eas_XY,Number=A,Type=Integer,Description="Count of homozygous individuals in XY samples in the East Asian genetic ancestry group">
##INFO=<ID=AC_eas,Number=A,Type=Integer,Description="Alternate allele count for samples in the East Asian genetic ancestry group">
##INFO=<ID=AF_eas,Number=A,Type=Float,Description="Alternate allele frequency in samples in the East Asian genetic ancestry group">
##INFO=<ID=AN_eas,Number=1,Type=Integer,Description="Total number of alleles in samples in the East Asian genetic ancestry group">
##INFO=<ID=nhomalt_eas,Number=A,Type=Integer,Description="Count of homozygous individuals in samples in the East Asian genetic ancestry group">
##INFO=<ID=AC_fin_XX,Number=A,Type=Integer,Description="Alternate allele count for XX samples in the Finnish genetic ancestry group">
##INFO=<ID=AF_fin_XX,Number=A,Type=Float,Description="Alternate allele frequency in XX samples in the Finnish genetic ancestry group">
##INFO=<ID=AN_fin_XX,Number=1,Type=Integer,Description="Total number of alleles in XX samples in the Finnish genetic ancestry group">
##INFO=<ID=nhomalt_fin_XX,Number=A,Type=Integer,Description="Count of homozygous individuals in XX samples in the Finnish genetic ancestry group">
##INFO=<ID=AC_fin_XY,Number=A,Type=Integer,Description="Alternate allele count for XY samples in the Finnish genetic ancestry group">
##INFO=<ID=AF_fin_XY,Number=A,Type=Float,Description="Alternate allele frequency in XY samples in the Finnish genetic ancestry group">
##INFO=<ID=AN_fin_XY,Number=1,Type=Integer,Description="Total number of alleles in XY samples in the Finnish genetic ancestry group">
##INFO=<ID=nhomalt_fin_XY,Number=A,Type=Integer,Description="Count of homozygous individuals in XY samples in the Finnish genetic ancestry group">
##INFO=<ID=AC_fin,Number=A,Type=Integer,Description="Alternate allele count for samples in the Finnish genetic ancestry group">
##INFO=<ID=AF_fin,Number=A,Type=Float,Description="Alternate allele frequency in samples in the Finnish genetic ancestry group">
##INFO=<ID=AN_fin,Number=1,Type=Integer,Description="Total number of alleles in samples in the Finnish genetic ancestry group">
##INFO=<ID=nhomalt_fin,Number=A,Type=Integer,Description="Count of homozygous individuals in samples in the Finnish genetic ancestry group">
##INFO=<ID=AC_mid_XX,Number=A,Type=Integer,Description="Alternate allele count for XX samples in the Middle Eastern genetic ancestry group">
##INFO=<ID=AF_mid_XX,Number=A,Type=Float,Description="Alternate allele frequency in XX samples in the Middle Eastern genetic ancestry group">
##INFO=<ID=AN_mid_XX,Number=1,Type=Integer,Description="Total number of alleles in XX samples in the Middle Eastern genetic ancestry group">
##INFO=<ID=nhomalt_mid_XX,Number=A,Type=Integer,Description="Count of homozygous individuals in XX samples in the Middle Eastern genetic ancestry group">
##INFO=<ID=AC_mid_XY,Number=A,Type=Integer,Description="Alternate allele count for XY samples in the Middle Eastern genetic ancestry group">
##INFO=<ID=AF_mid_XY,Number=A,Type=Float,Description="Alternate allele frequency in XY samples in the Middle Eastern genetic ancestry group">
##INFO=<ID=AN_mid_XY,Number=1,Type=Integer,Description="Total number of alleles in XY samples in the Middle Eastern genetic ancestry group">
##INFO=<ID=nhomalt_mid_XY,Number=A,Type=Integer,Description="Count of homozygous individuals in XY samples in the Middle Eastern genetic ancestry group">
##INFO=<ID=AC_mid,Number=A,Type=Integer,Description="Alternate allele count for samples in the Middle Eastern genetic ancestry group">
##INFO=<ID=AF_mid,Number=A,Type=Float,Description="Alternate allele frequency in samples in the Middle Eastern genetic ancestry group">
##INFO=<ID=AN_mid,Number=1,Type=Integer,Description="Total number of alleles in samples in the Middle Eastern genetic ancestry group">
##INFO=<ID=nhomalt_mid,Number=A,Type=Integer,Description="Count of homozygous individuals in samples in the Middle Eastern genetic ancestry group">
##INFO=<ID=AC_nfe_XX,Number=A,Type=Integer,Description="Alternate allele count for XX samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=AF_nfe_XX,Number=A,Type=Float,Description="Alternate allele frequency in XX samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=AN_nfe_XX,Number=1,Type=Integer,Description="Total number of alleles in XX samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=nhomalt_nfe_XX,Number=A,Type=Integer,Description="Count of homozygous individuals in XX samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=AC_nfe_XY,Number=A,Type=Integer,Description="Alternate allele count for XY samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=AF_nfe_XY,Number=A,Type=Float,Description="Alternate allele frequency in XY samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=AN_nfe_XY,Number=1,Type=Integer,Description="Total number of alleles in XY samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=nhomalt_nfe_XY,Number=A,Type=Integer,Description="Count of homozygous individuals in XY samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=AC_nfe,Number=A,Type=Integer,Description="Alternate allele count for samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=AF_nfe,Number=A,Type=Float,Description="Alternate allele frequency in samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=AN_nfe,Number=1,Type=Integer,Description="Total number of alleles in samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=nhomalt_nfe,Number=A,Type=Integer,Description="Count of homozygous individuals in samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=AC_raw,Number=A,Type=Integer,Description="Alternate allele count for samples, before removing low-confidence genotypes">
##INFO=<ID=AF_raw,Number=A,Type=Float,Description="Alternate allele frequency in samples, before removing low-confidence genotypes">
##INFO=<ID=AN_raw,Number=1,Type=Integer,Description="Total number of alleles in samples, before removing low-confidence genotypes">
##INFO=<ID=nhomalt_raw,Number=A,Type=Integer,Description="Count of homozygous individuals in samples, before removing low-confidence genotypes">
##INFO=<ID=AC_remaining_XX,Number=A,Type=Integer,Description="Alternate allele count for XX samples in the Remaining individuals genetic ancestry group">
##INFO=<ID=AF_remaining_XX,Number=A,Type=Float,Description="Alternate allele frequency in XX samples in the Remaining individuals genetic ancestry group">
##INFO=<ID=AN_remaining_XX,Number=1,Type=Integer,Description="Total number of alleles in XX samples in the Remaining individuals genetic ancestry group">
##INFO=<ID=nhomalt_remaining_XX,Number=A,Type=Integer,Description="Count of homozygous individuals in XX samples in the Remaining individuals genetic ancestry group">
##INFO=<ID=AC_remaining_XY,Number=A,Type=Integer,Description="Alternate allele count for XY samples in the Remaining individuals genetic ancestry group">
##INFO=<ID=AF_remaining_XY,Number=A,Type=Float,Description="Alternate allele frequency in XY samples in the Remaining individuals genetic ancestry group">
##INFO=<ID=AN_remaining_XY,Number=1,Type=Integer,Description="Total number of alleles in XY samples in the Remaining individuals genetic ancestry group">
##INFO=<ID=nhomalt_remaining_XY,Number=A,Type=Integer,Description="Count of homozygous individuals in XY samples in the Remaining individuals genetic ancestry group">
##INFO=<ID=AC_remaining,Number=A,Type=Integer,Description="Alternate allele count for samples in the Remaining individuals genetic ancestry group">
##INFO=<ID=AF_remaining,Number=A,Type=Float,Description="Alternate allele frequency in samples in the Remaining individuals genetic ancestry group">
##INFO=<ID=AN_remaining,Number=1,Type=Integer,Description="Total number of alleles in samples in the Remaining individuals genetic ancestry group">
##INFO=<ID=nhomalt_remaining,Number=A,Type=Integer,Description="Count of homozygous individuals in samples in the Remaining individuals genetic ancestry group">
##INFO=<ID=AC_sas_XX,Number=A,Type=Integer,Description="Alternate allele count for XX samples in the South Asian genetic ancestry group">
##INFO=<ID=AF_sas_XX,Number=A,Type=Float,Description="Alternate allele frequency in XX samples in the South Asian genetic ancestry group">
##INFO=<ID=AN_sas_XX,Number=1,Type=Integer,Description="Total number of alleles in XX samples in the South Asian genetic ancestry group">
##INFO=<ID=nhomalt_sas_XX,Number=A,Type=Integer,Description="Count of homozygous individuals in XX samples in the South Asian genetic ancestry group">
##INFO=<ID=AC_sas_XY,Number=A,Type=Integer,Description="Alternate allele count for XY samples in the South Asian genetic ancestry group">
##INFO=<ID=AF_sas_XY,Number=A,Type=Float,Description="Alternate allele frequency in XY samples in the South Asian genetic ancestry group">
##INFO=<ID=AN_sas_XY,Number=1,Type=Integer,Description="Total number of alleles in XY samples in the South Asian genetic ancestry group">
##INFO=<ID=nhomalt_sas_XY,Number=A,Type=Integer,Description="Count of homozygous individuals in XY samples in the South Asian genetic ancestry group">
##INFO=<ID=AC_sas,Number=A,Type=Integer,Description="Alternate allele count for samples in the South Asian genetic ancestry group">
##INFO=<ID=AF_sas,Number=A,Type=Float,Description="Alternate allele frequency in samples in the South Asian genetic ancestry group">
##INFO=<ID=AN_sas,Number=1,Type=Integer,Description="Total number of alleles in samples in the South Asian genetic ancestry group">
##INFO=<ID=nhomalt_sas,Number=A,Type=Integer,Description="Count of homozygous individuals in samples in the South Asian genetic ancestry group">
##INFO=<ID=AC_grpmax,Number=A,Type=Integer,Description="Allele count in the genetic ancestry group with the maximum allele frequency">
##INFO=<ID=AF_grpmax,Number=A,Type=Float,Description="Maximum allele frequency across genetic ancestry groups">
##INFO=<ID=AN_grpmax,Number=A,Type=Integer,Description="Total number of alleles in the genetic ancestry group with the maximum allele frequency">
##INFO=<ID=nhomalt_grpmax,Number=A,Type=Integer,Description="Count of homozygous individuals in the genetic ancestry group with the maximum allele frequency">
##INFO=<ID=faf95_XX,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for XX samples in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf95_XY,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for XY samples in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf95,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI)">
##INFO=<ID=faf95_afr_XX,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for XX samples in the African/African-American genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf95_afr_XY,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for XY samples in the African/African-American genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf95_afr,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for samples in the African/African-American genetic ancestry group">
##INFO=<ID=faf95_amr_XX,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for XX samples in the Admixed American genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf95_amr_XY,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for XY samples in the Admixed American genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf95_amr,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for samples in the Admixed American genetic ancestry group">
##INFO=<ID=faf95_eas_XX,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for XX samples in the East Asian genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf95_eas_XY,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for XY samples in the East Asian genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf95_eas,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for samples in the East Asian genetic ancestry group">
##INFO=<ID=faf95_nfe_XX,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for XX samples in the Non-Finnish European genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf95_nfe_XY,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for XY samples in the Non-Finnish European genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf95_nfe,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=faf95_sas_XX,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for XX samples in the South Asian genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf95_sas_XY,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for XY samples in the South Asian genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf95_sas,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 95% CI) for samples in the South Asian genetic ancestry group">
##INFO=<ID=faf99_XX,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for XX samples in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf99_XY,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for XY samples in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf99,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI)">
##INFO=<ID=faf99_afr_XX,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for XX samples in the African/African-American genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf99_afr_XY,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for XY samples in the African/African-American genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf99_afr,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for samples in the African/African-American genetic ancestry group">
##INFO=<ID=faf99_amr_XX,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for XX samples in the Admixed American genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf99_amr_XY,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for XY samples in the Admixed American genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf99_amr,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for samples in the Admixed American genetic ancestry group">
##INFO=<ID=faf99_eas_XX,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for XX samples in the East Asian genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf99_eas_XY,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for XY samples in the East Asian genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf99_eas,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for samples in the East Asian genetic ancestry group">
##INFO=<ID=faf99_nfe_XX,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for XX samples in the Non-Finnish European genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf99_nfe_XY,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for XY samples in the Non-Finnish European genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf99_nfe,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for samples in the Non-Finnish European genetic ancestry group">
##INFO=<ID=faf99_sas_XX,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for XX samples in the South Asian genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf99_sas_XY,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for XY samples in the South Asian genetic ancestry group in non-PAR regions of sex chromosomes only">
##INFO=<ID=faf99_sas,Number=A,Type=Float,Description="Filtering allele frequency (using Poisson 99% CI) for samples in the South Asian genetic ancestry group">
##INFO=<ID=fafmax_faf99_max,Number=A,Type=Float,Description="Maximum filtering allele frequency (using Poisson 99% CI) across genetic ancestry groups">
##INFO=<ID=fafmax_faf99_max_gen_anc,Number=A,Type=String,Description="Genetic ancestry group with maximum filtering allele frequency (using Poisson 99% CI)">
##INFO=<ID=age_hist_het_bin_freq,Number=A,Type=String,Description="Histogram of ages of heterozygous individuals; bin edges are: 30.0|35.0|40.0|45.0|50.0|55.0|60.0|65.0|70.0|75.0|80.0; total number of individuals of any genotype bin: 1332|1401|1642|2949|4283|3601|3282|2909|1955|1202">
##INFO=<ID=age_hist_het_n_smaller,Number=A,Type=Integer,Description="Count of age values falling below lowest histogram bin edge for heterozygous individuals">
##INFO=<ID=age_hist_het_n_larger,Number=A,Type=Integer,Description="Count of age values falling above highest histogram bin edge for heterozygous individuals">
##INFO=<ID=age_hist_hom_bin_freq,Number=A,Type=String,Description="Histogram of ages of homozygous alternate individuals; bin edges are: 30.0|35.0|40.0|45.0|50.0|55.0|60.0|65.0|70.0|75.0|80.0; total number of individuals of any genotype bin: 1332|1401|1642|2949|4283|3601|3282|2909|1955|1202">
##INFO=<ID=age_hist_hom_n_smaller,Number=A,Type=Integer,Description="Count of age values falling below lowest histogram bin edge for homozygous alternate individuals">
##INFO=<ID=age_hist_hom_n_larger,Number=A,Type=Integer,Description="Count of age values falling above highest histogram bin edge for homozygous alternate individuals">
##INFO=<ID=FS,Number=1,Type=Float,Description="Phred-scaled p-value of Fisher's exact test for strand bias">
##INFO=<ID=MQ,Number=1,Type=Float,Description="Root mean square of the mapping quality of reads across all samples">
##INFO=<ID=MQRankSum,Number=1,Type=Float,Description="Z-score from Wilcoxon rank sum test of alternate vs. reference read mapping qualities">
##INFO=<ID=QUALapprox,Number=1,Type=Integer,Description="Sum of PL[0] values; used to approximate the QUAL score">
##INFO=<ID=QD,Number=1,Type=Float,Description="Variant call confidence normalized by depth of sample reads supporting a variant">
##INFO=<ID=ReadPosRankSum,Number=1,Type=Float,Description="Z-score from Wilcoxon rank sum test of alternate vs. reference read position bias">
##INFO=<ID=SOR,Number=1,Type=Float,Description="Strand bias estimated by the symmetric odds ratio test">
##INFO=<ID=VarDP,Number=1,Type=Integer,Description="Depth over variant genotypes (does not include depth of reference samples)">
##INFO=<ID=monoallelic,Number=0,Type=Flag,Description="All samples are homozygous alternate for the variant">
##INFO=<ID=only_het,Number=0,Type=Flag,Description="All samples are heterozygous for the variant">
##INFO=<ID=transmitted_singleton,Number=0,Type=Flag,Description="Variant was a callset-wide doubleton that was transmitted within a family from a parent to a child (i.e., a singleton amongst unrelated samples in cohort)">
##INFO=<ID=AS_FS,Number=A,Type=Float,Description="Allele-specific phred-scaled p-value of Fisher's exact test for strand bias">
##INFO=<ID=AS_MQ,Number=A,Type=Float,Description="Allele-specific root mean square of the mapping quality of reads across all samples">
##INFO=<ID=AS_MQRankSum,Number=A,Type=Float,Description="Allele-specific z-score from Wilcoxon rank sum test of alternate vs. reference read mapping qualities">
##INFO=<ID=AS_pab_max,Number=A,Type=Float,Description="Maximum p-value over callset for binomial test of observed allele balance for a heterozygous genotype, given expectation of 0.5">
##INFO=<ID=AS_QUALapprox,Number=A,Type=Integer,Description="Allele-specific sum of PL[0] values; used to approximate the QUAL score">
##INFO=<ID=AS_QD,Number=A,Type=Float,Description="Allele-specific variant call confidence normalized by depth of sample reads supporting a variant">
##INFO=<ID=AS_ReadPosRankSum,Number=A,Type=Float,Description="Allele-specific z-score from Wilcoxon rank sum test of alternate vs. reference read position bias">
##INFO=<ID=AS_SB_TABLE,Number=.,Type=String,Description="Allele-specific forward/reverse read counts for strand bias tests">
##INFO=<ID=AS_SOR,Number=A,Type=Float,Description="Allele-specific strand bias estimated by the symmetric odds ratio test">
##INFO=<ID=AS_VarDP,Number=A,Type=Integer,Description="Allele-specific depth over variant genotypes (does not include depth of reference samples)">
##INFO=<ID=inbreeding_coeff,Number=A,Type=Float,Description="Inbreeding coefficient, the excess heterozygosity at a variant site, computed as 1 - (the number of heterozygous genotypes)/(the number of heterozygous genotypes expected under Hardy-Weinberg equilibrium)">
##INFO=<ID=AS_culprit,Number=A,Type=String,Description="Allele-specific worst-performing annotation in the VQSR Gaussian mixture model">
##INFO=<ID=AS_VQSLOD,Number=A,Type=Float,Description="Allele-specific log-odds ratio of being a true variant versus being a false positive under the trained VQSR Gaussian mixture model">
##INFO=<ID=negative_train_site,Number=0,Type=Flag,Description="Variant was used to build the negative training set of low-quality variants for VQSR">
##INFO=<ID=positive_train_site,Number=0,Type=Flag,Description="Variant was used to build the positive training set of high-quality variants for VQSR">
##INFO=<ID=allele_type,Number=1,Type=String,Description="Allele type (snv, insertion, deletion, or mixed)">
##INFO=<ID=n_alt_alleles,Number=1,Type=Integer,Description="Total number of alternate alleles observed at variant locus">
##INFO=<ID=variant_type,Number=1,Type=String,Description="Variant type (snv, indel, multi-snv, multi-indel, or mixed)">
##INFO=<ID=was_mixed,Number=0,Type=Flag,Description="Variant type was mixed">
##INFO=<ID=lcr,Number=0,Type=Flag,Description="Variant falls within a low complexity region">
##INFO=<ID=non_par,Number=0,Type=Flag,Description="Variant (on sex chromosome) falls outside a pseudoautosomal region">
##INFO=<ID=segdup,Number=0,Type=Flag,Description="Variant falls within a segmental duplication region">
##INFO=<ID=gq_hist_alt_bin_freq,Number=A,Type=String,Description="Histogram for GQ in heterozygous individuals calculated on high quality genotypes; bin edges are: 0|5|10|15|20|25|30|35|40|45|50|55|60|65|70|75|80|85|90|95|100">
##INFO=<ID=gq_hist_all_bin_freq,Number=A,Type=String,Description="Histogram for GQ calculated on high quality genotypes; bin edges are: 0|5|10|15|20|25|30|35|40|45|50|55|60|65|70|75|80|85|90|95|100">
##INFO=<ID=dp_hist_alt_bin_freq,Number=A,Type=String,Description="Histogram for DP in heterozygous individuals calculated on high quality genotypes; bin edges are: 0|5|10|15|20|25|30|35|40|45|50|55|60|65|70|75|80|85|90|95|100">
##INFO=<ID=dp_hist_alt_n_larger,Number=A,Type=Integer,Description="Count of DP values falling above highest histogram bin edge DP in heterozygous individuals calculated on high quality genotypes">
##INFO=<ID=dp_hist_all_bin_freq,Number=A,Type=String,Description="Histogram for DP calculated on high quality genotypes; bin edges are: 0|5|10|15|20|25|30|35|40|45|50|55|60|65|70|75|80|85|90|95|100">
##INFO=<ID=dp_hist_all_n_larger,Number=A,Type=Integer,Description="Count of DP values falling above highest histogram bin edge DP calculated on high quality genotypes">
##INFO=<ID=ab_hist_alt_bin_freq,Number=A,Type=String,Description="Histogram for AB in heterozygous individuals calculated on high quality genotypes; bin edges are: 0.00|0.05|0.10|0.15|0.20|0.25|0.30|0.35|0.40|0.45|0.50|0.55|0.60|0.65|0.70|0.75|0.80|0.85|0.90|0.95|1.00">
##INFO=<ID=cadd_raw_score,Number=1,Type=Float,Description="Raw CADD scores are interpretable as the extent to which the annotation profile for a given variant suggests that the variant is likely to be 'observed' (negative values) vs 'simulated' (positive values). Larger values are more deleterious.">
##INFO=<ID=cadd_phred,Number=1,Type=Float,Description="Cadd Phred-like scores ('scaled C-scores') ranging from 1 to 99, based on the rank of each variant relative to all possible 8.6 billion substitutions in the human reference genome. Larger values are more deleterious.">
##INFO=<ID=revel_max,Number=1,Type=Float,Description="The maximum REVEL score at a site's MANE Select or canonical transcript. It's an ensemble score for predicting the pathogenicity of missense variants (based on 13 other variant predictors). Scores ranges from 0 to 1. Variants with higher scores are predicted to be more likely to be deleterious.">
##INFO=<ID=spliceai_ds_max,Number=1,Type=Float,Description="Illumina's SpliceAI max delta score; interpreted as the probability of the variant being splice-altering.">
##INFO=<ID=pangolin_largest_ds,Number=1,Type=Float,Description="Pangolin's largest delta score across 2 splicing consequences, which reflects the probability of the variant being splice-altering">
##INFO=<ID=phylop,Number=1,Type=Float,Description="Base-wise conservation score across the 241 placental mammals in the Zoonomia project. Score ranges from -20 to 9.28, and reflects acceleration (faster evolution than expected under neutral drift, assigned negative scores) as well as conservation (slower than expected evolution, assigned positive scores).">
##INFO=<ID=sift_max,Number=1,Type=Float,Description="Score reflecting the scaled probability of the amino acid substitution being tolerated, ranging from 0 to 1. Scores below 0.05 are predicted to impact protein function. We prioritize max scores for MANE Select transcripts where possible and otherwise report a score for the canonical transcript.">
##INFO=<ID=polyphen_max,Number=1,Type=Float,Description="Score that predicts the possible impact of an amino acid substitution on the structure and function of a human protein, ranging from 0.0 (tolerated) to 1.0 (deleterious).  We prioritize max scores for MANE Select transcripts where possible and otherwise report a score for the canonical transcript.">
##INFO=<ID=VRS_Allele_IDs,Number=R,Type=String,Description="The computed identifiers for the GA4GH VRS Alleles corresponding to the values in the REF and ALT fields">
##INFO=<ID=VRS_Starts,Number=R,Type=Integer,Description="Interresidue coordinates used as the location starts for the GA4GH VRS Alleles corresponding to the values in the REF and ALT fields">
##INFO=<ID=VRS_Ends,Number=R,Type=Integer,Description="Interresidue coordinates used as the location ends for the GA4GH VRS Alleles corresponding to the values in the REF and ALT fields">
##INFO=<ID=VRS_States,Number=.,Type=String,Description="The literal sequence states used for the GA4GH VRS Alleles corresponding to the values in the REF and ALT fields">
##INFO=<ID=vep,Number=.,Type=String,Description="Consequence annotations from Ensembl VEP. Format: Allele|Consequence|IMPACT|SYMBOL|Gene|Feature_type|Feature|BIOTYPE|EXON|INTRON|HGVSc|HGVSp|cDNA_position|CDS_position|Protein_position|Amino_acids|Codons|ALLELE_NUM|DISTANCE|STRAND|FLAGS|VARIANT_CLASS|SYMBOL_SOURCE|HGNC_ID|CANONICAL|MANE_SELECT|MANE_PLUS_CLINICAL|TSL|APPRIS|CCDS|ENSP|UNIPROT_ISOFORM|SOURCE|DOMAINS|miRNA|HGVS_OFFSET|PUBMED|MOTIF_NAME|MOTIF_POS|HIGH_INF_POS|MOTIF_SCORE_CHANGE|TRANSCRIPTION_FACTORS|LoF|LoF_filter|LoF_flags|LoF_info">
##age_distribution=bin_edges=[30.0, 35.0, 40.0, 45.0, 50.0, 55.0, 60.0, 65.0, 70.0, 75.0, 80.0], bin_freq=[1332, 1401, 1642, 2949, 4283, 3601, 3282, 2909, 1955, 1202], n_smaller=3760, n_larger=438
##cadd_version=v1.6
##dbsnp_version=b156
##gencode_version=Release 39
##mane_select_version=v0.95
##pangolin_version=v1.3.12,v1.4.4
##phylop_version=v2
##polyphen_version=2.2.2
##revel_version=v1.3
##seqrepo_version=2018-11-26
##sift_version=5.2.2
##spliceai_version=v1.3
##vep_version=v105
##vrs_schema_version=1.3.0
##vrs_python_version=0.8.4
##contig=<ID=chr1,length=248956422,assembly=gnomAD_GRCh38>
##contig=<ID=chr2,length=242193529,assembly=gnomAD_GRCh38>
##contig=<ID=chr3,length=198295559,assembly=gnomAD_GRCh38>
##contig=<ID=chr4,length=190214555,assembly=gnomAD_GRCh38>
##contig=<ID=chr5,length=181538259,assembly=gnomAD_GRCh38>
##contig=<ID=chr6,length=170805979,assembly=gnomAD_GRCh38>
##contig=<ID=chr7,length=159345973,assembly=gnomAD_GRCh38>
##contig=<ID=chr8,length=145138636,assembly=gnomAD_GRCh38>
##contig=<ID=chr9,length=138394717,assembly=gnomAD_GRCh38>
##contig=<ID=chr10,length=133797422,assembly=gnomAD_GRCh38>
##contig=<ID=chr11,length=135086622,assembly=gnomAD_GRCh38>
##contig=<ID=chr12,length=133275309,assembly=gnomAD_GRCh38>
##contig=<ID=chr13,length=114364328,assembly=gnomAD_GRCh38>
##contig=<ID=chr14,length=107043718,assembly=gnomAD_GRCh38>
##contig=<ID=chr15,length=101991189,assembly=gnomAD_GRCh38>
##contig=<ID=chr16,length=90338345,assembly=gnomAD_GRCh38>
##contig=<ID=chr17,length=83257441,assembly=gnomAD_GRCh38>
##contig=<ID=chr18,length=80373285,assembly=gnomAD_GRCh38>
##contig=<ID=chr19,length=58617616,assembly=gnomAD_GRCh38>
##contig=<ID=chr20,length=64444167,assembly=gnomAD_GRCh38>
##contig=<ID=chr21,length=46709983,assembly=gnomAD_GRCh38>
##contig=<ID=chr22,length=50818468,assembly=gnomAD_GRCh38>
##contig=<ID=chrX,length=156040895,assembly=gnomAD_GRCh38>
##contig=<ID=chrY,length=57227415,assembly=gnomAD_GRCh38>
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
chr1	964594	rs7414551	G	A	.	PASS	AF=0.00000;DESCR=Allele A is not associated with trough concentration of vancomycin as compared to allele G.
chr1	2016961	rs13303344	C	A	.	PASS	AF=0.787032;DESCR=Allele A is not associated with response to methadone in people with Heroin Dependence as compared to allele C.
chr1	2016961	rs13303344	C	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to methadone in people with Heroin Dependence as compared to allele C.
chr1	2017366	rs4481796	T	A	.	AC0	AF=0.00000;DESCR=Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.
chr1	2017366	rs4481796	T	C	.	PASS	AF=0.905242;DESCR=Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.
chr1	2024923	rs2376805	G	A	.	PASS	AF=0.904090;DESCR=Allele A is not associated with response to methadone in people with Heroin Dependence as compared to allele G.
chr1	2025598	rs2229110	T	C	.	PASS	AF=0.711527;DESCR=Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.
chr1	3167148	rs2651899	T	C	.	PASS	AF=0.434908;DESCR=Allele C is associated with increased response to Selective serotonin (5HT1) agonists in people with Migraine with Aura or Migraine without Aura as compared to allele T.
chr1	3362704	rs11807862	T	A	.	PASS	AF=0.0576369;DESCR=Genotype AA is associated with decreased response to atorvastatin, hmg coa reductase inhibitors or simvastatin as compared to genotype TT.
chr1	7785635	rs228729	T	C	.	PASS	AF=0.622478;DESCR=Allele T is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.
chr1	7803233	rs228642	C	T	.	PASS	AF=0.642981;DESCR=Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.
chr1	7808665	rs228666	T	C	.	PASS	AF=0.330063;DESCR=Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.
chr1	7827519	rs228697	C	G	.	PASS	AF=0.141993;DESCR=Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.
chr1	7828155	rs2859388	A	G	.	PASS	AF=0.315638;DESCR=Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.
chr1	7830057	rs2640909	T	C	.	PASS	AF=0.298438;DESCR=Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.
chr1	11107089	rs12139042	G	A	.	PASS	AF=0.0541475;DESCR=Genotype GG is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AG.
chr1	11792243	rs1476413	C	T	.	PASS	AF=0.246105;DESCR=Genotypes CC + CT is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype TT.
chr1	11794419	rs1801131	T	G	.	PASS	AF=0.297001;DESCR=Genotypes GG + GT are associated with increased response to oxaliplatin in people with Colorectal Neoplasms as compared to genotype TT.
chr1	11796321	rs1801133	G	A	.	PASS	AF=0.460519;DESCR=Genotype AG is associated with increased response to l-methylfolate in men with Bipolar Disorder, Depression and Obsessive-Compulsive Disorder.
chr1	11797731	rs17421511	G	A	.	PASS	AF=0.208813;DESCR=Genotypes AG + GG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.
chr1	11846011	rs5065	A	G	.	PASS	AF=0.120392;DESCR=Genotype GG is associated with decreased response to bumetanide, furosemide and torasemide in healthy individuals as compared to genotype AA.
chr1	11847591	rs5063	C	T	.	PASS	AF=0.0204611;DESCR=Genotype TT is associated with decreased response to bumetanide, furosemide and torasemide in healthy individuals as compared to genotype CC.
chr1	12192898	rs1061622	T	G	.	PASS	AF=0.263857;DESCR=Genotypes GG + GT are associated with decreased response to adalimumab, etanercept, infliximab or ustekinumab in people with Psoriasis as compared to genotype TT.
chr1	12207208	rs1061624	A	G	.	PASS	AF=0.480692;DESCR=Genotype GG is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.
chr1	12207235	rs3397	C	T	.	PASS	AF=0.667435;DESCR=Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.
chr1	12208442	rs1061631	G	A	.	PASS	AF=0.225360;DESCR=Genotype AA is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.
chr1	15524108	rs4645983	G	A	.	PASS	AF=0.254037;DESCR=Genotypes AA + AG is associated with increased response to adalimumab in people with Crohn Disease as compared to genotype GG.
chr1	17307077	rs2477134	G	A	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased concentrations of uric acid in people with Hypertension as compared to allele T.
chr1	17307077	rs2100240509;rs2100240522;rs2100240544;rs2477134	G	T	.	PASS	AF=0.703576;DESCR=Allele G is associated with increased concentrations of uric acid in people with Hypertension as compared to allele T.
chr1	17336144	rs2240340	T	C	.	PASS	AF=0.617800;DESCR=Allele T is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.
chr1	19285983	rs2231198	C	T	.	PASS	AF=0.300346;DESCR=Genotype CC is not associated with metabolism of bupropion in healthy individuals as compared to genotypes CT + TT.
chr1	19287570	rs2013249	G	C	.	PASS	AF=0.299481;DESCR=Genotype CC is not associated with metabolism of bupropion in healthy individuals as compared to genotypes CG + GG.
chr1	19287570	rs2013249	G	T	.	PASS	AF=0.00000;DESCR=Genotype CC is not associated with metabolism of bupropion in healthy individuals as compared to genotypes CG + GG.
chr1	19308517	rs1043657	C	T	.	PASS	AF=0.137752;DESCR=Genotypes CT + TT are not associated with concentrations of exemestane in women with Breast Neoplasms as compared to genotype CC.
chr1	19666020	rs1805054	C	T	.	PASS	AF=0.164072;DESCR=Genotype CC is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.
chr1	20588679	rs532545	C	T	.	PASS	AF=0.410271;DESCR=Genotype CC is associated with decreased response to capecitabine in women with Breast Neoplasms as compared to genotypes CT + TT.
chr1	20589208	rs2072671	A	C	.	PASS	AF=0.435772;DESCR=Allele C is not associated with decreased metabolism of gemcitabine in people with Neoplasms as compared to allele A.
chr1	20605335	rs818194	A	T	.	PASS	AF=0.847262;DESCR=Allele A is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele T.
chr1	20616702	rs12404655	A	G	.	PASS	AF=0.248990;DESCR=Genotypes AG + GG is associated with increased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype AA.
chr1	20618562	rs1048977	C	T	.	PASS	AF=0.238905;DESCR=Genotype TT is associated with decreased metabolism of gemcitabine as compared to genotypes CC + CT.
chr1	20726200	rs10916852	G	A	.	PASS	AF=0.00000;DESCR=Genotypes GT + TT are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype GG.
chr1	20726200	rs10916852	G	T	.	PASS	AF=0.0538594;DESCR=Genotypes GT + TT are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype GG.
chr1	21549423	rs885814	C	T	.	PASS	AF=0.301729;DESCR=Allele T is associated with decreased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.
chr1	24601070	rs4553122	T	C	.	PASS	AF=0.572293;DESCR=Allele C is associated with increased response to rivaroxaban in people with Atrial Fibrillation as compared to allele T.
chr1	27530660	rs7512595	A	G	.	PASS	AF=0.0691244;DESCR=Allele A is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele G.
chr1	28810174	rs569356	A	G	.	PASS	AF=0.0810265;DESCR=Genotype GG is associated with decreased dose-adjusted trough concentrations of norbuprenorphine in people with Opioid-Related Disorders as compared to genotypes AA + AG.
chr1	28812463	rs1042114	G	T	.	PASS	AF=0.919839;DESCR=Allele G is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele T.
chr1	28814643	rs533123	G	A	.	PASS	AF=0.830836;DESCR=Allele G is not associated with dose of opioids in people with Pain as compared to allele A.
chr1	28818612	rs204047	G	C	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with increased dose of methadone as compared to genotypes GT + TT.
chr1	28818612	rs204047	G	T	.	PASS	AF=0.201729;DESCR=Genotype GG is associated with increased dose of methadone as compared to genotypes GT + TT.
chr1	28818676	rs678849	C	T	.	PASS	AF=0.537197;DESCR=Genotype TT is not associated with concentrations of methadone as compared to genotypes CC + CT.
chr1	28822849	rs6669447	T	C	.	PASS	AF=0.370317;DESCR=Allele C is not associated with response to heroin as compared to allele T.
chr1	28824671	rs797397	G	A	.	PASS	AF=0.543541;DESCR=Genotype AA is associated with increased concentrations of methadone as compared to genotypes AG + GG.
chr1	28835097	rs2236857	T	C	.	PASS	AF=0.300115;DESCR=Allele T is not associated with dose of opioids in people with Pain as compared to allele C.
chr1	28838070	rs10753331	G	A	.	PASS	AF=0.370958;DESCR=Allele A is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele G.
chr1	28839626	rs2298896	T	G	.	PASS	AF=0.370531;DESCR=Allele G is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele T.
chr1	28846112	rs482387	G	A	.	PASS	AF=0.459631;DESCR=Genotype AA is not associated with concentrations of methadone as compared to genotypes AG + GG.
chr1	28848434	rs529520	A	C	.	PASS	AF=0.551267;DESCR=Allele C is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.
chr1	28848434	rs529520	A	G	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.
chr1	28848861	rs581111	A	G	.	PASS	AF=0.796254;DESCR=Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.
chr1	28849701	rs12749204	A	G	.	PASS	AF=0.244816;DESCR=Genotype AA is not associated with dose of methadone as compared to genotypes AG + GG.
chr1	28852412	rs2298895	A	T	.	PASS	AF=0.0216014;DESCR=Genotype AA is not associated with concentrations of methadone as compared to genotypes AT + TT.
chr1	28855013	rs508448	A	G	.	PASS	AF=0.511547;DESCR=Genotype GG is not associated with concentrations of methadone as compared to genotypes AA + AG.
chr1	28863085	rs2234918	C	T	.	PASS	AF=0.474063;DESCR=Genotype CC is not associated with dose of methadone in people with Substance-Related Disorders as compared to genotypes CT + TT.
chr1	28863626	rs4654327	G	A	.	PASS	AF=0.440565;DESCR=Genotype AA is not associated with concentrations of methadone as compared to genotypes AG + GG.
chr1	28863878	rs204076	T	A	.	PASS	AF=0.632277;DESCR=Genotype AA is not associated with concentrations of methadone as compared to genotypes AT + TT.
chr1	32290838	rs1741981	T	C	.	PASS	AF=0.443707;DESCR=Genotype CC is associated with decreased response to corticosteroids in children with Asthma as compared to genotypes CT + TT.
chr1	33973693	rs506546	C	T	.	PASS	AF=0.421083;DESCR=Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.
chr1	36859876	rs6691840	A	C	.	PASS	AF=0.333237;DESCR=Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele A.
chr1	36859876	rs6691840	A	G	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele A.
chr1	40960192	rs12067645	G	A	.	PASS	AF=0.317003;DESCR=Genotypes AA + AG is associated with increased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype GG.
chr1	41003732	rs4364871	C	T	.	PASS	AF=0.142157;DESCR=Genotypes CT + TT is associated with decreased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype CC.
chr1	41011772	rs11577910	G	A	.	PASS	AF=0.0758362;DESCR=Genotype AG is associated with increased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype GG.
chr1	42692759	rs10493112	C	A	.	PASS	AF=0.508651;DESCR=Genotypes AC + CC is associated with increased clinical benefit to abiraterone in men with Prostatic Neoplasms as compared to genotype AA.
chr1	42692759	rs10493112	C	G	.	PASS	AF=0.00000;DESCR=Genotypes AC + CC is associated with increased clinical benefit to abiraterone in men with Prostatic Neoplasms as compared to genotype AA.
chr1	42692759	rs10493112	C	T	.	PASS	AF=0.00000;DESCR=Genotypes AC + CC is associated with increased clinical benefit to abiraterone in men with Prostatic Neoplasms as compared to genotype AA.
chr1	42805257	rs323719	G	A	.	PASS	AF=0.224366;DESCR=Allele A is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele G.
chr1	42805362	rs323720	T	C	.	PASS	AF=0.271050;DESCR=Allele C is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele T.
chr1	46932824	rs1126742	A	G	.	PASS	AF=0.128818;DESCR=Genotype GG is associated with decreased response to amiloride or spironolactone in people with Hypertension as compared to genotypes AA + AG.
chr1	46933071	rs3890011	G	C	.	PASS	AF=0.769896;DESCR=Genotype CC is associated with decreased response to spironolactone in people with Hypertension as compared to genotypes CG + GG.
chr1	46942278	rs9332978	T	C	.	PASS	AF=0.104899;DESCR=Genotype CT is not associated with concentrations of exemestane in women with Breast Neoplasms as compared to genotype TT.
chr1	47331951	rs3925058	G	A	.	PASS	AF=0.340739;DESCR=Genotype AA is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AG + GG.
chr1	47333967	rs7543016	G	C	.	PASS	AF=0.348002;DESCR=Genotype CC is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CG + GG.
chr1	47333967	rs7543016	G	T	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CG + GG.
chr1	47335173	rs4492666	A	C	.	PASS	AF=0.340346;DESCR=Allele A is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele C.
chr1	47367541	rs11211524	A	C	.	PASS	AF=0.115495;DESCR=Allele A is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele C.
chr1	47368537	rs35687416	G	T	.	PASS	AF=0.0164265;DESCR=Genotype GG is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes GT + TT.
chr1	47375885	rs12090346	C	T	.	PASS	AF=0.0187212;DESCR=Genotype CC is not associated with response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CT + TT.
chr1	47377105	rs1044457	C	A	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.
chr1	47377105	rs1044457	C	T	.	PASS	AF=0.638617;DESCR=Genotype CC is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.
chr1	48608973	rs191190	C	G	.	PASS	AF=0.00000;DESCR=Genotypes CC + CT is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotype TT.
chr1	48608973	rs191190	C	T	.	PASS	AF=0.574971;DESCR=Genotypes CC + CT is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotype TT.
chr1	53909897	rs2235544	C	A	.	PASS	AF=0.406809;DESCR=Allele A is not associated with dose of levothyroxine in people with Thyroid Neoplasms as compared to allele C.
chr1	53909897	rs2235544	C	G	.	PASS	AF=0.00000;DESCR=Allele A is not associated with dose of levothyroxine in people with Thyroid Neoplasms as compared to allele C.
chr1	53910028	rs11206244	C	T	.	PASS	AF=0.349856;DESCR=Allele T is not associated with dose of levothyroxine in people with Thyroid Neoplasms as compared to allele C.
chr1	55053079	rs7552841	C	T	.	PASS	AF=0.388985;DESCR=Genotypes CT + TT is not associated with response to atorvastatin in people with Hypercholesterolemia as compared to genotype CC.
chr1	55081023	rs17111584	T	C	.	PASS	AF=0.0348502;DESCR=Genotypes CC + CT are associated with decreased response to rosuvastatin as compared to genotype TT.
chr1	56417819	rs12749274	G	A	.	PASS	AF=0.0544355;DESCR=Allele A is associated with decreased response to naltrexone in people with Alcoholism as compared to allele G.
chr1	56417819	rs12749274	G	C	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased response to naltrexone in people with Alcoholism as compared to allele G.
chr1	59926822	rs890293	C	A	.	PASS	AF=0.0544355;DESCR=Genotypes AA + AC is associated with increased concentrations of trans 4-hydroxypraziquantel in children with Schistosomiasis as compared to genotype CC.
chr1	63659768	rs4643	A	C	.	PASS	AF=0.148991;DESCR=Genotype CC is associated with decreased concentrations of ethanol in healthy individuals as compared to genotypes AA + AC.
chr1	65104345	rs12729349	G	A	.	PASS	AF=0.0991926;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr1	65432298	rs1045895	G	A	.	PASS	AF=0.396770;DESCR=Genotypes AA + AG is associated with decreased clinical benefit to apremilast in people with Psoriasis as compared to genotype GG.
chr1	65432298	rs1045895	G	T	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG is associated with decreased clinical benefit to apremilast in people with Psoriasis as compared to genotype GG.
chr1	65592830	rs1137101	A	G	.	PASS	AF=0.418880;DESCR=Allele G is not associated with exposure to olanzapine in healthy individuals as compared to allele A.
chr1	65772696	rs12046844	G	A	.	PASS	AF=0.118869;DESCR=Allele A is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele G.
chr1	66121693	rs12745871	C	T	.	PASS	AF=0.392281;DESCR=Allele T is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele C.
chr1	66353940	rs598961	G	A	.	PASS	AF=0.474640;DESCR=Genotype AA is associated with decreased clinical benefit to ritodrine in women with Premature Birth as compared to genotypes AG + GG.
chr1	67240275	rs11209026	G	A	.	PASS	AF=0.0711406;DESCR=Genotype AG is not associated with response to adalimumab in people with Psoriasis as compared to genotype GG.
chr1	70410096	rs648743	C	T	.	PASS	AF=0.546686;DESCR=Genotype TT is not associated with clearance of busulfan in children with Hematopoietic stem cell transplantation as compared to genotypes CC + CT.
chr1	70439117	rs1021737	G	T	.	PASS	AF=0.274119;DESCR=Genotype TT is not associated with clearance of busulfan in children with Hematopoietic stem cell transplantation as compared to genotypes GG + GT.
chr1	74572544	rs11580409	A	C	.	PASS	AF=0.355453;DESCR=Allele C is associated with increased response to antidepressants as compared to allele A.
chr1	74591902	rs696692	T	A	.	AC0	AF=0.00000;DESCR=Allele T is associated with decreased concentrations of serotonin in people with Depressive Disorder as compared to allele C.
chr1	74591902	rs696692	T	C	.	PASS	AF=0.660426;DESCR=Allele T is associated with decreased concentrations of serotonin in people with Depressive Disorder as compared to allele C.
chr1	78490747	rs3753380	T	C	.	PASS	AF=0.709101;DESCR=Genotype CC is associated with increased response to latanoprost as compared to genotypes CT + TT.
chr1	78491756	rs3766355	C	A	.	PASS	AF=0.132488;DESCR=Genotype CC is associated with increased response to latanoprost in people with Glaucoma or Ocular Hypertension as compared to genotypes AA + AC.
chr1	78491756	rs3766355	C	T	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to latanoprost in people with Glaucoma or Ocular Hypertension as compared to genotypes AA + AC.
chr1	88090245	rs4278350	C	T	.	PASS	AF=0.818732;DESCR=Allele T is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele C.
chr1	89384015	rs928655	G	A	.	PASS	AF=0.838710;DESCR=Genotypes AG + GG is associated with increased response to etanercept in people with Psoriasis as compared to genotype AA.
chr1	89384015	rs928655	G	C	.	PASS	AF=0.00000;DESCR=Genotypes AG + GG is associated with increased response to etanercept in people with Psoriasis as compared to genotype AA.
chr1	90506613	rs815147	T	A	.	PASS	AF=0.380787;DESCR=Allele A is not associated with exposure to olanzapine in healthy individuals as compared to allele T.
chr1	91689780	rs12082710	T	A	.	AC0	AF=0.00000;DESCR=Genotype TT is associated with increased response to antidepressants in people with Depression as compared to genotypes CC + CT.
chr1	91689780	rs12082710	T	C	.	PASS	AF=0.321114;DESCR=Genotype TT is associated with increased response to antidepressants in people with Depression as compared to genotypes CC + CT.
chr1	94536311	rs3917643	T	C	.	PASS	AF=0.0230415;DESCR=Genotype CT is associated with increased response to simvastatin in people with Myocardial Ischemia as compared to genotype TT.
chr1	94892671	rs3818929	G	A	.	PASS	AF=0.124424;DESCR=Allele A is not associated with response to risperidone in people with Schizophrenia as compared to allele G.
chr1	96571527	rs10783050	T	C	.	PASS	AF=0.338134;DESCR=Genotype TT is associated with increased response to metformin in people with Diabetes Mellitus as compared to genotypes CC + CT.
chr1	97078702	rs56160474	A	G	.	PASS	AF=0.116427;DESCR=Genotype AG is not associated with response to capecitabine, fluorouracil or s 1 (combination) in people with Stomach Neoplasms as compared to genotype AA.
chr1	97305364	rs1801160	C	T	.	PASS	AF=0.106813;DESCR=Genotype CT is not associated with response to capecitabine, fluorouracil or s 1 (combination) in people with Stomach Neoplasms as compared to genotype CC.
chr1	97450068	rs17376848	A	G	.	PASS	AF=0.0129608;DESCR=Genotypes AG + GG is associated with increased concentrations of fluorouracil in people with Colorectal Neoplasms as compared to genotype AA.
chr1	97515839	rs1801159	T	C	.	PASS	AF=0.194284;DESCR=Allele C is not associated with metabolism of capecitabine in people with Breast Neoplasms as compared to allele T.
chr1	97699535	rs2297595	T	C	.	PASS	AF=0.0841984;DESCR=Genotype CT is not associated with response to capecitabine, fluorouracil or s 1 (combination) in people with Stomach Neoplasms as compared to genotype TT.
chr1	105853440	rs61816456	G	A	.	PASS	AF=0.305716;DESCR=Allele A is associated with increased response to allopurinol as compared to allele G.
chr1	109275684	rs629301	G	T	.	PASS	AF=0.829971;DESCR=Allele T is associated with decreased response to hmg coa reductase inhibitors in people with Cardiovascular Diseases and Hypercholesterolemia as compared to allele G.
chr1	109275908	rs646776	C	T	.	PASS	AF=0.830161;DESCR=Allele C is associated with increased response to hmg coa reductase inhibitors as compared to allele T.
chr1	109737079	rs7483	C	T	.	PASS	AF=0.268433;DESCR=Genotype TT is associated with decreased concentrations of tacrolimus in people with Liver transplantation as compared to genotypes CC + CT.
chr1	109825608	rs521093	C	T	.	PASS	AF=0.158698;DESCR=Allele T is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele C.
chr1	111499509	rs3394	T	C	.	PASS	AF=0.850720;DESCR=Allele C is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.
chr1	111499527	rs3393	C	T	.	PASS	AF=0.576125;DESCR=Allele C is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.
chr1	111500165	rs35511654	T	G	.	PASS	AF=0.148906;DESCR=Allele G is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.
chr1	111503935	rs1544223	C	T	.	PASS	AF=0.820173;DESCR=Allele C is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.
chr1	111505642	rs2298191	T	C	.	PASS	AF=0.348502;DESCR=Allele C is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.
chr1	112624914	rs12076902	G	A	.	PASS	AF=0.0135447;DESCR=Allele A is not associated with response to atenolol in people with Hypertension as compared to allele G.
chr1	112671791	rs12069113	C	T	.	PASS	AF=0.0245098;DESCR=Allele C is not associated with response to atenolol in people with Hypertension as compared to allele T.
chr1	112673921	rs2932538	A	G	.	PASS	AF=0.785591;DESCR=Allele A is not associated with response to atenolol in people with Hypertension as compared to allele G.
chr1	112912477	rs7169	G	A	.	PASS	AF=0.634815;DESCR=Genotype GG is associated with increased clinical benefit to valproic acid in children with Epilepsy as compared to genotypes AA + AG.
chr1	113834946	rs2476601	A	G	.	PASS	AF=0.944124;DESCR=Allele A is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr1	114693436	rs17602729	G	A	.	PASS	AF=0.0720877;DESCR=Genotypes AA + AG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.
chr1	115134562	rs2078371	T	C	.	PASS	AF=0.0956772;DESCR=Allele C is not associated with response to Selective serotonin (5HT1) agonists in people with Migraine without Aura as compared to allele T.
chr1	115295088	rs2239622	A	G	.	PASS	AF=0.641993;DESCR=Genotype AA is not associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes AG + GG.
chr1	116545157	rs12044852	C	A	.	PASS	AF=0.0741061;DESCR=Genotype CC is associated with decreased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to genotypes AA + AC.
chr1	116720516	rs11586238	C	G	.	PASS	AF=0.164937;DESCR=Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr1	119514623	rs1047303	C	A	.	PASS	AF=0.670415;DESCR=Genotypes AA + AC are associated with increased resistance to glucocorticoids in people with Asthma as compared to genotype CC.
chr1	119534961	rs7553527	T	C	.	PASS	AF=0.346110;DESCR=Genotypes CC + CT is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype TT.
chr1	119594822	rs10494227	A	G	.	PASS	AF=0.114187;DESCR=Allele A is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele G.
chr1	145709377	rs12129861	C	T	.	PASS	AF=0.355741;DESCR=Allele C is associated with increased dose of allopurinol in people with Gout as compared to allele T.
chr1	147209857	rs7541245	C	A	.	PASS	AF=0.0268012;DESCR=Allele A is associated with decreased response to metformin in people with Diabetes Mellitus as compared to allele C.
chr1	152924258	rs6661932	T	A	.	PASS	AF=0.00000;DESCR=Genotypes CT + TT is associated with decreased response to adalimumab or infliximab in people with Psoriasis as compared to genotype CC.
chr1	152924258	rs6661932	T	C	.	PASS	AF=0.515562;DESCR=Genotypes CT + TT is associated with decreased response to adalimumab or infliximab in people with Psoriasis as compared to genotype CC.
chr1	152924258	rs6661932	T	G	.	PASS	AF=0.00000;DESCR=Genotypes CT + TT is associated with decreased response to adalimumab or infliximab in people with Psoriasis as compared to genotype CC.
chr1	153348279	rs2916205	C	T	.	PASS	AF=0.804385;DESCR=Genotypes CC + CT are associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype TT.
chr1	153947810	rs8450	G	A	.	PASS	AF=0.299424;DESCR=Genotypes AA + AG are associated with increased concentrations of glucose in people with Transplantation as compared to genotype GG.
chr1	153956889	rs12117078	G	A	.	PASS	AF=0.00000;DESCR=Genotype GG is not associated with concentrations of glucose in people with Transplantation as compared to genotypes CC + CG.
chr1	153956889	rs12117078	G	C	.	PASS	AF=0.129107;DESCR=Genotype GG is not associated with concentrations of glucose in people with Transplantation as compared to genotypes CC + CG.
chr1	154408627	rs12083537	A	G	.	PASS	AF=0.139065;DESCR=Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.
chr1	154419406	rs35717427	G	A	.	PASS	AF=0.129320;DESCR=Genotypes AG + GG is associated with decreased clinical benefit to tocilizumab in people with Rheumatoid arthritis as compared to genotype AA.
chr1	154449591	rs4845625	T	C	.	PASS	AF=0.603458;DESCR=Genotypes CT + TT is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotype CC.
chr1	154454494	rs2228145	A	C	.	PASS	AF=0.411425;DESCR=Allele A is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.
chr1	154457616	rs11265618	C	T	.	PASS	AF=0.192108;DESCR=Genotype CC is associated with increased response to sarilumab in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.
chr1	154459944	rs4329505	T	C	.	PASS	AF=0.185591;DESCR=Genotype TT is associated with increased response to sarilumab in people with Arthritis, Rheumatoid as compared to genotypes CC + CT.
chr1	154460401	rs6690230	C	G	.	PASS	AF=0.598152;DESCR=Genotypes CG + GG is associated with decreased clinical benefit to tocilizumab in people with Rheumatoid arthritis as compared to genotype CC.
chr1	154470484	rs11265621	G	A	.	PASS	AF=0.634217;DESCR=Genotypes AA + AG is associated with decreased clinical benefit to tocilizumab in people with Rheumatoid arthritis as compared to genotype GG.
chr1	154565729	rs4845652	C	T	.	PASS	AF=0.134083;DESCR=Allele T is not associated with response to nicotine in women as compared to allele C.
chr1	154567749	rs2072658	G	A	.	PASS	AF=0.000576369;DESCR=Genotype AG is associated with increased response to nicotine in people with daily smoking as compared to genotype GG.
chr1	154574816	rs12072348	A	C	.	PASS	AF=0.164553;DESCR=Allele C is not associated with response to nicotine in women as compared to allele A.
chr1	154576245	rs2072660	T	C	.	PASS	AF=0.806452;DESCR=Genotypes CT + TT are not associated with response to varenicline in people with Tobacco Use Disorder as compared to genotype CC.
chr1	154576245	rs2072660	T	G	.	PASS	AF=0.00000;DESCR=Genotypes CT + TT are not associated with response to varenicline in people with Tobacco Use Disorder as compared to genotype CC.
chr1	154576404	rs2072661	G	A	.	PASS	AF=0.193260;DESCR=Genotypes AA + AG are not associated with response to varenicline in people with Tobacco Use Disorder as compared to genotype GG.
chr1	155309691	rs2297480	T	A	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with decreased response to Bisphosphonates in people with Osteoporosis, Postmenopausal as compared to genotypes GT + TT.
chr1	155309691	rs2297480	T	G	.	PASS	AF=0.219308;DESCR=Genotype GG is associated with decreased response to Bisphosphonates in people with Osteoporosis, Postmenopausal as compared to genotypes GT + TT.
chr1	155313038	rs11264359	A	G	.	PASS	AF=0.225937;DESCR=Allele A is associated with increased response to Bisphosphonates in people with Osteoporosis as compared to allele G.
chr1	156321809	rs12138564	G	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to bevacizumab and ranibizumab in people with Macular Degeneration as compared to allele G.
chr1	156321809	rs12138564	G	T	.	PASS	AF=0.313256;DESCR=Allele T is associated with increased response to bevacizumab and ranibizumab in people with Macular Degeneration as compared to allele G.
chr1	156464911	rs1050316	G	T	.	PASS	AF=0.660714;DESCR=Allele T is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.
chr1	156882671	rs2768759	A	C	.	PASS	AF=0.756484;DESCR=Genotypes AC + CC are associated with decreased response to aspirin or prasugrel as compared to genotype AA.
chr1	156882671	rs2768759	A	G	.	PASS	AF=0.00000;DESCR=Genotypes AC + CC are associated with decreased response to aspirin or prasugrel as compared to genotype AA.
chr1	156899255	rs12566888	G	T	.	PASS	AF=0.118664;DESCR=Genotype TT is associated with increased response to ticagrelor in healthy individuals as compared to genotype GT.
chr1	156899922	rs12041331	G	A	.	PASS	AF=0.120242;DESCR=Genotypes AA + AG are associated with increased response to aspirin, clopidogrel or prasugrel as compared to genotype GG.
chr1	156908005	rs77235035	C	A	.	PASS	AF=0.121520;DESCR=Genotype AA is associated with decreased concentrations of ticagrelor in healthy individuals as compared to genotypes AC + CC.
chr1	156908005	rs77235035	C	T	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with decreased concentrations of ticagrelor in healthy individuals as compared to genotypes AC + CC.
chr1	156915699	rs4661012	T	G	.	PASS	AF=0.382200;DESCR=Genotypes GT + TT is associated with decreased response to ticagrelor in healthy individuals as compared to genotype GG.
chr1	158658837	rs2106089	A	G	.	PASS	AF=0.0173010;DESCR=Allele G is associated with response to benazepril in men with Hypertension as compared to allele A.
chr1	159282212	rs10908703	G	A	.	PASS	AF=0.148095;DESCR=Allele A is not associated with response to desloratadine and mizolastine in people with Urticaria as compared to allele G.
chr1	159283882	rs2494262	C	A	.	PASS	AF=0.428777;DESCR=Allele A is not associated with response to desloratadine and mizolastine in people with Urticaria as compared to allele C.
chr1	159283882	rs2494262	C	G	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to desloratadine and mizolastine in people with Urticaria as compared to allele C.
chr1	159304153	rs2298805	G	A	.	PASS	AF=0.00345622;DESCR=Genotype AA is associated with increased response to desloratadine and mizolastine in people with Urticaria as compared to genotypes AG + GG.
chr1	159712443	rs1205	C	T	.	PASS	AF=0.360727;DESCR=Genotype CC is not associated with response to fenofibrate in people with Metabolic Syndrome as compared to genotypes CT + TT.
chr1	159713301	rs1130864	G	A	.	PASS	AF=0.306052;DESCR=Genotypes AG + GG are associated with increased response to adalimumab in people with Inflammatory Bowel Diseases as compared to genotype AA.
chr1	159714396	rs1417938	T	A	.	PASS	AF=0.306265;DESCR=Genotype TT is associated with increased response to fenofibrate in people with Metabolic Syndrome as compared to genotypes AA + AT.
chr1	159714875	rs3091244	G	A	.	PASS	AF=0.305187;DESCR=Genotypes AG + GG are associated with increased response to fenofibrate in people with Metabolic Syndrome as compared to genotypes AA + AT.
chr1	159714875	rs3091244	G	T	.	PASS	AF=0.116935;DESCR=Genotypes AG + GG are associated with increased response to fenofibrate in people with Metabolic Syndrome as compared to genotypes AA + AT.
chr1	159715346	rs3093059	A	G	.	PASS	AF=0.117138;DESCR=Genotype AA is not associated with response to fenofibrate in people with Metabolic Syndrome as compared to genotypes AG + GG.
chr1	160030645	rs12409352	A	T	.	PASS	AF=0.141417;DESCR=Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr1	160108064	rs6688363	C	T	.	PASS	AF=0.181452;DESCR=Allele T is associated with decreased response to olanzapine in people with Schizophrenia as compared to allele C.
chr1	160546518	rs6427528	A	G	.	PASS	AF=0.868664;DESCR=Genotypes AA + AG are associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype GG.
chr1	161081736	rs11265549	A	G	.	PASS	AF=0.952738;DESCR=Genotype AA is associated with decreased concentrations of methadone in people with Opioid-Related Disorders as compared to genotypes AG + GG.
chr1	161230796	rs2307418	T	G	.	PASS	AF=0.200576;DESCR=Allele G is not associated with concentrations of tacrolimus in people with Kidney Transplantation as compared to allele T.
chr1	161232815	rs2307424	G	A	.	PASS	AF=0.318836;DESCR=Genotypes AA + AG is associated with increased response to efavirenz or nevirapine in people with HIV Infections as compared to genotype GG.
chr1	161233437	rs2502815	G	A	.	PASS	AF=0.260369;DESCR=Genotype AA is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype GG.
chr1	161234427	rs3003596	A	G	.	PASS	AF=0.373900;DESCR=Genotypes AG + GG is associated with decreased response to efavirenz or nevirapine in people with HIV Infections as compared to genotype AA.
chr1	161234748	rs2501873	C	T	.	PASS	AF=0.376369;DESCR=Genotype TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CC + CT.
chr1	161242663	rs11584174	C	T	.	PASS	AF=0.101094;DESCR=Allele C is not associated with metabolism of tacrolimus in people with liver transplantation as compared to allele T.
chr1	161242779	rs2501870	G	A	.	PASS	AF=0.274510;DESCR=Allele A is not associated with metabolism of tacrolimus in people with liver transplantation as compared to allele G.
chr1	161242953	rs55802895	C	T	.	PASS	AF=0.101153;DESCR=Allele C is not associated with metabolism of tacrolimus in people with liver transplantation as compared to allele T.
chr1	161243273	rs11265572	G	T	.	PASS	AF=0.00000;DESCR=Genotypes GT + TT are associated with decreased metabolism of tacrolimus in people with liver transplantation as compared to genotype GG.
chr1	161308887	rs12065184	A	C	.	PASS	AF=0.104035;DESCR=Allele C is not associated with dose of warfarin in people with heart valve replacement as compared to allele A.
chr1	161509955	rs1801274	A	G	.	PASS	AF=0.421947;DESCR=Genotypes AG + GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Psoriatic, Crohn Disease, Psoriasis and Spondylitis, Ankylosing as compared to genotype AA.
chr1	161674008	rs1050501	T	C	.	PASS	AF=0.134234;DESCR=Genotypes CC + CT is associated with increased response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype TT.
chr1	162115895	rs10494366	G	T	.	PASS	AF=0.580450;DESCR=Allele T is associated with increased response to repaglinide in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr1	163063052	rs10917670	C	T	.	PASS	AF=0.394114;DESCR=Genotype TT is associated with increased response to risperidone in people with Schizophrenia as compared to genotype CC.
chr1	163063552	rs951436	A	C	.	PASS	AF=0.458742;DESCR=Allele C is not associated with response to antipsychotics in people with Schizophrenia as compared to allele A.
chr1	163063901	rs951439	C	G	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with increased response to quetiapine and ziprasidone in people with Schizophrenia as compared to genotype CC.
chr1	163063901	rs951439	C	T	.	PASS	AF=0.394342;DESCR=Genotype TT is associated with increased response to quetiapine and ziprasidone in people with Schizophrenia as compared to genotype CC.
chr1	163069987	rs2661319	T	C	.	PASS	AF=0.472334;DESCR=Allele C is associated with decreased response to risperidone in people with Schizophrenia as compared to allele T.
chr1	163070705	rs2842030	G	A	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with increased response to olanzapine and perphenazine in people with Schizophrenia as compared to genotypes GG + GT.
chr1	163070705	rs2842030	G	T	.	PASS	AF=0.583285;DESCR=Genotype TT is associated with increased response to olanzapine and perphenazine in people with Schizophrenia as compared to genotypes GG + GT.
chr1	163143470	rs1056515	G	C	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with increased response to bevacizumab, fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to genotypes GG + GT.
chr1	163143470	rs1056515	G	T	.	PASS	AF=0.384438;DESCR=Genotype TT is associated with increased response to bevacizumab, fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to genotypes GG + GT.
chr1	163166201	rs11580141	G	A	.	PASS	AF=0.385014;DESCR=Allele A is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele G.
chr1	163166201	rs11580141	G	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele G.
chr1	165372612	rs12081765	A	G	.	PASS	AF=0.536888;DESCR=Allele G is associated with increased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele A.
chr1	165422714	rs3767344	G	C	.	PASS	AF=0.477247;DESCR=Allele G is not associated with metabolism of irinotecan in people with Colorectal Neoplasms as compared to allele C.
chr1	165422714	rs3767344	G	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with metabolism of irinotecan in people with Colorectal Neoplasms as compared to allele C.
chr1	168681897	rs4437856	A	C	.	PASS	AF=0.351297;DESCR=Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr1	168683252	rs2419128	C	T	.	PASS	AF=0.351905;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr1	168689001	rs12094644	T	A	.	PASS	AF=0.351499;DESCR=Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr1	169567201	rs7542281	C	T	.	PASS	AF=0.264401;DESCR=Allele C is not associated with dose of warfarin in people with heart valve replacement as compared to allele T.
chr1	169731361	rs3917412	T	C	.	PASS	AF=0.805764;DESCR=Genotype CC is associated with decreased response to capecitabine, fluorouracil, leucovorin and oxaliplatin in people with Colonic Neoplasms as compared to allele T.
chr1	171076659	rs1920145	T	C	.	PASS	AF=0.322664;DESCR=Allele C is not associated with response to metformin in people with Diabetes Mellitus as compared to allele T.
chr1	171107794	rs1800822	C	T	.	PASS	AF=0.0813149;DESCR=Genotype CC is associated with increased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes CT + TT.
chr1	171107825	rs2266782	G	A	.	PASS	AF=0.314228;DESCR=Genotypes AG + GG is associated with decreased clearance of teneligliptin in men as compared to genotype AA.
chr1	171114034	rs909530	C	T	.	PASS	AF=0.192330;DESCR=Genotypes CT + TT is associated with decreased clearance of teneligliptin in men as compared to genotype CC.
chr1	171114102	rs2266780	A	G	.	PASS	AF=0.117291;DESCR=Genotypes AG + GG is associated with decreased clearance of teneligliptin in men as compared to genotype AA.
chr1	171182499	rs12752688	C	T	.	PASS	AF=0.0616359;DESCR=Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.
chr1	171210148	rs7512785	C	T	.	PASS	AF=0.339193;DESCR=Allele T is associated with increased response to glibenclamide in people with as compared to allele C.
chr1	171210338	rs7515157	C	T	.	PASS	AF=0.339677;DESCR=Allele T is associated with increased response to glibenclamide in people with as compared to allele C.
chr1	171266603	rs13376631	A	G	.	PASS	AF=0.132488;DESCR=Allele G is not associated with response to metformin in people with Diabetes Mellitus as compared to allele A.
chr1	171322878	rs2076322	A	G	.	PASS	AF=0.129107;DESCR=Allele G is not associated with response to metformin in people with Diabetes Mellitus as compared to allele A.
chr1	172630738	rs2213712	G	C	.	PASS	AF=0.726225;DESCR=Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr1	172644101	rs2859228	A	G	.	PASS	AF=0.477810;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr1	172645877	rs2859229	C	T	.	PASS	AF=0.396134;DESCR=Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.
chr1	172646255	rs1492899	C	T	.	PASS	AF=0.400058;DESCR=Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.
chr1	172658358	rs763110	C	T	.	PASS	AF=0.466840;DESCR=Genotypes CC + CT is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.
chr1	172662917	rs929087	A	G	.	PASS	AF=0.679539;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr1	172664835	rs10458360	G	C	.	PASS	AF=0.587132;DESCR=Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr1	176726343	rs77977790	T	C	.	PASS	AF=0.0311060;DESCR=Genotype CT is associated with increased response to salbutamol in children with Asthma as compared to genotype TT.
chr1	178597251	rs6700741	C	T	.	PASS	AF=0.148383;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr1	181490624	rs12060765	G	A	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype GG.
chr1	181490624	rs12060765	G	T	.	PASS	AF=0.0137106;DESCR=Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype GG.
chr1	181797301	rs3845446	T	C	.	PASS	AF=0.0591119;DESCR=Genotype TT is not associated with dose of fentanyl in people with Pain, Postoperative as compared to genotypes CC + CT.
chr1	186674636	rs5273	A	G	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to celecoxib in healthy individuals as compared to allele A.
chr1	186681189	rs20417	C	G	.	PASS	AF=0.233987;DESCR=Genotypes CG + GG are not associated with response to ibuprofen in people with Pain, Postoperative as compared to genotype CC.
chr1	186681619	rs689466	T	C	.	PASS	AF=0.149452;DESCR=Genotype CC is associated with increased response to celecoxib in healthy individuals as compared to genotypes CT + TT.
chr1	189871947	rs950569	G	T	.	PASS	AF=0.0904899;DESCR=Allele T is associated with increased concentrations of uric acid in people with Hypertension as compared to allele G.
chr1	196651787	rs3753394	C	T	.	PASS	AF=0.308314;DESCR=Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.
chr1	196673103	rs800292	G	A	.	PASS	AF=0.270208;DESCR=Genotype GG is associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype AA.
chr1	196677046	rs1329424	T	G	.	PASS	AF=0.662147;DESCR=Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.
chr1	196690107	rs1061170	C	T	.	PASS	AF=0.661383;DESCR=Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.
chr1	196691131	rs10801555	A	G	.	PASS	AF=0.661383;DESCR=Genotype AA is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype GG.
chr1	196691131	rs10801555	A	T	.	AC0	AF=0.00000;DESCR=Genotype AA is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype GG.
chr1	196710325	rs10737680	A	C	.	PASS	AF=0.521940;DESCR=Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele C.
chr1	196710325	rs10737680	A	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele C.
chr1	196727803	rs1410996	G	A	.	PASS	AF=0.521889;DESCR=Genotype GG is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype AA.
chr1	196733680	rs1329428	C	T	.	PASS	AF=0.521363;DESCR=Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.
chr1	198731313	rs10919563	G	A	.	PASS	AF=0.105020;DESCR=Allele A is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr1	203139380	rs10920573	T	C	.	PASS	AF=0.599424;DESCR=Genotype CC is associated with decreased clinical benefit to caffeine in infants with Apnea of prematurity as compared to genotypes CT + TT.
chr1	203166324	rs16851030	C	T	.	PASS	AF=0.0207373;DESCR=Genotype CC is associated with increased response to caffeine in infants with apnea of prematurity as compared to genotypes CT + TT.
chr1	204547449	rs1563828	A	G	.	PASS	AF=0.603408;DESCR=Genotype AA is associated with increased response to docetaxel and epirubicin in women with Breast Neoplasms as compared to genotypes AG + GG.
chr1	204547449	rs1563828	A	T	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with increased response to docetaxel and epirubicin in women with Breast Neoplasms as compared to genotypes AG + GG.
chr1	205911051	rs74546197	G	A	.	PASS	AF=0.0293948;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr1	205927107	rs11240594	G	A	.	PASS	AF=0.214574;DESCR=Allele A is associated with increased response to olanzapine in people with Schizophrenia as compared to allele G.
chr1	205930467	rs7512462	T	C	.	PASS	AF=0.398041;DESCR=Genotypes CC + CT is associated with increased response to ivacaftor in children with Cystic Fibrosis as compared to genotype TT.
chr1	206768184	rs3024498	T	C	.	PASS	AF=0.186851;DESCR=Genotypes CC + CT is associated with decreased clinical benefit to budesonide, fluticasone/salmeterol, formoterol or omalizumab in children with Asthma as compared to genotype TT.
chr1	206773062	rs1800872	T	G	.	PASS	AF=0.748991;DESCR=Genotype TT is associated with decreased dose of tacrolimus in people with liver transplantation as compared to genotypes GG + GT.
chr1	206773289	rs1800871	A	G	.	PASS	AF=0.749568;DESCR=Allele A is not associated with decreased dose of tacrolimus in people with Kidney Transplantation as compared to allele G.
chr1	206773552	rs1800896	T	C	.	PASS	AF=0.408434;DESCR=Genotype CC is associated with decreased dose of tacrolimus in people with Kidney Transplantation as compared to genotypes CT + TT.
chr1	207580276	rs2274567	A	G	.	PASS	AF=0.289960;DESCR=Genotypes AG + GG is associated with decreased response to eculizumab in people with paroxysmal nocturnal hemoglobinuria as compared to genotype AA.
chr1	207616743	rs3811381	C	G	.	PASS	AF=0.288229;DESCR=Genotypes CG + GG is not associated with response to eculizumab in people with paroxysmal nocturnal hemoglobinuria as compared to genotype CC.
chr1	209618584	rs2076222	G	T	.	PASS	AF=0.0129683;DESCR=Allele G is associated with increased dose of fentanyl in people with Pain, Postoperative as compared to allele T.
chr1	209685108	rs846908	A	G	.	PASS	AF=0.986751;DESCR=Genotype AA is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to genotypes AG + GG.
chr1	209697571	rs4844880	A	T	.	PASS	AF=0.888537;DESCR=Genotype AA is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to genotypes AT + TT.
chr1	209701909	rs846910	A	G	.	PASS	AF=0.976959;DESCR=Genotype AA is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to genotypes AG + GG.
chr1	209701909	rs846910	A	T	.	AC0	AF=0.00000;DESCR=Genotype AA is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to genotypes AG + GG.
chr1	212583051	rs11811628	G	A	.	PASS	AF=0.0547235;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr1	222596251	rs1995152	A	C	.	PASS	AF=0.104899;DESCR=Allele C is not associated with trough concentration of vancomycin as compared to allele A.
chr1	222598797	rs3002130	C	T	.	PASS	AF=0.886167;DESCR=Allele C is not associated with trough concentration of vancomycin as compared to allele T.
chr1	222609854	rs3008604	T	C	.	PASS	AF=0.865418;DESCR=Allele T is not associated with trough concentration of vancomycin as compared to allele C.
chr1	222612350	rs3008607	A	G	.	PASS	AF=0.864919;DESCR=Allele A is not associated with trough concentration of vancomycin as compared to allele G.
chr1	222612656	rs3008608	A	G	.	PASS	AF=0.864919;DESCR=Allele A is not associated with trough concentration of vancomycin as compared to allele G.
chr1	222614720	rs3002142	C	T	.	PASS	AF=0.864841;DESCR=Allele C is not associated with trough concentration of vancomycin as compared to allele T.
chr1	222615512	rs3002143	C	T	.	PASS	AF=0.864919;DESCR=Allele C is not associated with trough concentration of vancomycin as compared to allele T.
chr1	222617024	rs904323	G	A	.	PASS	AF=0.158213;DESCR=Allele A is not associated with trough concentration of vancomycin as compared to allele G.
chr1	222617179	rs35397194	A	G	.	PASS	AF=0.0723343;DESCR=Allele G is not associated with trough concentration of vancomycin as compared to allele A.
chr1	222617218	rs142155704	A	G	.	PASS	AF=0.00951009;DESCR=Allele G is not associated with trough concentration of vancomycin as compared to allele A.
chr1	222618565	rs3008610	A	G	.	PASS	AF=0.864343;DESCR=Allele A is not associated with trough concentration of vancomycin as compared to allele G.
chr1	222618565	rs3008610	A	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with trough concentration of vancomycin as compared to allele G.
chr1	222620358	rs10495197	C	T	.	PASS	AF=0.0319700;DESCR=Allele T is not associated with trough concentration of vancomycin as compared to allele C.
chr1	222621776	rs17163303	G	T	.	PASS	AF=0.0320254;DESCR=Allele T is not associated with trough concentration of vancomycin as compared to allele G.
chr1	222622785	rs75328711	A	C	.	PASS	AF=0.0319700;DESCR=Allele C is not associated with trough concentration of vancomycin as compared to allele A.
chr1	222633671	rs3002145	C	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with trough concentration of vancomycin.
chr1	222633671	rs3002145	C	T	.	PASS	AF=0.140878;DESCR=Allele T is not associated with trough concentration of vancomycin.
chr1	222658030	rs2088514	A	G	.	PASS	AF=0.177810;DESCR=Allele G is not associated with trough concentration of vancomycin as compared to allele A.
chr1	222658668	rs35822937	A	G	.	PASS	AF=0.204611;DESCR=Allele G is not associated with trough concentration of vancomycin as compared to allele A.
chr1	222658953	rs2291834	T	C	.	PASS	AF=0.714781;DESCR=Allele T is not associated with trough concentration of vancomycin as compared to allele C.
chr1	222666496	rs1053316	A	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with trough concentration of vancomycin as compared to allele G.
chr1	222666496	rs1053316	A	G	.	PASS	AF=0.892795;DESCR=Allele A is not associated with trough concentration of vancomycin as compared to allele G.
chr1	222671996	rs17011686	A	G	.	PASS	AF=0.0406574;DESCR=Allele G is not associated with trough concentration of vancomycin as compared to allele A.
chr1	222672069	rs3008634	T	C	.	PASS	AF=0.887385;DESCR=Allele T is not associated with trough concentration of vancomycin as compared to allele C.
chr1	222682073	rs17163429	T	C	.	PASS	AF=0.207781;DESCR=Allele C is not associated with trough concentration of vancomycin as compared to allele T.
chr1	222690817	rs2378597	T	A	.	PASS	AF=0.499135;DESCR=Allele T is not associated with trough concentration of vancomycin as compared to allele A.
chr1	222709060	rs35684750	A	C	.	PASS	AF=0.141129;DESCR=Allele C is not associated with trough concentration of vancomycin as compared to allele A.
chr1	222713246	rs3748631	G	A	.	PASS	AF=0.0573487;DESCR=Allele A is not associated with trough concentration of vancomycin as compared to allele G.
chr1	222713246	rs3748631	G	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with trough concentration of vancomycin as compared to allele G.
chr1	222714565	rs35762933	C	T	.	PASS	AF=0.140906;DESCR=Allele T is not associated with trough concentration of vancomycin as compared to allele C.
chr1	222801584	rs17162912	T	C	.	PASS	AF=0.0512968;DESCR=Allele C is not associated with response to citalopram, clomipramine, fluoxetine, fluvoxamine, paroxetine or sertraline in people with Obsessive-Compulsive Disorder as compared to allele T.
chr1	223111186	rs5744174	A	G	.	PASS	AF=0.399770;DESCR=Genotype AG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease as compared to genotype AA.
chr1	225807509	rs2100232376;rs2100232393;rs2100232374;rs2100232371;rs4653436	G	A	.	PASS	AF=0.253895;DESCR=Allele G is not associated with dose of warfarin.
chr1	225825654	rs1877724	C	T	.	PASS	AF=0.295507;DESCR=Genotype CC is associated with decreased dose of warfarin as compared to genotypes CT + TT.
chr1	225828857	rs3738046	G	C	.	PASS	AF=0.00000;DESCR=Genotype CG is associated with concentrations of carbamazepine in people with Epilepsy as compared to genotype GG.
chr1	225831932	rs1051740	T	C	.	PASS	AF=0.287730;DESCR=Allele C is not associated with dose of warfarin.
chr1	225831952	rs1131873	G	A	.	PASS	AF=0.201037;DESCR=Allele A is associated with decreased dose of warfarin.
chr1	225832073	rs2260863	G	C	.	PASS	AF=0.761534;DESCR=Allele G is not associated with dose of warfarin.
chr1	225838705	rs2234922	A	G	.	PASS	AF=0.139769;DESCR=Allele G is not associated with dose of warfarin.
chr1	225838705	rs2234922	A	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with dose of warfarin.
chr1	225844528	rs1051741	C	T	.	PASS	AF=0.0809798;DESCR=Genotype CT is associated with decreased dose of warfarin as compared to genotype CC.
chr1	230702585	rs7079	G	T	.	PASS	AF=0.412104;DESCR=Genotype TT is associated with increased response to benazepril in people with Hypertension as compared to genotypes GG + GT.
chr1	230710048	rs699	A	G	.	PASS	AF=0.429642;DESCR=Allele A is not associated with increased response to losartan in people with Liver Cirrhosis as compared to allele G.
chr1	230710231	rs4762	G	A	.	PASS	AF=0.141129;DESCR=Genotype GG is not associated with response to atenolol or irbesartan in people with Hypertension as compared to genotype AG.
chr1	230714126	rs5051	C	T	.	PASS	AF=0.448415;DESCR=Genotype CC is associated with increased response to benazepril or imidapril in people with Hypertension as compared to genotypes CT + TT.
chr1	230714140	rs5050	T	C	.	PASS	AF=0.00000;DESCR=Genotype GG is not associated with response to atenolol in people with Hypertension as compared to genotypes GT + TT.
chr1	230714140	rs5050	T	G	.	PASS	AF=0.179606;DESCR=Genotype GG is not associated with response to atenolol in people with Hypertension as compared to genotypes GT + TT.
chr1	236885200	rs1805087	A	G	.	PASS	AF=0.175216;DESCR=Allele G is associated with increased concentrations of methotrexate in people with Lymphoma, Non-Hodgkin or Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.
chr1	239622120	rs2165870	A	C	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with increased response to dexamethasone in people with Postoperative Nausea and Vomiting as compared to genotypes AG + GG.
chr1	239622120	rs2165870	A	G	.	PASS	AF=0.610438;DESCR=Genotype AA is associated with increased response to dexamethasone in people with Postoperative Nausea and Vomiting as compared to genotypes AG + GG.
chr1	240549089	rs77567654	A	G	.	PASS	AF=0.311490;DESCR=Allele G is associated with increased response to allopurinol as compared to allele A.
chr1	240550730	rs10802887	A	G	.	PASS	AF=0.305652;DESCR=Allele G is associated with increased response to allopurinol as compared to allele A.
chr1	240558252	rs1934341	C	G	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to allopurinol.
chr1	240558252	rs1934341	C	T	.	PASS	AF=0.320046;DESCR=Allele T is associated with increased response to allopurinol.
chr1	240566955	rs4659982	T	C	.	PASS	AF=0.415802;DESCR=Allele C is associated with increased response to allopurinol.
chr1	241878999	rs1047840	G	A	.	PASS	AF=0.380334;DESCR=Allele A is associated with increased response to capecitabine or fluorouracil in people with Neoplasm Metastasis as compared to allele G.
chr1	247435768	rs4612666	T	C	.	PASS	AF=0.785755;DESCR=Genotype TT is associated with decreased response to etanercept or infliximab in people with Arthritis, Rheumatoid as compared to genotypes CC + CT.
chr1	247448734	rs10754558	G	C	.	PASS	AF=0.421614;DESCR=Genotypes CG + GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammatory Bowel Diseases as compared to genotype CC.
chr1	247853076	rs72772787	C	T	.	PASS	AF=0.0337565;DESCR=Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.
chr10	4768369	rs1901633	A	G	.	PASS	AF=0.264145;DESCR=Allele G is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.
chr10	5094459	rs12529	C	G	.	PASS	AF=0.595732;DESCR=Genotypes CC + CG are not associated with response to abiraterone in men with Prostatic Neoplasms as compared to genotype GG.
chr10	5099115	rs1937840	C	G	.	PASS	AF=0.595211;DESCR=Genotype GG is associated with increased response to docetaxel and doxorubicin in women with Breast Neoplasms as compared to genotypes CC + CG.
chr10	5218719	rs17134592	C	G	.	PASS	AF=0.105370;DESCR=Genotypes CG + GG are not associated with concentrations of exemestane in women with Breast Neoplasms as compared to genotype CC.
chr10	5218719	rs17134592	C	T	.	PASS	AF=0.00000;DESCR=Genotypes CG + GG are not associated with concentrations of exemestane in women with Breast Neoplasms as compared to genotype CC.
chr10	6057082	rs2104286	T	C	.	PASS	AF=0.246682;DESCR=Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.
chr10	6351298	rs4750316	C	G	.	PASS	AF=0.818339;DESCR=Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr10	6351298	rs4750316	C	T	.	AC0	AF=0.00000;DESCR=Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr10	8062245	rs3824662	C	A	.	PASS	AF=0.242224;DESCR=Genotype AA is associated with decreased clinical benefit to prednisolone in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AC + CC.
chr10	8062245	rs3824662	C	T	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with decreased clinical benefit to prednisolone in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AC + CC.
chr10	8659256	rs10795668	G	A	.	PASS	AF=0.305187;DESCR=Allele A is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele G.
chr10	18148096	rs560765906	A	T	.	PASS	AF=0.0176739;DESCR=Allele T is associated with decreased clearance of dexmedetomidine in children with Pain, Postoperative as compared to allele A.
chr10	18249730	rs12245847	T	C	.	PASS	AF=0.392734;DESCR=Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CT.
chr10	18273609	rs1277733	C	T	.	PASS	AF=0.808535;DESCR=Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CC.
chr10	18418367	rs982003	C	T	.	PASS	AF=0.881048;DESCR=Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype TT.
chr10	18427216	rs10741058	T	C	.	PASS	AF=0.950720;DESCR=Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CC.
chr10	18509274	rs4237348	T	C	.	PASS	AF=0.461118;DESCR=Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CT.
chr10	26214873	rs2839669	C	T	.	PASS	AF=0.166763;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr10	26215411	rs2839670	C	A	.	PASS	AF=0.167051;DESCR=Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr10	26216567	rs2236418	A	G	.	PASS	AF=0.167243;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr10	26523246	rs11015149	C	A	.	PASS	AF=0.125072;DESCR=Genotypes AA + AC is associated with increased resistance to clopidogrel in people with Coronary Disease as compared to genotype CC.
chr10	31913141	rs2799018	C	G	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr10	31913141	rs2799018	C	T	.	PASS	AF=0.502017;DESCR=Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr10	33200124	rs2247383	G	A	.	PASS	AF=0.435735;DESCR=Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele A.
chr10	33221735	rs2229935	G	A	.	PASS	AF=0.293084;DESCR=Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele A.
chr10	33263767	rs2070296	C	T	.	PASS	AF=0.164937;DESCR=Allele T is associated with decreased response to ranibizumab in people with Macular Degeneration as compared to genotype CC.
chr10	33323572	rs2804495	G	T	.	PASS	AF=0.777393;DESCR=Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.
chr10	33785635	rs2777511	G	A	.	PASS	AF=0.0823733;DESCR=Allele G is not associated with response to nicotine in women as compared to allele A.
chr10	33785635	rs2777511	G	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to nicotine in women as compared to allele A.
chr10	35252098	rs12777960	C	A	.	PASS	AF=0.408304;DESCR=Genotype CC is associated with increased response to adalimumab in people with Crohn Disease as compared to genotypes AA + AC.
chr10	43114671	rs1799939	G	A	.	PASS	AF=0.201501;DESCR=Allele A is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele G.
chr10	44372809	rs1801157	C	T	.	PASS	AF=0.233295;DESCR=Genotypes CT + TT are associated with decreased response to alemtuzumab, chlorambucil, cyclophosphamide, fludarabine, prednisone, rituximab or vincristine in people with Leukemia, Lymphocytic, Chronic, B-Cell as compared to genotype CC.
chr10	49616071	rs1880676	G	A	.	PASS	AF=0.234159;DESCR=Allele A is associated with increased response to olanzapine in people with Schizophrenia as compared to allele G.
chr10	49616573	rs3810950	G	A	.	PASS	AF=0.234006;DESCR=Allele A is associated with increased response to olanzapine in people with Schizophrenia as compared to allele G.
chr10	49624063	rs4838391	C	T	.	PASS	AF=0.0818444;DESCR=Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49626932	rs4838392	A	G	.	PASS	AF=0.419067;DESCR=Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.
chr10	49627218	rs12246528	G	A	.	PASS	AF=0.330161;DESCR=Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.
chr10	49628987	rs11101187	C	T	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49630828	rs2177370	A	G	.	PASS	AF=0.361303;DESCR=Allele A is associated with increased response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele G.
chr10	49632690	rs3793790	G	A	.	PASS	AF=0.638825;DESCR=Allele G is associated with increased response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.
chr10	49632690	rs3793790	G	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.
chr10	49633658	rs3793791	C	T	.	PASS	AF=0.944988;DESCR=Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49635683	rs2177369	G	A	.	PASS	AF=0.364607;DESCR=Genotype AA is not associated with response to donepezil in people with Alzheimer Disease as compared to genotypes AG + GG.
chr10	49639951	rs12266458	C	T	.	PASS	AF=0.113191;DESCR=Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49641296	rs1917818	T	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49641296	rs1917818	T	G	.	PASS	AF=0.368012;DESCR=Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49646721	rs11101192	G	A	.	PASS	AF=0.00518433;DESCR=Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.
chr10	49647322	rs7094248	C	G	.	PASS	AF=0.516157;DESCR=Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele C.
chr10	49648092	rs11101193	G	T	.	PASS	AF=0.351585;DESCR=Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49649803	rs3793797	C	T	.	PASS	AF=0.801038;DESCR=Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49650300	rs10776586	T	A	.	AC0	AF=0.00000;DESCR=Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49650300	rs10776586	T	C	.	PASS	AF=0.437212;DESCR=Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49655037	rs12264845	A	C	.	PASS	AF=0.403403;DESCR=Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.
chr10	49655519	rs7076926	C	T	.	PASS	AF=0.856279;DESCR=Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49655577	rs7094421	A	G	.	PASS	AF=0.467435;DESCR=Allele A is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele G.
chr10	49663420	rs3793798	T	A	.	PASS	AF=0.369741;DESCR=Allele A is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49663420	rs3793798	T	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	49663670	rs3793800	A	G	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele G.
chr10	49664866	rs3793801	C	T	.	PASS	AF=0.0103746;DESCR=Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr10	51930014	rs7903366	C	T	.	PASS	AF=0.365706;DESCR=Allele T is associated with decreased response to salbutamol in children with Asthma as compared to allele C.
chr10	51930571	rs7081864	G	A	.	PASS	AF=0.366181;DESCR=Allele A is associated with decreased response to salbutamol in children with Asthma as compared to allele G.
chr10	59978394	rs7902657	G	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G.
chr10	59978394	rs7902657	G	C	.	AC0	AF=0.00000;DESCR=Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G.
chr10	59978394	rs7902657	G	T	.	PASS	AF=0.542676;DESCR=Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G.
chr10	61950345	rs10994982	A	G	.	PASS	AF=0.472062;DESCR=Allele A is associated with decreased clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.
chr10	62045858	rs4948496	T	C	.	PASS	AF=0.597926;DESCR=Allele C is not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.
chr10	62156213	rs7912580	G	A	.	PASS	AF=0.0406340;DESCR=Genotype GG is associated with increased response to haloperidol in people with Schizophrenia as compared to genotype AG.
chr10	62805174	rs10995311	C	G	.	PASS	AF=0.411527;DESCR=Allele C is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele G.
chr10	65919290	rs1786929	A	G	.	PASS	AF=0.243220;DESCR=Genotypes AA + AG is associated with increased response to fluticasone propionate or montelukast in children with Asthma as compared to genotype GG.
chr10	66576537	rs10997242	T	C	.	PASS	AF=0.166474;DESCR=Allele C is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr10	70598899	rs885821	G	A	.	PASS	AF=0.206052;DESCR=Allele G is associated with increased response to rivaroxaban in people with Atrial Fibrillation as compared to allele A.
chr10	70598899	rs885821	G	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to rivaroxaban in people with Atrial Fibrillation as compared to allele A.
chr10	71777857	rs17712523	G	A	.	PASS	AF=0.189228;DESCR=Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr10	72009749	rs4148943	C	T	.	PASS	AF=0.417820;DESCR=Allele C is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele T.
chr10	72009832	rs4148945	C	T	.	PASS	AF=0.408410;DESCR=Allele C is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele T.
chr10	72010359	rs4148947	T	C	.	PASS	AF=0.408016;DESCR=Allele T is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele C.
chr10	72011948	rs4148950	G	A	.	PASS	AF=0.408304;DESCR=Allele A is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele G.
chr10	72012256	rs1871450	G	A	.	PASS	AF=0.408146;DESCR=Allele A is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele G.
chr10	72012256	rs1871450	G	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele G.
chr10	72013004	rs730720	C	T	.	PASS	AF=0.417579;DESCR=Allele C is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele T.
chr10	72013256	rs12418	G	A	.	PASS	AF=0.408881;DESCR=Allele A is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele G.
chr10	77018976	rs16934182	G	A	.	PASS	AF=0.777522;DESCR=Genotypes AA + AG is associated with decreased dose of dexmedetomidine in people with surgery as compared to genotype GG.
chr10	77423280	rs35793	C	G	.	PASS	AF=0.100923;DESCR=Allele G is associated with response to quetiapine in people with Schizophrenia.
chr10	77811115	rs2289310	G	T	.	PASS	AF=0.139723;DESCR=Allele T is associated with increased response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele G.
chr10	80166946	rs1049550	G	A	.	PASS	AF=0.378028;DESCR=Genotype AA is associated with increased response to bevacizumab in people with Colorectal Neoplasms as compared to genotypes AG + GG.
chr10	80166946	rs1049550	G	C	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with increased response to bevacizumab in people with Colorectal Neoplasms as compared to genotypes AG + GG.
chr10	87960494	rs17431184	T	C	.	PASS	AF=0.150115;DESCR=Allele C is associated with increased response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele T.
chr10	88989499	rs2234767	G	A	.	PASS	AF=0.122837;DESCR=Genotypes AA + AG is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.
chr10	90859404	rs7905446	T	A	.	PASS	AF=0.00000;DESCR=Genotype TT is not associated with response to escitalopram or nortriptyline in people with Depression as compared to genotypes GG + GT.
chr10	90859404	rs7905446	T	G	.	PASS	AF=0.353314;DESCR=Genotype TT is not associated with response to escitalopram or nortriptyline in people with Depression as compared to genotypes GG + GT.
chr10	94136183	rs932764	A	G	.	PASS	AF=0.378674;DESCR=Allele A is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele G.
chr10	94645572	rs12772169	C	T	.	PASS	AF=0.213749;DESCR=Allele T is associated with dose of warfarin as compared to allele C.
chr10	94645745	rs12777823	G	A	.	PASS	AF=0.132353;DESCR=Allele A is associated with dose of warfarin as compared to allele G.
chr10	94645745	rs12777823	G	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with dose of warfarin as compared to allele G.
chr10	94648221	rs1998591	G	A	.	PASS	AF=0.213915;DESCR=Genotype GG is associated with increased dose of acenocoumarol in children as compared to genotypes AA + AG.
chr10	94660582	rs9732195	G	T	.	PASS	AF=0.213545;DESCR=Allele T is associated with concentrations of clopidogrel thiol metabolite H4 in healthy individuals as compared to allele G.
chr10	94687805	rs41291550	T	A	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased metabolism of warfarin in people with Atrial Fibrillation, venous thromboembolism or Heart Valve Diseases as compared to allele T.
chr10	94709142	rs11188059	G	A	.	PASS	AF=0.0790993;DESCR=Allele G is not associated with increased metabolism of lansoprazole or pantoprazole in children as compared to allele A.
chr10	94733301	rs1126545	C	T	.	PASS	AF=0.138040;DESCR=Allele T is associated with decreased metabolism of clozapine in people with Schizophrenia as compared to allele C.
chr10	94735475	rs2860840	C	T	.	PASS	AF=0.320542;DESCR=Allele T is not associated with increased metabolism of lansoprazole or pantoprazole in children as compared to allele C.
chr10	94759304	rs11188072	C	T	.	PASS	AF=0.212760;DESCR=Genotype TT is associated with increased metabolism of omeprazole in people with no disease as compared to genotype CC.
chr10	94761288	rs3814637	C	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with decreased clearance of warfarin as compared to allele C.
chr10	94761288	rs3814637	C	G	.	PASS	AF=0.00000;DESCR=Allele T is associated with decreased clearance of warfarin as compared to allele C.
chr10	94761288	rs3814637	C	T	.	PASS	AF=0.0843894;DESCR=Allele T is associated with decreased clearance of warfarin as compared to allele C.
chr10	94761900	rs12248560	C	T	.	PASS	AF=0.213379;DESCR=Genotypes CT + TT are not associated with response to clopidogrel in people with Acute coronary syndrome.
chr10	94766108	rs12768009	G	A	.	PASS	AF=0.131852;DESCR=Genotype AA is associated with decreased clearance of nevirapine in people with HIV Infections as compared to genotypes AG + GG.
chr10	94774506	rs6583954	C	T	.	PASS	AF=0.132353;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr10	94775367	rs12769205	A	G	.	PASS	AF=0.132565;DESCR=Genotypes AG + GG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype AA.
chr10	94780653	rs4986893	G	A	.	PASS	AF=0.00000;DESCR=Genotype AG is not associated with response to clopidogrel in people with Acute coronary syndrome as compared to genotype GG.
chr10	94781859	rs4244285	G	A	.	PASS	AF=0.132005;DESCR=Genotypes AA + AG is associated with increased clinical benefit to lacosamide in children with Epilepsy as compared to genotype GG.
chr10	94782225	rs12571421	A	G	.	PASS	AF=0.131928;DESCR=Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.
chr10	94808278	rs11188082	A	T	.	PASS	AF=0.925464;DESCR=Allele T is associated with decreased metabolism of warfarin in people with Atrial Fibrillation, venous thromboembolism or Heart Valve Diseases as compared to allele A.
chr10	94838682	rs11528090	T	G	.	PASS	AF=0.182553;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr10	94842865	rs3758580	C	T	.	PASS	AF=0.131336;DESCR=Genotypes CT + TT is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype CC.
chr10	94932870	rs77760615	A	G	.	PASS	AF=0.0827566;DESCR=Allele G is associated with increased concentrations of fluvastatin in healthy individuals as compared to allele A.
chr10	94935594	rs12782374	G	A	.	PASS	AF=0.140346;DESCR=Genotype AG is associated with increased metabolism of phenytoin as compared to genotype GG.
chr10	94936772	rs9332092	T	C	.	PASS	AF=0.0827089;DESCR=Genotype TT is associated with increased dose of warfarin as compared to genotype CT.
chr10	94937495	rs4918758	T	C	.	PASS	AF=0.368436;DESCR=Genotypes CC + CT is associated with increased exposure to valproic acid in people with Epilepsy as compared to genotype TT.
chr10	94937702	rs9332098	G	A	.	PASS	AF=0.0827089;DESCR=Genotype GG is associated with increased dose of warfarin as compared to genotype AG.
chr10	94938933	rs9332104	T	C	.	PASS	AF=0.211938;DESCR=Genotypes CC + CT are not associated with metabolism of losartan in healthy individuals as compared to genotype TT.
chr10	94942093	rs9332120	T	C	.	PASS	AF=0.212803;DESCR=Allele C is associated with increased response to carbamazepine, lamotrigine, phenytoin, primidone or valproic acid in children with Epilepsy as compared to allele T.
chr10	94942290	rs1799853	C	T	.	PASS	AF=0.135369;DESCR=Genotype TT is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.
chr10	94942309	rs7900194	G	A	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased dose of warfarin as compared to allele G.
chr10	94942309	rs7900194	G	C	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased dose of warfarin as compared to allele G.
chr10	94942309	rs7900194	G	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased dose of warfarin as compared to allele G.
chr10	94942538	rs2860905	G	A	.	PASS	AF=0.286744;DESCR=Allele A is associated with decreased dose of warfarin as compared to allele G.
chr10	94945466	rs7089580	A	G	.	PASS	AF=0.00000;DESCR=Allele T is associated with decreased dose of warfarin in children as compared to allele A.
chr10	94945466	rs7089580	A	T	.	PASS	AF=0.212558;DESCR=Allele T is associated with decreased dose of warfarin in children as compared to allele A.
chr10	94947445	rs4086116	C	T	.	PASS	AF=0.222190;DESCR=Allele T is associated with decreased dose of acenocoumarol as compared to allele C.
chr10	94947714	rs9332127	G	C	.	PASS	AF=0.00000;DESCR=Allele C is not associated with increased dose of warfarin in people with an international normalized ratio (INR) of 2.0-3.0 as compared to allele G.
chr10	94949217	rs2256871	A	G	.	PASS	AF=0.00000;DESCR=Allele G is associated with decreased metabolism of warfarin in people with Atrial Fibrillation, venous thromboembolism or Heart Valve Diseases as compared to allele A.
chr10	94950407	rs34532201	C	T	.	PASS	AF=0.140553;DESCR=Genotype TT is associated with increased exposure to apatinib and apatinib metabolite m1-1 in people with Neoplasms as compared to genotypes CC + CT.
chr10	94963667	rs2153628	A	G	.	PASS	AF=0.212558;DESCR=Allele G is associated with increased response to indomethacin as compared to allele A.
chr10	94965778	rs4917639	A	C	.	PASS	AF=0.222190;DESCR=Allele C is associated with decreased dose of warfarin as compared to allele A.
chr10	94972340	rs9332174	A	G	.	PASS	AF=0.212680;DESCR=Genotypes AG + GG are not associated with metabolism of losartan in healthy individuals as compared to genotype AA.
chr10	94974582	rs10509680	G	T	.	PASS	AF=0.102962;DESCR=Genotype GT is associated with increased concentrations of losartan and losartan E-3174 in healthy individuals as compared to genotype GG.
chr10	94981296	rs1057910	A	C	.	PASS	AF=0.0826613;DESCR=Allele A is associated with dose of warfarin as compared to allele C.
chr10	94981296	rs1057910	A	G	.	PASS	AF=0.00000;DESCR=Allele A is associated with dose of warfarin as compared to allele C.
chr10	94982060	rs1934968	A	G	.	PASS	AF=0.952161;DESCR=Genotype GG is associated with increased exposure to apatinib and apatinib metabolite m1-1 in people with Neoplasms as compared to genotypes AA + AG.
chr10	94988735	rs9332238	G	A	.	PASS	AF=0.217542;DESCR=Allele G is associated with increased dose of warfarin as compared to allele A.
chr10	94988738	rs1934969	A	T	.	PASS	AF=0.575836;DESCR=Genotypes AT + TT are associated with decreased metabolism of losartan in healthy individuals as compared to genotype AA.
chr10	94988980	rs1057911	A	T	.	PASS	AF=0.0826613;DESCR=Genotype AT is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype AA.
chr10	94989424	rs9332245	T	A	.	PASS	AF=0.0841499;DESCR=Genotype AT is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype TT.
chr10	95038992	rs10509681	T	C	.	PASS	AF=0.0913018;DESCR=Allele C is associated with decreased metabolism of paclitaxel as compared to allele T.
chr10	95044694	rs7910936	C	T	.	PASS	AF=0.647924;DESCR=Allele C is associated with increased concentrations of desethylchloroquine or hydroxychloroquine in people with Lupus Erythematosus, Systemic as compared to allele T.
chr10	95049216	rs1934980	A	G	.	PASS	AF=0.194925;DESCR=Genotypes AA + AG is not associated with resistance to clopidogrel in people with Stroke as compared to genotype GG.
chr10	95057540	rs10882521	G	T	.	PASS	AF=0.415225;DESCR=Allele T is associated with decreased concentrations of desethylchloroquine or hydroxychloroquine in people with Lupus Erythematosus, Systemic as compared to allele G.
chr10	95058349	rs11572103	T	A	.	PASS	AF=0.0152650;DESCR=Allele T is not associated with metabolism of paclitaxel in people with Neoplasms as compared to allele A.
chr10	95058362	rs1058930	G	A	.	PASS	AF=0.00000;DESCR=Allele C is not associated with metabolism of paclitaxel in people with Neoplasms as compared to allele G.
chr10	95058362	rs1058930	G	C	.	PASS	AF=0.0184651;DESCR=Allele C is not associated with metabolism of paclitaxel in people with Neoplasms as compared to allele G.
chr10	95067273	rs11572080	C	T	.	PASS	AF=0.0913545;DESCR=Allele T is not associated with metabolism of paclitaxel in people with Neoplasms as compared to allele C.
chr10	95069673	rs7909236	G	T	.	PASS	AF=0.195502;DESCR=Allele T is not associated with concentrations of imatinib in people with Neoplasms as compared to allele G.
chr10	95069772	rs17110453	A	C	.	PASS	AF=0.124496;DESCR=Allele C is not associated with concentrations of imatinib in people with Neoplasms as compared to allele A.
chr10	97152179	rs11189015	G	C	.	PASS	AF=0.0757925;DESCR=Allele C is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele G.
chr10	97169185	rs2784917	A	G	.	PASS	AF=0.789171;DESCR=Genotype AA is associated with decreased inhibition of etoposide as compared to genotypes AG + GG.
chr10	98417292	rs1061115	G	A	.	PASS	AF=0.455620;DESCR=Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr10	99781296	rs1885301	A	G	.	PASS	AF=0.526513;DESCR=Allele A is not associated with exposure to pitavastatin in healthy individuals as compared to allele G.
chr10	99781822	rs7910642	G	A	.	PASS	AF=0.109159;DESCR=Genotypes AA + AG is not associated with concentrations of lopinavir in people with HIV Infections as compared to genotype GG.
chr10	99781826	rs2804402	A	G	.	PASS	AF=0.471758;DESCR=Allele A is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele G.
chr10	99782821	rs717620	C	T	.	PASS	AF=0.210617;DESCR=Genotypes CT + TT is associated with decreased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.
chr10	99788711	rs4148386	G	A	.	PASS	AF=0.526498;DESCR=Genotypes AA + AG are associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotype GG.
chr10	99793502	rs2804400	C	T	.	PASS	AF=0.470300;DESCR=Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.
chr10	99798877	rs2804398	A	T	.	PASS	AF=0.367647;DESCR=Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.
chr10	99798989	rs2756109	G	T	.	PASS	AF=0.573157;DESCR=Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.
chr10	99804058	rs2273697	G	A	.	PASS	AF=0.205594;DESCR=Allele A is not associated with exposure to pitavastatin in healthy individuals as compared to allele G.
chr10	99811771	rs3740074	C	T	.	PASS	AF=0.588422;DESCR=Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.
chr10	99828174	rs2002042	C	T	.	PASS	AF=0.185409;DESCR=Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr10	99832865	rs4148398	A	G	.	PASS	AF=0.650058;DESCR=Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele G.
chr10	99836218	rs8187692	G	A	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele G.
chr10	99836218	rs8187692	G	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele G.
chr10	99836239	rs17222723	T	A	.	PASS	AF=0.121902;DESCR=Allele A is not associated with clearance of methotrexate in people with Lymphoma.
chr10	99842247	rs3758395	T	C	.	PASS	AF=0.0544355;DESCR=Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.
chr10	99843765	rs17216177	T	C	.	PASS	AF=0.122696;DESCR=Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele T.
chr10	99844024	rs3740067	C	G	.	PASS	AF=0.351382;DESCR=Genotypes CG + GG is not associated with response to carbamazepine in people with Epilepsies, Partial as compared to genotype CC.
chr10	99844350	rs17216317	C	T	.	PASS	AF=0.00000;DESCR=Genotype CT is associated with increased concentrations of n-desmethyltramadol and o-desmethyltramadol in people with Death as compared to genotype CC.
chr10	99844450	rs3740066	C	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with exposure to pitavastatin in healthy individuals as compared to allele C.
chr10	99844450	rs3740066	C	T	.	PASS	AF=0.351297;DESCR=Allele T is not associated with exposure to pitavastatin in healthy individuals as compared to allele C.
chr10	99845746	rs7899457	C	T	.	PASS	AF=0.000577034;DESCR=Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.
chr10	99845936	rs3740065	A	G	.	PASS	AF=0.176657;DESCR=Allele G is not associated with clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.
chr10	99850698	rs8187706	G	A	.	PASS	AF=0.000864055;DESCR=Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.
chr10	99850966	rs3740063	A	G	.	PASS	AF=0.477233;DESCR=Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.
chr10	99851537	rs8187710	G	A	.	PASS	AF=0.122478;DESCR=Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.
chr10	100216744	rs11591741	G	C	.	PASS	AF=0.312500;DESCR=Allele G is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.
chr10	102837395	rs743572	A	G	.	PASS	AF=0.398731;DESCR=Genotypes AG + GG are not associated with response to abiraterone in men with Prostatic Neoplasms as compared to genotype AA.
chr10	102837395	rs743572	A	T	.	PASS	AF=0.00000;DESCR=Genotypes AG + GG are not associated with response to abiraterone in men with Prostatic Neoplasms as compared to genotype AA.
chr10	102837723	rs2486758	T	C	.	PASS	AF=0.165513;DESCR=Genotypes CC + CT are not associated with response to abiraterone in men with Prostatic Neoplasms as compared to genotype TT.
chr10	102878966	rs11191439	T	C	.	PASS	AF=0.121037;DESCR=Allele C is associated with increased metabolism of Arsenic compounds in healthy individuals as compared to allele T.
chr10	103040448	rs58700372	T	C	.	PASS	AF=0.118444;DESCR=Genotypes CC + CT are associated with decreased metabolism of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype TT.
chr10	103118697	rs72846714	G	A	.	PASS	AF=0.151961;DESCR=Genotypes AA + AG are associated with decreased metabolism of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.
chr10	103138228	rs11598702	T	C	.	PASS	AF=0.383661;DESCR=Genotype TT is associated with decreased clearance of gemcitabine as compared to genotypes CC + CT.
chr10	103138228	rs11598702	T	G	.	PASS	AF=0.00230814;DESCR=Genotype TT is associated with decreased clearance of gemcitabine as compared to genotypes CC + CT.
chr10	103918139	rs4387287	A	C	.	PASS	AF=0.797290;DESCR=Allele A is associated with decreased response to atenolol in people with Hypertension as compared to allele C.
chr10	107285113	rs1416406	A	G	.	PASS	AF=0.663684;DESCR=Genotype GG is associated with increased response to exenatide in people with Diabetes Mellitus, Type 2 as compared to genotypes AA + AG.
chr10	111075832	rs521674	T	A	.	PASS	AF=0.719850;DESCR=Allele T is associated with increased dose of doxazosin or phenoxybenzamine in people with Pheochromocytoma or Paraganglioma as compared to allele A.
chr10	111076745	rs1800544	G	A	.	AC0	AF=0.00000;DESCR=Genotype GG is not associated with response to buprenorphine or methadone in people with Opioid-Related Disorders as compared to genotypes CC + CG.
chr10	111076745	rs1800544	G	C	.	PASS	AF=0.721581;DESCR=Genotype GG is not associated with response to buprenorphine or methadone in people with Opioid-Related Disorders as compared to genotypes CC + CG.
chr10	111077315	rs2484516	G	C	.	PASS	AF=0.923055;DESCR=Genotype CC is not associated with dose of dexmedetomidine in men as compared to genotype CG.
chr10	111077780	rs1800545	G	A	.	PASS	AF=0.0593660;DESCR=Genotype GG is associated with increased response to atenolol in people with Hypertrophy, Left Ventricular as compared to genotypes AA + AG.
chr10	111078794	rs1800035	C	G	.	PASS	AF=0.00116009;DESCR=Genotypes CG + GG are associated with decreased response to dexmedetomidine in women with Pain, Postoperative as compared to genotype CC.
chr10	111078794	rs1800035	C	T	.	PASS	AF=0.000580046;DESCR=Genotypes CG + GG are associated with decreased response to dexmedetomidine in women with Pain, Postoperative as compared to genotype CC.
chr10	111079610	rs11195419	C	A	.	PASS	AF=0.0686275;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele A.
chr10	111079821	rs553668	A	G	.	PASS	AF=0.781556;DESCR=Allele T is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele G.
chr10	111079843	rs3750625	C	A	.	PASS	AF=0.0486751;DESCR=Allele A is not associated with dose of dexmedetomidine in men as compared to allele C.
chr10	111079843	rs3750625	C	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with dose of dexmedetomidine in men as compared to allele C.
chr10	112998590	rs7903146	C	T	.	PASS	AF=0.287074;DESCR=Genotypes CT + TT is associated with increased response to exenatide in people with Diabetes Mellitus, Type 2 as compared to genotype CC.
chr10	113049143	rs12255372	G	T	.	PASS	AF=0.314484;DESCR=Genotype TT is associated with decreased response to sulfonamides, urea derivatives in people with Diabetes Mellitus, Type 2 as compared to genotype GG.
chr10	113149972	rs290487	C	T	.	PASS	AF=0.199885;DESCR=Genotype TT is associated with increased response to repaglinide in people with Diabetes Mellitus, Type 2 as compared to genotypes CC + CT.
chr10	113678445	rs12415607	C	A	.	PASS	AF=0.146313;DESCR=Genotypes AA + AC are associated with increased response to docetaxel, gemcitabine, paclitaxel, Platinum compounds or vinorelbine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.
chr10	113679810	rs7921977	C	T	.	PASS	AF=0.873991;DESCR=Genotype CC is not associated with response to docetaxel, gemcitabine, paclitaxel, Platinum compounds or vinorelbine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.
chr10	113729393	rs2227310	C	G	.	PASS	AF=0.184044;DESCR=Genotypes CG + GG are associated with increased response to docetaxel, gemcitabine, paclitaxel, Platinum compounds or vinorelbine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.
chr10	113729830	rs4353229	T	C	.	PASS	AF=0.184150;DESCR=Genotypes CC + CT are associated with increased response to docetaxel, gemcitabine, paclitaxel, Platinum compounds or vinorelbine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.
chr10	113730350	rs1127687	G	A	.	PASS	AF=0.262536;DESCR=Genotypes AA + AG are associated with decreased response to paclitaxel and Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.
chr10	114044277	rs1801252	A	G	.	PASS	AF=0.0905421;DESCR=Allele G is not associated with response to atenolol or metoprolol in people with Tachycardia as compared to allele A.
chr10	114045297	rs1801253	G	C	.	PASS	AF=0.620800;DESCR=Allele C is associated with increased response to atenolol in healthy individuals as compared to allele G.
chr10	117226885	rs363371	G	A	.	PASS	AF=0.158776;DESCR=Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G.
chr10	117244568	rs363390	G	C	.	PASS	AF=0.170507;DESCR=Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G.
chr10	117255437	rs363343	C	A	.	PASS	AF=0.825635;DESCR=Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele C.
chr10	117259615	rs929493	C	T	.	PASS	AF=0.821429;DESCR=Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele T.
chr10	117264991	rs363225	C	A	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CT + TT.
chr10	117264991	rs363225	C	T	.	PASS	AF=0.438040;DESCR=Genotype CC is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CT + TT.
chr10	117265701	rs363226	G	C	.	PASS	AF=0.673487;DESCR=Genotype GG is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CC + CG.
chr10	117265701	rs363226	G	T	.	PASS	AF=0.000288184;DESCR=Genotype GG is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CC + CG.
chr10	118669290	rs1247117	G	A	.	PASS	AF=0.851788;DESCR=Allele G is associated with increased resistance to vincristine as compared to allele A.
chr10	119326585	rs2230345	A	T	.	PASS	AF=0.0273775;DESCR=Genotype AA is not associated with response to atenolol in healthy individuals as compared to genotypes AT + TT.
chr10	119335888	rs3740563	A	C	.	PASS	AF=0.954781;DESCR=Allele A is associated with decreased response to Beta Blocking Agents in people with Coronary Artery Disease as compared to allele C.
chr10	119340641	rs4752292	T	G	.	PASS	AF=0.908698;DESCR=Allele T is associated with decreased response to Beta Blocking Agents in people with Coronary Artery Disease as compared to allele G.
chr10	119348388	rs11198893	G	A	.	PASS	AF=0.0354671;DESCR=Allele A is associated with decreased response to Beta Blocking Agents in people with Coronary Artery Disease as compared to allele G.
chr10	119371801	rs10787959	A	G	.	PASS	AF=0.707493;DESCR=Allele A is associated with decreased response to Beta Blocking Agents in people with Coronary Artery Disease as compared to allele G.
chr10	122454932	rs10490924	G	T	.	PASS	AF=0.202999;DESCR=Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.
chr10	122461028	rs11200638	G	A	.	PASS	AF=0.208189;DESCR=Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.
chr10	127541545	rs1931704	G	A	.	PASS	AF=0.296083;DESCR=Allele A is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele G.
chr10	133527063	rs2070673	A	T	.	PASS	AF=0.748991;DESCR=Allele T is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele A.
chr10	133535040	rs6413432	T	A	.	PASS	AF=0.0945245;DESCR=Allele A is associated with increased concentrations of isoniazid in people with Tuberculosis as compared to allele T (assigned as intermediate acetylator phenotype) .
chr11	636399	rs3758653	T	C	.	PASS	AF=0.177912;DESCR=Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.
chr11	640119	rs762502	C	G	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased clinical benefit to clozapine in people with Schizophrenia or Psychotic Disorder as compared to allele T.
chr11	640119	rs762502	C	T	.	PASS	AF=0.708333;DESCR=Allele C is associated with increased clinical benefit to clozapine in people with Schizophrenia or Psychotic Disorder as compared to allele T.
chr11	641191	rs11246226	C	A	.	PASS	AF=0.484726;DESCR=Genotype AA is associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotypes AC + CC.
chr11	656845	rs4963126	G	A	.	PASS	AF=0.538882;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr11	656845	rs4963126	G	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr11	1219991	rs35705950	G	A	.	PASS	AF=0.00000;DESCR=Genotype TT is not associated with response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes GG + GT.
chr11	1219991	rs35705950	G	T	.	PASS	AF=0.117291;DESCR=Genotype TT is not associated with response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes GG + GT.
chr11	1288726	rs3750920	C	T	.	PASS	AF=0.370392;DESCR=Genotype TT is associated with increased response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes CC + CT.
chr11	1303542	rs5743894	T	A	.	PASS	AF=0.00000;DESCR=Genotype TT is not associated with response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes CC + CT.
chr11	1303542	rs5743894	T	C	.	PASS	AF=0.146889;DESCR=Genotype TT is not associated with response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes CC + CT.
chr11	1304599	rs5743890	T	C	.	PASS	AF=0.118376;DESCR=Genotype TT is not associated with response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes CC + CT.
chr11	1310024	rs5743854	G	A	.	AC0	AF=0.00000;DESCR=Genotype CC is not associated with response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes CG + GG.
chr11	1310024	rs5743854	G	C	.	PASS	AF=0.863479;DESCR=Genotype CC is not associated with response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes CG + GG.
chr11	2143103	rs4244809	G	A	.	PASS	AF=0.251297;DESCR=Genotype GG is associated with decreased resistance to Platinum compounds in women with Ovarian Neoplasms as compared to genotypes AA + AG.
chr11	2158122	rs3842761	G	A	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with decreased resistance to Platinum compounds in women with Ovarian Neoplasms.
chr11	2158122	rs3842761	G	C	.	PASS	AF=0.345266;DESCR=Genotype GG is associated with decreased resistance to Platinum compounds in women with Ovarian Neoplasms.
chr11	2158122	rs3842761	G	T	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with decreased resistance to Platinum compounds in women with Ovarian Neoplasms.
chr11	2163618	rs3842727	G	T	.	PASS	AF=0.696830;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr11	2165105	rs2070762	A	G	.	PASS	AF=0.461028;DESCR=Genotype GG is associated with decreased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG.
chr11	2169721	rs6356	C	T	.	PASS	AF=0.385525;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr11	2172367	rs10770140	C	T	.	PASS	AF=0.645701;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr11	2172610	rs10770141	A	G	.	PASS	AF=0.618088;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr11	2174751	rs10743152	T	C	.	PASS	AF=0.635657;DESCR=Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.
chr11	2818521	rs2237892	C	T	.	PASS	AF=0.0567723;DESCR=Allele T is associated with increased clinical benefit to gliclazide in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr11	2825839	rs163184	T	G	.	PASS	AF=0.490196;DESCR=Genotype GG is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.
chr11	2835964	rs2237895	A	C	.	PASS	AF=0.448157;DESCR=Allele C is associated with increased clinical benefit to gliclazide in people with Diabetes Mellitus, Type 2 as compared to allele A.
chr11	2835964	rs2237895	A	T	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased clinical benefit to gliclazide in people with Diabetes Mellitus, Type 2 as compared to allele A.
chr11	2837316	rs2237897	C	T	.	PASS	AF=0.0421235;DESCR=Allele T is not associated with response to gliclazide in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr11	3668953	rs2741868	A	T	.	PASS	AF=0.739331;DESCR=Allele T is not associated with response to nicotine in women as compared to allele A.
chr11	4082830	rs2898950	A	C	.	PASS	AF=0.868588;DESCR=Genotypes AC + CC is associated with increased response to cladribine and cytarabine in children with Leukemia, Myeloid, Acute as compared to genotype AA.
chr11	4092165	rs1561876	G	A	.	PASS	AF=0.820565;DESCR=Genotypes AG + GG is associated with increased resistance to erythropoietin in people with Kidney Diseases and Anemia as compared to genotype AA.
chr11	4094257	rs11030918	T	C	.	PASS	AF=0.312644;DESCR=Genotype CT is associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + TT.
chr11	4094744	rs12806698	C	A	.	PASS	AF=0.253895;DESCR=Genotype AC is associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + CC.
chr11	4099619	rs2284449	T	C	.	PASS	AF=0.0198733;DESCR=Genotype TT is associated with decreased response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung.
chr11	4107615	rs725518	G	A	.	PASS	AF=0.530277;DESCR=Genotype GG is not associated with response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AG.
chr11	4117074	rs7940013	C	T	.	PASS	AF=0.383573;DESCR=Genotype CC is not associated with response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CT + TT.
chr11	4117895	rs232043	G	A	.	PASS	AF=0.919308;DESCR=Genotype AA is associated with decreased response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG.
chr11	4118748	rs720106	T	C	.	PASS	AF=0.0195965;DESCR=Genotype TT is associated with decreased response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CT.
chr11	4119902	rs183484	C	A	.	PASS	AF=0.511527;DESCR=Genotype CC is not associated with response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AC.
chr11	4121362	rs3817657	T	C	.	PASS	AF=0.385681;DESCR=Genotype TT is not associated with response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CT.
chr11	4138227	rs9937	A	G	.	PASS	AF=0.515300;DESCR=Genotype AA is not associated with response to carboplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.
chr11	4138236	rs1042858	G	A	.	PASS	AF=0.915176;DESCR=Genotype AA is not associated with response to carboplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.
chr11	4138236	rs1042858	G	T	.	PASS	AF=0.00000;DESCR=Genotype AA is not associated with response to carboplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.
chr11	4138534	rs1042919	A	T	.	PASS	AF=0.915274;DESCR=Genotype AT is associated with decreased response to cladribine and cytarabine in children with Leukemia, Myeloid, Acute as compared to genotype AA.
chr11	4583965	rs2566255	G	C	.	PASS	AF=0.834294;DESCR=Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr11	5040311	rs2499984	A	G	.	PASS	AF=0.545559;DESCR=Genotype GG is associated with increased response to lithium in people with Bipolar Disorder as compared to genotype AA.
chr11	5059614	rs16909440	T	C	.	PASS	AF=0.338134;DESCR=Genotype TT is associated with increased response to lithium in people with Bipolar Disorder as compared to genotype CC.
chr11	5573250	rs4575304	A	G	.	PASS	AF=0.733158;DESCR=Allele G is not associated with response to nicotine in women as compared to allele A.
chr11	5573250	rs4575304	A	T	.	AC0	AF=0.00000;DESCR=Allele G is not associated with response to nicotine in women as compared to allele A.
chr11	10303778	rs11042725	C	A	.	PASS	AF=0.388632;DESCR=Genotype CC is associated with decreased response to paroxetine in people with Depressive Disorder, Major as compared to genotypes AA + AC.
chr11	11354027	rs7937567	G	A	.	PASS	AF=0.585690;DESCR=Genotype GG is associated with increased response to cisplatin in people with Urinary Bladder Neoplasms as compared to genotypes AA + AG.
chr11	11458319	rs4910008	C	T	.	PASS	AF=0.450087;DESCR=Genotype CC is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.
chr11	13276938	rs2279287	T	C	.	PASS	AF=0.661383;DESCR=Allele T is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.
chr11	13328584	rs1982350	A	G	.	PASS	AF=0.597695;DESCR=Allele A is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.
chr11	13376331	rs2278749	C	T	.	PASS	AF=0.107266;DESCR=Allele T is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.
chr11	14972978	rs3781719	A	G	.	PASS	AF=0.263401;DESCR=Allele G is associated with decreased response to botulinum toxin type a in women with Migraine NOS as compared to allele A.
chr11	17330136	rs757081	C	G	.	PASS	AF=0.309689;DESCR=Allele C is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele G.
chr11	17386478	rs2285676	A	G	.	PASS	AF=0.300000;DESCR=Genotype CC is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.
chr11	17387083	rs5215	C	T	.	PASS	AF=0.645161;DESCR=Allele C is not associated with dose of glibenclamide, gliclazide, glimepiride, glipizide and gliquidone in people with Diabetes Mellitus as compared to allele T.
chr11	17388025	rs5219	T	C	.	PASS	AF=0.645617;DESCR=Allele T is not associated with decreased response to sulfonamides, urea derivatives.
chr11	17396930	rs757110	C	A	.	PASS	AF=0.623848;DESCR=Allele C is not associated with dose of glibenclamide, gliclazide, glimepiride, glipizide and gliquidone in people with Diabetes Mellitus as compared to allele A.
chr11	17418682	rs2237991	A	G	.	PASS	AF=0.292388;DESCR=Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.
chr11	18025708	rs1799913	G	A	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with decreased response to lithium in people with Bipolar Disorder.
chr11	18025708	rs1799913	G	T	.	PASS	AF=0.523356;DESCR=Genotype TT is associated with decreased response to lithium in people with Bipolar Disorder.
chr11	18026269	rs1800532	G	T	.	PASS	AF=0.523055;DESCR=Genotype GG is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes GT + TT.
chr11	18033757	rs211105	T	G	.	PASS	AF=0.202710;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr11	18042430	rs623580	A	T	.	PASS	AF=0.732143;DESCR=Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr11	23496859	rs1350948	A	C	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr11	23496859	rs1350948	A	G	.	PASS	AF=0.760657;DESCR=Allele A is associated with increased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr11	26578824	rs293983	C	T	.	PASS	AF=0.194813;DESCR=Allele T is not associated with response to belimumab in people with Lupus erythematosus as compared to allele C.
chr11	27648561	rs10501087	T	C	.	PASS	AF=0.270785;DESCR=Allele T is associated with increased resistance to antidepressants as compared to allele C.
chr11	27655494	rs7124442	C	G	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with decreased response to citalopram in people with Depressive Disorder, Major as compared to genotypes CC + CT.
chr11	27655494	rs7124442	C	T	.	PASS	AF=0.817003;DESCR=Genotype TT is associated with decreased response to citalopram in people with Depressive Disorder, Major as compared to genotypes CC + CT.
chr11	27658369	rs6265	C	T	.	PASS	AF=0.222478;DESCR=Allele C is not associated with response to modafinil in people with methamphetamine dependence as compared to allele T.
chr11	27659197	rs11030101	A	T	.	PASS	AF=0.500576;DESCR=Genotype AA is not associated with response to escitalopram in people with Depressive Disorder as compared to genotypes AT + TT.
chr11	27662970	rs11030104	A	G	.	PASS	AF=0.266724;DESCR=Genotypes AG + GG is associated with increased resistance to antipsychotics in people with Schizophrenia as compared to genotype AA.
chr11	27674363	rs10835210	C	A	.	PASS	AF=0.488459;DESCR=Genotype CC is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes AA + AC.
chr11	27674363	rs10835210	C	G	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes AA + AC.
chr11	27676827	rs16917234	T	A	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to heroin as compared to allele T.
chr11	27676827	rs16917234	T	C	.	PASS	AF=0.00201613;DESCR=Allele C is not associated with response to heroin as compared to allele T.
chr11	27678578	rs7103411	C	T	.	PASS	AF=0.708237;DESCR=Genotype TT is not associated with response to escitalopram in people with Depressive Disorder as compared to genotypes CC + CT.
chr11	27693337	rs7127507	T	C	.	PASS	AF=0.194813;DESCR=Allele C is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele T.
chr11	27700731	rs61888800	G	T	.	PASS	AF=0.127813;DESCR=Genotype GG is associated with increased response to antidepressants, desipramine and fluoxetine in people with Depressive Disorder, Major.
chr11	27703198	rs988748	C	G	.	PASS	AF=0.706509;DESCR=Allele C is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele G.
chr11	27705368	rs2030324	A	G	.	PASS	AF=0.512392;DESCR=Allele G is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele A.
chr11	27706555	rs11030119	G	A	.	PASS	AF=0.181268;DESCR=Allele G is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele A.
chr11	27710436	rs7934165	G	A	.	PASS	AF=0.512399;DESCR=Genotype AA is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes AG + GG.
chr11	27712873	rs962369	T	C	.	PASS	AF=0.180139;DESCR=Allele C is not associated with decreased response to escitalopram in people with Major Depressive Disorder as compared to allele T (assigned as normal metabolizer phenotype) .
chr11	27728178	rs1491850	T	C	.	PASS	AF=0.418061;DESCR=Genotype CC is not associated with response to escitalopram in people with Depressive Disorder as compared to genotypes CT + TT.
chr11	34438684	rs1001179	C	T	.	PASS	AF=0.223631;DESCR=Genotype CC is not associated with response to atorvastatin in people with Dyslipidaemia as compared to genotypes CT + TT.
chr11	34633816	rs286913	A	G	.	PASS	AF=0.947293;DESCR=Allele A is associated with increased response to ziprasidone in people with Schizophrenia as compared to allele G.
chr11	34633816	rs286913	A	T	.	AC0	AF=0.00000;DESCR=Allele A is associated with increased response to ziprasidone in people with Schizophrenia as compared to allele G.
chr11	35419429	rs4354668	T	G	.	PASS	AF=0.523919;DESCR=Allele G is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele T.
chr11	46723453	rs5896	C	T	.	PASS	AF=0.0794931;DESCR=Genotype TT is associated with decreased dose of warfarin as compared to genotypes CC + CT.
chr11	46739206	rs3136516	G	A	.	PASS	AF=0.521313;DESCR=Allele G is not associated with dose of warfarin in people with heart valve replacement as compared to allele A.
chr11	57599749	rs1005510	C	T	.	PASS	AF=0.457612;DESCR=Genotype CC is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype TT.
chr11	57610852	rs2511989	C	T	.	PASS	AF=0.254608;DESCR=Genotype TT is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype CC.
chr11	58624028	rs1800169	G	A	.	PASS	AF=0.126440;DESCR=Genotype GG is associated with increased response to iloperidone in people with Schizophrenia as compared to genotypes AA + AG.
chr11	61792609	rs174538	G	A	.	PASS	AF=0.247408;DESCR=Allele A is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr11	61796827	rs4246215	G	C	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr11	61796827	rs4246215	G	T	.	PASS	AF=0.291234;DESCR=Allele T is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr11	62916053	rs1942499	A	G	.	PASS	AF=0.351297;DESCR=Genotype GG is associated with decreased dose of clozapine in people with Schizophrenia as compared to genotypes AA + AG.
chr11	62916053	rs1942499	A	T	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with decreased dose of clozapine in people with Schizophrenia as compared to genotypes AA + AG.
chr11	62920797	rs2075748	C	G	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with decreased dose of clozapine in people with Schizophrenia as compared to genotypes CT + TT.
chr11	62920797	rs2075748	C	T	.	PASS	AF=0.172434;DESCR=Genotype CC is associated with decreased dose of clozapine in people with Schizophrenia as compared to genotypes CT + TT.
chr11	62984817	rs4149170	C	T	.	PASS	AF=0.0835735;DESCR=Genotype TT is associated with increased concentrations of tenofovir in people with Hepatitis B, Chronic as compared to genotypes CC + CT.
chr11	62995792	rs11568482	T	A	.	PASS	AF=0.000288184;DESCR=Genotype AT is associated with decreased clearance of cefotaxime in healthy individuals as compared to genotype TT.
chr11	64185649	rs3751122	G	A	.	PASS	AF=0.000288184;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr11	64185649	rs3751122	G	C	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr11	64185649	rs3751122	G	T	.	PASS	AF=0.0734870;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr11	64189598	rs2701528	A	G	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr11	64191787	rs4980524	A	C	.	PASS	AF=0.333622;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr11	64191884	rs6591838	A	G	.	PASS	AF=0.157621;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr11	64194680	rs2282490	T	C	.	PASS	AF=0.175691;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr11	64196475	rs11607165	T	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr11	64196475	rs11607165	T	G	.	PASS	AF=0.175808;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr11	64197133	rs2236647	C	T	.	PASS	AF=0.406052;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr11	64197185	rs2236648	C	T	.	PASS	AF=0.333237;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr11	64203153	rs2070232	G	A	.	PASS	AF=0.0708934;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr11	64205924	rs1011219	G	A	.	PASS	AF=0.0760369;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr11	64205924	rs1011219	G	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr11	64278557	rs671976	G	A	.	PASS	AF=0.608934;DESCR=Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele A.
chr11	64535478	rs11231809	T	A	.	PASS	AF=0.340542;DESCR=Genotypes AT + TT are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.
chr11	64563990	rs17300741	A	G	.	PASS	AF=0.538351;DESCR=Allele G is not associated with dose of allopurinol in people with Gout as compared to allele A.
chr11	64566642	rs2078267	C	T	.	PASS	AF=0.534334;DESCR=Allele T is not associated with response to furosemide in healthy individuals as compared to allele C.
chr11	64589600	rs505802	T	C	.	PASS	AF=0.286455;DESCR=Allele T is associated with increased dose of allopurinol in people with Gout as compared to allele C.
chr11	64591337	rs3825018	G	A	.	PASS	AF=0.713956;DESCR=Allele G is not associated with dose of allopurinol in people with Gout as compared to allele A.
chr11	64591814	rs3825016	C	T	.	PASS	AF=0.714574;DESCR=Genotypes CT + TT is associated with decreased response to losartan in people with Hypertension and Hyperuricemia as compared to genotype CC.
chr11	64598471	rs1529909	T	C	.	PASS	AF=0.713833;DESCR=Genotypes CC + CT is associated with decreased response to losartan in people with Hypertension and Hyperuricemia as compared to genotype TT.
chr11	64728885	rs2230414	G	T	.	PASS	AF=0.149366;DESCR=Allele T is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele G.
chr11	65297219	rs487989	G	A	.	PASS	AF=0.195790;DESCR=Genotype GG is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AG.
chr11	65498698	rs619586	A	G	.	PASS	AF=0.0138329;DESCR=Genotypes AG + GG are associated with decreased response to Platinum compounds in people with Lung Neoplasms as compared to genotype AA.
chr11	67585218	rs1695	A	G	.	PASS	AF=0.211894;DESCR=Genotype GG is associated with decreased response to dimethyl fumarate in people with Psoriasis as compared to genotypes AA + AG.
chr11	67586108	rs1138272	C	T	.	PASS	AF=0.0397924;DESCR=Allele C is not associated with response to oxaliplatin in people with Gastrointestinal Neoplasms as compared to allele T.
chr11	67647583	rs2514036	C	G	.	AC0	AF=0.00000;DESCR=Allele T is associated with increased response to bisoprolol in men with Hypertension as compared to allele C.
chr11	67647583	rs2514036	C	T	.	PASS	AF=0.865783;DESCR=Allele T is associated with increased response to bisoprolol in men with Hypertension as compared to allele C.
chr11	68433827	rs3736228	C	T	.	PASS	AF=0.107143;DESCR=Allele T is not associated with response to risedronate in people with Osteoporosis as compared to allele C.
chr11	68682735	rs948854	C	T	.	PASS	AF=0.760807;DESCR=Allele C is associated with decreased response to antidepressants, benzodiazepine derivatives, mirtazapine or Selective serotonin reuptake inhibitors in women Depressive Disorder, Major as compared to allele T.
chr11	69648142	rs9344	G	A	.	PASS	AF=0.446141;DESCR=Genotypes CA/CA + CA/CG are associated with increased response to lapatinib in women with Breast Neoplasms as compared to genotype CG/CG.
chr11	72028377	rs10898815	G	A	.	PASS	AF=0.577881;DESCR=Genotypes AA + AG is associated with increased discontinuation of Dihydropyridine derivatives as compared to genotype GG.
chr11	72139084	rs61734430	C	T	.	PASS	AF=0.0414330;DESCR=Genotypes CT + TT is associated with decreased response to pemetrexed in people with Carcinoma, Non-Small-Cell Lung and Mesothelioma as compared to genotype CC.
chr11	75150836	rs2712807	G	A	.	PASS	AF=0.883285;DESCR=Allele A is not associated with clearance of montelukast in healthy individuals as compared to allele G.
chr11	75169325	rs35199625	G	A	.	PASS	AF=0.0184332;DESCR=Allele A is not associated with clearance of montelukast in healthy individuals as compared to allele G.
chr11	75172532	rs12422149	G	A	.	PASS	AF=0.128530;DESCR=Genotypes AA + AG is associated with increased concentrations of tamoxifen in women with Breast Neoplasms as compared to genotype GG.
chr11	75172532	rs12422149	G	T	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG is associated with increased concentrations of tamoxifen in women with Breast Neoplasms as compared to genotype GG.
chr11	75190556	rs1077858	G	A	.	PASS	AF=0.643804;DESCR=Genotypes AA + AG is associated with increased concentrations of abiraterone in healthy individuals as compared to genotype GG.
chr11	75196537	rs2306168	C	T	.	PASS	AF=0.0550432;DESCR=Genotype TT is not associated with increased exposure to atenolol in healthy individuals as compared to genotype CC.
chr11	75204976	rs3781727	T	C	.	PASS	AF=0.00374640;DESCR=Genotypes CC + CT are associated with decreased exposure to voriconazole in healthy individuals as compared to genotype TT.
chr11	75267688	rs140226575	G	A	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased clinical benefit to albiglutide, dulaglutide or Glucagon-like peptide-1 (GLP-1) analogues in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr11	75267688	rs140226575	G	C	.	AC0	AF=0.00000;DESCR=Allele A is associated with increased clinical benefit to albiglutide, dulaglutide or Glucagon-like peptide-1 (GLP-1) analogues in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr11	75267688	rs140226575	G	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased clinical benefit to albiglutide, dulaglutide or Glucagon-like peptide-1 (GLP-1) analogues in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr11	76590272	rs7927894	C	T	.	PASS	AF=0.466282;DESCR=Genotype CC is associated with increased response to adalimumab in people with Crohn Disease as compared to genotypes CT + TT.
chr11	80347435	rs7395555	G	C	.	PASS	AF=0.137255;DESCR=Allele C is associated with increased response to risperidone in people with Schizophrenia as compared to allele G.
chr11	82853252	rs2229437	T	A	.	PASS	AF=0.00000;DESCR=Genotypes GG + GT are associated with decreased response to benazepril in people with Hypertension as compared to genotype TT.
chr11	82853252	rs2229437	T	G	.	PASS	AF=0.194700;DESCR=Genotypes GG + GT are associated with decreased response to benazepril in people with Hypertension as compared to genotype TT.
chr11	83983729	rs2449598	T	G	.	PASS	AF=0.916955;DESCR=Allele T is associated with decreased response to anastrozole in women with Breast Neoplasms as compared to allele G.
chr11	85980619	rs588076	G	C	.	PASS	AF=0.749280;DESCR=Genotype GG is associated with increased response to calcium channel blockers in people with Hypertension as compared to genotype CC.
chr11	85980619	rs588076	G	T	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with increased response to calcium channel blockers in people with Hypertension as compared to genotype CC.
chr11	86948171	rs10898563	A	G	.	PASS	AF=0.398789;DESCR=Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele A.
chr11	92969796	rs8192552	G	A	.	PASS	AF=0.0311239;DESCR=Genotype AG is associated with increased exposure to vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma, Hodgkin Disease, Rhabdomyosarcoma, Medulloblastoma or Glioma as compared to genotype GG.
chr11	93951643	rs2511398	A	G	.	PASS	AF=0.597977;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr11	93958166	rs2456568	T	A	.	PASS	AF=0.590542;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr11	94398973	rs3758785	A	G	.	PASS	AF=0.243376;DESCR=Genotype GG is associated with increased response to candesartan in people with Essential hypertension as compared to genotype AA.
chr11	100140279	rs1813443	G	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr11	100140279	rs1813443	G	C	.	PASS	AF=0.303170;DESCR=Allele C is associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr11	101117303	rs537681	C	T	.	PASS	AF=0.815274;DESCR=Genotypes CT + TT is associated with decreased steady-state concentration of etonogestrel in women as compared to genotype CC.
chr11	105027116	rs557905	T	C	.	PASS	AF=0.164937;DESCR=Allele T is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele C.
chr11	105033843	rs568910	A	C	.	PASS	AF=0.164553;DESCR=Allele A is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele C.
chr11	105041731	rs1503391	A	C	.	PASS	AF=0.164841;DESCR=Allele A is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele C.
chr11	105041826	rs1792774	C	T	.	PASS	AF=0.106567;DESCR=Allele C is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele T.
chr11	105553068	rs2513265	T	A	.	PASS	AF=0.482133;DESCR=Allele A is associated with increased response to antipsychotics in people with Schizophrenia as compared to allele T.
chr11	108412434	rs11212617	C	A	.	PASS	AF=0.639481;DESCR=Allele C is associated with increased clinical benefit to metformin in people with Diabetes Mellitus, Type 2 as compared to allele A.
chr11	112155433	rs5744247	G	C	.	PASS	AF=0.146601;DESCR=Allele C is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.
chr11	112164265	rs187238	C	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased response to interferon alfa-2a, recombinant, interferon alfa-2b, recombinant, interferons, peginterferon alfa-2a, peginterferon alfa-2b or ribavirin in people with Hepatitis C, Chronic as compared to allele G.
chr11	112164265	rs187238	C	G	.	PASS	AF=0.268012;DESCR=Allele C is associated with decreased response to interferon alfa-2a, recombinant, interferon alfa-2b, recombinant, interferons, peginterferon alfa-2a, peginterferon alfa-2b or ribavirin in people with Hepatitis C, Chronic as compared to allele G.
chr11	112164735	rs1946518	T	G	.	PASS	AF=0.488178;DESCR=Allele T is associated with increased response to interferon alfa-2a, recombinant, interferon alfa-2b, recombinant, interferons, peginterferon alfa-2a, peginterferon alfa-2b or ribavirin in people with Hepatitis C, Chronic as compared to allele G.
chr11	112164784	rs1946519	A	C	.	PASS	AF=0.487615;DESCR=Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele C.
chr11	113240779	rs2303377	T	C	.	PASS	AF=0.414986;DESCR=Genotype TT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes CC + CT.
chr11	113393748	rs4938013	A	C	.	PASS	AF=0.672811;DESCR=Allele C is not associated with response to clozapine in people with Schizophrenia as compared to allele A.
chr11	113396099	rs7118900	G	A	.	PASS	AF=0.153802;DESCR=Genotypes AA + AG are associated with decreased dose of methadone in people with Heroin Dependence as compared to genotype GG.
chr11	113400106	rs1800497	G	A	.	PASS	AF=0.168876;DESCR=Genotype AA is not associated with dose of methadone in people with Substance-Related Disorders as compared to genotypes AG + GG.
chr11	113402203	rs2587550	G	A	.	PASS	AF=0.654446;DESCR=Allele G is associated with increased response to haloperidol in people with Schizophrenia as compared to allele A.
chr11	113402914	rs1003641	A	G	.	PASS	AF=0.655331;DESCR=Allele A is associated with increased response to haloperidol in people with Schizophrenia as compared to allele G.
chr11	113407761	rs2234689	G	C	.	PASS	AF=0.776240;DESCR=Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr11	113408042	rs1554929	C	T	.	PASS	AF=0.535755;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr11	113410351	rs6279	G	C	.	PASS	AF=0.655133;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele G.
chr11	113412737	rs6277	G	A	.	PASS	AF=0.539459;DESCR=Allele A is not associated with exposure to olanzapine in healthy individuals as compared to allele G.
chr11	113412755	rs6275	A	G	.	PASS	AF=0.657530;DESCR=Genotypes AA + AG are associated with decreased response to rizatriptan in people with Migraine without Aura as compared to genotype GG.
chr11	113412762	rs1801028	G	C	.	PASS	AF=0.0363112;DESCR=Genotypes CG + GG are not associated with response to antipsychotics in people with Schizophrenia as compared to genotype CC.
chr11	113412966	rs1076560	C	A	.	PASS	AF=0.115850;DESCR=Genotype CC is associated with increased response to rasagiline in people with Parkinson Disease as compared to genotypes AA + AC.
chr11	113414814	rs2283265	C	A	.	PASS	AF=0.107431;DESCR=Genotypes AA + AC are associated with decreased dose of methadone in people with Heroin Dependence as compared to genotype CC.
chr11	113422198	rs2734833	G	A	.	PASS	AF=0.645329;DESCR=Allele A is not associated with response to heroin as compared to allele G.
chr11	113424176	rs2075652	G	A	.	PASS	AF=0.0144009;DESCR=Allele A is not associated with response to heroin as compared to allele G.
chr11	113425564	rs1079597	C	T	.	PASS	AF=0.107617;DESCR=Allele C is associated with increased response to amisulpride in people with Schizophrenia as compared to allele T.
chr11	113425897	rs1079596	C	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to heroin as compared to allele C.
chr11	113425897	rs1079596	C	T	.	PASS	AF=0.107266;DESCR=Allele T is not associated with response to heroin as compared to allele C.
chr11	113426463	rs1125394	T	C	.	PASS	AF=0.107493;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr11	113429188	rs7131440	C	T	.	PASS	AF=0.647839;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr11	113433735	rs7122246	G	A	.	PASS	AF=0.645533;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr11	113436043	rs4436578	C	G	.	AC0	AF=0.00000;DESCR=Allele C is not associated with response to heroin as compared to allele T.
chr11	113436043	rs4436578	C	T	.	PASS	AF=0.866571;DESCR=Allele C is not associated with response to heroin as compared to allele T.
chr11	113441417	rs11214607	T	G	.	PASS	AF=0.106052;DESCR=Allele G is not associated with response to heroin as compared to allele T.
chr11	113442667	rs4648318	T	C	.	PASS	AF=0.244092;DESCR=Allele T is not associated with response to heroin as compared to allele C.
chr11	113445514	rs12574471	C	T	.	PASS	AF=0.0832853;DESCR=Allele T is not associated with response to heroin as compared to allele C.
chr11	113447023	rs17601612	G	C	.	PASS	AF=0.429971;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele G.
chr11	113448730	rs4274224	G	A	.	PASS	AF=0.508944;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr11	113459052	rs7131056	A	C	.	PASS	AF=0.648906;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele A.
chr11	113459052	rs7131056	A	G	.	PASS	AF=0.00000;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele A.
chr11	113459729	rs4936274	A	G	.	PASS	AF=0.939228;DESCR=Allele A is not associated with response to heroin as compared to allele G.
chr11	113460810	rs4648317	G	A	.	PASS	AF=0.136599;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr11	113475629	rs1799978	T	C	.	PASS	AF=0.0775216;DESCR=Allele C is associated with increased resistance to haloperidol, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr11	113522272	rs2514218	C	T	.	PASS	AF=0.432198;DESCR=Allele T is associated with increased response to clozapine in people with Schizophrenia as compared to allele C.
chr11	113904173	rs11214763	G	A	.	PASS	AF=0.247693;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr11	113910259	rs11606194	T	C	.	PASS	AF=0.0357555;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr11	113919377	rs7103572	C	T	.	PASS	AF=0.281719;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr11	113932306	rs1176744	A	C	.	PASS	AF=0.337276;DESCR=Genotype AA is not associated with response to granisetron in healthy individuals as compared to genotypes AC + CC.
chr11	113933165	rs2276307	A	G	.	PASS	AF=0.289459;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr11	113936885	rs3782025	G	A	.	PASS	AF=0.634160;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr11	113942011	rs1672717	G	A	.	PASS	AF=0.673687;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr11	113946564	rs7943062	G	A	.	PASS	AF=0.232853;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr11	113974819	rs1150226	A	G	.	PASS	AF=0.969452;DESCR=Allele G is associated with increased response to clozapine in people with Schizophrenia as compared to allele A.
chr11	113975284	rs1062613	T	C	.	PASS	AF=0.750432;DESCR=Genotype CC is not associated with response to granisetron in healthy individuals as compared to genotypes CT + TT.
chr11	113979418	rs2276302	G	A	.	PASS	AF=0.712968;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr11	113981465	rs1176719	G	A	.	PASS	AF=0.291187;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr11	113989703	rs1176713	A	G	.	PASS	AF=0.268454;DESCR=Allele G is not associated with response to risperidone in people with Schizophrenia as compared to allele A.
chr11	116778201	rs964184	G	C	.	PASS	AF=0.824005;DESCR=Allele G is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to allele C.
chr11	116791691	rs3135506	G	A	.	PASS	AF=0.00000;DESCR=Genotypes CG + GG are associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC.
chr11	116791691	rs3135506	G	C	.	PASS	AF=0.0657061;DESCR=Genotypes CG + GG are associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC.
chr11	116792991	rs662799	G	A	.	PASS	AF=0.911578;DESCR=Genotype AA is associated with increased response to simvastatin in people with Dyslipidaemia as compared to genotypes AG + GG.
chr11	116819996	rs1263177	C	T	.	PASS	AF=0.559469;DESCR=Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.
chr11	116820959	rs675	T	A	.	PASS	AF=0.220716;DESCR=Genotypes AA + AT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.
chr11	116820959	rs675	T	C	.	PASS	AF=0.00317186;DESCR=Genotypes AA + AT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.
chr11	116821618	rs5104	C	T	.	PASS	AF=0.801843;DESCR=Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.
chr11	116822748	rs5092	C	T	.	PASS	AF=0.782997;DESCR=Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.
chr11	116823339	rs5090	C	G	.	PASS	AF=0.0455331;DESCR=Genotype CG is not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype GG.
chr11	116827022	rs2542051	C	A	.	PASS	AF=0.550691;DESCR=Genotypes AC + CC are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype AA.
chr11	116829268	rs2542052	A	C	.	PASS	AF=0.660727;DESCR=Genotypes AA + AC are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC.
chr11	116829426	rs2854117	T	C	.	PASS	AF=0.706797;DESCR=Genotypes CT + TT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC.
chr11	116829453	rs2854116	C	T	.	PASS	AF=0.576945;DESCR=Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.
chr11	116830819	rs4520	T	C	.	PASS	AF=0.702017;DESCR=Allele C is not associated with exposure to olanzapine in healthy individuals as compared to allele T.
chr11	116832924	rs5128	G	C	.	PASS	AF=0.858213;DESCR=Genotypes CC + CG are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype GG.
chr11	116837697	rs670	C	A	.	PASS	AF=0.00000;DESCR=Genotypes CT + TT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC.
chr11	116837697	rs670	C	T	.	PASS	AF=0.147924;DESCR=Genotypes CT + TT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC.
chr11	116840252	rs613808	A	G	.	PASS	AF=0.664747;DESCR=Genotypes AA + AG are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype GG.
chr11	116840425	rs2727784	C	G	.	PASS	AF=0.00000;DESCR=Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.
chr11	116840425	rs2727784	C	T	.	PASS	AF=0.624062;DESCR=Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.
chr11	116840634	rs11216158	G	A	.	PASS	AF=0.112039;DESCR=Genotypes AA + AG are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype GG.
chr11	116870856	rs533556	A	C	.	PASS	AF=0.537176;DESCR=Genotype AA is associated with decreased response to hmg coa reductase inhibitors in people with Hyperlipidemias as compared to genotype CC.
chr11	120792654	rs1954787	T	C	.	PASS	AF=0.546216;DESCR=Genotype CC is associated with increased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotypes CT + TT.
chr11	123522138	rs61123830	G	A	.	PASS	AF=0.426921;DESCR=Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr11	123522138	rs61123830	G	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr11	126157578	rs3133084	A	G	.	PASS	AF=0.370456;DESCR=Allele A is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele G.
chr11	126292948	rs8177374	C	T	.	PASS	AF=0.130548;DESCR=Genotypes CT + TT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype CC.
chr11	130041952	rs112914324	G	T	.	PASS	AF=0.0397465;DESCR=Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G.
chr11	131320708	rs139945292	C	T	.	PASS	AF=0.0898618;DESCR=Allele T is associated with decreased response to Beta Blocking Agents in people with Hypertension as compared to allele C.
chr11	132623600	rs751655	C	T	.	PASS	AF=0.144380;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr12	2052395	rs723672	C	T	.	PASS	AF=0.373272;DESCR=Allele C is not associated with response to olanzapine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr12	2073132	rs2283271	T	A	.	PASS	AF=0.832853;DESCR=Allele A is not associated with response to olanzapine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr12	2111239	rs758723	T	A	.	PASS	AF=0.722926;DESCR=Allele A is not associated with response to olanzapine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr12	2113566	rs2238032	T	G	.	PASS	AF=0.00778547;DESCR=Genotype TT is not associated with response to nimodipine in healthy individuals as compared to genotype GT.
chr12	2207029	rs10848635	T	A	.	PASS	AF=0.397695;DESCR=Allele A is not associated with response to olanzapine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr12	2338248	rs2239050	G	C	.	PASS	AF=0.180692;DESCR=Genotype CG is associated with increased response to nimodipine in healthy individuals as compared to genotype CC.
chr12	2504550	rs2238087	C	T	.	PASS	AF=0.124279;DESCR=Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype TT.
chr12	2585472	rs215976	C	T	.	PASS	AF=0.137673;DESCR=Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.
chr12	2611971	rs216008	C	T	.	PASS	AF=0.232565;DESCR=Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.
chr12	2620466	rs216013	A	G	.	PASS	AF=0.194813;DESCR=Allele A is not associated with dose of warfarin.
chr12	2627452	rs12813888	A	C	.	PASS	AF=0.201325;DESCR=Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.
chr12	2627452	rs12813888	A	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.
chr12	2648603	rs2239128	T	A	.	AC0	AF=0.00000;DESCR=Genotype CC is associated with increased response to nimodipine in healthy individuals as compared to genotype CT.
chr12	2648603	rs2239128	T	C	.	PASS	AF=0.755055;DESCR=Genotype CC is associated with increased response to nimodipine in healthy individuals as compared to genotype CT.
chr12	2695289	rs7316246	G	A	.	PASS	AF=0.0236448;DESCR=Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.
chr12	2695289	rs7316246	G	C	.	PASS	AF=0.00000;DESCR=Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.
chr12	4052705	rs2532560	G	A	.	PASS	AF=0.766571;DESCR=Allele G is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele A.
chr12	4408974	rs1024905	G	C	.	PASS	AF=0.590202;DESCR=Allele G is not associated with response to Selective serotonin (5HT1) agonists in people with Migraine without Aura as compared to allele C.
chr12	5642176	rs2110166	C	T	.	PASS	AF=0.0282421;DESCR=Genotype TT is associated with increased clinical benefit to aflibercept or ranibizumab in people with Macular Degeneration as compared to genotypes CC + CT.
chr12	5915594	rs61908402	T	C	.	PASS	AF=0.227771;DESCR=Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr12	5915639	rs61908403	G	A	.	PASS	AF=0.227378;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr12	5916105	rs61908404	C	T	.	PASS	AF=0.228060;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr12	5916164	rs61908405	C	A	.	PASS	AF=0.234447;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr12	5916322	rs17724452	C	A	.	PASS	AF=0.228091;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr12	5916322	rs17724452	C	T	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr12	5916418	rs17724464	G	C	.	PASS	AF=0.226190;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr12	5916924	rs17786394	T	C	.	PASS	AF=0.227089;DESCR=Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr12	5916985	rs17786400	A	G	.	PASS	AF=0.227194;DESCR=Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr12	5916985	rs17786400	A	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr12	5917081	rs61908406	G	A	.	PASS	AF=0.227194;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr12	5917148	rs17786412	G	A	.	PASS	AF=0.227797;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr12	5917148	rs17786412	G	T	.	PASS	AF=0.00000;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr12	5917207	rs61908407	A	G	.	PASS	AF=0.227089;DESCR=Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr12	5917289	rs61908408	A	G	.	PASS	AF=0.227220;DESCR=Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr12	5917405	rs61908409	C	G	.	PASS	AF=0.227797;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr12	5917412	rs61908410	T	A	.	PASS	AF=0.227640;DESCR=Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr12	5917824	rs78482393	G	A	.	PASS	AF=0.227535;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr12	5917867	rs78615940	A	C	.	PASS	AF=0.227666;DESCR=Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr12	5918126	rs17724494	C	T	.	PASS	AF=0.227089;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr12	5918478	rs61908411	C	T	.	PASS	AF=0.227325;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr12	6341779	rs767455	T	C	.	PASS	AF=0.424827;DESCR=Genotype TT is not associated with response to adalimumab, etanercept and infliximab in people with Arthritis, Rheumatoid as compared to genotypes CC + CT.
chr12	6342197	rs2234649	T	G	.	PASS	AF=0.0346021;DESCR=Genotype GT is not associated with response to etanercept in people with Spondylitis, Ankylosing as compared to genotypes GG + TT.
chr12	6342424	rs4149570	A	C	.	PASS	AF=0.672921;DESCR=Genotype AA is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease or Inflammatory Bowel Diseases as compared to genotypes AC + CC.
chr12	6342424	rs4149570	A	T	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease or Inflammatory Bowel Diseases as compared to genotypes AC + CC.
chr12	6839862	rs5441	A	G	.	PASS	AF=0.572911;DESCR=Genotype GG is associated with increased response to sertraline in people with Depressive Disorder, Major as compared to genotypes AA + AG.
chr12	6844093	rs11064426	A	C	.	PASS	AF=0.0931800;DESCR=Genotype AA is associated with increased response to atenolol in people with Essential hypertension as compared to genotype CC.
chr12	6844093	rs11064426	A	G	.	PASS	AF=0.00594295;DESCR=Genotype AA is associated with increased response to atenolol in people with Essential hypertension as compared to genotype CC.
chr12	6844093	rs11064426	A	T	.	PASS	AF=0.277601;DESCR=Genotype AA is associated with increased response to atenolol in people with Essential hypertension as compared to genotype CC.
chr12	6845711	rs5443	C	T	.	PASS	AF=0.315850;DESCR=Genotype CC is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.
chr12	6867132	rs12302749	C	T	.	PASS	AF=0.260807;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr12	9657125	rs7316769	G	T	.	PASS	AF=0.920219;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr12	9657855	rs7306991	A	T	.	PASS	AF=0.909850;DESCR=Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr12	9658801	rs10771997	T	C	.	PASS	AF=0.905655;DESCR=Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr12	9658872	rs10771998	A	G	.	PASS	AF=0.909433;DESCR=Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr12	9658876	rs10771999	C	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr12	9658876	rs10771999	C	G	.	PASS	AF=0.919850;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr12	9670356	rs1560011	A	G	.	PASS	AF=0.516157;DESCR=Genotype GG is associated with increased clinical benefit to tocilizumab in people with Rheumatoid arthritis.
chr12	9753094	rs11052877	A	G	.	PASS	AF=0.475504;DESCR=Allele A is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.
chr12	10307944	rs2302489	A	T	.	PASS	AF=0.672145;DESCR=Genotype TT is associated with decreased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AA + AT.
chr12	10372766	rs1049174	G	C	.	PASS	AF=0.600576;DESCR=Genotype GG is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes CC + CG.
chr12	10406893	rs1154831	G	T	.	PASS	AF=0.208934;DESCR=Genotype GG is associated with increased clinical benefit to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylarthropathy as compared to genotypes GT + TT.
chr12	10446203	rs2734414	A	T	.	PASS	AF=0.206628;DESCR=Genotype TT is not associated with response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AA + AT.
chr12	10449091	rs7301582	C	T	.	PASS	AF=0.201096;DESCR=Genotype CC is associated with decreased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.
chr12	10449478	rs2734440	C	T	.	PASS	AF=0.596254;DESCR=Genotype TT is not associated with response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CC + CT.
chr12	13562374	rs890	A	C	.	PASS	AF=0.516138;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.
chr12	13562374	rs890	A	G	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.
chr12	13713238	rs2284411	C	T	.	PASS	AF=0.382948;DESCR=Genotype CC is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CT + TT.
chr12	13785842	rs1072388	G	A	.	PASS	AF=0.206052;DESCR=Genotypes AA + AG are associated with increased response to clozapine in people with Schizophrenia as compared to genotype GG.
chr12	13800184	rs2058878	T	A	.	PASS	AF=0.555652;DESCR=Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.
chr12	13800184	rs2058878	T	C	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.
chr12	13828793	rs2160733	A	C	.	PASS	AF=0.245963;DESCR=Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.
chr12	13831415	rs2160734	C	T	.	PASS	AF=0.598152;DESCR=Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele T.
chr12	13981909	rs1019385	C	A	.	PASS	AF=0.520196;DESCR=Genotype AC is associated with decreased dose of valproic acid in people with Epilepsy as compared to genotype AA.
chr12	20020830	rs12579720	C	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to allele G.
chr12	20020830	rs12579720	C	G	.	PASS	AF=0.727954;DESCR=Allele C is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to allele G.
chr12	20020830	rs12579720	C	T	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to allele G.
chr12	20707159	rs3794271	G	A	.	PASS	AF=0.742066;DESCR=Allele G is not associated with decreased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele A.
chr12	20858546	rs4149117	T	C	.	PASS	AF=0.00000;DESCR=Genotypes GG + GT is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.
chr12	20858546	rs4149117	T	G	.	PASS	AF=0.889689;DESCR=Genotypes GG + GT is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.
chr12	20858647	rs4149118	G	A	.	PASS	AF=0.672722;DESCR=Allele G is associated with decreased clearance of docetaxel in people with Nasopharyngeal Neoplasms.
chr12	20862826	rs7311358	G	A	.	PASS	AF=0.889689;DESCR=Allele A is associated with decreased clearance of docetaxel in people with Nasopharyngeal Neoplasms.
chr12	20875274	rs60140950	G	C	.	PASS	AF=0.193084;DESCR=Allele C is associated with increased concentrations of telmisartan in healthy individuals as compared to allele G.
chr12	20892760	rs11045585	A	G	.	PASS	AF=0.109159;DESCR=Allele G is associated with decreased clearance of docetaxel in people with Nasopharyngeal Neoplasms.
chr12	21053900	rs1910167	T	C	.	PASS	AF=0.164934;DESCR=Allele C is associated with increased concentrations of bilirubin in children as compared to allele T.
chr12	21130388	rs4149015	G	A	.	PASS	AF=0.0731988;DESCR=Genotype AG is associated with decreased response to pravastatin as compared to genotype GG.
chr12	21130388	rs4149015	G	C	.	PASS	AF=0.00000;DESCR=Genotype AG is associated with decreased response to pravastatin as compared to genotype GG.
chr12	21143541	rs2417955	T	A	.	PASS	AF=0.556358;DESCR=Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.
chr12	21162481	rs4149026	A	C	.	PASS	AF=0.373126;DESCR=Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.
chr12	21164734	rs10444413	T	C	.	PASS	AF=0.211850;DESCR=Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.
chr12	21164857	rs4149032	C	T	.	PASS	AF=0.380046;DESCR=Genotypes CT + TT is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype CC.
chr12	21164988	rs4149034	G	A	.	PASS	AF=0.379539;DESCR=Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele G.
chr12	21164988	rs4149034	G	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele G.
chr12	21165331	rs4149035	T	C	.	PASS	AF=0.600576;DESCR=Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr12	21168436	rs10841753	T	C	.	PASS	AF=0.255767;DESCR=Genotypes CT + TT are associated with decreased concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.
chr12	21172880	rs2291073	T	G	.	PASS	AF=0.0655312;DESCR=Genotypes GT + TT are associated with increased response to lovastatin as compared to genotype GG.
chr12	21174806	rs4149036	C	A	.	PASS	AF=0.188439;DESCR=Genotypes AC + CC are associated with increased response to atorvastatin as compared to genotype AA.
chr12	21176804	rs2306283	A	G	.	PASS	AF=0.459007;DESCR=Genotype GG is associated with increased concentrations of rosuvastatin in healthy individuals as compared to genotype AA.
chr12	21176804	rs2306283	A	T	.	AC0	AF=0.00000;DESCR=Genotype GG is associated with increased concentrations of rosuvastatin in healthy individuals as compared to genotype AA.
chr12	21176879	rs11045819	C	A	.	PASS	AF=0.212060;DESCR=Allele A is associated with increased exposure to grazoprevir in people with Hepatitis C, Chronic as compared to allele C.
chr12	21177062	rs4149044	A	T	.	PASS	AF=0.188293;DESCR=Genotypes AA + AT is not associated with concentrations of lopinavir in people with HIV Infections as compared to genotype TT.
chr12	21177086	rs4149045	G	A	.	PASS	AF=0.188402;DESCR=Genotypes AG + GG is not associated with concentrations of lopinavir in people with HIV Infections as compared to genotype AA.
chr12	21178615	rs4149056	T	C	.	PASS	AF=0.177131;DESCR=Genotypes CC + CT are associated with increased exposure to rosuvastatin in people with Diabetes Mellitus and Hypercholesterolemia as compared to genotype TT.
chr12	21178665	rs4149057	T	C	.	PASS	AF=0.637385;DESCR=Genotypes CC + CT is not associated with concentrations of lopinavir in people with HIV Infections as compared to genotype TT.
chr12	21179489	rs11045821	G	A	.	PASS	AF=0.211771;DESCR=Allele A is associated with decreased clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.
chr12	21182447	rs1463565	G	C	.	PASS	AF=0.424986;DESCR=Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele G.
chr12	21182447	rs1463565	G	T	.	PASS	AF=0.00000;DESCR=Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele G.
chr12	21183129	rs2900476	C	T	.	PASS	AF=0.765841;DESCR=Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.
chr12	21197100	rs11045854	G	A	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.
chr12	21200738	rs12305884	G	A	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.
chr12	21204777	rs58310495	C	T	.	PASS	AF=0.164743;DESCR=Allele T is associated with increased concentrations of fluvastatin in healthy individuals as compared to allele C.
chr12	21215788	rs4363657	T	C	.	PASS	AF=0.171659;DESCR=Allele A is associated with increased exposure to pitavastatin and pitavastatin lactone in healthy individuals as compared to allele T.
chr12	21215863	rs2900478	T	A	.	PASS	AF=0.164356;DESCR=Allele A is associated with decreased response to hmg coa reductase inhibitors as compared to allele T.
chr12	21219410	rs11045872	A	G	.	PASS	AF=0.214245;DESCR=Allele G is associated with increased clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma.
chr12	21219410	rs11045872	A	T	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma.
chr12	21222127	rs11045873	T	A	.	PASS	AF=0.213256;DESCR=Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele T.
chr12	21222129	rs11045874	G	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.
chr12	21222129	rs11045874	G	C	.	PASS	AF=0.213214;DESCR=Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.
chr12	21225087	rs4149081	G	A	.	PASS	AF=0.171956;DESCR=Genotype AA is associated with increased concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG.
chr12	21229685	rs11045879	T	C	.	PASS	AF=0.171659;DESCR=Allele C is not associated with response to methotrexate in children with Lymphoma, Non-Hodgkin or Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.
chr12	21239042	rs34671512	A	C	.	PASS	AF=0.0587558;DESCR=Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele A.
chr12	21250045	rs113681054	T	C	.	PASS	AF=0.169883;DESCR=Allele C is associated with increased concentrations of ticagrelor in people with Acute coronary syndrome as compared to allele T.
chr12	21267537	rs4149009	C	T	.	PASS	AF=0.345821;DESCR=Allele T is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.
chr12	21271069	rs7967354	T	C	.	PASS	AF=0.203811;DESCR=Genotype CC is associated with decreased dose of rocuronium in women as compared to genotypes CT + TT.
chr12	21304500	rs11568563	T	G	.	PASS	AF=0.0314121;DESCR=Genotypes GT + TT are not associated with clearance of rocuronium in healthy individuals as compared to genotype GG.
chr12	21334610	rs10841795	A	G	.	PASS	AF=0.152048;DESCR=Allele A is not associated with concentrations of ceftriaxone in people with Central Nervous System Infections as compared to allele G.
chr12	21335070	rs3764043	C	T	.	PASS	AF=0.0244816;DESCR=Genotypes CT + TT are not associated with clearance of rocuronium in healthy individuals as compared to genotype CC.
chr12	21335741	rs4148978	C	T	.	PASS	AF=0.356772;DESCR=Genotypes CT + TT is associated with increased dose-adjusted trough concentrations of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotype CC.
chr12	21355244	rs11045995	T	C	.	PASS	AF=0.0467398;DESCR=Genotype CC is associated with decreased dose of rocuronium in women as compared to genotypes CT + TT.
chr12	21795389	rs141294036	C	T	.	PASS	AF=0.000288351;DESCR=Genotype CC is associated with increased response to dexmedetomidine in people with surgery as compared to genotypes CT + TT.
chr12	21852069	rs2307024	T	A	.	PASS	AF=0.00000;DESCR=Genotype TT is not associated with concentrations of efavirenz in people with HIV Infections.
chr12	21852069	rs2307024	T	G	.	PASS	AF=0.430219;DESCR=Genotype TT is not associated with concentrations of efavirenz in people with HIV Infections.
chr12	21891410	rs704212	C	T	.	PASS	AF=0.213956;DESCR=Allele T is associated with decreased concentrations of montelukast in healthy individuals as compared to allele C.
chr12	25207290	rs61764370	A	C	.	PASS	AF=0.0922722;DESCR=Allele C is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to allele A.
chr12	25207290	rs61764370	A	G	.	AC0;AS_VQSR	AF=0.00000;DESCR=Allele C is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to allele A.
chr12	25654374	rs6487504	C	T	.	PASS	AF=0.846774;DESCR=Allele T is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele C.
chr12	29205634	rs7301408	T	G	.	PASS	AF=0.486744;DESCR=Allele G is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.
chr12	47844974	rs731236	A	G	.	PASS	AF=0.358627;DESCR=Allele G is not associated with response to zoledronate in people with beta-Thalassemia.
chr12	47845054	rs7975232	C	A	.	PASS	AF=0.582757;DESCR=Allele A is associated with increased response to amoxicillin, clarithromycin and omeprazole in people with Helicobacter Infections as compared to allele C.
chr12	47846052	rs1544410	C	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased clearance of midazolam as compared to allele T.
chr12	47846052	rs1544410	C	G	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased clearance of midazolam as compared to allele T.
chr12	47846052	rs1544410	C	T	.	PASS	AF=0.362168;DESCR=Allele C is associated with increased clearance of midazolam as compared to allele T.
chr12	47859144	rs11574077	T	C	.	PASS	AF=0.0198847;DESCR=Genotype TT is associated with increased metabolism of irinotecan in people with Colorectal Neoplasms as compared to genotype CT.
chr12	47863543	rs1540339	C	T	.	PASS	AF=0.305427;DESCR=Allele C is associated with decreased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele T.
chr12	47863983	rs2239179	T	C	.	PASS	AF=0.393433;DESCR=Allele C is associated with decreased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele T.
chr12	47865343	rs12717991	C	T	.	PASS	AF=0.304724;DESCR=Allele T is not associated with metabolism of irinotecan in people with Colorectal Neoplasms as compared to allele C.
chr12	47879112	rs2228570	A	G	.	PASS	AF=0.571552;DESCR=Allele A is associated with increased response to amoxicillin, clarithromycin and omeprazole in people with Helicobacter Infections as compared to allele G.
chr12	47899822	rs11168292	C	A	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with increased dose of warfarin as compared to genotypes CC + CG.
chr12	47899822	rs11168292	C	G	.	PASS	AF=0.287896;DESCR=Genotype GG is associated with increased dose of warfarin as compared to genotypes CC + CG.
chr12	47899933	rs11168293	G	A	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with increased dose of warfarin as compared to genotypes GG + GT.
chr12	47899933	rs11168293	G	T	.	PASS	AF=0.288184;DESCR=Genotype TT is associated with increased dose of warfarin as compared to genotypes GG + GT.
chr12	47902703	rs4760658	A	G	.	PASS	AF=0.303283;DESCR=Genotype GG is associated with increased dose of warfarin as compared to genotypes AA + AG.
chr12	47906043	rs4516035	T	C	.	PASS	AF=0.340830;DESCR=Allele T is associated with increased clearance of midazolam as compared to allele C.
chr12	47908762	rs11568820	C	T	.	PASS	AF=0.246832;DESCR=Genotypes CT + TT are associated with increased clearance of midazolam as compared to genotype CC.
chr12	48005245	rs3809324	G	T	.	PASS	AF=0.276081;DESCR=Genotypes GT + TT is associated with decreased response to salbutamol in children with Asthma as compared to genotype GG.
chr12	48861425	rs2453488	T	C	.	PASS	AF=0.711982;DESCR=Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.
chr12	49903887	rs706795	T	C	.	PASS	AF=0.738604;DESCR=Allele T is associated with increased response to citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine or sertraline in people with Obsessive-Compulsive Disorder as compared to allele C.
chr12	49946258	rs7314734	C	T	.	PASS	AF=0.00979827;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr12	49947827	rs7305534	T	C	.	PASS	AF=0.411578;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr12	49949825	rs3759125	A	C	.	PASS	AF=0.639193;DESCR=Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr12	49950079	rs3759126	A	G	.	PASS	AF=0.299712;DESCR=Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.
chr12	49951423	rs461872	G	A	.	PASS	AF=0.352738;DESCR=Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.
chr12	49957170	rs296766	T	C	.	PASS	AF=0.992800;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr12	49957292	rs10875989	T	C	.	PASS	AF=0.380334;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr12	51657346	rs4512905	T	C	.	PASS	AF=0.654934;DESCR=Genotype TT is not associated with increased response to lithium in people with Bipolar Disorder as compared to genotype CC.
chr12	53429100	rs784892	G	A	.	PASS	AF=0.00115274;DESCR=Allele A is not associated with exposure to metformin as compared to allele G.
chr12	53430724	rs784888	G	C	.	PASS	AF=0.00432028;DESCR=Allele C is not associated with exposure to metformin as compared to allele G.
chr12	53430724	rs784888	G	T	.	PASS	AF=0.00000;DESCR=Allele C is not associated with exposure to metformin as compared to allele G.
chr12	53963768	rs7958904	C	A	.	PASS	AF=0.00000;DESCR=Genotypes CC + CG are associated with decreased response to Platinum compounds in people with Lung Neoplasms as compared to genotype GG.
chr12	53963768	rs7958904	C	G	.	PASS	AF=0.540946;DESCR=Genotypes CC + CG are associated with decreased response to Platinum compounds in people with Lung Neoplasms as compared to genotype GG.
chr12	53967210	rs1899663	C	A	.	PASS	AF=0.415802;DESCR=Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele A.
chr12	53968051	rs4759314	G	A	.	PASS	AF=0.992512;DESCR=Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.
chr12	55629199	rs17117817	T	G	.	PASS	AF=0.00000;DESCR=Allele G is associated with decreased response to atenolol or metoprolol in people with Hypertension as compared to allele T.
chr12	56093417	rs2229046	T	C	.	PASS	AF=0.0741489;DESCR=Allele C is associated with decreased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms.
chr12	56101214	rs773123	A	T	.	PASS	AF=0.105081;DESCR=Allele A is associated with decreased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms.
chr12	57095926	rs1059513	T	C	.	PASS	AF=0.0596542;DESCR=Genotypes CC + CT are associated with increased response to esomeprazole in children with eosinophilic esophagitis as compared to genotype TT.
chr12	57099213	rs841718	G	A	.	PASS	AF=0.533487;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr12	57099944	rs3024971	T	G	.	PASS	AF=0.0596886;DESCR=Allele G is not associated with dose of opioids in people with Pain as compared to allele T.
chr12	57109992	rs167769	C	T	.	PASS	AF=0.297866;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr12	57118687	rs12368672	C	G	.	PASS	AF=0.285014;DESCR=Genotypes CC + CG is associated with increased response to Proton pump inhibitors in people with eosinophilic esophagitis as compared to genotype GG.
chr12	57133500	rs11172113	T	C	.	PASS	AF=0.386678;DESCR=Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele T.
chr12	57191361	rs1800139	C	G	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CC + CT.
chr12	57191361	rs1800139	C	T	.	PASS	AF=0.677707;DESCR=Genotype TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CC + CT.
chr12	57195876	rs1800154	C	T	.	PASS	AF=0.310196;DESCR=Genotype CC is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CT + TT.
chr12	57750882	rs2069502	C	T	.	PASS	AF=0.289459;DESCR=Genotype CC is associated with decreased response to somatropin recombinant in children with Turner Syndrome as compared to genotypes CT + TT.
chr12	57751373	rs2270777	C	T	.	PASS	AF=0.518465;DESCR=Genotype TT is associated with increased response to somatropin recombinant in children with growth hormone deficiency as compared to genotypes CC + CT.
chr12	57764205	rs4646536	A	G	.	PASS	AF=0.285920;DESCR=Genotypes AG + GG is associated with increased concentrations of rifampin in people with Tuberculosis as compared to genotype AA.
chr12	57768302	rs10877012	G	T	.	PASS	AF=0.284726;DESCR=Genotypes GT + TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotype GG.
chr12	58920931	rs7970054	T	C	.	PASS	AF=0.0790081;DESCR=Allele C is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.
chr12	59710259	rs12231740	C	T	.	PASS	AF=0.232256;DESCR=Allele T is associated with decreased response to methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to allele C.
chr12	59779575	rs3763980	A	T	.	PASS	AF=0.224078;DESCR=Allele A is associated with decreased response to methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to allele T.
chr12	68158742	rs2430561	T	A	.	PASS	AF=0.441908;DESCR=Allele A is not associated with decreased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele T.
chr12	68161231	rs2069705	G	A	.	PASS	AF=0.725648;DESCR=Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele A.
chr12	68161231	rs2069705	G	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele A.
chr12	68742472	rs79419059	T	C	.	PASS	AF=0.0385945;DESCR=Allele C is associated with increased resistance to Platinum compounds in women with Ovarian Neoplasms as compared to allele T.
chr12	68813382	rs1470383	G	A	.	PASS	AF=0.843030;DESCR=Allele A is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele G.
chr12	69643740	rs61747221	G	A	.	PASS	AF=0.0467128;DESCR=Genotypes AA + AG is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype GG.
chr12	71584007	rs17109924	T	C	.	PASS	AF=0.0712226;DESCR=Genotypes CC + CT is associated with increased response to fluorouracil in people with Colonic Neoplasms as compared to genotype TT.
chr12	71938143	rs4570625	G	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to allele G.
chr12	71938143	rs4570625	G	T	.	PASS	AF=0.230548;DESCR=Allele T is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to allele G.
chr12	71938373	rs11178997	T	A	.	PASS	AF=0.0357143;DESCR=Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele T.
chr12	71938935	rs11178998	A	G	.	PASS	AF=0.0322767;DESCR=Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.
chr12	71946293	rs2129575	G	T	.	PASS	AF=0.255908;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr12	71954918	rs1843809	G	T	.	PASS	AF=0.869741;DESCR=Genotype TT is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to genotypes GG + GT.
chr12	71958055	rs10879346	C	T	.	PASS	AF=0.596597;DESCR=Allele C is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotype TT.
chr12	71958763	rs1386494	T	A	.	AC0	AF=0.00000;DESCR=Allele C is not associated with response to citalopram, fluoxetine or paroxetine in people with Depressive Disorder, Major as compared to allele T.
chr12	71958763	rs1386494	T	C	.	PASS	AF=0.870029;DESCR=Allele C is not associated with response to citalopram, fluoxetine or paroxetine in people with Depressive Disorder, Major as compared to allele T.
chr12	71961399	rs1386493	A	G	.	PASS	AF=0.847350;DESCR=Genotype GG is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype AG.
chr12	71966484	rs2171363	A	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr12	71966484	rs2171363	A	G	.	PASS	AF=0.608382;DESCR=Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr12	71979082	rs7305115	A	C	.	PASS	AF=0.00000;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr12	71979082	rs7305115	A	G	.	PASS	AF=0.626728;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr12	71991720	rs10506645	C	T	.	PASS	AF=0.216138;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr12	72003216	rs4760820	C	G	.	PASS	AF=0.483266;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr12	72007071	rs1487278	T	C	.	PASS	AF=0.192684;DESCR=Allele C is associated with increased response to mirtazapine and venlafaxine in people with Depression as compared to genotype TT.
chr12	72013697	rs9325202	A	G	.	PASS	AF=0.644464;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr12	72016512	rs1487275	C	A	.	PASS	AF=0.678674;DESCR=Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr12	72022455	rs4290270	A	T	.	PASS	AF=0.608583;DESCR=Genotypes AA + AT is associated with increased response to disulfiram in people with Cocaine-Related Disorders as compared to genotype TT (assigned as high activity phenotype) .
chr12	89645549	rs12817819	C	T	.	PASS	AF=0.128456;DESCR=Genotypes CT + TT are associated with increased resistance to Antihypertensives in people with Coronary Artery Disease or Hypertension as compared to genotype CC.
chr12	99423064	rs7968606	C	T	.	PASS	AF=0.142734;DESCR=Genotype CC is associated with increased response to amisulpride in people with Schizophrenia as compared to genotypes CT + TT.
chr12	100491329	rs4764980	G	A	.	PASS	AF=0.604443;DESCR=Genotype AA is not associated with increased exposure to rosuvastatin in healthy individuals as compared to genotypes AG + GG.
chr12	107001328	rs8192440	A	G	.	PASS	AF=0.551038;DESCR=Allele G is associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.
chr12	107001328	rs8192440	A	T	.	AC0	AF=0.00000;DESCR=Allele G is associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.
chr12	108883716	rs11114083	C	A	.	PASS	AF=0.124424;DESCR=Genotypes AA + AC are not associated with concentrations of methadone in people with Heroin Dependence as compared to genotype CC.
chr12	108883944	rs2070586	G	A	.	PASS	AF=0.183285;DESCR=Genotypes AG + GG are not associated with concentrations of methadone in people with Heroin Dependence as compared to genotype AA.
chr12	108883967	rs2070587	T	G	.	PASS	AF=0.216878;DESCR=Genotypes GT + TT are not associated with dose of methadone in people with Heroin Dependence as compared to genotype GG.
chr12	108898654	rs55944529	C	T	.	PASS	AF=0.0821326;DESCR=Genotype TT is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes CC + CT.
chr12	109446562	rs7959663	G	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr12	109446562	rs7959663	G	C	.	PASS	AF=0.311419;DESCR=Allele C is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr12	109604543	rs10161126	A	G	.	PASS	AF=0.542989;DESCR=Genotype GG is associated with increased response to alendronate in women with Bone Diseases as compared to genotypes AA + AG.
chr12	109604543	rs10161126	A	T	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with increased response to alendronate in women with Bone Diseases as compared to genotypes AA + AG.
chr12	111446804	rs3184504	T	C	.	PASS	AF=0.329683;DESCR=Allele T is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele C.
chr12	111634620	rs11065987	A	G	.	PASS	AF=0.646194;DESCR=Genotypes AA + AG is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype GG.
chr12	111803962	rs671	G	A	.	PASS	AF=0.00000;DESCR=Genotype AG is associated with increased concentrations of ethanol in healthy individuals as compared to genotype GG.
chr12	118152057	rs795484	T	A	.	AC0	AF=0.00000;DESCR=Genotype TT is associated with decreased response to opioids in people with Neoplasms and Pain as compared to genotypes CC + CT.
chr12	118152057	rs795484	T	C	.	PASS	AF=0.703053;DESCR=Genotype TT is associated with decreased response to opioids in people with Neoplasms and Pain as compared to genotypes CC + CT.
chr12	118168184	rs1277441	G	A	.	PASS	AF=0.703170;DESCR=Genotypes AG + GG are associated with increased dose of opioids in people with Neoplasms and Pain as compared to genotype AA.
chr12	118168184	rs1277441	G	C	.	PASS	AF=0.00000;DESCR=Genotypes AG + GG are associated with increased dose of opioids in people with Neoplasms and Pain as compared to genotype AA.
chr12	120978847	rs1169288	A	C	.	PASS	AF=0.457877;DESCR=Allele A is not associated with response to metformin in women with Polycystic Ovary Syndrome as compared to allele C.
chr12	120978847	rs1169288	A	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to metformin in women with Polycystic Ovary Syndrome as compared to allele C.
chr12	120997624	rs2464196	G	A	.	PASS	AF=0.459366;DESCR=Allele A is not associated with response to metformin in women with Polycystic Ovary Syndrome as compared to allele G.
chr12	121088083	rs2708092	G	A	.	PASS	AF=0.745817;DESCR=Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele A.
chr12	121092645	rs1180012	T	C	.	PASS	AF=0.795507;DESCR=Allele T is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele C.
chr12	121155216	rs1718125	C	T	.	PASS	AF=0.0731988;DESCR=Genotypes CT + TT are associated with increased dose of fentanyl in people with Lung Neoplasms and Pain, Postoperative as compared to genotype CC.
chr12	121162377	rs208293	C	T	.	PASS	AF=0.212846;DESCR=Allele A is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele G.
chr12	121171805	rs1718136	A	G	.	PASS	AF=0.342090;DESCR=Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele A.
chr12	121177131	rs7132846	C	T	.	PASS	AF=0.0567723;DESCR=Allele T is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele C.
chr12	121177300	rs1718119	G	A	.	PASS	AF=0.343804;DESCR=Allele A is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.
chr12	121184393	rs2230912	A	G	.	PASS	AF=0.164937;DESCR=Allele G is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele A.
chr12	121237772	rs1653586	G	T	.	PASS	AF=0.0418350;DESCR=Genotype GT is associated with decreased clinical benefit to pemetrexed in people with Lung Neoplasms as compared to genotype GG.
chr12	121624817	rs12320939	G	T	.	PASS	AF=0.373630;DESCR=Genotypes GG + GT is associated with increased resistance to erythropoietin in people with Kidney Diseases and Anemia as compared to genotype TT.
chr12	124800202	rs5888	A	G	.	PASS	AF=0.429971;DESCR=Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.
chr12	124800202	rs5888	A	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.
chr12	124863717	rs4238001	C	T	.	PASS	AF=0.160714;DESCR=Genotypes CT + TT are associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC.
chr13	20988809	rs558614	G	A	.	PASS	AF=0.875793;DESCR=Allele A is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to allele G.
chr13	20988809	rs558614	G	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to allele G.
chr13	28050157	rs1933437	G	A	.	PASS	AF=0.585591;DESCR=Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele A.
chr13	28050157	rs1933437	G	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele A.
chr13	28305784	rs12877323	T	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele T.
chr13	28305784	rs12877323	T	C	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele T.
chr13	28305784	rs12877323	T	G	.	PASS	AF=0.111239;DESCR=Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele T.
chr13	28308924	rs7993418	G	A	.	PASS	AF=0.854179;DESCR=Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele A.
chr13	28366923	rs7995976	A	C	.	PASS	AF=0.814516;DESCR=Allele A is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele C.
chr13	28496864	rs664393	T	A	.	PASS	AF=0.00000;DESCR=Genotypes CT + TT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype CC.
chr13	28496864	rs664393	T	C	.	PASS	AF=0.942075;DESCR=Genotypes CT + TT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype CC.
chr13	30459095	rs1045411	C	T	.	PASS	AF=0.181084;DESCR=Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T.
chr13	30463766	rs2249825	G	C	.	PASS	AF=0.180980;DESCR=Genotype GG is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotypes CC + CG.
chr13	30463766	rs2249825	G	T	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotypes CC + CG.
chr13	30467458	rs1412125	C	G	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotypes CT + TT.
chr13	30467458	rs1412125	C	T	.	PASS	AF=0.506624;DESCR=Genotype CC is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotypes CT + TT.
chr13	34376390	rs17798800	C	T	.	PASS	AF=0.145905;DESCR=Allele T is associated with decreased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C.
chr13	34777294	rs9315310	T	C	.	PASS	AF=0.692330;DESCR=Allele T is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele C.
chr13	35202457	rs57081354	T	C	.	PASS	AF=0.0967742;DESCR=Allele C is associated with decreased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele T.
chr13	40126485	rs953977	G	T	.	PASS	AF=0.178674;DESCR=Allele T is associated with increased response to montelukast in people with Asthma as compared to allele G.
chr13	40553948	rs17446593	A	G	.	PASS	AF=0.134793;DESCR=Genotype AA is associated with increased clinical benefit to glucocorticoids in children with Thrombocytopenia as compared to genotypes AG + GG.
chr13	42068674	rs9315885	C	T	.	PASS	AF=0.490762;DESCR=Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.
chr13	42079301	rs1012053	C	A	.	PASS	AF=0.715398;DESCR=Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele A.
chr13	42101357	rs1170191	A	G	.	PASS	AF=0.657349;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.
chr13	46482264	rs585719	C	T	.	PASS	AF=0.111592;DESCR=Genotype CT is associated with increased response to citalopram in people with Depression as compared to genotype CC.
chr13	46834435	rs3803189	T	G	.	PASS	AF=0.122478;DESCR=Genotypes GG + GT are associated with increased response to escitalopram, fluoxetine, fluvoxamine or sertraline in people with Depressive Disorder, Major as compared to genotype TT.
chr13	46834899	rs6314	G	A	.	PASS	AF=0.132565;DESCR=Genotype AG is not associated with exposure to olanzapine in healthy individuals as compared to genotype GG.
chr13	46837850	rs7997012	A	G	.	PASS	AF=0.718894;DESCR=Genotype GG is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes AA + AG.
chr13	46845442	rs3742278	A	G	.	PASS	AF=0.139931;DESCR=Allele G is not associated with response to sertraline in people with Anxiety Disorders as compared to allele A.
chr13	46856128	rs2274639	C	A	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.
chr13	46856128	rs2274639	C	G	.	PASS	AF=0.180507;DESCR=Allele C is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.
chr13	46856128	rs2274639	C	T	.	PASS	AF=0.00432526;DESCR=Allele C is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.
chr13	46859220	rs9316233	C	G	.	PASS	AF=0.293541;DESCR=Allele G is not associated with decreased response to escitalopram in people with Major Depressive Disorder as compared to allele C (assigned as normal metabolizer phenotype) .
chr13	46859220	rs9316233	C	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with decreased response to escitalopram in people with Major Depressive Disorder as compared to allele C (assigned as normal metabolizer phenotype) .
chr13	46866425	rs2770296	C	T	.	PASS	AF=0.772911;DESCR=Genotype CC is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CT + TT.
chr13	46882413	rs9567746	A	G	.	PASS	AF=0.100230;DESCR=Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.
chr13	46895805	rs6313	G	A	.	PASS	AF=0.497403;DESCR=Genotypes AA + AG are not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotype GG.
chr13	46896689	rs6312	C	T	.	PASS	AF=0.906340;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr13	46897343	rs6311	C	T	.	PASS	AF=0.497118;DESCR=Genotype CC is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.
chr13	46897583	rs17289304	T	G	.	PASS	AF=0.148127;DESCR=Allele T is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.
chr13	48045719	rs116855232	C	T	.	PASS	AF=0.00317186;DESCR=Genotypes CT + TT are associated with decreased dose of azathioprine in people with Colitis, Ulcerative, Crohn Disease and Hepatitis, Autoimmune as compared to genotype CC.
chr13	51950352	rs1061472	T	C	.	PASS	AF=0.564553;DESCR=Allele T is not associated with resistance to Platinum compounds in people with Lung Neoplasms as compared to allele C.
chr13	51950352	rs1061472	T	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with resistance to Platinum compounds in people with Lung Neoplasms as compared to allele C.
chr13	51971359	rs7999812	A	C	.	PASS	AF=0.429602;DESCR=Allele C is not associated with resistance to Platinum compounds in people with Lung Neoplasms as compared to allele A.
chr13	51991990	rs9535826	T	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to allele T.
chr13	51991990	rs9535826	T	G	.	PASS	AF=0.455306;DESCR=Allele G is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to allele T.
chr13	51999286	rs9535828	G	A	.	PASS	AF=0.452134;DESCR=Allele A is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to allele G.
chr13	51999286	rs9535828	G	C	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to allele G.
chr13	51999286	rs9535828	G	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to allele G.
chr13	59744885	rs77876672	C	T	.	PASS	AF=0.0521313;DESCR=Allele C is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele T.
chr13	87301793	rs10450811	G	A	.	PASS	AF=0.293999;DESCR=Allele A is associated with increased response to citalopram, clomipramine, escitalopram, fluoxetine, fluvoxamine, paroxetine or sertraline in people with Obsessive-Compulsive Disorder as compared to allele G.
chr13	90718584	rs828199	T	C	.	PASS	AF=1.00000;DESCR=Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.
chr13	95020203	rs9516519	T	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.
chr13	95020203	rs9516519	T	C	.	PASS	AF=0.00000;DESCR=Allele G is not associated with clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.
chr13	95020203	rs9516519	T	G	.	PASS	AF=0.202594;DESCR=Allele G is not associated with clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.
chr13	95020696	rs1059751	A	G	.	PASS	AF=0.435772;DESCR=Genotypes AA + AG is associated with decreased concentrations of tenofovir in people with Hepatitis B, Chronic as compared to genotype GG.
chr13	95021537	rs3742106	A	C	.	PASS	AF=0.351702;DESCR=Genotypes AC + CC are associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotype AA.
chr13	95030989	rs9561765	G	A	.	PASS	AF=0.0406809;DESCR=Genotype AG is associated with increased response to imatinib in people with Gastrointestinal Stromal Tumors as compared to genotype AA.
chr13	95061461	rs9561778	G	A	.	PASS	AF=0.00000;DESCR=Genotype GG is not associated with increased response to cyclophosphamide in people with Lupus Nephritis as compared to genotypes GT + TT.
chr13	95061461	rs9561778	G	T	.	PASS	AF=0.116138;DESCR=Genotype GG is not associated with increased response to cyclophosphamide in people with Lupus Nephritis as compared to genotypes GT + TT.
chr13	95062722	rs1751034	C	T	.	PASS	AF=0.742503;DESCR=Genotype TT is associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotypes CC + CT.
chr13	95163161	rs3765534	C	T	.	PASS	AF=0.00576369;DESCR=Genotype CC is not associated with dose of mercaptopurine or methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CT.
chr13	95206781	rs2274407	C	A	.	PASS	AF=0.132488;DESCR=Allele A is not associated with clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.
chr13	95209550	rs899494	A	G	.	PASS	AF=0.759227;DESCR=Genotypes AA + AG is not associated with increased discontinuation of tenofovir in people with HIV Infections as compared to genotype GG.
chr13	95210754	rs11568658	C	A	.	PASS	AF=0.0414986;DESCR=Genotype AC is associated with decreased response to latanoprost in people with Glaucoma, Open-Angle as compared to genotype CC.
chr13	95271269	rs7317112	A	G	.	PASS	AF=0.299596;DESCR=Allele G is associated with decreased clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.
chr13	95273060	rs17268282	G	T	.	PASS	AF=0.0391931;DESCR=Allele T is associated with increased response to furosemide in people with Heart Failure as compared to allele G.
chr13	95302822	rs868853	C	T	.	PASS	AF=0.913833;DESCR=Allele C is not associated with clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.
chr13	95978967	rs9590353	T	G	.	PASS	AF=0.128530;DESCR=Allele G is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele T.
chr13	98704358	rs1339067	A	C	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with decreased response to cannabidiol in people with Epilepsy as compared to genotypes AA + AT.
chr13	98704358	rs1339067	A	G	.	PASS	AF=0.631200;DESCR=Genotype TT is associated with decreased response to cannabidiol in people with Epilepsy as compared to genotypes AA + AT.
chr13	101071689	rs9585618	T	C	.	PASS	AF=0.576369;DESCR=Allele C is associated with response to ziprasidone in people with Schizophrenia.
chr13	102844409	rs2094258	C	T	.	PASS	AF=0.206171;DESCR=Allele T is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele C.
chr13	102845848	rs751402	A	G	.	PASS	AF=0.859942;DESCR=Allele A is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr13	102846025	rs2296147	T	C	.	PASS	AF=0.506912;DESCR=Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele T.
chr13	102852167	rs1047768	T	C	.	PASS	AF=0.590490;DESCR=Allele C is not associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele T.
chr13	102875652	rs17655	G	C	.	PASS	AF=0.273645;DESCR=Genotype GG is associated with increased response to platinum in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.
chr13	102875987	rs873601	G	A	.	PASS	AF=0.700173;DESCR=Allele A is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr13	108267192	rs3759467	T	C	.	PASS	AF=0.227247;DESCR=Genotype CC is associated with decreased response to rituximab in people with Vasculitis as compared to genotypes CT + TT.
chr13	113105440	rs510317	A	G	.	PASS	AF=0.924496;DESCR=Genotype AA is not associated with response to phenprocoumon as compared to genotypes AG + GG.
chr13	113105441	rs510335	G	T	.	PASS	AF=0.192729;DESCR=Genotype GG is not associated with response to phenprocoumon as compared to genotypes GT + TT.
chr13	113118845	rs6046	G	A	.	PASS	AF=0.205594;DESCR=Allele A is not associated with dose of warfarin as compared to allele G.
chr14	23183979	rs7141505	C	A	.	PASS	AF=0.631488;DESCR=Genotype AA is not associated with clearance of busulfan in children with Transplantation as compared to genotype CC.
chr14	24369415	rs1955915	C	T	.	PASS	AF=0.321326;DESCR=Genotypes CC + CT is associated with increased dose-adjusted trough concentrations of tacrolimus in people with lung transplantation as compared to genotype TT.
chr14	29832143	rs57803087	A	G	.	PASS	AF=0.0556196;DESCR=Allele G is associated with increased response to linagliptin, saxagliptin, sitagliptin or vildagliptin in people with Diabetes Mellitus, Type 2 as compared to allele A.
chr14	33098544	rs1315115	G	A	.	PASS	AF=0.924539;DESCR=Allele G is associated with response to risperidone in people with Schizophrenia.
chr14	33098544	rs1315115	G	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with response to risperidone in people with Schizophrenia.
chr14	33944620	rs1629140	A	G	.	PASS	AF=0.531124;DESCR=Allele A is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele G.
chr14	34057613	rs4982133	A	C	.	PASS	AF=0.789049;DESCR=Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.
chr14	34057613	rs4982133	A	G	.	AC0	AF=0.00000;DESCR=Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.
chr14	35069925	rs79403677	T	G	.	PASS	AF=0.211316;DESCR=Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr14	35169914	rs12436663	G	A	.	PASS	AF=0.142651;DESCR=Genotype AA is associated with decreased response to zileuton in people with Asthma as compared to genotypes AG + GG.
chr14	35370030	rs2145623	G	C	.	PASS	AF=0.226959;DESCR=Genotype CC is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotypes CG + GG.
chr14	35401887	rs696	C	T	.	PASS	AF=0.399770;DESCR=Allele T is associated with response to etanercept in people with Psoriasis as compared to allele C.
chr14	35402011	rs8904	G	A	.	PASS	AF=0.398383;DESCR=Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.
chr14	37642665	rs177852	C	T	.	PASS	AF=0.332277;DESCR=Genotypes CC + CT is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype TT.
chr14	53033179	rs17126068	A	G	.	PASS	AF=0.0328530;DESCR=Allele G is associated with decreased dose of warfarin as compared to allele A.
chr14	54844851	rs752688	C	T	.	PASS	AF=0.146194;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr14	54853845	rs4411417	T	C	.	PASS	AF=0.146686;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr14	54893421	rs3783641	T	A	.	PASS	AF=0.132277;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele T.
chr14	60298527	rs2273623	A	G	.	PASS	AF=0.465817;DESCR=Genotype AA is associated with decreased response to nortriptyline in people with Depression as compared to genotypes AG + GG.
chr14	64233098	rs4986938	C	T	.	PASS	AF=0.427336;DESCR=Genotype CC is not associated with increased response to leflunomide in women with Arthritis, Rheumatoid as compared to genotypes CT + TT.
chr14	64233327	rs944050	T	C	.	PASS	AF=0.0120968;DESCR=Genotype TT is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CC + CT.
chr14	64257333	rs1256049	C	T	.	PASS	AF=0.0109510;DESCR=Genotype CC is not associated with increased response to leflunomide in women with Arthritis, Rheumatoid as compared to genotypes CT + TT.
chr14	64442127	rs2236225	G	A	.	PASS	AF=0.436311;DESCR=Allele A is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.
chr14	64909368	rs4902333	C	T	.	PASS	AF=0.302882;DESCR=Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr14	64986345	rs11623866	G	C	.	PASS	AF=0.401786;DESCR=Genotype GG is associated with response to carboplatin, lonafarnib and paclitaxel in women with Ovarian Neoplasms.
chr14	67648284	rs3742879	A	G	.	PASS	AF=0.219758;DESCR=Allele G is associated with increased response to Methyldopa in women with Pregnancy and Pre-Eclampsia as compared to allele A.
chr14	69778476	rs2296651	G	A	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased clearance of pravastatin in healthy individuals as compared to allele G.
chr14	71133491	rs221903	T	C	.	PASS	AF=0.552707;DESCR=Allele T is associated with decreased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.
chr14	77326864	rs7975	G	A	.	PASS	AF=0.340150;DESCR=Allele G is associated with decreased clearance of dichloroacetic acid in children with Mitochondrial Diseases.
chr14	77326894	rs7972	G	A	.	PASS	AF=0.0507205;DESCR=Allele G is associated with decreased clearance of dichloroacetic acid in children with Mitochondrial Diseases.
chr14	77327940	rs1046428	T	C	.	PASS	AF=0.831221;DESCR=Allele T is associated with decreased clearance of dichloroacetic acid in children Mitochondrial Diseases.
chr14	77905060	rs56240334	A	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to paliperidone in people with as compared to allele A.
chr14	77905060	rs56240334	A	G	.	PASS	AF=0.138905;DESCR=Allele G is associated with increased response to paliperidone in people with as compared to allele A.
chr14	80203237	rs225014	T	C	.	PASS	AF=0.433449;DESCR=Allele C is not associated with dose of levothyroxine in people with Thyroid Neoplasms as compared to allele A.
chr14	80211923	rs12885300	C	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with dose of levothyroxine in people with Thyroid Neoplasms as compared to allele C.
chr14	80211923	rs12885300	C	T	.	PASS	AF=0.246667;DESCR=Allele T is not associated with dose of levothyroxine in people with Thyroid Neoplasms as compared to allele C.
chr14	87161812	rs2776546	C	A	.	PASS	AF=0.884438;DESCR=Allele A is associated with increased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.
chr14	89989844	rs2401863	G	A	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with increased response to irinotecan in people with Colorectal Neoplasms as compared to genotypes GT + TT.
chr14	89989844	rs2401863	G	T	.	PASS	AF=0.664459;DESCR=Genotype GG is associated with increased response to irinotecan in people with Colorectal Neoplasms as compared to genotypes GT + TT.
chr14	90397013	rs12885713	C	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to cyclosporine in people with Psoriasis as compared to allele C.
chr14	90397013	rs12885713	C	G	.	AC0	AF=0.00000;DESCR=Allele T is associated with increased response to cyclosporine in people with Psoriasis as compared to allele C.
chr14	90397013	rs12885713	C	T	.	PASS	AF=0.491354;DESCR=Allele T is associated with increased response to cyclosporine in people with Psoriasis as compared to allele C.
chr14	94587512	rs6113	T	C	.	PASS	AF=0.0285138;DESCR=Allele T is not associated with response to clomipramine in people with Obsessive-Compulsive Disorder as compared to allele C.
chr14	96204802	rs1799722	C	T	.	PASS	AF=0.384593;DESCR=Genotype TT is associated with decreased response to enalapril in people with Hypertension as compared to genotypes CC + CT.
chr14	96241120	rs5224	A	G	.	PASS	AF=0.844470;DESCR=Allele A is associated with increased response to glibenclamide in people with as compared to allele G.
chr14	96241120	rs5224	A	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to glibenclamide in people with as compared to allele G.
chr14	96262416	rs12050217	A	G	.	PASS	AF=0.208478;DESCR=Genotypes AA + AG is associated with decreased response to perindopril in people with Coronary Artery Disease as compared to genotype GG.
chr14	100857798	rs116907618	G	A	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.
chr14	100857798	rs116907618	G	C	.	PASS	AF=0.0187212;DESCR=Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.
chr14	103699416	rs861539	G	A	.	PASS	AF=0.413018;DESCR=Allele A is not associated with response to radiotherapy in people with Nasopharyngeal Neoplasms as compared to allele G.
chr14	104772855	rs2494732	T	C	.	PASS	AF=0.422389;DESCR=Allele T is not associated with response to risperidone in people with Schizophrenia as compared to allele C.
chr14	104796031	rs2498786	C	G	.	PASS	AF=0.617935;DESCR=Genotype GG is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CG.
chr14	104796444	rs74090038	C	T	.	PASS	AF=0.252598;DESCR=Genotype CC is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CT + TT.
chr14	104796575	rs2494750	G	C	.	PASS	AF=0.887896;DESCR=Genotype GG is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CG.
chr14	104797271	rs2494752	A	G	.	PASS	AF=0.885369;DESCR=Genotype AG is associated with decreased response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + GG.
chr14	104803442	rs3803300	T	C	.	PASS	AF=0.887385;DESCR=Allele C is not associated with response to risperidone in people with Schizophrenia as compared to allele T.
chr15	25806438	rs12595802	G	A	.	PASS	AF=0.549797;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr15	29882173	rs785423	A	G	.	PASS	AF=0.799135;DESCR=Allele A is associated with increased response to risperidone in people with Schizophrenia as compared to allele G.
chr15	29901113	rs813676	T	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele C.
chr15	29901113	rs813676	T	C	.	PASS	AF=0.738754;DESCR=Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele C.
chr15	29901265	rs711355	T	C	.	PASS	AF=0.738905;DESCR=Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele C.
chr15	32033473	rs883473	A	G	.	PASS	AF=0.662442;DESCR=Allele A is not associated with response to nicotine in women as compared to allele G.
chr15	32104256	rs6494223	C	T	.	PASS	AF=0.385615;DESCR=Allele T is associated with increased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C.
chr15	32151995	rs2337980	C	T	.	PASS	AF=0.453917;DESCR=Genotype CC is associated with increased response to nicotine in women as compared to genotypes CT + TT.
chr15	32702555	rs4779584	T	C	.	PASS	AF=0.874063;DESCR=Allele T is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele C.
chr15	40003758	rs2412459	C	T	.	PASS	AF=0.896025;DESCR=Genotype TT is associated with increased response to haloperidol in people with Schizophrenia as compared to genotype CT.
chr15	40695330	rs1801320	G	C	.	PASS	AF=0.0440668;DESCR=Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr15	40731896	rs7180135	G	A	.	PASS	AF=0.609122;DESCR=Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele A.
chr15	45253280	rs11854484	C	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.
chr15	45253280	rs11854484	C	T	.	PASS	AF=0.505476;DESCR=Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.
chr15	45262069	rs1060896	C	A	.	PASS	AF=0.580738;DESCR=Genotype AA is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AC + CC.
chr15	51210647	rs4646	A	C	.	PASS	AF=0.769031;DESCR=Allele A is associated with increased clinical benefit to letrozole in people with Breast Neoplasms as compared to allele C.
chr15	51210789	rs10046	G	A	.	PASS	AF=0.551356;DESCR=Genotype AA is not associated with response to exemestane in women with Breast Neoplasms as compared to genotypes AG + GG.
chr15	51215311	rs2289105	T	C	.	PASS	AF=0.565130;DESCR=Allele C is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele T.
chr15	51236915	rs700518	T	C	.	PASS	AF=0.519896;DESCR=Genotype CC is associated with response to Enzyme inhibitors in women with Breast Neoplasms as compared to genotypes CC + CT.
chr15	51237068	rs3759811	T	C	.	PASS	AF=0.519585;DESCR=Allele C is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele T.
chr15	51243825	rs4775936	C	T	.	PASS	AF=0.495101;DESCR=Allele C is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele T.
chr15	51255741	rs1062033	C	G	.	PASS	AF=0.479227;DESCR=Allele G is associated with increased concentrations of hdl cholesterol in women with Breast Neoplasms and Menopause as compared to allele C.
chr15	51257402	rs1008805	G	A	.	PASS	AF=0.613256;DESCR=Allele G is associated with decreased concentrations of hdl cholesterol in women with Breast Neoplasms and Menopause as compared to allele A.
chr15	51266534	rs749292	G	A	.	PASS	AF=0.495965;DESCR=Allele A is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele G.
chr15	55830149	rs2288344	T	G	.	PASS	AF=0.264129;DESCR=Allele G is associated with increased dose of warfarin as compared to allele T.
chr15	58137065	rs1516400	G	A	.	PASS	AF=0.531988;DESCR=Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.
chr15	58137348	rs1554203	A	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.
chr15	58137348	rs1554203	A	G	.	PASS	AF=0.00374856;DESCR=Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.
chr15	58184082	rs1867380	A	G	.	PASS	AF=0.963422;DESCR=Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.
chr15	58186751	rs2077737	T	C	.	PASS	AF=0.400519;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr15	58189995	rs8023369	T	G	.	PASS	AF=0.290202;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.
chr15	58190874	rs9920375	T	C	.	PASS	AF=0.651471;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr15	58341621	rs261316	C	T	.	PASS	AF=0.652048;DESCR=Allele T is associated with decreased response to atenolol and hydrochlorothiazide in people with Hypertension as compared to allele C.
chr15	58431476	rs1800588	C	T	.	PASS	AF=0.192197;DESCR=Genotypes CC + CT are associated with increased response to fluvastatin as compared to genotype TT.
chr15	61037589	rs809736	A	G	.	PASS	AF=0.294813;DESCR=Allele G is associated with increased response to citalopram in people with Depressive Disorder, Major as compared to allele A.
chr15	61174799	rs4774388	C	T	.	PASS	AF=0.879539;DESCR=Genotype TT is associated with increased response to interferon beta-1a in people with Multiple Sclerosis as compared to genotypes CC + CT.
chr15	74719300	rs4646903	A	G	.	PASS	AF=0.123264;DESCR=Genotypes AA + AG are not associated with concentrations of deferasirox in people with beta-Thalassemia as compared to genotype GG.
chr15	74720644	rs1048943	T	C	.	PASS	AF=0.0317003;DESCR=Genotypes AG + GG are associated with increased response to capecitabine and docetaxel in women with Breast Neoplasms as compared to genotype AA.
chr15	74724835	rs2606345	C	A	.	PASS	AF=0.544957;DESCR=Genotype AA is associated with decreased response to antiepileptics in women with Epilepsy as compared to genotypes AC + CC.
chr15	74726549	rs3826041	A	C	.	PASS	AF=0.241359;DESCR=Genotype CC is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes AA + AC.
chr15	74735539	rs2472297	C	T	.	PASS	AF=0.0792051;DESCR=Genotype CT is associated with decreased dose-adjusted trough concentrations of clozapine in people with Tobacco Use Disorder as compared to genotype CC.
chr15	74741568	rs2472300	A	G	.	PASS	AF=0.708069;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr15	74745879	rs2069514	G	A	.	PASS	AF=0.0337176;DESCR=Allele A is associated with increased clinical benefit to acetaminophen in infants with Patent Ductus Arteriosus.
chr15	74746626	rs2069521	G	A	.	PASS	AF=0.0576369;DESCR=Allele A is associated with increased metabolism of escitalopram in people with Depressive Disorder, Major as compared to allele G.
chr15	74746892	rs2069522	T	C	.	PASS	AF=0.0576037;DESCR=Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.
chr15	74749000	rs2069526	T	G	.	PASS	AF=0.0576369;DESCR=Allele G is not associated with metabolism of leflunomide in people with Arthritis as compared to genotype TT.
chr15	74749576	rs762551	C	A	.	PASS	AF=0.685591;DESCR=Genotype AA is associated with increased dose of clomipramine in women with Depression.
chr15	74750940	rs4646425	C	T	.	PASS	AF=0.0576037;DESCR=Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.
chr15	74751897	rs2472304	G	A	.	PASS	AF=0.549280;DESCR=Allele A is not associated with metabolism of escitalopram in people with Depressive Disorder, Major as compared to allele G.
chr15	74752059	rs3743484	G	C	.	PASS	AF=0.0435159;DESCR=Allele C is not associated with metabolism of escitalopram in people with Depressive Disorder, Major as compared to allele G.
chr15	74753351	rs4646427	T	C	.	PASS	AF=0.0576701;DESCR=Allele C is associated with increased metabolism of escitalopram in people with Depressive Disorder, Major as compared to allele T.
chr15	74755259	rs11636419	A	G	.	PASS	AF=0.103239;DESCR=Allele G is not associated with increased dose of warfarin in people with an international normalized ratio (INR) of 2.0-3.0 as compared to allele A.
chr15	74764017	rs11631682	G	A	.	PASS	AF=0.0613833;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr15	74785026	rs1378942	C	A	.	PASS	AF=0.561671;DESCR=Allele C is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele A.
chr15	74785026	rs1378942	C	T	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele A.
chr15	74837253	rs2290573	G	A	.	PASS	AF=0.413206;DESCR=Genotype GG is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AA + AG.
chr15	74837253	rs2290573	G	T	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AA + AG.
chr15	75345055	rs7402844	C	G	.	PASS	AF=0.616138;DESCR=Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr15	75355623	rs4462560	G	C	.	PASS	AF=0.612233;DESCR=Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele C.
chr15	75355623	rs4462560	G	T	.	AC0	AF=0.00000;DESCR=Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele C.
chr15	75390172	rs7166737	A	G	.	PASS	AF=0.388473;DESCR=Genotype GG is associated with decreased response to hydroxyurea in people with Beta-thalassemia and related diseases as compared to genotypes AA + AG.
chr15	78510715	rs7164594	C	T	.	PASS	AF=0.267013;DESCR=Genotypes CT + TT are associated with increased response to varenicline in people with Tobacco Use Disorder as compared to genotype CC.
chr15	78540694	rs57064725	C	A	.	PASS	AF=0.241359;DESCR=Allele A is associated with increased concentrations of cotinine in people with Tobacco Use Disorder as compared to allele C.
chr15	78559273	rs2036527	G	A	.	PASS	AF=0.355331;DESCR=Genotypes AA + AG are associated with increased response to bupropion, nicotine or varenicline in women with Tobacco Use Disorder as compared to genotype GG.
chr15	78565554	rs503464	T	A	.	PASS	AF=0.244233;DESCR=Allele A is associated with increased response to bupropion, nicotine and varenicline in people with Tobacco Use Disorder as compared to allele T.
chr15	78565597	rs55853698	T	G	.	PASS	AF=0.353602;DESCR=Allele G is not associated with response to bupropion, nicotine and varenicline in people with Tobacco Use Disorder as compared to allele T.
chr15	78565644	rs55781567	C	G	.	PASS	AF=0.357843;DESCR=Allele G is not associated with response to bupropion, nicotine and varenicline in people with Tobacco Use Disorder as compared to allele C.
chr15	78571130	rs667282	T	C	.	PASS	AF=0.217291;DESCR=Allele C is not associated with exposure to nicotine in men as compared to allele T.
chr15	78573083	rs588765	T	C	.	PASS	AF=0.625216;DESCR=Genotype TT is not associated with response to nicotine or varenicline in people with Tobacco Use Disorder as compared to genotypes CC + CT.
chr15	78573551	rs6495306	G	A	.	PASS	AF=0.622261;DESCR=Allele G is not associated with exposure to nicotine in men as compared to allele A.
chr15	78573551	rs6495306	G	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with exposure to nicotine in men as compared to allele A.
chr15	78578946	rs680244	T	C	.	PASS	AF=0.602076;DESCR=Allele C is associated with increased response to Drugs used in nicotine dependence in people with Tobacco Use Disorder.
chr15	78580519	rs621849	G	A	.	PASS	AF=0.610311;DESCR=Allele G is not associated with exposure to nicotine in men as compared to allele A.
chr15	78584163	rs692780	C	G	.	PASS	AF=0.654246;DESCR=Allele C is not associated with exposure to nicotine in men as compared to allele G.
chr15	78586900	rs555018	G	A	.	PASS	AF=0.622837;DESCR=Allele G is not associated with exposure to nicotine in men as compared to allele A.
chr15	78588139	rs647041	T	C	.	PASS	AF=0.637464;DESCR=Allele T is not associated with exposure to nicotine in men as compared to allele C.
chr15	78590583	rs16969968	G	A	.	PASS	AF=0.375216;DESCR=Allele G is associated with increased response to Drugs used in nicotine dependence in people with Tobacco Use Disorder.
chr15	78591885	rs514743	T	A	.	PASS	AF=0.654179;DESCR=Allele T is not associated with exposure to nicotine in men as compared to allele A.
chr15	78591885	rs514743	T	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with exposure to nicotine in men as compared to allele A.
chr15	78593646	rs615470	T	C	.	PASS	AF=0.654179;DESCR=Allele T is not associated with exposure to nicotine in men as compared to allele C.
chr15	78595490	rs660652	A	G	.	PASS	AF=0.653868;DESCR=Allele A is not associated with exposure to nicotine in men as compared to allele G.
chr15	78596058	rs578776	G	A	.	PASS	AF=0.266724;DESCR=Allele A is not associated with concentrations of 3-hydroxycotinine, cotinine or nicotine in people with Tobacco Use Disorder as compared to allele G.
chr15	78597979	rs6495307	C	T	.	PASS	AF=0.364265;DESCR=Allele T is not associated with exposure to nicotine in men as compared to allele C.
chr15	78601997	rs1051730	G	A	.	PASS	AF=0.380046;DESCR=Allele A is not associated with response to bupropion, nicotine or varenicline in people with Tobacco Use Disorder as compared to allele G.
chr15	78602554	rs3743077	C	T	.	PASS	AF=0.363663;DESCR=Allele T is not associated with exposure to nicotine in men as compared to allele C.
chr15	78615003	rs2869546	C	T	.	PASS	AF=0.653114;DESCR=Allele C is not associated with exposure to nicotine in men as compared to allele T.
chr15	78617110	rs3743075	T	C	.	PASS	AF=0.637752;DESCR=Allele T is not associated with exposure to nicotine in men as compared to allele C.
chr15	78617138	rs3743074	G	A	.	PASS	AF=0.636967;DESCR=Allele G is not associated with exposure to nicotine in men as compared to allele A.
chr15	78620601	rs7170068	G	A	.	PASS	AF=0.223570;DESCR=Allele A is associated with increased concentrations of cotinine in people with Tobacco Use Disorder as compared to allele G.
chr15	78620601	rs7170068	G	C	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased concentrations of cotinine in people with Tobacco Use Disorder as compared to allele G.
chr15	78623522	rs10851907	G	A	.	PASS	AF=0.452629;DESCR=Allele A is associated with increased concentrations of cotinine in people with Tobacco Use Disorder as compared to allele G.
chr15	78625057	rs1948	A	G	.	PASS	AF=0.672344;DESCR=Allele A is not associated with exposure to nicotine in men as compared to allele G.
chr15	78628735	rs7178270	C	G	.	PASS	AF=0.378386;DESCR=Allele G is not associated with exposure to nicotine in men as compared to allele C.
chr15	78628735	rs7178270	C	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with exposure to nicotine in men as compared to allele C.
chr15	78633676	rs950776	T	C	.	PASS	AF=0.315562;DESCR=Allele C is not associated with exposure to nicotine in men as compared to allele T.
chr15	81296654	rs4778889	T	C	.	PASS	AF=0.182631;DESCR=Genotype TT is associated with increased clinical benefit to morphine in people with Neoplasms and Pain as compared to genotypes CC + CT.
chr15	84137308	rs66486766	G	A	.	PASS	AF=0.265418;DESCR=Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr15	84904200	rs2290272	G	A	.	PASS	AF=0.316138;DESCR=Allele A is not associated with metabolism of capecitabine in people with Breast Neoplasms as compared to allele G.
chr15	84905644	rs8187758	C	A	.	PASS	AF=0.212846;DESCR=Genotype CC is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AA + AC.
chr15	84913115	rs11853372	T	C	.	PASS	AF=0.00000;DESCR=Genotype TT is not associated with metabolism of gemcitabine as compared to genotypes GG + GT.
chr15	84913115	rs11853372	T	G	.	PASS	AF=0.728975;DESCR=Genotype TT is not associated with metabolism of gemcitabine as compared to genotypes GG + GT.
chr15	84935179	rs2242048	A	G	.	PASS	AF=0.934006;DESCR=Genotype GG is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AG.
chr15	84935465	rs2242047	C	T	.	PASS	AF=0.0657061;DESCR=Genotype CC is associated with increased response to gemcitabine in people with Colorectal Neoplasms as compared to genotype TT.
chr15	84935498	rs2242046	G	A	.	PASS	AF=0.562824;DESCR=Genotype GG is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AG.
chr15	88610513	rs1470108	C	A	.	PASS	AF=0.299942;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.
chr15	91526975	rs7170769	C	T	.	PASS	AF=0.370242;DESCR=Allele T is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele C.
chr15	91528728	rs4932551	G	C	.	PASS	AF=0.630259;DESCR=Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele G.
chr15	91941607	rs8027174	G	T	.	PASS	AF=0.0331221;DESCR=Genotypes GT + TT is associated with decreased clearance of darunavir in people with HIV Infections as compared to genotypes GG + TT.
chr15	92104415	rs1517618	G	C	.	PASS	AF=0.886744;DESCR=Allele G is not associated with increased resistance to efavirenz, lamivudine, nevirapine and zidovudine in people with HIV Infections as compared to allele C.
chr15	95072557	rs291028	C	T	.	PASS	AF=0.841499;DESCR=Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.
chr15	99069944	rs1703794	T	C	.	PASS	AF=0.242643;DESCR=Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.
chr16	286916	rs1048786	C	T	.	PASS	AF=0.143887;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr16	1175628	rs11640796	A	G	.	PASS	AF=0.0677233;DESCR=Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.
chr16	1197482	rs3794619	T	C	.	PASS	AF=0.115274;DESCR=Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.
chr16	1202369	rs61734410	C	T	.	PASS	AF=0.363191;DESCR=Allele T is associated with decreased clinical benefit to ethosuximide in children with Epilepsy as compared to allele C.
chr16	1202737	rs7191246	G	C	.	PASS	AF=0.112457;DESCR=Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.
chr16	1204369	rs3751664	C	T	.	PASS	AF=0.126513;DESCR=Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.
chr16	1211219	rs2753326	A	G	.	PASS	AF=0.705764;DESCR=Allele A is associated with increased clinical benefit to lamotrigine in children with Epilepsy as compared to allele G.
chr16	1211222	rs2753325	A	G	.	PASS	AF=0.705764;DESCR=Allele A is associated with increased clinical benefit to lamotrigine in children with Epilepsy as compared to allele G.
chr16	1220162	rs1054645	G	A	.	PASS	AF=0.711118;DESCR=Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.
chr16	1324950	rs9597	C	G	.	PASS	AF=0.0316820;DESCR=Genotype CG is associated with increased response to cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.
chr16	1324950	rs9597	C	T	.	PASS	AF=0.00000;DESCR=Genotype CG is associated with increased response to cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.
chr16	2278649	rs150929	G	C	.	PASS	AF=0.00000;DESCR=Genotypes GG + GT is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.
chr16	2278649	rs150929	G	T	.	PASS	AF=0.455043;DESCR=Genotypes GG + GT is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.
chr16	3983435	rs2230739	T	C	.	PASS	AF=0.318156;DESCR=Genotype CC is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.
chr16	4015582	rs1967309	A	G	.	PASS	AF=0.584535;DESCR=Genotype AA is associated with increased response to dalcetrapib in people with as compared to genotype GG.
chr16	4382028	rs3810818	A	C	.	PASS	AF=0.816897;DESCR=Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr16	8746097	rs1731017	A	G	.	PASS	AF=0.540127;DESCR=Genotypes AA + AG is associated with increased resistance to valproic acid in people with Epilepsy as compared to genotype GG.
chr16	9849809	rs2229193	C	T	.	PASS	AF=0.290081;DESCR=Genotype CC is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype CT.
chr16	11155472	rs6498169	G	A	.	PASS	AF=0.634217;DESCR=Allele A is associated with increased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele G.
chr16	11680345	rs3784921	G	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with dose of hydrochlorothiazide in people with Hypertension as compared to allele T.
chr16	11680345	rs3784921	G	T	.	PASS	AF=0.165706;DESCR=Allele G is not associated with dose of hydrochlorothiazide in people with Hypertension as compared to allele T.
chr16	12826709	rs111860321	T	C	.	PASS	AF=0.0325648;DESCR=Allele C is associated with decreased clearance of fentanyl in children with Pain, Postoperative as compared to allele T.
chr16	13656002	rs7405404	T	C	.	PASS	AF=0.759109;DESCR=Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.
chr16	13919809	rs6498486	A	C	.	PASS	AF=0.286044;DESCR=Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele A.
chr16	13919809	rs6498486	A	T	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele A.
chr16	13948101	rs1799801	T	C	.	PASS	AF=0.305012;DESCR=Genotype TT is associated with decreased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CT.
chr16	13949073	rs2276464	G	A	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr16	13949073	rs2276464	G	C	.	PASS	AF=0.305540;DESCR=Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr16	13949318	rs2276466	C	G	.	PASS	AF=0.304097;DESCR=Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele C.
chr16	15938949	rs6498588	A	T	.	PASS	AF=0.685014;DESCR=Genotypes AT + TT are associated with increased exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.
chr16	15966537	rs215095	G	A	.	PASS	AF=0.870819;DESCR=Genotypes AG + GG are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.
chr16	16004618	rs11075291	G	A	.	PASS	AF=0.526559;DESCR=Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.
chr16	16008018	rs8187843	G	A	.	PASS	AF=0.0485903;DESCR=Genotypes AA + AG are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype GG.
chr16	16008018	rs8187843	G	C	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype GG.
chr16	16008018	rs8187843	G	T	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype GG.
chr16	16017034	rs3784862	G	A	.	PASS	AF=0.737327;DESCR=Allele A is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.
chr16	16025167	rs246240	A	G	.	PASS	AF=0.146686;DESCR=Genotypes AG + GG are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.
chr16	16031468	rs3784864	G	A	.	PASS	AF=0.419597;DESCR=Genotypes AG + GG are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.
chr16	16044465	rs246221	T	C	.	PASS	AF=0.321037;DESCR=Genotype CC is not associated with increased response to cyclophosphamide in people with Lupus Nephritis as compared to genotype CT.
chr16	16047966	rs35592	T	C	.	PASS	AF=0.267610;DESCR=Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.
chr16	16074751	rs35621	C	T	.	PASS	AF=0.125937;DESCR=Genotypes CT + TT are associated with increased exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype CC.
chr16	16076620	rs4148350	G	T	.	PASS	AF=0.0584677;DESCR=Genotype GG is not associated with increased response to cyclophosphamide in people with Lupus Nephritis as compared to genotype GT.
chr16	16090375	rs2074087	C	G	.	PASS	AF=0.775087;DESCR=Allele G is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.
chr16	16120015	rs2238476	G	A	.	PASS	AF=0.0573487;DESCR=Genotype GG is associated with increased response to methotrexate in people with Psoriasis as compared to allele A.
chr16	16133290	rs212082	A	G	.	PASS	AF=0.105886;DESCR=Genotypes AG + GG are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.
chr16	16134385	rs2230671	G	A	.	PASS	AF=0.223889;DESCR=Allele A is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.
chr16	16141824	rs3743527	C	T	.	PASS	AF=0.208886;DESCR=Allele T is not associated with increased resistance to lamivudine, lopinavir, ritonavir and zidovudine in people with HIV Infections as compared to allele C.
chr16	16142793	rs212091	T	A	.	PASS	AF=0.00000;DESCR=Genotypes CC + CT are associated with increased resistance to lamivudine, lopinavir, ritonavir and zidovudine in people with HIV Infections as compared to genotype TT.
chr16	16142793	rs212091	T	C	.	PASS	AF=0.107143;DESCR=Genotypes CC + CT are associated with increased resistance to lamivudine, lopinavir, ritonavir and zidovudine in people with HIV Infections as compared to genotype TT.
chr16	20356368	rs12917707	G	T	.	PASS	AF=0.136599;DESCR=Genotypes GT + TT is associated with increased response to cyclosporine in people with Kidney Transplantation as compared to genotype GG.
chr16	24324351	rs1859204	T	C	.	PASS	AF=0.878674;DESCR=Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CC.
chr16	25946919	rs9933692	G	A	.	PASS	AF=0.281430;DESCR=Allele A is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.
chr16	25948029	rs4074471	T	G	.	PASS	AF=0.282044;DESCR=Allele T is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.
chr16	27325106	rs1110470	G	A	.	PASS	AF=0.486135;DESCR=Genotype AA is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AG + GG.
chr16	27339366	rs3024530	A	G	.	PASS	AF=0.391417;DESCR=Genotype AA is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AG + GG.
chr16	27344882	rs1805010	A	G	.	PASS	AF=0.396254;DESCR=Genotype AA is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AG + GG.
chr16	27347700	rs2239347	A	C	.	PASS	AF=0.418108;DESCR=Genotype AA is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AC + CC.
chr16	27362859	rs1805015	T	C	.	PASS	AF=0.135104;DESCR=Allele C is associated with increased response to Hepatitis vaccines as compared to allele T.
chr16	27364466	rs8832	A	G	.	PASS	AF=0.588184;DESCR=Genotype GG is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AA + AG.
chr16	27364896	rs1029489	A	G	.	PASS	AF=0.619954;DESCR=Genotype GG is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AA + AG.
chr16	27452127	rs3093390	C	T	.	PASS	AF=0.244951;DESCR=Allele C is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele T.
chr16	28592334	rs1059491	T	G	.	PASS	AF=0.276270;DESCR=Genotype TT are associated with decreased concentrations of 4-hydroxytamoxifen or endoxifen in women with Breast Neoplasms as compared to genotypes GG + GT.
chr16	28595911	rs1136703	A	G	.	PASS	AF=0.271695;DESCR=Genotype AA are associated with decreased concentrations of 4-hydroxytamoxifen or endoxifen in women with Breast Neoplasms as compared to genotypes AG + GG.
chr16	28826194	rs8049439	T	C	.	PASS	AF=0.270029;DESCR=Genotypes CT + TT is associated with increased response to adalimumab in people with Crohn Disease as compared to genotype CC.
chr16	28878165	rs3888190	C	A	.	PASS	AF=0.269119;DESCR=Genotype CC is associated with increased concentrations of low density lipoprotein in people with Bipolar Disorder, Depressive Disorder, Psychotic Disorders or schizoaffective disorder as compared to genotypes AA + AC.
chr16	28878165	rs3888190	C	T	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased concentrations of low density lipoprotein in people with Bipolar Disorder, Depressive Disorder, Psychotic Disorders or schizoaffective disorder as compared to genotypes AA + AC.
chr16	29819105	rs4788184	T	C	.	PASS	AF=1.00000;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr16	29822167	rs1057451	G	T	.	PASS	AF=0.168111;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.
chr16	29829904	rs4788186	A	G	.	PASS	AF=0.563725;DESCR=Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.
chr16	29852848	rs7204252	C	T	.	PASS	AF=1.00000;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr16	30506720	rs2230433	G	C	.	PASS	AF=0.313940;DESCR=Allele C is associated with increased clinical benefit to verapamil in people with Migraine NOS as compared to allele G.
chr16	30999862	rs4889606	A	G	.	PASS	AF=0.502307;DESCR=Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA.
chr16	31011318	rs2141715262;rs2141715264;rs2141715268;rs72800847	G	A	.	PASS	AF=0.275087;DESCR=Genotypes AA + AG is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype GG.
chr16	31036758	rs10871454	C	T	.	PASS	AF=0.503466;DESCR=Allele T is associated with decreased dose of warfarin.
chr16	31077026	rs749671	G	A	.	PASS	AF=0.468588;DESCR=Allele G is associated with increased dose of warfarin as compared to allele A.
chr16	31087690	rs11150606	T	C	.	PASS	AF=0.0138249;DESCR=Allele C is associated with decreased dose of warfarin as compared to allele T.
chr16	31091000	rs7294	C	T	.	PASS	AF=0.299827;DESCR=Allele T is associated with increased dose of warfarin as compared to allele C.
chr16	31091268	rs7200749	G	A	.	PASS	AF=0.00518433;DESCR=Genotypes AA + AG is associated with increased dose of acenocoumarol as compared to genotype GG.
chr16	31092475	rs2359612	A	G	.	PASS	AF=0.492795;DESCR=Genotype AA is associated with decreased dose of warfarin as compared to genotype GG.
chr16	31093126	rs17886199	A	G	.	PASS	AF=0.000866051;DESCR=Allele A is associated with decreased dose of warfarin as compared to allele G.
chr16	31093188	rs8050894	C	G	.	PASS	AF=0.497681;DESCR=Genotypes CG + GG are associated with decreased dose of warfarin as compared to genotype CC.
chr16	31093188	rs8050894	C	T	.	PASS	AF=0.00492754;DESCR=Genotypes CG + GG are associated with decreased dose of warfarin as compared to genotype CC.
chr16	31093557	rs9934438	G	A	.	PASS	AF=0.499712;DESCR=Allele A is associated with dose of acenocoumarol in people with a stable maintenance dose.
chr16	31094032	rs17708472	G	A	.	PASS	AF=0.153002;DESCR=Allele A is associated with increased dose of warfarin as compared to allele G.
chr16	31094233	rs2884737	A	C	.	PASS	AF=0.334487;DESCR=Genotypes AC + CC are associated with decreased dose of warfarin as compared to genotype AA.
chr16	31096368	rs9923231	C	T	.	PASS	AF=0.499424;DESCR=Genotype TT is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotypes CC + CT.
chr16	31096606	rs17878544	T	C	.	PASS	AF=0.00576701;DESCR=Genotype TT is associated with decreased dose of acenocoumarol as compared to genotypes CC + CT.
chr16	31099180	rs17880887	G	T	.	PASS	AF=0.232411;DESCR=Allele T is not associated with decreased dose of warfarin as compared to allele G.
chr16	31099660	rs7196161	G	A	.	PASS	AF=0.495092;DESCR=Allele A is not associated with increased dose of acenocoumarol as compared to allele G.
chr16	31099660	rs7196161	G	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with increased dose of acenocoumarol as compared to allele G.
chr16	31102913	rs61162043	A	G	.	PASS	AF=0.456597;DESCR=Allele G is associated with increased dose of warfarin.
chr16	31102913	rs61162043	A	T	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased dose of warfarin.
chr16	31484256	rs9924771	A	G	.	PASS	AF=0.606106;DESCR=Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr16	31484350	rs11646054	G	C	.	PASS	AF=0.477784;DESCR=Allele C is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr16	31484350	rs11646054	G	T	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr16	31484405	rs3116149	G	A	.	PASS	AF=0.0527697;DESCR=Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr16	31486560	rs3813008	G	A	.	PASS	AF=0.176081;DESCR=Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr16	31486560	rs3813008	G	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr16	31486700	rs3116150	G	A	.	PASS	AF=0.324597;DESCR=Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr16	52885654	rs7184292	G	A	.	PASS	AF=0.481855;DESCR=Allele A is associated with increased response to atenolol in people with Hypertension as compared to allele G.
chr16	53779455	rs17817449	T	A	.	PASS	AF=0.00000;DESCR=Genotype GG is not associated with dose of ethanol as compared to genotypes GT + TT.
chr16	53779455	rs17817449	T	G	.	PASS	AF=0.504905;DESCR=Genotype GG is not associated with dose of ethanol as compared to genotypes GT + TT.
chr16	53786615	rs9939609	T	A	.	PASS	AF=0.506336;DESCR=Genotypes AA + AT is associated with decreased response to interferon alfa-2a, recombinant, interferon alfa-2b, recombinant and ribavirin in people with Hepatitis C, Chronic and HIV Infections as compared to genotype TT.
chr16	53821379	rs11075995	A	T	.	PASS	AF=0.735447;DESCR=Genotypes AT + TT is associated with increased clinical benefit to PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors in people with Neoplasms as compared to genotype AA.
chr16	55477894	rs243865	C	T	.	PASS	AF=0.198271;DESCR=Allele T is associated with decreased response to ulinastatin in people with Pancreatitis as compared to allele C.
chr16	55652906	rs28386840	T	A	.	PASS	AF=0.668443;DESCR=Allele T is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.
chr16	55654572	rs1362621	G	A	.	PASS	AF=0.707085;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr16	55655632	rs168924	A	G	.	PASS	AF=0.157061;DESCR=Allele G is not associated with response to 3,4-methylenedioxymethamphetamine as compared to allele A.
chr16	55656513	rs2242446	C	T	.	PASS	AF=0.705933;DESCR=Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.
chr16	55661194	rs3785143	C	T	.	PASS	AF=0.0815092;DESCR=Allele T is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.
chr16	55662844	rs36029	A	G	.	PASS	AF=0.411765;DESCR=Genotype AA is associated with increased response to 3,4-methylenedioxymethamphetamine as compared to genotypes AG + GG.
chr16	55692063	rs5564	A	G	.	PASS	AF=0.118952;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr16	55692550	rs47958	C	A	.	PASS	AF=0.541499;DESCR=Allele C is not associated with response to 3,4-methylenedioxymethamphetamine as compared to allele A.
chr16	55694494	rs1861647	G	A	.	PASS	AF=0.314195;DESCR=Genotype GG is associated with increased response to 3,4-methylenedioxymethamphetamine as compared to genotypes AA + AG.
chr16	55695924	rs3785157	C	T	.	PASS	AF=0.261671;DESCR=Allele T is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.
chr16	55696212	rs5568	A	C	.	PASS	AF=0.386101;DESCR=Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.
chr16	55697687	rs12708954	C	A	.	PASS	AF=0.154755;DESCR=Allele A is associated with increased response to atomoxetine in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.
chr16	55697923	rs5569	G	A	.	PASS	AF=0.264265;DESCR=Genotype GG is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes AA + AG.
chr16	55698034	rs998424	G	A	.	PASS	AF=0.268898;DESCR=Allele A is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele G.
chr16	55698034	rs998424	G	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele G.
chr16	55703779	rs7194256	C	T	.	PASS	AF=0.156772;DESCR=Allele T is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.
chr16	55759783	rs3785161	A	C	.	PASS	AF=0.121684;DESCR=Allele C is not associated with response to trandolapril in people with Hypertension as compared to allele A.
chr16	55810697	rs2244613	G	T	.	PASS	AF=0.769634;DESCR=Genotype GT is associated with decreased half-life time of fesoterodine in healthy individuals as compared to genotype TT.
chr16	55810891	rs74019272	G	A	.	PASS	AF=0.0149770;DESCR=Genotypes AA + AG is associated with decreased dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype GG.
chr16	55815590	rs2002577	G	A	.	PASS	AF=0.00000;DESCR=Genotype CC is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CG + GG.
chr16	55815590	rs2002577	G	C	.	PASS	AF=0.766358;DESCR=Genotype CC is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CG + GG.
chr16	55815590	rs2002577	G	T	.	PASS	AF=0.00000;DESCR=Genotype CC is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CG + GG.
chr16	55819534	rs4513095	C	A	.	PASS	AF=0.0155709;DESCR=Allele A is associated with decreased response to sofosbuvir in people with Hepatitis C, Chronic as compared to allele C.
chr16	55819633	rs115629050	C	A	.	PASS	AF=0.0723760;DESCR=Allele A is associated with decreased response to sofosbuvir in people with Hepatitis C, Chronic as compared to allele C.
chr16	55819633	rs115629050	C	G	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased response to sofosbuvir in people with Hepatitis C, Chronic as compared to allele C.
chr16	55822805	rs4122238	A	C	.	PASS	AF=0.00000;DESCR=Genotypes AG + GG is associated with decreased dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype AA.
chr16	55822805	rs4122238	A	G	.	PASS	AF=0.803416;DESCR=Genotypes AG + GG is associated with decreased dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype AA.
chr16	55823540	rs147055479	G	A	.	PASS	AF=0.0774096;DESCR=Genotype GG is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG.
chr16	55823540	rs147055479	G	C	.	PASS	AF=0.0112626;DESCR=Genotype GG is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG.
chr16	55827882	rs8192935	A	G	.	PASS	AF=0.635229;DESCR=Allele G is not associated with clearance of Dabigatran in healthy individuals as compared to allele A.
chr16	55828800	rs2307240	C	T	.	PASS	AF=0.0720511;DESCR=Genotype CT is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype CC.
chr16	55832425	rs12443580	T	C	.	PASS	AF=0.389242;DESCR=Genotype TT is not associated with dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CC + CT.
chr16	56955678	rs247616	C	T	.	PASS	AF=0.265300;DESCR=Allele T is associated with increased response to hmg coa reductase inhibitors as compared to allele C.
chr16	56960982	rs4783961	G	A	.	PASS	AF=0.472575;DESCR=Genotype GG is associated with increased response to fluvastatin in people with Hypercholesterolemia as compared to genotypes AA + AG.
chr16	56961324	rs1800775	C	A	.	PASS	AF=0.504037;DESCR=Genotype AA is not associated with response to atorvastatin as compared to genotype CC.
chr16	56962376	rs708272	G	A	.	PASS	AF=0.383929;DESCR=Allele A is associated with decreased response to rosuvastatin as compared to allele G.
chr16	56971567	rs1532624	C	A	.	PASS	AF=0.389850;DESCR=Genotype AA is associated with decreased response to hmg coa reductase inhibitors in people with Hyperlipidemias as compared to genotype CC.
chr16	56982180	rs5882	G	A	.	PASS	AF=0.585253;DESCR=Genotype GG is associated with decreased response to fluvastatin in people with Hypercholesterolemia as compared to genotype AG.
chr16	58662802	rs11648166	A	G	.	PASS	AF=0.0512673;DESCR=Allele G is associated with increased concentrations of anastrozole in women with Breast Neoplasms as compared to allele A.
chr16	64410685	rs1437153	G	T	.	PASS	AF=0.0564516;DESCR=Allele T is associated with decreased response to anastrozole in women with Breast Neoplasms as compared to allele G.
chr16	66124833	rs8050896	A	T	.	PASS	AF=0.129032;DESCR=Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele A.
chr16	66521842	rs3826160	T	C	.	PASS	AF=0.0216138;DESCR=Genotypes CC + CT is associated with increased concentrations of telbivudine in people with Hepatitis B, Chronic as compared to genotype TT.
chr16	66935273	rs11075646	C	G	.	PASS	AF=0.136599;DESCR=Allele C is not associated with metabolism of capecitabine in people with Breast Neoplasms as compared to allele G.
chr16	69709857	rs10517	A	G	.	PASS	AF=0.848991;DESCR=Genotype GG is associated with decreased dose of warfarin as compared to genotypes AA + AG.
chr16	69709857	rs10517	A	T	.	AC0	AF=0.00000;DESCR=Genotype GG is associated with decreased dose of warfarin as compared to genotypes AA + AG.
chr16	69711242	rs1800566	G	A	.	PASS	AF=0.178571;DESCR=Genotypes AA + AG is associated with increased dose of warfarin as compared to genotype GG.
chr16	69716946	rs2917677	C	T	.	PASS	AF=0.429025;DESCR=Genotype CC is not associated with dose of warfarin as compared to genotypes CT + TT.
chr16	69725060	rs2917670	T	C	.	PASS	AF=0.567513;DESCR=Genotype CC is not associated with dose of warfarin as compared to genotypes CT + TT.
chr16	72008783	rs3213422	A	C	.	PASS	AF=0.524784;DESCR=Genotype CC is associated with increased clinical benefit to leflunomide in people with Arthritis, Rheumatoid as compared to genotypes AA + AC.
chr16	75213347	rs7202877	T	C	.	PASS	AF=0.00000;DESCR=Genotypes GG + GT is associated with decreased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus, Type 2 as compared to genotype TT.
chr16	75213347	rs7202877	T	G	.	PASS	AF=0.0763249;DESCR=Genotypes GG + GT is associated with decreased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus, Type 2 as compared to genotype TT.
chr16	78134009	rs13338697	A	G	.	PASS	AF=0.285426;DESCR=Genotypes AA + GG are not associated with response to cisplatin and fluorouracil in people with Liver Neoplasms as compared to genotype AG.
chr16	78134009	rs13338697	A	T	.	PASS	AF=0.00000;DESCR=Genotypes AA + GG are not associated with response to cisplatin and fluorouracil in people with Liver Neoplasms as compared to genotype AG.
chr16	79957795	rs10514475	G	A	.	PASS	AF=0.0841984;DESCR=Allele A is associated with increased response to Selective serotonin reuptake inhibitors in people with Depression as compared to allele G.
chr16	81123748	rs16954698	G	A	.	PASS	AF=0.0501730;DESCR=Allele A is associated with decreased clearance of methotrexate in children with Acute lymphoblastic leukemia as compared to allele G.
chr16	82632534	rs2116971	G	A	.	PASS	AF=0.399482;DESCR=Allele G is associated with response to perphenazine in people with Schizophrenia.
chr16	83678830	rs3784943	A	C	.	PASS	AF=0.00000;DESCR=Genotypes AG + GG is associated with increased response to amphetamine as compared to genotype AA.
chr16	83678830	rs3784943	A	G	.	PASS	AF=0.199885;DESCR=Genotypes AG + GG is associated with increased response to amphetamine as compared to genotype AA.
chr16	84814217	rs7205113	C	T	.	PASS	AF=0.0868436;DESCR=Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.
chr16	84975857	rs3210967	T	C	.	PASS	AF=0.289171;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr16	87855597	rs4240803	G	A	.	PASS	AF=0.300461;DESCR=Genotype AG is associated with increased dose of gabapentin in people with neuropathic pain as compared to genotype GG.
chr16	87855597	rs4240803	G	T	.	PASS	AF=0.00000;DESCR=Genotype AG is associated with increased dose of gabapentin in people with neuropathic pain as compared to genotype GG.
chr16	88468933	rs56292801	G	A	.	PASS	AF=0.262687;DESCR=Genotypes AA + AG are not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.
chr17	1769982	rs1136287	C	T	.	PASS	AF=0.720749;DESCR=Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.
chr17	2312964	rs391300	T	C	.	PASS	AF=0.644297;DESCR=Genotypes CC + CT are associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to genotype TT.
chr17	3518181	rs7217270	A	G	.	PASS	AF=0.600230;DESCR=Allele A is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.
chr17	3577153	rs8065080	T	C	.	PASS	AF=0.462536;DESCR=Genotype CC is associated with increased clinical benefit to cannabinoids in people with Pain as compared to genotypes CT + TT.
chr17	3583408	rs224534	G	A	.	PASS	AF=0.383573;DESCR=Genotypes AA + AG is associated with increased response to acetaminophen in healthy individuals as compared to genotype GG.
chr17	3583408	rs224534	G	C	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG is associated with increased response to acetaminophen in healthy individuals as compared to genotype GG.
chr17	3589906	rs222747	C	G	.	PASS	AF=0.737615;DESCR=Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.
chr17	3592080	rs222749	G	A	.	PASS	AF=0.0216014;DESCR=Allele A is associated with decreased response to botulinum toxin type a in women with Migraine NOS as compared to allele G.
chr17	3605586	rs222741	G	A	.	PASS	AF=0.738767;DESCR=Allele G is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele A.
chr17	4711302	rs4790693	C	G	.	PASS	AF=0.00000;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr17	4711302	rs4790693	C	T	.	PASS	AF=0.0765012;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr17	4711803	rs3786047	A	G	.	PASS	AF=0.680507;DESCR=Allele A is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele G.
chr17	4717202	rs7208257	C	T	.	PASS	AF=0.883065;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr17	4719343	rs1045280	C	T	.	PASS	AF=0.680300;DESCR=Allele C is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele T.
chr17	4719585	rs2271167	A	G	.	PASS	AF=0.680588;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr17	4721864	rs2036657	G	A	.	PASS	AF=0.678098;DESCR=Allele A is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele G.
chr17	4932600	rs2243093	T	C	.	PASS	AF=0.112940;DESCR=Genotypes CC + CT are not associated with response to aspirin in men as compared to genotype TT.
chr17	4933086	rs6065	C	G	.	PASS	AF=0.00000;DESCR=Genotypes CT + TT are associated with increased response to aspirin in men as compared to genotype CC.
chr17	4933086	rs6065	C	T	.	PASS	AF=0.130259;DESCR=Genotypes CT + TT are associated with increased response to aspirin in men as compared to genotype CC.
chr17	5379957	rs1000940	A	G	.	PASS	AF=0.305315;DESCR=Genotypes AG + GG is associated with decreased concentrations of glucose in people with Bipolar Disorder, Depressive Disorder, Psychotic Disorders and schizoaffective disorder as compared to genotype AA.
chr17	7260420	rs4562	A	G	.	PASS	AF=0.632565;DESCR=Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr17	7559238	rs11552708	G	A	.	PASS	AF=0.122478;DESCR=Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr17	7559238	rs11552708	G	C	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr17	7580783	rs9901673	C	A	.	PASS	AF=0.180588;DESCR=Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr17	7580783	rs9901673	C	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr17	7581494	rs9901675	G	A	.	PASS	AF=0.0599078;DESCR=Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr17	7676154	rs1042522	G	C	.	PASS	AF=0.720588;DESCR=Genotypes CG + GG is associated with decreased response to oxaliplatin in people with Colorectal Neoplasms as compared to genotype CC.
chr17	18264083	rs3889402	G	A	.	AS_VQSR	AF=0.00000;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr17	18264083	rs3889402	G	T	.	PASS	AF=0.0731567;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr17	18264370	rs12603700	G	A	.	PASS	AF=0.0729527;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr17	18265930	rs56355515	G	A	.	PASS	AF=0.0731988;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr17	18265930	rs56355515	G	T	.	PASS	AF=0.00605187;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr17	18266633	rs58042962	A	G	.	PASS	AF=0.0731567;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr17	18266633	rs58042962	A	T	.	PASS	AF=0.00000;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr17	18328782	rs1979277	G	A	.	PASS	AF=0.326801;DESCR=Allele A is not associated with response to folic acid, hydroxychloroquine, methotrexate and sulfasalazine in people with Arthritis, Rheumatoid.
chr17	19533874	rs2252281	T	C	.	PASS	AF=0.398030;DESCR=Allele C is not associated with exposure to metformin as compared to allele T.
chr17	19560030	rs2289669	G	A	.	PASS	AF=0.515265;DESCR=Allele A is not associated with response to tipiracil hydrochloride and trifluridine in people with Colorectal Neoplasms as compared to allele G.
chr17	19561878	rs8065082	C	T	.	PASS	AF=0.611592;DESCR=Genotypes CT + TT is associated with increased response to metformin in people with Glucose Intolerance as compared to genotype CC.
chr17	19614455	rs2120274	A	G	.	PASS	AF=0.478022;DESCR=Allele A is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr17	19614455	rs2120274	A	T	.	AC0	AF=0.00000;DESCR=Allele A is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr17	19646957	rs4621031	T	C	.	PASS	AF=0.324106;DESCR=Allele T is not associated with decreased clinical benefit to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr17	19716685	rs12943590	G	A	.	PASS	AF=0.334294;DESCR=Genotype GG is not associated with increased clearance of metformin in healthy individuals as compared to genotypes AA + AG.
chr17	22180454	rs1975974	A	G	.	PASS	AF=0.339100;DESCR=Genotypes AG + GG is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype AA.
chr17	30196708	rs7224199	G	T	.	PASS	AF=0.560012;DESCR=Allele T is not associated with dose of morphine in people with Lung Neoplasms and Pain as compared to allele G.
chr17	30197993	rs1042173	A	C	.	PASS	AF=0.547550;DESCR=Genotype CC is associated with decreased dose of morphine in people with Lung Neoplasms and Pain as compared to genotypes AA + AC.
chr17	30237328	rs25531	T	C	.	PASS	AF=0.0853081;DESCR=Allele C is not associated with response to nortriptyline in people with Tobacco Use Disorder as compared to allele T.
chr17	30237328	rs25531	T	G	.	AC0;AS_VQSR	AF=0.00000;DESCR=Allele C is not associated with response to nortriptyline in people with Tobacco Use Disorder as compared to allele T.
chr17	34011852	rs11869731	G	C	.	PASS	AF=0.789171;DESCR=Genotype CC is associated with increased response to lithium in people with Bipolar Disorder as compared to genotypes CG + GG.
chr17	34011852	rs11869731	G	T	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to lithium in people with Bipolar Disorder as compared to genotypes CG + GG.
chr17	34247429	rs4795893	G	A	.	PASS	AF=0.368800;DESCR=Allele G is associated with decreased response to antipsychotics in people with Schizophrenia as compared to allele A.
chr17	34256113	rs2857657	G	C	.	PASS	AF=0.842166;DESCR=Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.
chr17	34256250	rs4586	T	C	.	PASS	AF=0.354792;DESCR=Allele T is associated with decreased response to antipsychotics in people with Schizophrenia as compared to allele C.
chr17	34285425	rs17809012	A	C	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with decreased clinical benefit to morphine in people with Neoplasms and Pain as compared to genotypes AG + GG.
chr17	34285425	rs17809012	A	G	.	PASS	AF=0.465935;DESCR=Genotype AA is associated with decreased clinical benefit to morphine in people with Neoplasms and Pain as compared to genotypes AG + GG.
chr17	34285425	rs17809012	A	T	.	AC0	AF=0.00000;DESCR=Genotype AA is associated with decreased clinical benefit to morphine in people with Neoplasms and Pain as compared to genotypes AG + GG.
chr17	37692682	rs11868513	G	A	.	PASS	AF=0.214862;DESCR=Genotypes AA + AG are associated with increased response to metformin as compared to genotype GG.
chr17	39723335	rs1136201	A	G	.	PASS	AF=0.138792;DESCR=Allele G is associated with decreased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms.
chr17	39884510	rs2872507	G	A	.	PASS	AF=0.416330;DESCR=Genotypes AA + AG are associated with increased response to fluticasone propionate in children with Asthma as compared to genotype GG.
chr17	39884510	rs2872507	G	T	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG are associated with increased response to fluticasone propionate in children with Asthma as compared to genotype GG.
chr17	40094529	rs4794826	C	T	.	PASS	AF=0.138825;DESCR=Allele T is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.
chr17	40096959	rs2314339	C	T	.	PASS	AF=0.146889;DESCR=Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.
chr17	40098239	rs2071427	C	T	.	PASS	AF=0.267723;DESCR=Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.
chr17	40098436	rs2269457	T	C	.	PASS	AF=0.268588;DESCR=Allele T is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.
chr17	40099341	rs12941497	G	A	.	PASS	AF=0.270737;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.
chr17	40100440	rs939347	G	A	.	PASS	AF=0.220173;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.
chr17	40100837	rs2071570	C	A	.	PASS	AF=0.236448;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.
chr17	42390192	rs4796793	G	C	.	PASS	AF=0.691643;DESCR=Genotype GG is associated with increased response to interferons in people with Carcinoma, Renal Cell as compared to genotypes CC + CG.
chr17	44260984	rs45545233	T	C	.	PASS	AF=0.0723343;DESCR=Genotypes CC + CT are associated with decreased response to atenolol or metoprolol in people with Hypertension as compared to genotype TT.
chr17	44977671	rs894685	A	G	.	PASS	AF=0.287197;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr17	45290287	rs7222094	T	C	.	PASS	AF=0.554210;DESCR=Allele C is not associated with response to adalimumab or infliximab in people with Crohn Disease as compared to allele T.
chr17	45793325	rs9892359	A	G	.	PASS	AF=0.127089;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr17	45799466	rs4792886	G	A	.	PASS	AF=0.122837;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr17	45799654	rs4792887	C	T	.	PASS	AF=0.122691;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr17	45802681	rs110402	G	A	.	PASS	AF=0.442907;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr17	45802681	rs110402	G	C	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr17	45807885	rs12103667	A	G	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr17	45814822	rs3785877	G	A	.	PASS	AF=0.0420507;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr17	45815154	rs242941	A	C	.	PASS	AF=0.714862;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr17	45816121	rs171440	G	A	.	PASS	AF=0.474611;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr17	45817624	rs739645	T	A	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to fluticasone propionate in people with Asthma as compared to allele T.
chr17	45817624	rs739645	T	G	.	PASS	AF=0.240484;DESCR=Allele G is associated with increased response to fluticasone propionate in people with Asthma as compared to allele T.
chr17	45818213	rs242939	C	T	.	PASS	AF=0.908698;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr17	45818862	rs12150390	T	C	.	PASS	AF=0.240773;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr17	45821843	rs242936	A	G	.	PASS	AF=0.887961;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr17	45825578	rs1912151	C	T	.	PASS	AF=0.240783;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr17	45825631	rs1396862	G	A	.	PASS	AF=0.240634;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr17	45828115	rs17763086	T	G	.	PASS	AF=0.240495;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr17	45830379	rs1876831	C	T	.	PASS	AF=0.240773;DESCR=Allele T is associated with increased response to fluticasone propionate in people with Asthma as compared to allele C.
chr17	45830530	rs16940665	T	C	.	PASS	AF=0.240634;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr17	45833089	rs17689966	G	A	.	PASS	AF=0.540323;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr17	45833141	rs16940674	C	T	.	PASS	AF=0.234258;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr17	45834077	rs1876829	T	C	.	PASS	AF=0.241349;DESCR=Allele C is associated with increased response to fluticasone propionate in people with Asthma as compared to allele T.
chr17	45834159	rs1876828	C	T	.	PASS	AF=0.240783;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr17	45834976	rs28364032	G	A	.	PASS	AF=0.0495963;DESCR=Genotypes AA + AG is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotype GG.
chr17	45835124	rs878886	C	G	.	PASS	AF=0.240783;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr17	45835216	rs878887	C	T	.	PASS	AF=0.240922;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr17	45835269	rs878888	A	G	.	PASS	AF=0.240484;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr17	45835357	rs4525537	T	C	.	PASS	AF=0.240634;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr17	45835420	rs4640231	G	C	.	PASS	AF=0.240783;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr17	45835664	rs16940686	G	T	.	PASS	AF=0.0414986;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr17	45974480	rs1800547	A	G	.	PASS	AF=0.240196;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr17	46024197	rs9468	T	C	.	PASS	AF=0.239908;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr17	46025238	rs1052587	T	C	.	PASS	AF=0.240058;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr17	46159359	rs1528072	C	A	.	PASS	AF=0.240634;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr17	46159702	rs2532292	A	T	.	PASS	AF=0.240623;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr17	46939875	rs758391	G	A	.	PASS	AF=0.291643;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr17	47257956	rs58847127	G	A	.	PASS	AF=0.00000;DESCR=Allele C is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele G.
chr17	47257956	rs58847127	G	C	.	PASS	AF=0.0754608;DESCR=Allele C is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele G.
chr17	47283364	rs5918	T	C	.	PASS	AF=0.143599;DESCR=Allele C is not associated with resistance to aspirin or clopidogrel as compared to allele T.
chr17	47301872	rs3785873	G	A	.	PASS	AF=0.147839;DESCR=Allele A is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele G.
chr17	47731941	rs17250932	T	C	.	PASS	AF=0.127378;DESCR=Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotype TT.
chr17	47733553	rs2240017	C	G	.	PASS	AF=0.0703170;DESCR=Genotype CG is associated with increased response to corticosteroids in children with Asthma as compared to genotype CC.
chr17	50200388	rs1800012	C	A	.	PASS	AF=0.182448;DESCR=Genotype AA is associated with decreased dose of somatropin recombinant in people with growth hormone deficiency as compared to genotype CC.
chr17	50634726	rs4793665	C	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with decreased clearance of morphine in children as compared to allele C.
chr17	50634726	rs4793665	C	G	.	AC0	AF=0.00000;DESCR=Allele T is associated with decreased clearance of morphine in children as compared to allele C.
chr17	50634726	rs4793665	C	T	.	PASS	AF=0.506916;DESCR=Allele T is associated with decreased clearance of morphine in children as compared to allele C.
chr17	50656454	rs4148412	T	C	.	PASS	AF=0.556484;DESCR=Genotype TT is associated with increased concentrations of morphine-3-glucuronide in children with tonsillectomy as compared to genotypes CC + CT.
chr17	50675018	rs11079921	T	C	.	PASS	AF=0.0996544;DESCR=Allele C is associated with increased clearance of fentanyl in children with Pain and Premature Birth as compared to allele T.
chr17	50675018	rs11079921	T	G	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased clearance of fentanyl in children with Pain and Premature Birth as compared to allele T.
chr17	50676062	rs4148416	C	T	.	PASS	AF=0.0619597;DESCR=Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr17	50676161	rs8077268	C	T	.	PASS	AF=0.0997118;DESCR=Allele T is associated with increased clearance of fentanyl in children with Pain and Premature Birth as compared to allele C.
chr17	51153130	rs2151350551;rs2151350553;rs2151350556;rs3760468	A	T	.	PASS	AF=0.408357;DESCR=Genotype AA is not associated with increased clinical benefit to daclatasvir null sofosbuvir in people with Hepatitis C, Chronic as compared to genotypes AT + TT.
chr17	51882949	rs967676	T	C	.	PASS	AF=0.533795;DESCR=Genotypes CC + CT is associated with increased response to fluticasone propionate or montelukast in children with Asthma as compared to genotype TT.
chr17	56355850	rs9915451	A	G	.	PASS	AF=0.717542;DESCR=Allele G is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele A.
chr17	61406405	rs8068318	C	T	.	PASS	AF=0.698733;DESCR=Allele C is associated with decreased response to atenolol in people with Hypertension as compared to allele T.
chr17	63316455	rs2429427	G	A	.	PASS	AF=0.281719;DESCR=Genotype GG is associated with increased response to calcium channel blockers in people with Hypertension as compared to genotype AA.
chr17	63476833	rs4291	T	A	.	PASS	AF=0.556805;DESCR=Genotype TT is not associated with response to sertraline in people with Depressive Disorder.
chr17	63486691	rs4331	A	G	.	PASS	AF=0.367147;DESCR=Genotype AA is not associated with response to fluvastatin as compared to genotype GG.
chr17	63486691	rs4331	A	T	.	PASS	AF=0.00000;DESCR=Genotype AA is not associated with response to fluvastatin as compared to genotype GG.
chr17	63488629	rs4341	G	A	.	AC0;AS_VQSR	AF=0.00000;DESCR=Genotypes CG + GG are associated with increased response to pravastatin as compared to genotype CC.
chr17	63488629	rs4341	G	C	.	AS_VQSR	AF=0.357787;DESCR=Genotypes CG + GG are associated with increased response to pravastatin as compared to genotype CC.
chr17	63488670	rs4343	G	A	.	PASS	AF=0.378198;DESCR=Genotype GG is not associated with response to sertraline in people with Depressive Disorder.
chr17	63489363	rs4344	G	A	.	PASS	AF=0.367435;DESCR=Genotypes AA + GG are associated with increased response to ramipril in people with Hypertension as compared to genotype AG.
chr17	63489363	rs4344	G	C	.	PASS	AF=0.00000;DESCR=Genotypes AA + GG are associated with increased response to ramipril in people with Hypertension as compared to genotype AG.
chr17	63494982	rs4359	T	C	.	PASS	AF=0.360807;DESCR=Genotypes CC + TT are associated with increased response to ramipril in people with Hypertension as compared to genotype CT.
chr17	63497131	rs4363	G	A	.	PASS	AF=0.353145;DESCR=Genotypes AA + AG are not associated with increased response to ramipril in people with Hypertension as compared to genotype GG.
chr17	63497131	rs4363	G	C	.	AC0	AF=0.00000;DESCR=Genotypes AA + AG are not associated with increased response to ramipril in people with Hypertension as compared to genotype GG.
chr17	63505531	rs8075924	C	T	.	PASS	AF=0.190421;DESCR=Genotype TT is associated with decreased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CC + CT.
chr17	66212167	rs1801690	C	G	.	PASS	AF=0.0386613;DESCR=Allele C is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele G.
chr17	66214462	rs1801689	A	C	.	PASS	AF=0.0627880;DESCR=Allele A is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele C.
chr17	66214462	rs1801689	A	G	.	PASS	AF=0.00000;DESCR=Allele A is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele C.
chr17	66220736	rs52797880	A	G	.	PASS	AF=0.0714286;DESCR=Allele A is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele G.
chr17	66229411	rs8178822	G	A	.	AS_VQSR	AF=0.00000;DESCR=Allele G is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele T.
chr17	66229411	rs8178822	G	T	.	PASS	AF=0.0714697;DESCR=Allele G is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele T.
chr17	66235598	rs12944940	T	C	.	PASS	AF=0.216878;DESCR=Allele T is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele C.
chr17	66240200	rs10048158	T	A	.	AC0	AF=0.00000;DESCR=Allele C is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele T.
chr17	66240200	rs10048158	T	C	.	PASS	AF=0.485574;DESCR=Allele C is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele T.
chr17	66240200	rs10048158	T	G	.	PASS	AF=0.00000;DESCR=Allele C is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele T.
chr17	66310015	rs9909004	C	T	.	PASS	AF=0.465975;DESCR=Allele C is not associated with response to Ace Inhibitors, Plain, Angiotensin II Antagonists or Beta Blocking Agents in people with Heart Failure as compared to allele T.
chr17	66319248	rs9303504	G	C	.	PASS	AF=0.465994;DESCR=Allele G is not associated with response to Ace Inhibitors, Plain, Angiotensin II Antagonists or Beta Blocking Agents in people with Heart Failure as compared to allele C.
chr17	66791455	rs4791040	T	C	.	PASS	AF=0.0509793;DESCR=Allele T is associated with decreased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.
chr17	66792709	rs16960228	G	A	.	PASS	AF=0.0478111;DESCR=Allele A is associated with increased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.
chr17	78214286	rs9904341	G	C	.	PASS	AF=0.365783;DESCR=Genotype CG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.
chr18	659829	rs2853539	A	G	.	PASS	AF=0.485591;DESCR=Genotype AA is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.
chr18	661005	rs2244500	A	G	.	PASS	AF=0.485303;DESCR=Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.
chr18	661647	rs2847153	G	A	.	PASS	AF=0.253744;DESCR=Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.
chr18	673016	rs699517	C	T	.	PASS	AF=0.393372;DESCR=Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.
chr18	683607	rs2612091	C	G	.	AC0	AF=0.00000;DESCR=Genotype CC is not associated with response to bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin or trastuzumab in people with Stomach Neoplasms as compared to genotypes CT + TT.
chr18	683607	rs2612091	C	T	.	PASS	AF=0.503170;DESCR=Genotype CC is not associated with response to bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin or trastuzumab in people with Stomach Neoplasms as compared to genotypes CT + TT.
chr18	4970507	rs1466882	A	C	.	PASS	AF=0.667627;DESCR=Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr18	6550118	rs4411591	C	T	.	PASS	AF=0.130760;DESCR=Allele C is associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.
chr18	8275859	rs6506569	T	C	.	PASS	AF=0.403458;DESCR=Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.
chr18	8730055	rs2377898	G	A	.	PASS	AF=0.479527;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr18	9522608	rs329007	G	A	.	PASS	AF=0.796083;DESCR=Genotype GG is associated with decreased response to bevacizumab, fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to genotypes AA + AG.
chr18	11980461	rs971363	T	G	.	PASS	AF=0.0740634;DESCR=Allele G is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.
chr18	12877061	rs7234029	A	G	.	PASS	AF=0.127592;DESCR=Allele G is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele A.
chr18	24464436	rs4483927	G	T	.	PASS	AF=0.796713;DESCR=Genotype TT is associated with decreased response to risperidone in people with Schizophrenia as compared to genotypes GG + GT.
chr18	28132643	rs8094439	G	A	.	PASS	AF=0.312788;DESCR=Genotype AA is associated with increased response to methadone as compared to genotypes AG + GG.
chr18	28136925	rs17446819	A	C	.	PASS	AF=0.312464;DESCR=Genotype CC is associated with increased response to methadone as compared to genotypes AA + AC.
chr18	36251226	rs594445	C	A	.	PASS	AF=0.287032;DESCR=Genotypes AA + AC is associated with decreased dose of azathioprine in people with Kidney Transplantation as compared to genotype CC.
chr18	40449909	rs16973410	C	T	.	PASS	AF=0.109827;DESCR=Genotype CC is associated with increased response to lithium in people with Bipolar Disorder as compared to genotypes CT + TT.
chr18	45334299	rs12456693	C	T	.	PASS	AF=0.180035;DESCR=Allele T is associated with increased response to clopidogrel in people with Coronary Artery Disease as compared to allele C.
chr18	47228280	rs9952628	G	A	.	PASS	AF=0.479251;DESCR=Allele G is associated with response to perphenazine in people with Schizophrenia.
chr18	48927093	rs4939827	T	C	.	PASS	AF=0.437176;DESCR=Allele C is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele T.
chr18	56651611	rs501415	A	G	.	PASS	AF=0.161866;DESCR=Allele G is not associated with response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele A.
chr18	58043776	rs75982813	A	G	.	PASS	AF=0.0365994;DESCR=Allele A is not associated with response to atenolol in people with Hypertension as compared to allele G.
chr18	58140841	rs520210	G	A	.	PASS	AF=0.435447;DESCR=Allele A is associated with increased response to citalopram in people with Depression as compared to allele G.
chr18	58149559	rs4149601	G	A	.	PASS	AF=0.410271;DESCR=Allele G is not associated with response to atenolol in people with Hypertension as compared to allele A.
chr18	58195615	rs1008899	G	A	.	PASS	AF=0.331124;DESCR=Genotypes AA + AG are associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype GG.
chr18	58227849	rs292449	G	C	.	PASS	AF=0.387385;DESCR=Allele C is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.
chr18	58792367	rs2874116	G	A	.	PASS	AF=0.519297;DESCR=Allele G is associated with increased response to cyclosporine in people with Psoriasis as compared to allele A.
chr18	62337813	rs7239261	A	C	.	PASS	AF=0.548155;DESCR=Allele A is not associated with response to alendronate in women with Osteoporosis as compared to allele C.
chr18	62337813	rs7239261	A	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to alendronate in women with Osteoporosis as compared to allele C.
chr18	62338910	rs12969154	G	A	.	PASS	AF=0.0682997;DESCR=Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.
chr18	62348517	rs3826619	G	A	.	PASS	AF=0.140715;DESCR=Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.
chr18	62348517	rs3826619	G	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.
chr18	62348702	rs11877530	G	A	.	PASS	AF=0.0164265;DESCR=Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.
chr18	62360008	rs1805034	C	T	.	PASS	AF=0.544931;DESCR=Allele C is not associated with response to alendronate in women with Osteoporosis as compared to allele T.
chr18	62361422	rs8083511	A	C	.	PASS	AF=0.216801;DESCR=Allele A is not associated with response to alendronate in women with Osteoporosis as compared to allele C.
chr18	62361422	rs8083511	A	G	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to alendronate in women with Osteoporosis as compared to allele C.
chr18	62361422	rs8083511	A	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to alendronate in women with Osteoporosis as compared to allele C.
chr18	62361625	rs17069895	C	T	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to alendronate in women with Osteoporosis as compared to allele T.
chr18	62364256	rs7231887	G	A	.	PASS	AF=0.138329;DESCR=Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.
chr18	62412879	rs2980976	G	A	.	PASS	AF=0.235294;DESCR=Allele A is associated with decreased response to risperidone in people with Schizophrenia as compared to allele G.
chr19	1005231	rs2240158	C	T	.	PASS	AF=0.345245;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr19	1008684	rs2285906	G	A	.	PASS	AF=0.239193;DESCR=Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr19	1008880	rs2285907	G	A	.	PASS	AF=0.00000;DESCR=Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr19	1008880	rs2285907	G	C	.	PASS	AF=0.253602;DESCR=Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr19	1238900	rs2301759	T	C	.	PASS	AF=0.221198;DESCR=Genotype TT is associated with decreased clinical benefit to metformin in people with Diabetes Mellitus, Type 2 as compared to genotypes CC + CT.
chr19	1538139	rs12610827	T	G	.	PASS	AF=0.232968;DESCR=Allele T is associated with increased clinical benefit to olanzapine in people with Schizophrenia as compared to allele G.
chr19	2194897	rs2269879	T	C	.	PASS	AF=0.914697;DESCR=Genotypes CT + TT are associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype CC.
chr19	2232222	rs740406	A	G	.	PASS	AF=0.0713460;DESCR=Allele A is associated with decreased response to candesartan in people with Hypertension as compared to allele G.
chr19	6709693	rs2230205	C	T	.	PASS	AF=0.193707;DESCR=Genotype TT is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype CC.
chr19	6718376	rs2230199	G	C	.	PASS	AF=0.207373;DESCR=Genotypes CC + CG is not associated with response to eculizumab in people with paroxysmal nocturnal hemoglobinuria as compared to genotype GG.
chr19	6718523	rs2250656	T	C	.	PASS	AF=0.281268;DESCR=Genotype TT is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype CC.
chr19	7246650	rs2396185	A	C	.	PASS	AF=0.183285;DESCR=Allele C is associated with increased response to topiramate as compared to genotype AA.
chr19	7246650	rs2396185	A	G	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased response to topiramate as compared to genotype AA.
chr19	7690399	rs28364072	A	G	.	PASS	AF=0.299885;DESCR=Allele G is associated with increased dose of corticosteroids in children Asthma as compared to allele A.
chr19	10115376	rs2305795	G	A	.	PASS	AF=0.558468;DESCR=Allele G is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele A.
chr19	10115376	rs2305795	G	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele A.
chr19	10687087	rs76966440	C	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele C.
chr19	10687087	rs76966440	C	G	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele C.
chr19	10687087	rs76966440	C	T	.	PASS	AF=0.0187212;DESCR=Allele T is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele C.
chr19	11116926	rs688	C	T	.	PASS	AF=0.418685;DESCR=Genotype CT is associated with response to atenolol in people with Hypertension.
chr19	11120205	rs5925	T	C	.	PASS	AF=0.420173;DESCR=Genotype CC is not associated with response to fluvastatin as compared to genotype TT.
chr19	11131368	rs14158	G	A	.	PASS	AF=0.208069;DESCR=Genotype GG is not associated with response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic and HIV Infections as compared to genotypes AA + AG.
chr19	11131982	rs1433099	T	A	.	AC0	AF=0.00000;DESCR=Genotype TT is associated with increased response to pravastatin in people with Vascular Diseases as compared to genotype CC.
chr19	11131982	rs1433099	T	C	.	PASS	AF=0.678963;DESCR=Genotype TT is associated with increased response to pravastatin in people with Vascular Diseases as compared to genotype CC.
chr19	11132089	rs2738466	A	G	.	PASS	AF=0.209175;DESCR=Genotype GG is associated with increased response to pravastatin in people with Vascular Diseases as compared to genotype AA.
chr19	11232027	rs12979813	A	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele A.
chr19	11232027	rs12979813	A	G	.	PASS	AF=0.117003;DESCR=Allele G is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele A.
chr19	11313027	rs322144	C	G	.	PASS	AF=0.413733;DESCR=Allele C is associated with decreased clinical benefit to apremilast in people with Psoriasis as compared to allele G.
chr19	11333455	rs896412	C	G	.	PASS	AF=0.553695;DESCR=Allele G is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr19	11336275	rs172731	T	C	.	PASS	AF=0.454729;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr19	11354453	rs7251786	C	T	.	PASS	AF=0.457925;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr19	13207166	rs7254351	G	T	.	PASS	AF=0.529734;DESCR=Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.
chr19	13261817	rs2074880	A	C	.	PASS	AF=0.354755;DESCR=Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.
chr19	13277090	rs16030	A	G	.	PASS	AF=0.182238;DESCR=Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.
chr19	13334394	rs2248069	C	T	.	PASS	AF=0.644092;DESCR=Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.
chr19	13410714	rs10416717	A	G	.	PASS	AF=0.125937;DESCR=Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.
chr19	13479598	rs2112460	G	A	.	PASS	AF=0.519896;DESCR=Allele A is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele G.
chr19	15848390	rs2189784	G	A	.	PASS	AF=0.440346;DESCR=Allele A is not associated with dose of warfarin as compared to allele G.
chr19	15848390	rs2189784	G	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with dose of warfarin as compared to allele G.
chr19	15879621	rs2108622	C	T	.	PASS	AF=0.347174;DESCR=Genotype CC is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotypes CT + TT.
chr19	15886010	rs2074900	G	A	.	PASS	AF=0.253026;DESCR=Genotype AA is associated with decreased clearance of ticagrelor in healthy individuals as compared to genotypes AG + GG.
chr19	15889356	rs3093158	C	T	.	PASS	AF=0.659850;DESCR=Allele T is not associated with dose of warfarin in people with heart valve replacement as compared to allele C.
chr19	15890405	rs3093153	C	A	.	PASS	AF=0.0403924;DESCR=Allele C is not associated with dose of warfarin as compared to allele A.
chr19	15897578	rs3093105	A	C	.	PASS	AF=0.212392;DESCR=Allele C is not associated with response to vitamin e in people with Fatty liver disease as compared to allele A.
chr19	15913728	rs1060467	A	G	.	PASS	AF=0.282584;DESCR=Allele G is associated with decreased dose of warfarin as compared to allele A.
chr19	15923904	rs8104361	A	G	.	PASS	AF=0.773541;DESCR=Allele A is not associated with dose of warfarin as compared to allele G.
chr19	15923904	rs8104361	A	T	.	AC0	AF=0.00000;DESCR=Allele A is not associated with dose of warfarin as compared to allele G.
chr19	17641880	rs12608932	A	C	.	PASS	AF=0.271758;DESCR=Allele C is not associated with response to creatine in people with Amyotrophic Lateral Sclerosis as compared to allele A.
chr19	35851310	rs3814995	C	T	.	PASS	AF=0.265418;DESCR=Allele T is associated with increased response to losartan in men with Hypertension as compared to allele C.
chr19	36183403	rs4805162	A	G	.	PASS	AF=0.551267;DESCR=Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr19	39241143	rs12980275	A	G	.	PASS	AF=0.403458;DESCR=Genotype AA is not associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotypes AG + GG.
chr19	39241861	rs8105790	T	C	.	PASS	AF=0.213545;DESCR=Allele C is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to allele T.
chr19	39243580	rs4803217	C	A	.	PASS	AF=0.382574;DESCR=Genotypes AC + CC are associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to genotype AA.
chr19	39243580	rs4803217	C	T	.	PASS	AF=0.000288184;DESCR=Genotypes AC + CC are associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to genotype AA.
chr19	39244283	rs11881222	A	G	.	PASS	AF=0.389209;DESCR=Allele G is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to allele A.
chr19	39244466	rs8103142	T	C	.	PASS	AF=0.428489;DESCR=Allele C is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to allele T.
chr19	39245004	rs28416813	C	G	.	PASS	AF=0.382285;DESCR=Allele C is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to allele G.
chr19	39245279	rs4803219	C	T	.	PASS	AF=0.373604;DESCR=Allele C is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to allele T.
chr19	39248147	rs12979860	C	G	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with decreased clearance of atorvastatin.
chr19	39248147	rs12979860	C	T	.	PASS	AF=0.394297;DESCR=Genotype CC is associated with decreased clearance of atorvastatin.
chr19	39252122	rs8109886	C	A	.	PASS	AF=0.561778;DESCR=Genotype CC is not associated with response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes AA + AC.
chr19	39252463	rs8113007	A	T	.	PASS	AF=0.388985;DESCR=Genotype AA is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C and HIV Infections as compared to genotypes AT + TT.
chr19	39252525	rs8099917	T	G	.	PASS	AF=0.204611;DESCR=Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic and Hepatitis C, Chronic as compared to genotypes GG + GT.
chr19	39253181	rs7248668	G	A	.	PASS	AF=0.204323;DESCR=Allele A is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to allele G.
chr19	39254506	rs10853728	C	A	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes CC + CG.
chr19	39254506	rs10853728	C	G	.	PASS	AF=0.693836;DESCR=Genotype GG is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes CC + CG.
chr19	40286682	rs34716810	G	A	.	PASS	AF=0.169164;DESCR=Genotype AA is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG.
chr19	40287019	rs62107593	C	G	.	PASS	AF=0.168685;DESCR=Genotype CC is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CG + GG.
chr19	40718299	rs28493229	G	C	.	PASS	AF=0.114409;DESCR=Genotypes CC + CG are associated with decreased response to Immunoglobulins in children with Mucocutaneous Lymph Node Syndrome as compared to genotype GG.
chr19	40796801	rs7937	C	T	.	PASS	AF=0.603111;DESCR=Allele C is associated with increased concentrations of letrozole in women with Breast Neoplasms as compared to allele T.
chr19	40804666	rs3733829	A	G	.	PASS	AF=0.296830;DESCR=Genotypes AA + AG are associated with decreased concentrations of 3-hydroxycotinine in people with Tobacco Use Disorder as compared to genotype GG.
chr19	40833991	rs12459249	T	C	.	PASS	AF=0.708357;DESCR=Allele C is associated with decreased metabolism of nicotine as compared to allele T.
chr19	40835324	rs12461964	A	G	.	PASS	AF=0.488761;DESCR=Allele A is associated with decreased clearance of nicotine as compared to allele G.
chr19	40845362	rs28399454	C	T	.	PASS	AF=0.00000;DESCR=Genotypes CT + TT are associated with decreased metabolism of nicotine as compared to genotype CC.
chr19	40847202	rs56113850	T	C	.	PASS	AF=0.574394;DESCR=Allele T is associated with increased concentrations of letrozole in women with Breast Neoplasms as compared to allele C.
chr19	40848591	rs8192726	C	A	.	PASS	AF=0.0657061;DESCR=Allele A is not associated with metabolism of efavirenz in people with HIV Infections as compared to allele C.
chr19	40848807	rs8192725	A	G	.	PASS	AF=0.753314;DESCR=Genotypes AG + GG are associated with increased metabolism of tegafur as compared to genotype AA.
chr19	40850376	rs1137115	T	C	.	PASS	AF=0.747542;DESCR=Allele C is not associated with metabolism of nicotine as compared to allele T.
chr19	40850405	rs8192720	G	A	.	PASS	AF=0.0190862;DESCR=Genotypes AA + AG are associated with increased metabolism of tegafur as compared to genotype GG.
chr19	40850474	rs28399433	A	C	.	PASS	AF=0.0662999;DESCR=Allele C is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele A.
chr19	40850474	rs28399433	A	T	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele A.
chr19	40852719	rs4105144	T	C	.	InbreedingCoeff	AF=0.494480;DESCR=Allele T is not associated with concentrations of cotinine or nicotine in people with Tobacco Use Disorder as compared to allele C.
chr19	40855903	rs111645190	G	A	.	PASS	AF=0.00000;DESCR=Allele A is not associated with metabolism of nicotine as compared to allele G.
chr19	40856388	rs113288603	C	T	.	PASS	AF=0.0914352;DESCR=Allele T is associated with decreased clearance of nicotine as compared to allele C.
chr19	40875742	rs12460590	A	C	.	PASS	AF=0.679858;DESCR=Allele A is not associated with increased dose of warfarin in people with an international normalized ratio (INR) of 2.0-3.0 as compared to allele C.
chr19	40986013	rs8109525	A	G	.	PASS	AF=0.321799;DESCR=Genotype GG is associated with increased response to bupropion in people with Tobacco Use Disorder as compared to genotypes AA + AG.
chr19	40988986	rs7254579	T	C	.	PASS	AF=0.322478;DESCR=Allele C is associated with metabolism of cyclophosphamide in people with Lupus erythematosus as compared to allele T.
chr19	40989528	rs3760657	A	G	.	PASS	AF=0.0875576;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr19	40990556	rs4802101	T	C	.	PASS	AF=0.612810;DESCR=Allele C is associated with decreased metabolism of cyclophosphamide in people with Lupus erythematosus as compared to allele T.
chr19	40991369	rs8192709	C	T	.	PASS	AF=0.0879977;DESCR=Genotype CC is not associated with clearance of efavirenz in people with HIV Infections as compared to genotypes CT + TT.
chr19	40994308	rs8100458	T	C	.	PASS	AF=0.321902;DESCR=Genotypes CT + TT are not associated with concentrations of efavirenz in people with HIV Infections as compared to genotype CC.
chr19	40998172	rs16974799	C	G	.	PASS	AF=0.00000;DESCR=Genotype CT is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.
chr19	40998172	rs16974799	C	T	.	PASS	AF=0.285055;DESCR=Genotype CT is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.
chr19	41004222	rs2279342	A	G	.	PASS	AF=0.00000;DESCR=Genotypes AT + TT is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype AA.
chr19	41004222	rs2279342	A	T	.	PASS	AF=0.0993072;DESCR=Genotypes AT + TT is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype AA.
chr19	41006887	rs4803419	C	T	.	PASS	AF=0.312860;DESCR=Genotype CT is associated with decreased concentrations of levonorgestrel in women with HIV Infections as compared to genotype CC.
chr19	41006936	rs3745274	G	T	.	PASS	AF=0.263249;DESCR=Allele T (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele G (assigned as normal metabolizer phenotype) .
chr19	41009578	rs2279344	G	A	.	PASS	AF=0.682159;DESCR=Allele A is not associated with concentrations of methadone as compared to allele G.
chr19	41009797	rs2279345	T	C	.	PASS	AF=0.681661;DESCR=Allele T is not associated with exposure to olanzapine in healthy individuals as compared to allele C.
chr19	41012316	rs28399499	T	C	.	PASS	AF=0.00000;DESCR=Allele C (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele T (assigned as normal metabolizer phenotype) .
chr19	41012868	rs8192719	C	T	.	PASS	AF=0.263401;DESCR=Allele T is not associated with concentrations of (S)-EDDP as compared to allele C.
chr19	41013401	rs36118214	G	A	.	PASS	AF=0.00489914;DESCR=Genotype GG is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotype AA.
chr19	41013401	rs36118214	G	T	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotype AA.
chr19	41016810	rs3211371	C	A	.	PASS	AF=0.00000;DESCR=Genotype TT is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype CC.
chr19	41016810	rs3211371	C	T	.	PASS	AF=0.110375;DESCR=Genotype TT is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype CC.
chr19	41017111	rs3181842	C	T	.	PASS	AF=0.682631;DESCR=Genotypes CC + CT are associated with increased metabolism of efavirenz in healthy individuals as compared to genotype TT.
chr19	41017398	rs7246465	T	A	.	AC0	AF=0.00000;DESCR=Genotypes CT + TT are associated with increased metabolism of efavirenz in healthy individuals as compared to genotype CC.
chr19	41017398	rs7246465	T	C	.	PASS	AF=0.675894;DESCR=Genotypes CT + TT are associated with increased metabolism of efavirenz in healthy individuals as compared to genotype CC.
chr19	41018182	rs707265	A	C	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG are associated with increased metabolism of efavirenz in healthy individuals as compared to genotype GG.
chr19	41018182	rs707265	A	G	.	PASS	AF=0.693483;DESCR=Genotypes AA + AG are associated with increased metabolism of efavirenz in healthy individuals as compared to genotype GG.
chr19	41018248	rs1042389	T	C	.	PASS	AF=0.170795;DESCR=Allele C is not associated with response to efavirenz or non-nucleoside reverse transcriptase inhibitors in women with HIV Infections as compared to genotype TT.
chr19	41025692	rs35930845	C	G	.	PASS	AF=0.101671;DESCR=Genotypes CG + GG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype CC.
chr19	41025692	rs35930845	C	T	.	PASS	AF=0.00000;DESCR=Genotypes CG + GG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype CC.
chr19	41025920	rs3745276	A	G	.	PASS	AF=0.713998;DESCR=Genotypes AA + AG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype GG.
chr19	41026100	rs434606	G	A	.	PASS	AF=0.220046;DESCR=Genotypes AA + AG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype GG.
chr19	41052973	rs56156262	G	A	.	PASS	AF=0.0937680;DESCR=Genotypes AA + AG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype GG.
chr19	41352971	rs1800471	C	G	.	PASS	AF=0.0434908;DESCR=Genotype CG is associated with decreased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype GG.
chr19	41352971	rs1800471	C	T	.	PASS	AF=0.00000;DESCR=Genotype CG is associated with decreased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype GG.
chr19	41353016	rs1800470	G	A	.	PASS	AF=0.500577;DESCR=Genotype AG is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.
chr19	41353016	rs1800470	G	C	.	PASS	AF=0.00000;DESCR=Genotype AG is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.
chr19	41354391	rs1800469	A	G	.	PASS	AF=0.544669;DESCR=Allele A is associated with decreased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele G.
chr19	43334601	rs7247267	G	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with decreased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.
chr19	43334601	rs7247267	G	T	.	PASS	AF=0.143516;DESCR=Allele T is associated with decreased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.
chr19	43551574	rs25487	T	C	.	PASS	AF=0.595965;DESCR=Allele C is not associated with response to radiotherapy in people with Nasopharyngeal Neoplasms as compared to allele T.
chr19	43553422	rs1799782	G	A	.	PASS	AF=0.0591119;DESCR=Genotypes AA + AG is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.
chr19	44891079	rs71352238	T	C	.	PASS	AF=0.114475;DESCR=Genotypes CC + CT are associated with decreased response to rosuvastatin as compared to genotype TT.
chr19	44892362	rs2075650	A	G	.	PASS	AF=0.114475;DESCR=Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to allele A.
chr19	44905579	rs405509	T	G	.	PASS	AF=0.534622;DESCR=Genotype TT is associated with increased response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to genotypes GG + GT.
chr19	44908684	rs429358	T	C	.	PASS	AF=0.119089;DESCR=Genotype CC is not associated with increased response to acitretin in people with Psoriasis as compared to genotypes CT + TT.
chr19	44908822	rs7412	C	T	.	PASS	AF=0.0694524;DESCR=Genotype CC is not associated with increased response to acitretin in people with Psoriasis as compared to genotypes CT + TT.
chr19	44912383	rs445925	G	A	.	PASS	AF=0.100000;DESCR=Allele A is associated with increased response to hmg coa reductase inhibitors as compared to allele G.
chr19	44919689	rs4420638	A	G	.	PASS	AF=0.149942;DESCR=Allele G is associated with decreased response to hmg coa reductase inhibitors in people with Cardiovascular Diseases or Hypercholesterolemia as compared to allele A.
chr19	45351661	rs13181	T	G	.	PASS	AF=0.398847;DESCR=Genotypes GG + GT is not associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.
chr19	45352266	rs1052555	G	A	.	PASS	AF=0.359862;DESCR=Genotypes AA + AG is associated with decreased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.
chr19	45359191	rs50872	A	G	.	PASS	AF=0.772622;DESCR=Allele A is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr19	45364001	rs1799793	C	T	.	PASS	AF=0.351585;DESCR=Genotypes CT + TT is associated with decreased clinical benefit to cisplatin, doxorubicin and methotrexate in people with Osteosarcoma as compared to genotype CC.
chr19	45365051	rs238406	T	G	.	PASS	AF=0.588422;DESCR=Genotypes GT + TT is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.
chr19	45370684	rs3810366	G	C	.	PASS	AF=0.473214;DESCR=Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele C.
chr19	45370684	rs3810366	G	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele C.
chr19	45408744	rs735482	A	C	.	PASS	AF=0.136967;DESCR=Allele C is not associated with response to cisplatin in women with Ovarian Neoplasms as compared to allele A.
chr19	45409148	rs2336219	G	A	.	PASS	AF=0.137073;DESCR=Genotypes AG + GG are associated with increased response to cisplatin in women with Ovarian Neoplasms as compared to genotype AA.
chr19	45409478	rs3212986	C	A	.	PASS	AF=0.244669;DESCR=Genotypes AA + AC is not associated with increased clinical benefit to Platinum compounds in people with Neoplasms as compared to genotype CC.
chr19	45413183	rs3212980	T	G	.	PASS	AF=0.243804;DESCR=Genotype GT is associated with increased response to cisplatin in women with Ovarian Neoplasms as compared to genotype TT.
chr19	45417538	rs3212964	C	T	.	PASS	AF=0.141003;DESCR=Allele T is not associated with response to cisplatin in women with Ovarian Neoplasms as compared to allele C.
chr19	45420395	rs11615	A	G	.	PASS	AF=0.396254;DESCR=Allele A is not associated with response to carboplatin and pemetrexed in people with Mesothelioma as compared to allele G.
chr19	45421104	rs3212948	G	C	.	PASS	AF=0.351734;DESCR=Allele C is associated with increased response to fluorouracil, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to genotype GG.
chr19	45423658	rs2298881	C	A	.	PASS	AF=0.121317;DESCR=Genotypes AA + AC is not associated with increased clinical benefit to Platinum compounds in people with Neoplasms as compared to genotype CC.
chr19	45423658	rs2298881	C	G	.	PASS	AF=0.00000;DESCR=Genotypes AA + AC is not associated with increased clinical benefit to Platinum compounds in people with Neoplasms as compared to genotype CC.
chr19	45526896	rs10995	G	A	.	PASS	AF=0.787032;DESCR=Genotypes AG + GG are associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype AA.
chr19	45679046	rs10423928	T	A	.	PASS	AF=0.295101;DESCR=Allele A is not associated with response to sitagliptin or vildagliptin in people with Diabetes Mellitus, Type 2 as compared to allele T.
chr19	45872521	rs16980091	C	T	.	PASS	AF=0.138120;DESCR=Allele T is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele C.
chr19	48234449	rs2043211	A	T	.	PASS	AF=0.266878;DESCR=Genotype TT is associated with decreased response to etanercept or infliximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AT.
chr19	52048768	rs3752120	C	T	.	PASS	AF=0.115917;DESCR=Genotype TT is associated with decreased response to budesonide, corticosteroids, fluticasone propionate or fluticasone/salmeterol in people with Asthma.
chr19	52948038	rs9304742	T	C	.	PASS	AF=0.430507;DESCR=Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotypes CT + TT.
chr19	54885501	rs11666735	G	A	.	PASS	AF=0.128316;DESCR=Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.
chr19	55368504	rs1126757	C	T	.	PASS	AF=0.407205;DESCR=Genotypes CT + TT is associated with increased response to escitalopram in people with Depression as compared to genotype CC.
chr19	57620255	rs10413455	G	A	.	PASS	AF=0.0864553;DESCR=Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr19	57620255	rs10413455	G	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr19	57633193	rs10420097	A	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr19	57633193	rs10420097	A	G	.	PASS	AF=0.0855908;DESCR=Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr2	2269048	rs79663562	T	C	.	PASS	AF=0.0989613;DESCR=Allele C is associated with decreased response to allopurinol as compared to allele T.
chr2	10122793	rs1130609	T	G	.	PASS	AF=0.671083;DESCR=Genotypes GT + TT is associated with decreased response to cladribine and cytarabine in children with Leukemia, Myeloid, Acute as compared to genotype GG.
chr2	10123747	rs5030743	C	G	.	PASS	AF=0.00000;DESCR=Genotypes CG + GG is associated with decreased response to cladribine and cytarabine in children with Leukemia, Myeloid, Acute as compared to genotype CC.
chr2	10538412	rs13002976	A	G	.	PASS	AF=0.353060;DESCR=Allele G is not associated with response to bevacizumab and ranibizumab in people with as compared to allele A.
chr2	11750302	rs10192566	C	G	.	PASS	AF=0.441210;DESCR=Allele G is associated with increased response to rosiglitazone in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr2	14177682	rs10193126	T	C	.	PASS	AF=0.584965;DESCR=Allele C is associated with increased response to allopurinol as compared to allele T.
chr2	15383918	rs1019358	A	G	.	PASS	AF=0.737024;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.
chr2	21005955	rs1801701	C	T	.	PASS	AF=0.0535714;DESCR=Genotype CC is associated with increased response to irbesartan in people with Hypertrophy, Left Ventricular as compared to genotypes CT + TT.
chr2	21008652	rs676210	G	A	.	PASS	AF=0.188652;DESCR=Genotype AA is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotypes AG + GG.
chr2	21008652	rs676210	G	T	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotypes AG + GG.
chr2	21041028	rs1367117	G	A	.	PASS	AF=0.183468;DESCR=Genotype AG is associated with response to irbesartan in people with Hypertension.
chr2	25235677	rs2304429	C	T	.	PASS	AF=0.482400;DESCR=Genotype TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CC + CT.
chr2	26691496	rs1275988	C	T	.	PASS	AF=0.597926;DESCR=Allele C is associated with increased response to candesartan in people with Hypertension as compared to allele T.
chr2	27518370	rs780094	T	C	.	PASS	AF=0.456459;DESCR=Genotypes CT + TT are associated with increased response to fenofibrate in people with Hypertriglyceridemia.
chr2	31022784	rs12999804	A	T	.	PASS	AF=0.279090;DESCR=Allele A is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chr2	31023383	rs10209881	T	C	.	PASS	AF=0.432776;DESCR=Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chr2	31024619	rs6752303	T	C	.	PASS	AF=0.433180;DESCR=Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chr2	31024648	rs9679162	G	T	.	PASS	AF=0.433180;DESCR=Genotype TT is associated with increased response to cisplatin, fluorouracil and mitoxantrone in people with Liver Neoplasms as compared to genotypes GG + GT.
chr2	31026148	rs5009910	T	C	.	PASS	AF=0.433930;DESCR=Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chr2	31026561	rs12613732	T	G	.	PASS	AF=0.299481;DESCR=Allele G is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chr2	31027108	rs7608731	T	C	.	PASS	AF=0.430588;DESCR=Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chr2	31348920	rs1884725	A	G	.	PASS	AF=0.817972;DESCR=Allele G is associated with decreased dose of allopurinol or febuxostat in people with Gout as compared to allele A.
chr2	31580636	rs523349	G	C	.	PASS	AF=0.755760;DESCR=Genotype CC is associated with increased response to abiraterone in men with Prostatic Neoplasms as compared to genotypes CG + GG.
chr2	38071007	rs1056837	A	G	.	PASS	AF=0.488171;DESCR=Allele A is associated with decreased clinical benefit to codeine or tramadol in men with Pain as compared to allele G.
chr2	38071734	rs162561	T	A	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with decreased response to docetaxel in people with Breast Neoplasms as compared to genotypes GT + TT.
chr2	38071734	rs162561	T	G	.	PASS	AF=0.830450;DESCR=Genotype GG is associated with decreased response to docetaxel in people with Breast Neoplasms as compared to genotypes GT + TT.
chr2	38075034	rs1056827	C	A	.	PASS	AF=0.216138;DESCR=Allele A is associated with decreased response to risperidone in people with Schizophrenia as compared to allele C.
chr2	38075247	rs10012	G	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased response to risperidone in people with Schizophrenia as compared to allele G.
chr2	38075247	rs10012	G	C	.	PASS	AF=0.213833;DESCR=Allele C is associated with decreased response to risperidone in people with Schizophrenia as compared to allele G.
chr2	38080367	rs162555	T	C	.	PASS	AF=0.193772;DESCR=Genotypes CT + TT are not associated with concentrations of exemestane in women with Breast Neoplasms as compared to genotype CC.
chr2	43813262	rs6720173	G	C	.	PASS	AF=0.187428;DESCR=Allele C is associated with increased clearance of 5'-deoxy-5-fluorouridine in people with Colorectal Neoplasms as compared to allele G.
chr2	43839108	rs11887534	G	C	.	PASS	AF=0.0896254;DESCR=Genotypes CC + CG is associated with decreased clinical benefit to atorvastatin or simvastatin in people with Dyslipidaemia as compared to genotype GG.
chr2	45797073	rs6720975	T	A	.	AC0	AF=0.00000;DESCR=Allele T is associated with increased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C.
chr2	45797073	rs6720975	T	C	.	PASS	AF=0.647144;DESCR=Allele T is associated with increased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C.
chr2	46185283	rs2278773	C	G	.	PASS	AF=0.0103746;DESCR=Allele C is associated with response to perphenazine in people with Schizophrenia.
chr2	46325319	rs4953344	T	C	.	PASS	AF=0.191465;DESCR=Allele C is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele T.
chr2	46329494	rs12712973	A	C	.	PASS	AF=0.510375;DESCR=Allele A is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele C.
chr2	46330505	rs9679290	G	C	.	PASS	AF=0.411765;DESCR=Allele C is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele G.
chr2	46334063	rs6726454	A	G	.	PASS	AF=0.516148;DESCR=Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele A.
chr2	46355243	rs7589621	G	A	.	PASS	AF=0.254320;DESCR=Allele A is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele G.
chr2	46363652	rs3768728	T	C	.	PASS	AF=0.219470;DESCR=Allele C is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele T.
chr2	46369294	rs1374749	G	A	.	PASS	AF=0.472622;DESCR=Allele A is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele G.
chr2	47402759	rs1863332	T	G	.	PASS	AF=0.0878456;DESCR=Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele T.
chr2	48962782	rs6166	C	T	.	PASS	AF=0.481246;DESCR=Genotype CC is associated with increased dose of gonadotropin,chorionic in women as compared to genotype CT.
chr2	50438029	rs4971678	T	A	.	PASS	AF=0.116849;DESCR=Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr2	51015132	rs12467557	A	G	.	PASS	AF=0.0536642;DESCR=Genotype AA is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes AG + GG.
chr2	51020519	rs10490162	T	C	.	PASS	AF=0.0914599;DESCR=Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes CC + CT.
chr2	60487726	rs6545816	A	C	.	PASS	AF=0.464553;DESCR=Allele A is not associated with increased response to hydroxyurea in people with beta-Thalassemia.
chr2	60490908	rs1427407	T	G	.	PASS	AF=0.717003;DESCR=Allele T is associated with increased response to hydroxyurea in people with beta-Thalassemia as compared to allele G.
chr2	60492835	rs766432	C	A	.	PASS	AF=0.697293;DESCR=Allele C is associated with increased clinical benefit to hydroxyurea in people with Beta-thalassemia and related diseases as compared to allele A.
chr2	60493816	rs4671393	A	G	.	PASS	AF=0.699712;DESCR=Allele A is associated with increased response to hydroxyurea in people with beta-Thalassemia as compared to allele G.
chr2	60494905	rs6706648	C	T	.	PASS	AF=0.252595;DESCR=Allele T is not associated with increased response to hydroxyurea in people with beta-Thalassemia as compared to allele C.
chr2	60892336	rs842647	G	A	.	PASS	AF=0.790035;DESCR=Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.
chr2	60908994	rs13031237	G	T	.	PASS	AF=0.287154;DESCR=Allele T is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr2	64980940	rs10211524	G	A	.	PASS	AF=0.427378;DESCR=Genotype AA is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotypes AG + GG.
chr2	68181905	rs1868402	G	A	.	PASS	AF=0.789625;DESCR=Allele A is associated with increased response to cyclosporine in people with Psoriasis as compared to allele G.
chr2	68181905	rs1868402	G	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to cyclosporine in people with Psoriasis as compared to allele G.
chr2	75049302	rs881	C	G	.	PASS	AF=0.181164;DESCR=Allele G is not associated with dose of opioids in people with Pain as compared to allele C.
chr2	75059979	rs4439987	G	A	.	PASS	AF=0.575461;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr2	75074636	rs6546952	C	T	.	PASS	AF=0.545507;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr2	75107645	rs2160652	T	G	.	PASS	AF=0.732256;DESCR=Allele G is not associated with dose of opioids in people with Pain as compared to allele T.
chr2	75147139	rs12475818	T	G	.	PASS	AF=0.445502;DESCR=Allele G is not associated with dose of opioids in people with Pain as compared to allele T.
chr2	75153826	rs3771836	T	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with dose of opioids in people with Pain as compared to allele T.
chr2	75153826	rs3771836	T	C	.	PASS	AF=0.00000;DESCR=Allele G is not associated with dose of opioids in people with Pain as compared to allele T.
chr2	75153826	rs3771836	T	G	.	PASS	AF=0.546686;DESCR=Allele G is not associated with dose of opioids in people with Pain as compared to allele T.
chr2	75158066	rs10191107	G	A	.	PASS	AF=0.536311;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr2	75177828	rs12713837	C	G	.	PASS	AF=0.555012;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele G.
chr2	75195905	rs6725334	A	G	.	PASS	AF=0.380334;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr2	75198497	rs2024512	G	A	.	PASS	AF=0.376945;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr2	75198602	rs6715729	A	G	.	PASS	AF=0.377522;DESCR=Genotype GG is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes AA + AG.
chr2	75198602	rs6715729	A	T	.	AC0	AF=0.00000;DESCR=Genotype GG is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes AA + AG.
chr2	75200752	rs2111375	G	A	.	PASS	AF=0.460496;DESCR=Genotype AA is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes AG + GG.
chr2	79673969	rs11126740	A	G	.	PASS	AF=0.756336;DESCR=Genotype AA is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotypes AG + GG.
chr2	85550510	rs11676382	C	G	.	PASS	AF=0.0371758;DESCR=Allele G is associated with decreased dose of warfarin as compared to allele C.
chr2	85553008	rs2592551	G	A	.	PASS	AF=0.218030;DESCR=Genotypes AA + AG is associated with increased dose of warfarin in people with Atrial Fibrillation as compared to genotype GG.
chr2	85553413	rs699664	C	T	.	PASS	AF=0.258511;DESCR=Genotypes CC + CT are not associated with dose of warfarin in people with heart valve replacement as compared to genotype TT.
chr2	85560218	rs12714145	C	T	.	PASS	AF=0.341590;DESCR=Allele T is not associated with dose of warfarin.
chr2	88124547	rs2241883	T	C	.	PASS	AF=0.339585;DESCR=Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.
chr2	96941334	rs6728642	A	G	.	PASS	AF=0.205933;DESCR=Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr2	99438696	rs3087399	T	C	.	PASS	AF=0.0512968;DESCR=Genotypes CC + CT are not associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype TT.
chr2	99439044	rs3087386	A	G	.	PASS	AF=0.500288;DESCR=Genotypes AA + AG are not associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype GG.
chr2	99442408	rs3087403	C	T	.	PASS	AF=0.351585;DESCR=Genotypes CT + TT are associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype CC.
chr2	105653155	rs10193895	A	G	.	PASS	AF=0.0455069;DESCR=Genotypes AG + GG are not associated with response to clozapine in people with Schizophrenia as compared to genotype AA.
chr2	107989380	rs6542746	C	T	.	PASS	AF=0.565744;DESCR=Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr2	107995063	rs11685873	G	A	.	PASS	AF=0.0567723;DESCR=Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.
chr2	108006866	rs6720783	T	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr2	108006866	rs6720783	T	G	.	PASS	AF=0.371182;DESCR=Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.
chr2	108258788	rs6722745	T	C	.	PASS	AF=0.359700;DESCR=Allele T is associated with decreased response to candesartan in people with Hypertension as compared to allele C.
chr2	108378352	rs1402467	C	G	.	PASS	AF=0.247839;DESCR=Allele G is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele C.
chr2	111150114	rs724710	T	C	.	PASS	AF=0.609510;DESCR=Allele T is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele C.
chr2	112771663	rs11677416	T	C	.	PASS	AF=0.342090;DESCR=Allele C is associated with increased response to olanzapine in people with Schizophrenia as compared to allele T.
chr2	112779646	rs17561	C	A	.	PASS	AF=0.343030;DESCR=Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele C.
chr2	112785383	rs1800587	G	A	.	PASS	AF=0.343228;DESCR=Allele A is not associated with clinical benefit to almotriptan, eletriptan, frovatriptan, rizatriptan, sumatriptan or zolmitriptan in people with Migraine without Aura as compared to allele G.
chr2	112785383	rs1800587	G	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with clinical benefit to almotriptan, eletriptan, frovatriptan, rizatriptan, sumatriptan or zolmitriptan in people with Migraine without Aura as compared to allele G.
chr2	112832813	rs1143634	G	A	.	PASS	AF=0.273356;DESCR=Genotype GG is not associated with response to omeprazole and rabeprazole in people with Helicobacter Infections as compared to genotypes AA + AG.
chr2	112836810	rs1143627	G	A	.	PASS	AF=0.651585;DESCR=Genotypes AG + GG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors or ustekinumab in people with Psoriasis as compared to genotype AA.
chr2	112837290	rs16944	A	G	.	PASS	AF=0.651498;DESCR=Genotype AG is associated with increased response to lansoprazole, omeprazole or rabeprazole in people with Helicobacter Infections as compared to genotype GG.
chr2	112838252	rs1143623	C	G	.	PASS	AF=0.219146;DESCR=Genotype GG is associated with increased response to metformin in people with Diabetes Mellitus as compared to genotypes CC + CG.
chr2	112840530	rs4848306	G	A	.	PASS	AF=0.399596;DESCR=Genotypes AA + AG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative and Inflammatory Bowel Diseases as compared to genotype GG.
chr2	113109277	rs7580634	G	T	.	PASS	AF=0.404789;DESCR=Allele G is not associated with response to anakinra or canakinumab in children with Arthritis, Juvenile Rheumatoid as compared to allele T.
chr2	113109711	rs55709272	T	A	.	AC0	AF=0.00000;DESCR=Allele T is not associated with response to anakinra or canakinumab in children with Arthritis, Juvenile Rheumatoid as compared to allele C.
chr2	113109711	rs55709272	T	C	.	PASS	AF=0.429809;DESCR=Allele T is not associated with response to anakinra or canakinumab in children with Arthritis, Juvenile Rheumatoid as compared to allele C.
chr2	113111989	rs62158853	C	T	.	PASS	AF=0.393887;DESCR=Allele C is not associated with response to anakinra or canakinumab in children with Arthritis, Juvenile Rheumatoid as compared to allele T.
chr2	113113148	rs62158854	T	G	.	PASS	AF=0.394813;DESCR=Allele T is not associated with response to anakinra or canakinumab in children with Arthritis, Juvenile Rheumatoid as compared to allele G.
chr2	113116890	rs4251961	T	C	.	PASS	AF=0.383506;DESCR=Genotypes CC + CT is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotype TT.
chr2	113129630	rs419598	T	C	.	PASS	AF=0.290899;DESCR=Allele C is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele T.
chr2	127260487	rs3738948	A	C	.	PASS	AF=0.00000;DESCR=Genotypes AG + GG is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype AA.
chr2	127260487	rs3738948	A	G	.	PASS	AF=0.151210;DESCR=Genotypes AG + GG is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype AA.
chr2	127418286	rs1799808	C	T	.	PASS	AF=0.341119;DESCR=Genotype CC is associated with increased dose of phenprocoumon as compared to genotypes CT + TT.
chr2	127418299	rs1799809	G	A	.	PASS	AF=0.502018;DESCR=Genotype AA is not associated with increased dose of phenprocoumon as compared to genotypes AG + GG.
chr2	127421977	rs2069919	G	A	.	PASS	AF=0.349568;DESCR=Allele G is not associated with dose of warfarin.
chr2	134445591	rs661899	T	C	.	PASS	AF=0.793491;DESCR=Genotype TT is associated with decreased clinical benefit to ursodeoxycholic acid in people with Cholangitis as compared to genotypes CC + CT.
chr2	138521352	rs10170310	G	A	.	PASS	AF=0.793710;DESCR=Allele C is associated with decreased response to olanzapine in people with Schizophrenia as compared to allele A.
chr2	138521352	rs10170310	G	C	.	AC0	AF=0.00000;DESCR=Allele C is associated with decreased response to olanzapine in people with Schizophrenia as compared to allele A.
chr2	141731023	rs874295	G	A	.	PASS	AF=0.290537;DESCR=Allele G is associated with response to risperidone in people with Schizophrenia.
chr2	141731023	rs874295	G	T	.	PASS	AF=0.00000;DESCR=Allele G is associated with response to risperidone in people with Schizophrenia.
chr2	151869423	rs3768652	C	A	.	PASS	AF=0.129107;DESCR=Genotypes AA + AC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CC.
chr2	157933913	rs35806662	A	G	.	PASS	AF=0.104323;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr2	161151237	rs1267067	T	C	.	PASS	AF=0.350806;DESCR=Genotype CC is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.
chr2	161308497	rs9713	A	T	.	PASS	AF=0.701729;DESCR=Allele A is associated with response to risperidone in people with Schizophrenia.
chr2	162015288	rs2909451	C	A	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.
chr2	162015288	rs2909451	C	T	.	PASS	AF=0.192907;DESCR=Genotype TT is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.
chr2	162029379	rs4664443	A	G	.	PASS	AF=0.541499;DESCR=Genotype GG is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.
chr2	162047874	rs17848916	A	C	.	PASS	AF=0.00576369;DESCR=Genotype AC is not associated with response to peginterferon alfa-2a or peginterferon alfa-2b in people with Hepatitis C, Chronic as compared to genotype AA.
chr2	162073469	rs17574	A	G	.	PASS	AF=0.315061;DESCR=Genotype AA is not associated with response to peginterferon alfa-2a or peginterferon alfa-2b in people with Hepatitis C, Chronic as compared to genotype AG.
chr2	162074215	rs13015258	T	G	.	PASS	AF=0.647550;DESCR=Genotype GG is not associated with response to peginterferon alfa-2a or peginterferon alfa-2b in people with Hepatitis C, Chronic as compared to genotypes GT + TT.
chr2	162404181	rs17716942	T	C	.	PASS	AF=0.223889;DESCR=Genotype CC is not associated with response to etanercept in people with Psoriasis as compared to genotype TT.
chr2	164106976	rs1446468	T	C	.	PASS	AF=0.453629;DESCR=Allele T is associated with increased response to metoprolol in people with Hypertension as compared to allele C.
chr2	165295879	rs17183814	G	A	.	PASS	AF=0.0651672;DESCR=Allele A is not associated with response to carbamazepine or valproic acid in people with Epilepsy as compared to allele G.
chr2	165311993	rs2304016	A	G	.	PASS	AF=0.0118224;DESCR=Genotype GG is not associated with resistance to carbamazepine or oxcarbazepine in people with Epilepsy as compared to genotype AA.
chr2	166036278	rs2298771	C	T	.	PASS	AF=0.602594;DESCR=Allele C is not associated with increased dose of carbamazepine in people with Epilepsy as compared to allele T.
chr2	166053034	rs3812718	C	T	.	PASS	AF=0.539193;DESCR=Allele T is associated with increased clinical benefit to valproic acid in children with Epilepsy as compared to allele C.
chr2	166059387	rs10188577	T	C	.	PASS	AF=0.384882;DESCR=Genotype CT is associated with increased resistance to antiepileptics in people with Epilepsy.
chr2	166242648	rs6746030	A	G	.	PASS	AF=0.913545;DESCR=Allele A is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.
chr2	166521468	rs13015447	A	C	.	PASS	AF=0.337558;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.
chr2	166596951	rs1596996	T	C	.	PASS	AF=0.448415;DESCR=Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.
chr2	166616233	rs2218603	A	G	.	PASS	AF=0.414360;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr2	167134845	rs7606603	C	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased response to atenolol in people with Hypertension as compared to allele T.
chr2	167134845	rs7606603	C	T	.	PASS	AF=0.0681687;DESCR=Allele C is associated with decreased response to atenolol in people with Hypertension as compared to allele T.
chr2	168343185	rs16855294	C	A	.	PASS	AF=0.434544;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.
chr2	168532581	rs13393173	G	A	.	PASS	AF=0.242931;DESCR=Allele A is associated with increased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr2	168532581	rs13393173	G	C	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr2	168973818	rs2287622	A	G	.	PASS	AF=0.575173;DESCR=Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A.
chr2	169014372	rs4148776	A	G	.	PASS	AF=0.101153;DESCR=Allele G is associated with increased response to glibenclamide in people with as compared to allele A.
chr2	170815568	rs3762556	C	G	.	PASS	AF=0.293710;DESCR=Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele C.
chr2	170815681	rs3791878	G	T	.	PASS	AF=0.278130;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr2	170815885	rs3762555	C	A	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele C.
chr2	170815885	rs3762555	C	G	.	PASS	AF=0.698445;DESCR=Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele C.
chr2	170816965	rs3749034	G	A	.	PASS	AF=0.259793;DESCR=Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele A.
chr2	170816965	rs3749034	G	T	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele A.
chr2	170822115	rs769404	T	C	.	PASS	AF=0.411527;DESCR=Genotype CT is not associated with dose of methadone in people with Heroin Dependence as compared to genotype CC.
chr2	170860293	rs769395	G	A	.	PASS	AF=0.753460;DESCR=Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr2	175056029	rs1153702	T	C	.	PASS	AF=0.403403;DESCR=Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.
chr2	175057654	rs7583431	A	C	.	PASS	AF=0.266417;DESCR=Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele A.
chr2	175074876	rs2302663	G	A	.	PASS	AF=0.0786744;DESCR=Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele A.
chr2	175078526	rs3845744	C	T	.	PASS	AF=0.857431;DESCR=Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.
chr2	175168487	rs268214	C	T	.	PASS	AF=0.765553;DESCR=Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.
chr2	175183178	rs1982235	T	G	.	PASS	AF=0.580450;DESCR=Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.
chr2	181691408	rs6719578	C	G	.	PASS	AF=0.00144092;DESCR=Genotype CG is associated with increased response to metformin as compared to genotype GG.
chr2	184885915	rs62200793	T	C	.	PASS	AF=0.160519;DESCR=Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.
chr2	184913701	rs1344706	A	C	.	PASS	AF=0.355620;DESCR=Genotype AA is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotypes AC + CC.
chr2	184913701	rs1344706	A	T	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotypes AC + CC.
chr2	184943352	rs12693402	C	T	.	PASS	AF=0.171091;DESCR=Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.
chr2	186089405	rs77583603	A	G	.	PASS	AF=0.120819;DESCR=Allele G is associated with decreased response to acamprosate in people with Alcoholism as compared to allele A.
chr2	187396194	rs6710852	T	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased clinical benefit to erenumab in people with Migraine with Aura or Migraine without Aura as compared to allele T.
chr2	187396194	rs6710852	T	G	.	PASS	AF=0.0545927;DESCR=Allele G is associated with increased clinical benefit to erenumab in people with Migraine with Aura or Migraine without Aura as compared to allele T.
chr2	191099907	rs7574865	T	G	.	PASS	AF=0.768300;DESCR=Allele T is associated with decreased response to etanercept in people with Arthritis, Rheumatoid as compared to allele G.
chr2	192057530	rs3738883	T	A	.	PASS	AF=0.00000;DESCR=Allele G is associated with response to risperidone in people with Schizophrenia.
chr2	192057530	rs3738883	T	G	.	PASS	AF=0.512125;DESCR=Allele G is associated with response to risperidone in people with Schizophrenia.
chr2	200121622	rs7588746	A	G	.	PASS	AF=0.817396;DESCR=Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr2	200285317	rs295137	C	T	.	PASS	AF=0.362745;DESCR=Allele C is not associated with response to salbutamol in children with Asthma as compared to allele T.
chr2	200330879	rs295114	C	T	.	PASS	AF=0.409798;DESCR=Allele C is not associated with response to salbutamol in children with Asthma as compared to allele T.
chr2	200604661	rs75995567	T	C	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased dose of allopurinol or febuxostat in people with Gout as compared to allele C.
chr2	200659013	rs10931910	A	G	.	PASS	AF=0.389273;DESCR=Allele G is not associated with decreased clearance of XK469 in people with Neoplasms as compared to allele A.
chr2	200659013	rs10931910	A	T	.	PASS	AF=0.000288351;DESCR=Allele G is not associated with decreased clearance of XK469 in people with Neoplasms as compared to allele A.
chr2	200661607	rs55754655	A	G	.	PASS	AF=0.0953341;DESCR=Allele G is associated with decreased response to azathioprine in people with Inflammatory Bowel Diseases as compared to allele A.
chr2	200669666	rs3731722	A	G	.	PASS	AF=0.0334487;DESCR=Allele G is associated with dose of allopurinol or febuxostat in people with Gout as compared to allele A.
chr2	200676898	rs11678615	C	T	.	PASS	AF=0.0334101;DESCR=Allele T is associated with dose of allopurinol or febuxostat in people with Gout as compared to allele C.
chr2	200678773	rs6729738	C	T	.	PASS	AF=0.438257;DESCR=Genotype CC is associated with increased response to cannabidiol in people with Epilepsy as compared to genotypes AA + AC.
chr2	203745673	rs1980422	C	T	.	PASS	AF=0.687500;DESCR=Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.
chr2	203866282	rs4553808	A	G	.	PASS	AF=0.169355;DESCR=Genotypes AG + GG is associated with increased exposure to tacrolimus in people with Kidney Transplantation as compared to genotype AA.
chr2	203866282	rs4553808	A	T	.	PASS	AF=0.00000;DESCR=Genotypes AG + GG is associated with increased exposure to tacrolimus in people with Kidney Transplantation as compared to genotype AA.
chr2	203866796	rs16840252	C	T	.	PASS	AF=0.174063;DESCR=Allele T is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele C.
chr2	203867991	rs231775	A	G	.	PASS	AF=0.300173;DESCR=Allele A is not associated with increased clinical benefit to avatrombopag, corticosteroids, eltrombopag or rituximab Thrombocytopenia as compared to allele G.
chr2	203874196	rs3087243	G	A	.	PASS	AF=0.500288;DESCR=Allele G is not associated with increased clinical benefit to avatrombopag, corticosteroids, eltrombopag or rituximab Thrombocytopenia as compared to allele A.
chr2	207534205	rs889895	A	G	.	PASS	AF=0.192618;DESCR=Allele A is not associated with response to antidepressants in people with Mental Disorders as compared to allele G.
chr2	207564627	rs6740584	T	C	.	PASS	AF=0.488171;DESCR=Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr2	207629510	rs2952768	T	A	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased dose of morphine in women with Pain, Postoperative as compared to genotypes CT + TT.
chr2	207629510	rs2952768	T	C	.	PASS	AF=0.291354;DESCR=Genotype CC is associated with increased dose of morphine in women with Pain, Postoperative as compared to genotypes CT + TT.
chr2	208188356	rs7579275	A	C	.	PASS	AF=0.155421;DESCR=Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A.
chr2	208188356	rs7579275	A	G	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A.
chr2	210016169	rs7570090	C	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.
chr2	210016169	rs7570090	C	T	.	PASS	AF=0.402481;DESCR=Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.
chr2	214780740	rs2229571	C	G	.	PASS	AF=0.586118;DESCR=Allele C is not associated with decreased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms.
chr2	214780821	rs2070096	C	G	.	PASS	AF=0.240773;DESCR=Allele A is associated with decreased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms.
chr2	215321102	rs10197559	C	T	.	PASS	AF=0.202189;DESCR=Genotypes CT + TT is associated with increased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.
chr2	215325297	rs2372536	C	G	.	PASS	AF=0.349193;DESCR=Allele C is not associated with response to folic acid, hydroxychloroquine, methotrexate and sulfasalazine in people with Arthritis, Rheumatoid as compared to allele G.
chr2	215325931	rs7563206	C	T	.	PASS	AF=0.410663;DESCR=Genotypes CT + TT is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.
chr2	215333248	rs12995526	T	C	.	PASS	AF=0.589492;DESCR=Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.
chr2	215340444	rs16853826	G	A	.	PASS	AF=0.0933718;DESCR=Genotype GG is associated with increased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.
chr2	215341330	rs4673990	A	G	.	PASS	AF=0.442684;DESCR=Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.
chr2	215345513	rs16853834	C	T	.	PASS	AF=0.186167;DESCR=Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.
chr2	215347616	rs4673993	T	C	.	PASS	AF=0.349307;DESCR=Genotype CC is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.
chr2	219218557	rs1109866	C	T	.	PASS	AF=0.845533;DESCR=Allele T is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele C.
chr2	219218731	rs1109867	G	T	.	PASS	AF=0.846420;DESCR=Allele T is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.
chr2	219219747	rs3731885	G	A	.	PASS	AF=0.0216014;DESCR=Allele A is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.
chr2	219220142	rs3755047	G	A	.	PASS	AF=0.0216014;DESCR=Allele A is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.
chr2	226155937	rs7578326	A	G	.	PASS	AF=0.286621;DESCR=Allele G is not associated with response to Drugs Used In Diabetes in people with Diabetes Mellitus, Type 2 as compared to allele A.
chr2	226229029	rs2943641	T	C	.	PASS	AF=0.716965;DESCR=Allele T is not associated with response to Drugs Used In Diabetes in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr2	226795828	rs1801278	C	A	.	PASS	AF=0.00000;DESCR=Genotypes CT + TT is associated with decreased response to Drugs Used In Diabetes in people with Diabetes Mellitus, Type 2 as compared to genotype CC.
chr2	226795828	rs1801278	C	T	.	PASS	AF=0.0434908;DESCR=Genotypes CT + TT is associated with decreased response to Drugs Used In Diabetes in people with Diabetes Mellitus, Type 2 as compared to genotype CC.
chr2	232355544	rs28845026	C	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased concentrations of anastrozole in women with Breast Neoplasms as compared to allele C.
chr2	232355544	rs28845026	C	T	.	PASS	AF=0.170029;DESCR=Allele T is associated with increased concentrations of anastrozole in women with Breast Neoplasms as compared to allele C.
chr2	233250193	rs10210302	C	A	.	PASS	AF=0.00000;DESCR=Genotypes CT + TT is associated with increased response to adalimumab in people with Crohn Disease as compared to genotype CC.
chr2	233250193	rs10210302	C	T	.	PASS	AF=0.600346;DESCR=Genotypes CT + TT is associated with increased response to adalimumab in people with Crohn Disease as compared to genotype CC.
chr2	233274722	rs2241880	A	G	.	PASS	AF=0.600923;DESCR=Genotypes AG + GG is associated with increased concentrations of methotrexate polyglutamate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.
chr2	233618225	rs1042597	C	G	.	PASS	AF=0.253176;DESCR=Genotype CC is associated with increased response to raloxifene in women with Menopause and Schizophrenia as compared to genotype CG.
chr2	233618225	rs1042597	C	T	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to raloxifene in women with Menopause and Schizophrenia as compared to genotype CG.
chr2	233669782	rs17868320	C	T	.	PASS	AF=0.0418108;DESCR=Genotype CC is not associated with metabolism of mycophenolic acid as compared to genotype TT.
chr2	233670047	rs6731242	T	A	.	PASS	AF=0.00000;DESCR=Genotype GG is not associated with increased dose of valproic acid in people with Epilepsy as compared to genotypes GG + GT.
chr2	233670047	rs6731242	T	G	.	PASS	AF=0.100634;DESCR=Genotype GG is not associated with increased dose of valproic acid in people with Epilepsy as compared to genotypes GG + GT.
chr2	233671494	rs2741045	C	T	.	PASS	AF=0.333429;DESCR=Allele C is not associated with metabolism of mycophenolic acid in people with Kidney Transplantation as compared to allele T.
chr2	233671603	rs2741046	T	C	.	PASS	AF=0.333429;DESCR=Allele C is not associated with metabolism of mycophenolic acid in people with Kidney Transplantation as compared to allele T.
chr2	233671659	rs6714486	T	A	.	PASS	AF=0.0423631;DESCR=Genotypes AA + AT is associated with decreased dose-adjusted trough concentrations of mycophenolic acid in children with Kidney Transplantation as compared to genotype TT.
chr2	233673188	rs2741049	T	C	.	PASS	AF=0.571799;DESCR=Allele T is not associated with response to azathioprine or mycophenolic acid in people with lung transplantation as compared to allele C.
chr2	233682324	rs17868323	T	A	.	PASS	AF=0.000289184;DESCR=Allele G is associated with concentrations of axitinib in people with Carcinoma, Renal Cell as compared to allele T.
chr2	233682324	rs17868323	T	G	.	PASS	AF=0.572585;DESCR=Allele G is associated with concentrations of axitinib in people with Carcinoma, Renal Cell as compared to allele T.
chr2	233682328	rs17863778	C	A	.	PASS	AF=0.572213;DESCR=Allele A is not associated with metabolism of mycophenolic acid in people with Kidney Transplantation as compared to allele C.
chr2	233693023	rs6759892	T	A	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with increased concentrations of valproic acid in people with Epilepsy as compared to genotypes GG + GT.
chr2	233693023	rs6759892	T	G	.	PASS	AF=0.465150;DESCR=Genotype TT is associated with increased concentrations of valproic acid in people with Epilepsy as compared to genotypes GG + GT.
chr2	233693545	rs2070959	A	G	.	PASS	AF=0.397177;DESCR=Genotype AA is associated with increased response to deferiprone in people with beta-Thalassemia as compared to genotypes AG + GG.
chr2	233693556	rs1105879	A	C	.	PASS	AF=0.423587;DESCR=Allele A is not associated with response to deferiprone in people with beta-Thalassemia as compared to allele C.
chr2	233718890	rs6755571	C	A	.	PASS	AF=0.0420507;DESCR=Allele A is not associated with concentrations of lamotrigine in people with Epilepsy as compared to allele C.
chr2	233718962	rs2011425	T	A	.	PASS	AF=0.00000;DESCR=Genotype GG is not associated with increased clearance of lamotrigine as compared to genotypes GT + TT.
chr2	233718962	rs2011425	T	G	.	PASS	AF=0.102305;DESCR=Genotype GG is not associated with increased clearance of lamotrigine as compared to genotypes GT + TT.
chr2	233719291	rs2011404	T	C	.	PASS	AF=0.830738;DESCR=Allele C is associated with increased concentrations of clozapine in people with Schizophrenia or Psychotic Disorder as compared to allele T.
chr2	233719291	rs2011404	T	G	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased concentrations of clozapine in people with Schizophrenia or Psychotic Disorder as compared to allele T.
chr2	233728369	rs2008584	A	G	.	PASS	AF=0.535179;DESCR=Genotype AA is associated with decreased half-life time of mirabegron in healthy individuals as compared to genotype AG.
chr2	233728376	rs1983023	T	C	.	PASS	AF=0.436023;DESCR=Genotype TT is associated with increased response to deferasirox in people with beta-Thalassemia as compared to genotypes CC + CT.
chr2	233729061	rs3806596	T	C	.	PASS	AF=0.541499;DESCR=Genotype CC is associated with increased response to deferasirox in people with beta-Thalassemia as compared to genotypes CT + TT.
chr2	233729207	rs6706232	G	A	.	PASS	AF=0.535467;DESCR=Allele A is associated with increased response to risperidone in people with Schizophrenia as compared to allele G.
chr2	233729207	rs6706232	G	C	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to risperidone in people with Schizophrenia as compared to allele G.
chr2	233749470	rs7604115	C	T	.	PASS	AF=0.382353;DESCR=Allele T is associated with decreased concentrations of montelukast in healthy individuals as compared to allele C.
chr2	233757013	rs4124874	T	G	.	PASS	AF=0.537818;DESCR=Genotypes GG + GT are not associated with response to cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.
chr2	233757136	rs10929302	G	A	.	PASS	AF=0.339688;DESCR=Genotype AA is associated with increased clearance of fesoterodine in healthy individuals as compared to genotype AG.
chr2	233757935	rs12052787	C	T	.	PASS	AF=0.0945245;DESCR=Allele T is associated with increased response to simvastatin as compared to allele C.
chr2	233759291	rs2003569	G	A	.	PASS	AF=0.155133;DESCR=Allele A is associated with increased response to simvastatin as compared to allele G.
chr2	233759291	rs2003569	G	C	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to simvastatin as compared to allele G.
chr2	233759924	rs887829	C	T	.	PASS	AF=0.382574;DESCR=Allele T is associated with increased metabolism of atorvastatin as compared to allele C.
chr2	233760498	rs4148323	G	A	.	PASS	AF=0.00317003;DESCR=Genotype AA is associated with decreased response to cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG.
chr2	233764076	rs4148324	T	G	.	PASS	AF=0.381200;DESCR=Genotypes GG + GT is associated with increased dose-adjusted trough concentrations of topiramate in children with Epilepsy as compared to genotype TT.
chr2	233764816	rs4148326	T	C	.	PASS	AF=0.523618;DESCR=Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.
chr2	233767183	rs34650714	C	T	.	PASS	AF=0.00547550;DESCR=Genotype CC is associated with decreased concentrations of n-desmethyltramadol and o-desmethyltramadol in people with Death as compared to genotype CT.
chr2	233767812	rs12471326	T	C	.	PASS	AF=0.0455331;DESCR=Genotype CT is associated with increased concentrations of cotinine glucuronide as compared to genotype TT.
chr2	233769013	rs4148328	C	T	.	PASS	AF=0.284766;DESCR=Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr2	233772770	rs10929303	T	C	.	PASS	AF=0.698788;DESCR=Genotype CC is associated with decreased concentrations of n-desmethyltramadol in people with Death as compared to genotypes CT + TT.
chr2	233772999	rs8330	G	C	.	PASS	AF=0.683180;DESCR=Genotype GG is associated with increased formation of acetaminophen glucuronide in healthy individuals as compared to genotypes CC + CG.
chr2	233774704	rs11563250	A	G	.	PASS	AF=0.151585;DESCR=Allele G is not associated with increased dose of levothyroxine in people with Thyroid Neoplasms.
chr2	233911933	rs6724624	C	G	.	PASS	AF=0.157061;DESCR=Allele G is not associated with response to Selective serotonin (5HT1) agonists in people with Migraine without Aura as compared to allele C.
chr2	233916448	rs10166942	T	C	.	PASS	AF=0.157242;DESCR=Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele T.
chr2	236086401	rs1869295	G	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with response to risperidone in people with Schizophrenia.
chr2	236086401	rs1869295	G	C	.	PASS	AF=0.309070;DESCR=Allele C is associated with response to risperidone in people with Schizophrenia.
chr2	237865062	rs12465864	A	G	.	PASS	AF=0.204847;DESCR=Allele G is associated with decreased clinical benefit to erenumab in people with Migraine with Aura or Migraine without Aura as compared to allele A.
chr2	237880275	rs13386048	G	A	.	PASS	AF=0.362717;DESCR=Allele A is associated with decreased clinical benefit to erenumab in people with Migraine with Aura or Migraine without Aura as compared to allele G.
chr2	237905305	rs6431564	A	G	.	PASS	AF=0.535179;DESCR=Allele G is associated with increased clinical benefit to erenumab in people with Migraine with Aura or Migraine without Aura as compared to allele A.
chr2	237913557	rs7590387	G	A	.	PASS	AF=0.00000;DESCR=Allele G is associated with decreased clinical benefit to erenumab in people with Migraine NOS as compared to allele C.
chr2	237913557	rs7590387	G	C	.	PASS	AF=0.609159;DESCR=Allele G is associated with decreased clinical benefit to erenumab in people with Migraine NOS as compared to allele C.
chr2	237927498	rs12615320	A	G	.	PASS	AF=0.0604839;DESCR=Allele G is associated with decreased response to erenumab, fremanezumab or galcanezumab in people with Migraine without Aura or Migraine with Aura as compared to allele A.
chr2	238197074	rs113095083	T	C	.	PASS	AF=0.0758362;DESCR=Allele C is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele T.
chr2	238240329	rs56294817	C	A	.	PASS	AF=0.448733;DESCR=Allele A is not associated with response to citalopram, fluoxetine or paroxetine in people with Depressive Disorder, Major as compared to allele C.
chr2	238241004	rs1374385	C	G	.	PASS	AF=0.242651;DESCR=Allele C is not associated with response to citalopram, fluoxetine or paroxetine in people with Depressive Disorder, Major as compared to allele G.
chr2	238277948	rs2304672	G	C	.	PASS	AF=0.116647;DESCR=Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.
chr2	240592062	rs3792269	A	G	.	PASS	AF=0.0835253;DESCR=Allele G is associated with decreased response to metformin in people with Diabetes Mellitus as compared to allele A.
chr2	241431686	rs757978	C	T	.	PASS	AF=0.148415;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr20	388261	rs2295490	A	G	.	PASS	AF=0.218245;DESCR=Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr20	1979580	rs910080	A	G	.	PASS	AF=0.275504;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr20	1989288	rs2235751	A	G	.	PASS	AF=0.266417;DESCR=Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr20	1994212	rs1997794	T	C	.	PASS	AF=0.345533;DESCR=Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr20	2520225	rs4815273	C	T	.	PASS	AF=0.465994;DESCR=Allele T is associated with increased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.
chr20	2522094	rs6083538	C	T	.	PASS	AF=0.448097;DESCR=Allele T is associated with increased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.
chr20	3081821	rs2740204	G	T	.	PASS	AF=0.386744;DESCR=Allele T is associated with increased response to clozapine in people with Schizophrenia as compared to allele G.
chr20	3203488	rs2295553	C	T	.	PASS	AF=0.478650;DESCR=Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.
chr20	3213196	rs1127354	C	A	.	PASS	AF=0.0694524;DESCR=Genotype CC is not associated with dose of mercaptopurine or methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AC.
chr20	3213247	rs7270101	A	C	.	PASS	AF=0.0806452;DESCR=Genotype AA is not associated with dose of mercaptopurine or methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AC + CC.
chr20	3668514	rs2787094	C	G	.	PASS	AF=0.779862;DESCR=Genotype CC is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotypes CG + GG.
chr20	3670825	rs2853209	T	A	.	PASS	AF=0.459942;DESCR=Genotype AA is associated with decreased clinical benefit to corticosteroids and selective beta-2-adrenoreceptor agonists in people with Asthma as compared to genotype TT.
chr20	3671118	rs3918396	C	T	.	PASS	AF=0.0668203;DESCR=Genotype TT is associated with decreased clinical benefit to corticosteroids and selective beta-2-adrenoreceptor agonists in people with Asthma as compared to genotypes CC + CT.
chr20	6802627	rs2650972	T	C	.	PASS	AF=0.446078;DESCR=Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.
chr20	8591578	rs6108160	G	A	.	PASS	AF=0.184620;DESCR=Allele A is associated with increased response to Selective serotonin reuptake inhibitors in people with Depression as compared to allele G.
chr20	10256575	rs363020	T	A	.	PASS	AF=0.908357;DESCR=Genotype AA is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to genotypes AT + TT.
chr20	10306436	rs3746544	G	T	.	PASS	AF=0.712182;DESCR=Genotype TT is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to genotypes GG + GT.
chr20	10306440	rs1051312	T	C	.	PASS	AF=0.294220;DESCR=Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.
chr20	10307094	rs8636	T	C	.	PASS	AF=0.714862;DESCR=Genotype CT is associated with increased response to amisulpride in people with Schizophrenia as compared to genotypes CC + TT.
chr20	15144218	rs76026520	A	G	.	PASS	AF=0.0874207;DESCR=Allele G is associated with increased clinical benefit to hydrocodone or oxycodone in people with Pain as compared to allele A.
chr20	35177813	rs1415774	A	G	.	PASS	AF=0.599135;DESCR=Allele G is not associated with dose of warfarin in people with heart valve replacement as compared to allele A.
chr20	44351775	rs1884613	C	A	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased concentrations of efavirenz in people with HIV Infections as compared to genotypes CG + GG.
chr20	44351775	rs1884613	C	G	.	PASS	AF=0.231658;DESCR=Genotype CC is associated with increased concentrations of efavirenz in people with HIV Infections as compared to genotypes CG + GG.
chr20	44351775	rs1884613	C	T	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased concentrations of efavirenz in people with HIV Infections as compared to genotypes CG + GG.
chr20	44401795	rs2071197	G	A	.	PASS	AF=0.0495963;DESCR=Genotype AA is associated with decreased concentrations of lamotrigine in people with Epilepsy as compared to genotypes AG + GG.
chr20	44406498	rs3212183	C	T	.	PASS	AF=0.641417;DESCR=Allele C is not associated with response to lamotrigine in people with Epilepsy as compared to allele T.
chr20	44409344	rs3212185	T	C	.	PASS	AF=0.00000;DESCR=Genotype CT is not associated with response to metformin as compared to genotype CC.
chr20	44409609	rs6031587	C	T	.	PASS	AF=0.0366417;DESCR=Allele T is not associated with metabolism of irinotecan in people with Colorectal Neoplasms as compared to allele C.
chr20	44415722	rs3212198	C	T	.	PASS	AF=0.683573;DESCR=Allele T is associated with increased dose of warfarin in people with heart valve replacement as compared to allele C.
chr20	44430057	rs11086926	T	G	.	PASS	AF=0.0498847;DESCR=Genotype GG is not associated with response to metformin as compared to genotypes GT + TT.
chr20	44624274	rs244076	T	C	.	PASS	AF=0.186924;DESCR=Allele C is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid.
chr20	44651586	rs73598374	C	T	.	PASS	AF=0.0931373;DESCR=Allele C is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.
chr20	45094986	rs734784	T	C	.	PASS	AF=0.400000;DESCR=Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele T.
chr20	46007337	rs3918242	C	T	.	PASS	AF=0.156484;DESCR=Allele T is associated with increased response to ulinastatin in people with Pancreatitis as compared to allele C.
chr20	46011053	rs2274755	G	T	.	PASS	AF=0.157637;DESCR=Allele T is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.
chr20	46011936	rs2236416	A	G	.	PASS	AF=0.157061;DESCR=Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.
chr20	46014472	rs17577	G	A	.	PASS	AF=0.157349;DESCR=Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.
chr20	46118343	rs1883832	T	C	.	PASS	AF=0.727640;DESCR=Genotype CC is associated with decreased clinical benefit to prednisolone in children with Thrombocytopenia as compared to genotypes CT + TT.
chr20	46119308	rs4810485	T	G	.	PASS	AF=0.727247;DESCR=Allele T is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr20	46448270	rs446112	A	G	.	PASS	AF=0.367647;DESCR=Genotype AA is associated with increased resistance to etoposide as compared to genotypes AG + GG.
chr20	49885069	rs645544	A	G	.	PASS	AF=0.497406;DESCR=Genotype GG is associated with decreased response to adalimumab or infliximab in people with Psoriasis as compared to genotypes AA + AG.
chr20	51536805	rs3787186	T	C	.	PASS	AF=0.636809;DESCR=Genotypes CC + CT is associated with decreased response to adalimumab, etanercept or infliximab in people with Arthritis, Rheumatoid as compared to genotype TT.
chr20	54156202	rs927650	T	C	.	PASS	AF=0.560842;DESCR=Genotypes CT + TT is associated with decreased metabolism of deferasirox in people with beta-Thalassemia as compared to genotype CC.
chr20	54164712	rs2762939	G	C	.	PASS	AF=0.261383;DESCR=Allele G is not associated with response to calcitriol, cisplatin and docetaxel in people with Carcinoma, Non-Small-Cell Lung as compared to allele C.
chr20	54166141	rs3787554	G	A	.	PASS	AF=0.148415;DESCR=Allele G is not associated with response to calcitriol, cisplatin and docetaxel in people with Carcinoma, Non-Small-Cell Lung as compared to allele A.
chr20	54170358	rs2585428	C	T	.	PASS	AF=0.561743;DESCR=Allele C is associated with decreased trough concentration of telaprevir in people with Hepatitis C as compared to allele T.
chr20	54174979	rs2248359	C	T	.	PASS	AF=0.568260;DESCR=Genotypes CT + TT is associated with increased concentrations of daclatasvir in people with Hepatitis C as compared to genotype CC.
chr20	56864307	rs6025211	C	G	.	PASS	AF=0.00000;DESCR=Genotypes CC + TT are not associated with response to cisplatin and fluorouracil in people with Liver Neoplasms as compared to genotype CT.
chr20	56864307	rs6025211	C	T	.	PASS	AF=0.232853;DESCR=Genotypes CC + TT are not associated with response to cisplatin and fluorouracil in people with Liver Neoplasms as compared to genotype CT.
chr20	56905221	rs6064463	T	C	.	PASS	AF=0.388184;DESCR=Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.
chr20	57063694	rs6127921	A	C	.	PASS	AF=0.180507;DESCR=Allele C is associated with decreased response to citalopram in people with Depressive Disorder, Major as compared to allele A.
chr20	57545215	rs4810083	T	C	.	PASS	AF=0.566359;DESCR=Genotypes CT + TT is associated with increased clinical benefit to metformin in people with Diabetes Mellitus, Type 2 as compared to genotype CC.
chr20	58903752	rs7121	C	T	.	PASS	AF=0.629330;DESCR=Genotype CC is associated with increased response to cisplatin and fluorouracil in people with Esophageal Neoplasms as compared to genotypes CT + TT.
chr20	58987047	rs2273359	C	G	.	PASS	AF=0.0432277;DESCR=Genotype CG is associated with increased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to genotype CC.
chr20	58987047	rs2273359	C	T	.	PASS	AF=0.00000;DESCR=Genotype CG is associated with increased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to genotype CC.
chr20	61816982	rs4925300	G	A	.	PASS	AF=0.688581;DESCR=Allele A is associated with response to ziprasidone in people with Schizophrenia.
chr20	62216348	rs3787429	C	G	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CT.
chr20	62216348	rs3787429	C	T	.	PASS	AF=0.355991;DESCR=Genotype TT is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CT.
chr20	62216366	rs3787430	C	T	.	PASS	AF=0.0970622;DESCR=Genotype TT is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CT.
chr20	63346204	rs2236196	G	A	.	PASS	AF=0.599424;DESCR=Genotypes AA + AG is not associated with response to varenicline in people with Tobacco Use Disorder as compared to genotype GG.
chr20	63349639	rs3827020	T	C	.	PASS	AF=0.148329;DESCR=Allele C is not associated with exposure to nicotine in men as compared to allele T.
chr20	63349782	rs1044396	G	A	.	PASS	AF=0.431700;DESCR=Genotype GG is associated with decreased response to varenicline in people with Tobacco Use Disorder as compared to genotypes AA + AG.
chr20	63349782	rs1044396	G	C	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with decreased response to varenicline in people with Tobacco Use Disorder as compared to genotypes AA + AG.
chr20	63350202	rs2229959	C	A	.	PASS	AF=0.836982;DESCR=Allele C is associated with increased response to nicotine in people with daily smoking as compared to allele A.
chr20	63350202	rs2229959	C	T	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased response to nicotine in people with daily smoking as compared to allele A.
chr20	63356470	rs2273502	C	T	.	PASS	AF=0.0885236;DESCR=Allele T is not associated with response to nicotine in women as compared to allele C.
chr20	63359522	rs6090384	T	C	.	PASS	AF=0.924539;DESCR=Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.
chr20	64083430	rs6010717	C	G	.	PASS	AF=0.661476;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr20	64096562	rs7271530	C	T	.	PASS	AF=0.479515;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr20	64098078	rs2229205	C	T	.	PASS	AF=0.131912;DESCR=Genotype CT is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.
chr21	16329273	rs239022	A	G	.	PASS	AF=0.939804;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr21	18938575	rs79663003	T	C	.	PASS	AF=0.0317369;DESCR=Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.
chr21	18940294	rs78015114	T	C	.	PASS	AF=0.0317003;DESCR=Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.
chr21	18954018	rs74795342	G	A	.	PASS	AF=0.0317369;DESCR=Allele G is associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.
chr21	18955109	rs75222709	T	G	.	PASS	AF=0.0322674;DESCR=Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.
chr21	20732377	rs2826494	C	G	.	PASS	AF=0.437788;DESCR=Allele G is associated with response to lithium in people with Bipolar Disorder as compared to allele C.
chr21	24531791	rs4816969	A	G	.	PASS	AF=0.945565;DESCR=Allele G is not associated with clearance of tenofovir in people with HIV Infections as compared to allele A.
chr21	24533660	rs9305223	C	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.
chr21	24533660	rs9305223	C	G	.	PASS	AF=0.945565;DESCR=Allele G is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.
chr21	24544203	rs2226443	T	C	.	PASS	AF=0.944380;DESCR=Allele C is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.
chr21	24551597	rs2829163	C	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.
chr21	24551597	rs2829163	C	T	.	PASS	AF=0.918444;DESCR=Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.
chr21	24559612	rs7282679	T	A	.	PASS	AF=0.943836;DESCR=Allele A is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.
chr21	28055779	rs2831440	G	C	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele G.
chr21	28055779	rs2831440	G	T	.	PASS	AF=0.362457;DESCR=Allele T is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele G.
chr21	28883961	rs2254638	A	G	.	PASS	AF=0.889337;DESCR=Allele G is associated with decreased response to clopidogrel in people with Coronary Artery Disease as compared to allele A.
chr21	28883961	rs2254638	A	T	.	PASS	AF=0.00000;DESCR=Allele G is associated with decreased response to clopidogrel in people with Coronary Artery Disease as compared to allele A.
chr21	29595188	rs2832407	C	A	.	PASS	AF=0.312572;DESCR=Allele A is not associated with increased response to naltrexone null topiramate in people with Alcoholism as compared to allele C.
chr21	29595188	rs2832407	C	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with increased response to naltrexone null topiramate in people with Alcoholism as compared to allele C.
chr21	33341701	rs1012335	G	C	.	PASS	AF=0.375072;DESCR=Allele G is associated with decreased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele C.
chr21	33403138	rs8126756	T	C	.	PASS	AF=0.129412;DESCR=Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease as compared to genotype TT.
chr21	33403138	rs8126756	T	G	.	AS_VQSR	AF=0.00000;DESCR=Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease as compared to genotype TT.
chr21	34996362	rs11702779	G	A	.	PASS	AF=0.394464;DESCR=Genotype AA is associated with increased response to methacholine chloride in children with Asthma as compared to genotypes AG + GG.
chr21	36070334	rs25678	G	C	.	PASS	AF=0.138040;DESCR=Genotype CC is associated with decreased exposure to daunorubicin in people with Leukemia, Myeloid, Acute as compared to genotypes CG + GG.
chr21	36072675	rs20572	C	T	.	PASS	AF=0.0629330;DESCR=Allele T is associated with increased concentrations of doxorubicin in women with Breast Neoplasms as compared to allele C.
chr21	36073015	rs9024	G	A	.	PASS	AF=0.0643022;DESCR=Genotype GG is associated with increased clearance of doxorubicin in people with Breast Neoplasms as compared to genotype AG.
chr21	37645860	rs2835859	T	C	.	PASS	AF=0.133372;DESCR=Genotype TT is associated with increased dose of fentanyl in people with Pain, Postoperative as compared to genotypes CC + CT.
chr21	37714662	rs2070995	T	C	.	PASS	AF=0.825173;DESCR=Genotype TT is associated with increased dose of methadone in people with Substance-Related Disorders as compared to genotypes CC + CT.
chr21	37917643	rs6517442	C	T	.	PASS	AF=0.733583;DESCR=Genotype CC is associated with increased dose of opioids in people with Low Back Pain as compared to genotypes CT + TT.
chr21	39371919	rs3761372	T	C	.	PASS	AF=0.241638;DESCR=Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr21	42278705	rs182694	A	G	.	PASS	AF=0.700980;DESCR=Allele A is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.
chr21	42278705	rs182694	A	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.
chr21	43066854	rs234709	C	T	.	AS_VQSR	AF=0.0490614;DESCR=Genotypes CT + TT are associated with increased metabolism of Arsenic compounds as compared to genotype CC.
chr21	43687681	rs9306160	T	C	.	PASS	AF=0.649482;DESCR=Allele T is associated with increased response to atenolol in people with Hypertension as compared to allele C.
chr21	45512414	rs7499	G	A	.	PASS	AF=0.378744;DESCR=Allele G is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.
chr21	45512704	rs17004785	G	A	.	PASS	AF=0.00000;DESCR=Genotype CG is associated with increased clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.
chr21	45512704	rs17004785	G	C	.	PASS	AF=0.108871;DESCR=Genotype CG is associated with increased clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.
chr21	45514947	rs1051296	A	C	.	PASS	AF=0.398329;DESCR=Genotypes AC + CC are associated with decreased concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.
chr21	45525110	rs2838956	A	G	.	PASS	AF=0.375504;DESCR=Allele G is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.
chr21	45528653	rs2838958	G	A	.	PASS	AF=0.625576;DESCR=Genotypes AG + GG are not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.
chr21	45531642	rs12659	A	G	.	PASS	AF=0.621972;DESCR=Allele A is associated with decreased response to carboplatin, cisplatin and fluorouracil in people with Uterine Cervical Neoplasms as compared to allele G.
chr21	45536657	rs3788200	A	G	.	PASS	AF=0.605536;DESCR=Genotypes AG + GG are not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.
chr21	45537880	rs1051266	T	C	.	PASS	AF=0.601729;DESCR=Genotype CT is associated with decreased response to methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype TT.
chr21	45538002	rs1131596	G	A	.	PASS	AF=0.600806;DESCR=Genotypes AG + GG are not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.
chr22	17084145	rs4819554	G	A	.	PASS	AF=0.810484;DESCR=Genotype AA is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotypes AG + GG.
chr22	17108319	rs879577	C	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to allele C.
chr22	17108319	rs879577	C	T	.	PASS	AF=0.248270;DESCR=Allele T is not associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to allele C.
chr22	18994050	rs1210638	T	C	.	PASS	AF=0.666378;DESCR=Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.
chr22	19932836	rs9606186	C	G	.	PASS	AF=0.706171;DESCR=Allele C is not associated with response to risperidone in people with Schizophrenia as compared to allele G.
chr22	19940569	rs2075507	G	A	.	PASS	AF=0.706509;DESCR=Allele G is associated with decreased dose of morphine in people with Neoplasms as compared to allele A.
chr22	19941361	rs2020917	C	T	.	PASS	AF=0.426140;DESCR=Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr22	19941504	rs13306278	C	T	.	PASS	AF=0.172811;DESCR=Genotype CT is not associated with exposure to olanzapine in healthy individuals as compared to genotype CC.
chr22	19942586	rs737866	T	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with decreased dose of morphine in people with Neoplasms as compared to allele C.
chr22	19942586	rs737866	T	C	.	PASS	AF=0.427131;DESCR=Allele T is associated with decreased dose of morphine in people with Neoplasms as compared to allele C.
chr22	19942598	rs737865	A	G	.	PASS	AF=0.427131;DESCR=Genotype AA is associated with decreased response to bupropion in smokers as compared to genotypes AG + GG.
chr22	19943884	rs933271	T	C	.	PASS	AF=0.304901;DESCR=Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr22	19944453	rs7287550	T	C	.	PASS	AF=0.284025;DESCR=Allele C is associated with decreased dose of morphine in people with Neoplasms as compared to allele T.
chr22	19946528	rs174675	T	C	.	PASS	AF=0.716263;DESCR=Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr22	19950010	rs5993882	T	G	.	PASS	AF=0.245386;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr22	19950115	rs5993883	T	G	.	PASS	AF=0.675130;DESCR=Allele T is associated with decreased response to quetiapine in people with Schizophrenia as compared to allele G.
chr22	19955474	rs5746849	A	G	.	PASS	AF=0.655908;DESCR=Allele A is associated with decreased dose of morphine in people with Neoplasms as compared to allele G.
chr22	19957654	rs740603	A	G	.	PASS	AF=0.650346;DESCR=Allele A is associated with decreased dose of morphine in people with Neoplasms as compared to allele G.
chr22	19960814	rs4646312	T	C	.	PASS	AF=0.470622;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr22	19961490	rs165722	C	T	.	PASS	AF=0.459654;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr22	19962429	rs6269	A	G	.	PASS	AF=0.474928;DESCR=Genotype GG is associated with decreased response to butorphanol in healthy individuals as compared to genotypes AA + AG.
chr22	19962712	rs4633	C	T	.	PASS	AF=0.459919;DESCR=Genotype CC is associated with decreased response to butorphanol in healthy individuals as compared to genotypes CT + TT.
chr22	19962905	rs2239393	A	G	.	PASS	AF=0.475202;DESCR=Allele A is associated with decreased dose of morphine in people with Neoplasms as compared to allele G.
chr22	19963684	rs4818	C	G	.	PASS	AF=0.470605;DESCR=Allele G is not associated with response to butorphanol in healthy individuals as compared to allele C.
chr22	19963748	rs4680	G	A	.	PASS	AF=0.453260;DESCR=Genotype GG is associated with increased response to modafinil in people with methamphetamine dependence as compared to genotypes AA + AG.
chr22	19965038	rs165774	G	A	.	PASS	AF=0.318260;DESCR=Allele G is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.
chr22	19966935	rs174699	C	T	.	PASS	AF=0.959078;DESCR=Allele T is associated with decreased dose of morphine in people with Neoplasms as compared to allele C.
chr22	19969258	rs165599	G	A	.	PASS	AF=0.608646;DESCR=Genotypes AA + AG are associated with increased response to bupropion in smokers as compared to genotype GG.
chr22	19969500	rs165728	C	A	.	AC0	AF=0.00000;DESCR=Allele T is associated with decreased dose of morphine in people with Neoplasms as compared to allele C.
chr22	19969500	rs165728	C	T	.	PASS	AF=0.961694;DESCR=Allele T is associated with decreased dose of morphine in people with Neoplasms as compared to allele C.
chr22	19971950	rs165815	C	T	.	PASS	AF=0.846974;DESCR=Genotypes CT + TT are not associated with response to antipsychotics in people with Schizophrenia as compared to genotype CC.
chr22	20813499	rs165854	G	A	.	PASS	AF=0.425360;DESCR=Genotypes AG + GG is associated with decreased response to antipsychotics in people with Schizophrenia.
chr22	21760715	rs6928	C	G	.	PASS	AF=0.612680;DESCR=Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele G.
chr22	21761597	rs13515	C	T	.	PASS	AF=0.197232;DESCR=Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr22	21807837	rs3729910	A	G	.	PASS	AF=0.105991;DESCR=Allele G is associated with increased response to glibenclamide in people with as compared to allele A.
chr22	21850504	rs8136867	G	A	.	PASS	AF=0.624424;DESCR=Allele A is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele G.
chr22	23075491	rs3788339	A	G	.	PASS	AF=0.147550;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr22	23285182	rs140504	A	G	.	PASS	AF=0.885879;DESCR=Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr22	24406596	rs5751862	G	A	.	PASS	AF=0.439158;DESCR=Allele A is not associated with response to regadenoson as compared to allele G.
chr22	24406596	rs5751862	G	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to regadenoson as compared to allele G.
chr22	24429543	rs2298383	C	T	.	PASS	AF=0.560231;DESCR=Allele T is not associated with response to regadenoson as compared to allele C.
chr22	24430704	rs3761422	T	C	.	PASS	AF=0.594813;DESCR=Allele T is not associated with response to regadenoson as compared to allele C.
chr22	24434627	rs2267076	T	C	.	PASS	AF=0.636967;DESCR=Allele T is not associated with response to regadenoson as compared to allele C.
chr22	24440056	rs2236624	T	C	.	PASS	AF=0.776657;DESCR=Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.
chr22	24441333	rs5751876	T	C	.	PASS	AF=0.592454;DESCR=Allele T is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid.
chr22	24444708	rs17004921	C	T	.	PASS	AF=0.126728;DESCR=Genotypes CT + TT are associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.
chr22	28800769	rs2269577	G	C	.	PASS	AF=0.331315;DESCR=Genotype CG is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.
chr22	36700882	rs2284017	T	C	.	PASS	AF=0.608131;DESCR=Allele C is associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.
chr22	36701519	rs2284018	C	G	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with decreased response to lithium in people with Bipolar Disorder as compared to genotypes CC + CT.
chr22	36701519	rs2284018	C	T	.	PASS	AF=0.200463;DESCR=Genotype TT is associated with decreased response to lithium in people with Bipolar Disorder as compared to genotypes CC + CT.
chr22	36860804	rs1883112	G	A	.	PASS	AF=0.399654;DESCR=Genotype AA is associated with increased response to idarubicin in people with Leukemia, Myeloid, Acute as compared to genotype GG.
chr22	37148770	rs3218253	G	A	.	PASS	AF=0.261685;DESCR=Allele A is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr22	37236730	rs13058338	T	A	.	PASS	AF=0.215194;DESCR=Genotype AT is associated with increased response to idarubicin in people with Leukemia, Myeloid, Acute as compared to genotype TT.
chr22	37236730	rs13058338	T	G	.	PASS	AF=0.0303118;DESCR=Genotype AT is associated with increased response to idarubicin in people with Leukemia, Myeloid, Acute as compared to genotype TT.
chr22	39570851	rs3747178	C	T	.	PASS	AF=0.303808;DESCR=Allele T is associated with decreased clinical benefit to ethosuximide in children with Epilepsy as compared to allele C.
chr22	40831082	rs138335	C	A	.	PASS	AF=0.00000;DESCR=Allele G is associated with decreased response to corticosteroids in children with Asthma as compared to allele C.
chr22	40831082	rs138335	C	G	.	PASS	AF=0.668494;DESCR=Allele G is associated with decreased response to corticosteroids in children with Asthma as compared to allele C.
chr22	40835049	rs138337	A	G	.	PASS	AF=0.536044;DESCR=Allele G is associated with decreased response to corticosteroids in children with Asthma as compared to allele A.
chr22	41682662	rs6519270	A	G	.	PASS	AF=0.690421;DESCR=Allele G is associated with increased concentrations of vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma, Hodgkin Disease, Rhabdomyosarcoma, Medulloblastoma or Glioma as compared to allele A.
chr22	41880738	rs2228314	G	C	.	PASS	AF=0.359942;DESCR=Genotype GG is not associated with response to simvastatin in people with Hypercholesterolemia as compared to genotypes CC + CG.
chr22	41992822	rs56234624	A	G	.	PASS	AF=0.374928;DESCR=Allele G is associated with increased concentrations of metoprolol as compared to allele A.
chr22	42016707	rs5758550	G	A	.	PASS	AF=0.788927;DESCR=Allele A is associated with decreased clearance of risperidone as compared to allele G.
chr22	42108675	rs6002616	A	G	.	PASS	AF=0.389689;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr22	42126390	rs28371738	G	A	.	PASS	AF=0.245528;DESCR=Allele A is associated with increased concentrations of alpha-hydroxymetoprolol as compared to allele G.
chr22	42126390	rs28371738	G	C	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased concentrations of alpha-hydroxymetoprolol as compared to allele G.
chr22	42128945	rs3892097	C	T	.	PASS	AF=0.184333;DESCR=Genotype CC is associated with increased response to fluoxetine in men with Alcoholism and Depressive Disorder, Major as compared to genotype CT.
chr22	42129770	rs28371706	G	A	.	PASS	AF=0.0155530;DESCR=Genotypes AA + AG are associated with decreased clearance of nevirapine in children with HIV Infections as compared to genotype GG.
chr22	42129770	rs28371706	G	T	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG are associated with decreased clearance of nevirapine in children with HIV Infections as compared to genotype GG.
chr22	42129819	rs28371703	G	T	.	PASS	AF=0.185789;DESCR=Genotype GT is associated with increased half-life time of fluoxetine in healthy individuals as compared to genotype GG.
chr22	42130692	rs1065852	G	A	.	PASS	AF=0.245812;DESCR=Allele A is associated with decreased clearance of alpha-hydroxymetoprolol in healthy individuals as compared to allele G.
chr22	42131289	rs74966855	G	T	.	PASS	AF=0.00173310;DESCR=Genotype TT is not associated with metabolism of dextromethorphan as compared to genotype GG.
chr22	42171084	rs9306356	T	C	.	PASS	AF=0.160714;DESCR=Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.
chr22	42213142	rs5758651	T	C	.	PASS	AF=0.258929;DESCR=Allele C is associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to allele T.
chr22	42516091	rs11553441	C	T	.	PASS	AF=0.0613479;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr22	43001030	rs2413739	C	T	.	PASS	AF=0.369013;DESCR=Genotype CC is not associated with dose of mercaptopurine or methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes CT + TT.
chr22	43928847	rs738409	C	A	.	PASS	AF=0.00000;DESCR=Genotypes CG + GG is associated with increased clinical benefit to alogliptin in people with Diabetes Mellitus, Type 2, Fatty liver disease and Body Weight Changes as compared to genotype CC.
chr22	43928847	rs738409	C	G	.	PASS	AF=0.211118;DESCR=Genotypes CG + GG is associated with increased clinical benefit to alogliptin in people with Diabetes Mellitus, Type 2, Fatty liver disease and Body Weight Changes as compared to genotype CC.
chr22	46202410	rs4823613	A	G	.	PASS	AF=0.301903;DESCR=Allele G is associated with decreased metabolism of tacrolimus in people with Kidney Transplantation as compared to allele A.
chr22	46214170	rs4253728	G	A	.	PASS	AF=0.271050;DESCR=Genotype AA is not associated with metabolism of cyclosporine in people with Kidney Transplantation as compared to allele G.
chr22	46214512	rs4253730	A	G	.	PASS	AF=0.330171;DESCR=Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.
chr22	46218377	rs1800206	C	G	.	PASS	AF=0.0395268;DESCR=Allele C is not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to allele G.
chr22	46219983	rs1800234	T	C	.	PASS	AF=0.00172911;DESCR=Genotypes CC + CT is associated with decreased clinical benefit to chiglitazar in people with Diabetes Mellitus, Type 2 as compared to genotype TT.
chr22	46234737	rs4253778	G	C	.	PASS	AF=0.174640;DESCR=Genotype GG is associated with increased response to fenofibrate in people with Diabetes Mellitus as compared to genotypes CC + CG.
chr22	46234737	rs4253778	G	T	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with increased response to fenofibrate in people with Diabetes Mellitus as compared to genotypes CC + CG.
chr22	47888765	rs9627183	G	A	.	PASS	AF=0.0357143;DESCR=Allele G is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.
chr22	50525807	rs11479	G	A	.	PASS	AF=0.0697406;DESCR=Genotypes AA + AG is associated with dose of capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype GG.
chr22	50525807	rs11479	G	C	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG is associated with dose of capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype GG.
chr22	50528485	rs470119	T	C	.	PASS	AF=0.661671;DESCR=Allele T is not associated with response to fluorouracil in people with Colonic Neoplasms as compared to allele C.
chr22	50625988	rs2071421	T	C	.	PASS	AF=0.137543;DESCR=Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr3	195076	rs1516338	C	T	.	PASS	AF=0.708357;DESCR=Genotype TT is associated with increased response to antidepressants in people with Bipolar Disorder, Depressive Disorder or Depressive Disorder, Major as compared to genotype CC.
chr3	2423407	rs17194378	A	G	.	PASS	AF=0.413018;DESCR=Allele A is associated with response to ziprasidone in people with Schizophrenia.
chr3	2423407	rs17194378	A	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with response to ziprasidone in people with Schizophrenia.
chr3	6992862	rs2069062	G	C	.	PASS	AF=0.199942;DESCR=Genotype CC is associated with increased response to risperidone in people with as compared to genotypes CG + GG.
chr3	6992862	rs2069062	G	T	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to risperidone in people with as compared to genotypes CG + GG.
chr3	7625097	rs3792452	C	T	.	PASS	AF=0.223055;DESCR=Allele T is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.
chr3	9757089	rs1052133	C	G	.	PASS	AF=0.197406;DESCR=Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele C.
chr3	9757429	rs293795	A	G	.	PASS	AF=0.104551;DESCR=Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele A.
chr3	9918386	rs708567	C	T	.	PASS	AF=0.455933;DESCR=Genotype CC is associated with increased clinical benefit to tildrakizumab in people with Psoriasis as compared to genotypes CT + TT.
chr3	11055173	rs2933304	G	C	.	PASS	AF=0.00000;DESCR=Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr3	11055173	rs2933304	G	T	.	PASS	AF=0.388697;DESCR=Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr3	11224228	rs13064530	G	A	.	PASS	AF=0.245533;DESCR=Allele G is not associated with response to clozapine in people with Schizophrenia as compared to allele A.
chr3	11249929	rs2606731	A	C	.	PASS	AF=0.559146;DESCR=Allele G is not associated with dose of opioids in people with Pain as compared to allele T.
chr3	11249929	rs2606731	A	G	.	PASS	AF=0.00000;DESCR=Allele G is not associated with dose of opioids in people with Pain as compared to allele T.
chr3	11250996	rs346076	C	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with dose of opioids in people with Pain as compared to allele C.
chr3	11250996	rs346076	C	T	.	PASS	AF=0.552161;DESCR=Allele T is not associated with dose of opioids in people with Pain as compared to allele C.
chr3	11259021	rs901865	T	C	.	PASS	AF=0.743228;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr3	11262188	rs346070	T	C	.	PASS	AF=0.744669;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr3	12351626	rs1801282	C	G	.	PASS	AF=0.0576701;DESCR=Genotype CG is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype CC.
chr3	14145949	rs2228001	G	T	.	PASS	AF=0.532872;DESCR=Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele T.
chr3	14178523	rs1870134	G	C	.	PASS	AF=0.00316820;DESCR=Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr3	14178523	rs1870134	G	T	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr3	14801652	rs294610	C	A	.	PASS	AF=0.404556;DESCR=Allele A is associated with increased response to atenolol or metoprolol in people with Hypertension as compared to allele C.
chr3	21753382	rs4261893	C	G	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes CC + CT.
chr3	21753382	rs4261893	C	T	.	PASS	AF=0.614764;DESCR=Genotype TT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes CC + CT.
chr3	21753431	rs9873889	C	G	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr3	21753431	rs9873889	C	T	.	PASS	AF=0.613741;DESCR=Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr3	21754288	rs9879065	C	T	.	PASS	AF=0.614187;DESCR=Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr3	21756083	rs9310657	T	G	.	PASS	AF=0.723214;DESCR=Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr3	21756084	rs9310658	C	T	.	PASS	AF=0.723214;DESCR=Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr3	21756203	rs7616119	G	C	.	PASS	AF=0.723055;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr3	21756203	rs7616119	G	T	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr3	21756949	rs7653345	A	G	.	PASS	AF=0.724018;DESCR=Allele A is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr3	21757051	rs9819548	G	A	.	PASS	AF=0.722895;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr3	21757155	rs13093500	T	A	.	PASS	AF=0.722392;DESCR=Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr3	21757155	rs13093500	T	G	.	AC0	AF=0.00000;DESCR=Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr3	21757421	rs12630569	G	A	.	PASS	AF=0.00000;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr3	21757421	rs12630569	G	C	.	PASS	AF=0.244233;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr3	21757835	rs9824595	G	A	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr3	21757835	rs9824595	G	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr3	21757835	rs9824595	G	T	.	PASS	AF=0.723760;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr3	21757936	rs4334661	T	C	.	PASS	AF=0.723760;DESCR=Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr3	23132388	rs7625956	G	A	.	PASS	AF=0.416907;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr3	23132842	rs4858478	G	A	.	PASS	AF=0.416859;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr3	23132842	rs4858478	G	C	.	AC0	AF=0.00000;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr3	27715527	rs2371108	G	T	.	PASS	AF=0.455357;DESCR=Allele T is associated with increased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele G.
chr3	30420911	rs7640543	G	A	.	PASS	AF=0.332949;DESCR=Allele A is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.
chr3	30420911	rs7640543	G	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.
chr3	30845325	rs17026688	C	T	.	PASS	AF=0.000288018;DESCR=Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.
chr3	32259860	rs4627790	T	C	.	PASS	AF=0.302882;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr3	39492990	rs616147	A	G	.	PASS	AF=0.704847;DESCR=Genotypes AA + AG are associated with increased response to creatine in people with Amyotrophic Lateral Sclerosis as compared to genotype GG.
chr3	41200847	rs4533622	C	A	.	PASS	AF=0.381336;DESCR=Genotype AA is associated with increased response to thalidomide in people with Multiple Myeloma as compared to genotypes AC + CC.
chr3	41200847	rs4533622	C	T	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with increased response to thalidomide in people with Multiple Myeloma as compared to genotypes AC + CC.
chr3	41237949	rs4135385	A	G	.	PASS	AF=0.229107;DESCR=Genotype AA is associated with increased response to cyclophosphamide, dexamethasone and thalidomide in people with Multiple Myeloma as compared to genotypes AG + GG.
chr3	46941247	rs4682844	T	C	.	PASS	AF=0.445565;DESCR=Allele C is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.
chr3	47418189	rs12487736	C	T	.	PASS	AF=0.504325;DESCR=Allele T is not associated with response to fluvastatin in people with Coronary Artery Disease as compared to allele C.
chr3	48695413	rs61740999	G	A	.	PASS	AF=0.0141129;DESCR=Genotype AG is associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to genotype GG.
chr3	49026677	rs11706052	A	G	.	PASS	AF=0.123272;DESCR=Genotype AA is not associated with dose of mercaptopurine or methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG.
chr3	49357401	rs1050450	G	A	.	PASS	AF=0.460739;DESCR=Allele G is not associated with response to clozapine in people with Schizophrenia as compared to allele A.
chr3	49368662	rs11716445	G	A	.	PASS	AF=0.0896254;DESCR=Allele A is associated with decreased response to pravastatin or simvastatin in people with Hypercholesterolemia as compared to allele G.
chr3	50332115	rs2073498	C	A	.	PASS	AF=0.0731567;DESCR=Genotypes AA + AC is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to genotype CC.
chr3	52224356	rs352139	T	C	.	PASS	AF=0.554498;DESCR=Genotype TT is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease or Inflammatory Bowel Diseases as compared to genotypes CC + CT.
chr3	52799203	rs2535629	G	A	.	PASS	AF=0.378098;DESCR=Genotype AA is associated with increased response to clozapine in people with Schizophrenia as compared to genotypes AG + GG.
chr3	53517875	rs312481	A	G	.	PASS	AF=0.843804;DESCR=Genotype GG is associated with increased clinical benefit to amlodipine in people with Hypertension as compared to genotypes AA + AG.
chr3	53842191	rs6801605	A	G	.	PASS	AF=0.624712;DESCR=Allele A is associated with increased clinical benefit to acamprosate in people with Alcoholism as compared to allele G.
chr3	54220102	rs4505744	G	A	.	PASS	AF=0.101617;DESCR=Genotype AA is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype GG.
chr3	54365581	rs7427395	T	A	.	AC0	AF=0.00000;DESCR=Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype TT.
chr3	54365581	rs7427395	T	C	.	PASS	AF=0.835735;DESCR=Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype TT.
chr3	54544778	rs11130424	G	A	.	PASS	AF=0.539171;DESCR=Genotypes AG + GG is associated with increased resistance to radiotherapy in people with Nasopharyngeal Neoplasms as compared to genotype AA.
chr3	54940131	rs6806020	T	C	.	PASS	AF=0.791475;DESCR=Allele C is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele T.
chr3	59771849	rs49411	T	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr3	59771849	rs49411	T	C	.	PASS	AF=0.595101;DESCR=Allele C is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr3	60113241	rs760316	C	T	.	PASS	AF=0.640625;DESCR=Allele C is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele T.
chr3	60424454	rs241692	A	G	.	PASS	AF=0.129395;DESCR=Allele G is not associated with response to bevacizumab and ranibizumab in people with as compared to allele A.
chr3	88809891	rs13093031	A	G	.	PASS	AF=0.151156;DESCR=Genotype GG is associated with increased response to fentanyl in people with Pain, Postoperative as compared to genotypes AA + AG.
chr3	98140850	rs35123024	T	C	.	PASS	AF=0.167627;DESCR=Allele C is associated with decreased response to atenolol and hydrochlorothiazide in people with Hypertension as compared to allele T.
chr3	111506078	rs9828223	C	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with decreased response to adalimumab in people with Crohn Disease as compared to allele C.
chr3	111506078	rs9828223	C	T	.	PASS	AF=0.0939500;DESCR=Allele T is associated with decreased response to adalimumab in people with Crohn Disease as compared to allele C.
chr3	113327793	rs13064411	A	G	.	PASS	AF=0.157925;DESCR=Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to genotype AA.
chr3	114127166	rs2125146420;rs2125146421;rs2125146428;rs2399496	T	A	.	PASS	AF=0.599135;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele T.
chr3	114128261	rs9817063	T	C	.	PASS	AF=0.389786;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr3	114128436	rs3732790	T	A	.	PASS	AF=0.322376;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele T.
chr3	114144040	rs963468	G	A	.	PASS	AF=0.318732;DESCR=Genotype GG is associated with decreased response to duloxetine in people with Anxiety Disorders as compared to genotypes AA + AG.
chr3	114150488	rs3773679	C	T	.	PASS	AF=0.319412;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr3	114157428	rs167771	G	A	.	PASS	AF=0.805876;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr3	114157428	rs167771	G	C	.	AC0	AF=0.00000;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr3	114160715	rs167770	G	A	.	PASS	AF=0.715811;DESCR=Genotype AG is associated with decreased response to duloxetine in people with Anxiety Disorders as compared to genotypes AA + GG.
chr3	114166548	rs324023	T	C	.	PASS	AF=0.715850;DESCR=Genotype CT is associated with decreased response to duloxetine in people with Anxiety Disorders as compared to genotypes CC + TT.
chr3	114171968	rs6280	C	T	.	PASS	AF=0.707493;DESCR=Genotypes CC + CT is associated with increased response to risperidone in children with Autistic Disorder as compared to genotype TT.
chr3	114172195	rs324026	C	T	.	PASS	AF=0.707205;DESCR=Genotypes CC + CT are associated with decreased response to duloxetine in people with Anxiety Disorders as compared to genotype TT.
chr3	119778198	rs2125139887;rs2125139890;rs7643038;rs2125139900;rs2125139885	G	A	.	PASS	AF=0.499134;DESCR=Allele G is associated with decreased metabolism of methotrexate in children with Osteosarcoma as compared to allele A.
chr3	119780660	rs1523130	T	C	.	PASS	AF=0.547344;DESCR=Allele C is not associated with concentrations of atazanavir in people with HIV Infections as compared to allele T.
chr3	119781188	rs3814055	C	T	.	PASS	AF=0.498560;DESCR=Genotype TT is associated with decreased metabolism of temsirolimus in people with Urinary Bladder Neoplasms as compared to genotypes CC + CT.
chr3	119782192	rs1523127	C	A	.	PASS	AF=0.497693;DESCR=Genotypes AA + AC is associated with decreased response to efavirenz or nevirapine in people with HIV Infections as compared to genotype CC.
chr3	119782460	rs2276706	G	A	.	PASS	AF=0.499710;DESCR=Genotype GG is associated with decreased metabolism of repaglinide in men as compared to genotype AA.
chr3	119785534	rs10934498	G	A	.	PASS	AF=0.479527;DESCR=Genotype AA is associated with decreased exposure to irinotecan in people with Colonic Neoplasms as compared to genotypes AG + GG.
chr3	119785534	rs10934498	G	T	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with decreased exposure to irinotecan in people with Colonic Neoplasms as compared to genotypes AG + GG.
chr3	119799570	rs2472677	C	T	.	PASS	AF=0.638985;DESCR=Genotype TT is associated with decreased concentrations of atazanavir in people with HIV Infections as compared to genotypes CC + CT.
chr3	119802208	rs13059232	T	C	.	PASS	AF=0.669741;DESCR=Allele C is not associated with metabolism of cyclophosphamide in people with as compared to allele T.
chr3	119805244	rs4688040	G	C	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to allele G.
chr3	119805244	rs4688040	G	T	.	PASS	AF=0.238315;DESCR=Allele T is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to allele G.
chr3	119805804	rs2461817	A	C	.	PASS	AF=0.639884;DESCR=Genotype CC is associated with increased concentrations of midazolam in people with respiratory failure requiring assisted ventilation as compared to genotypes AA + AC.
chr3	119806650	rs7643645	A	G	.	PASS	AF=0.327089;DESCR=Allele G is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to allele A.
chr3	119807525	rs1464602	G	A	.	PASS	AF=0.675504;DESCR=Genotype GG is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype AA.
chr3	119810032	rs12721616	C	T	.	PASS	AF=0.00000;DESCR=Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.
chr3	119812011	rs3732357	G	A	.	PASS	AF=0.692507;DESCR=Genotypes AA + AG is associated with decreased exposure to rifampin in people with Tuberculosis as compared to genotype GG.
chr3	119813805	rs2472682	A	C	.	PASS	AF=0.645737;DESCR=Allele C is not associated with dose of warfarin as compared to allele A.
chr3	119815306	rs2276707	C	G	.	PASS	AF=0.00000;DESCR=Genotypes CT + TT is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to genotype CC.
chr3	119815306	rs2276707	C	T	.	PASS	AF=0.188870;DESCR=Genotypes CT + TT is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to genotype CC.
chr3	119817582	rs3732359	G	A	.	PASS	AF=0.765418;DESCR=Genotype GG is associated with increased concentrations of voriconazole as compared to genotype AA.
chr3	119817734	rs3732360	C	G	.	PASS	AF=0.00000;DESCR=Genotype CC is not associated with concentrations of efavirenz in people with HIV Infections as compared to genotypes CT + TT.
chr3	119817734	rs3732360	C	T	.	PASS	AF=0.746832;DESCR=Genotype CC is not associated with concentrations of efavirenz in people with HIV Infections as compared to genotypes CT + TT.
chr3	119817871	rs1054190	C	T	.	PASS	AF=0.136101;DESCR=Genotype CC is not associated with concentrations of efavirenz in people with HIV Infections as compared to genotypes CT + TT.
chr3	119818050	rs1054191	G	A	.	PASS	AF=0.154467;DESCR=Genotype GG is not associated with concentrations of efavirenz in people with HIV Infections as compared to genotypes AA + AG.
chr3	119818407	rs3814057	A	C	.	PASS	AF=0.190311;DESCR=Genotype CC is associated with increased concentrations of voriconazole as compared to genotypes AA + AC.
chr3	119818407	rs3814057	A	T	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased concentrations of voriconazole as compared to genotypes AA + AC.
chr3	119818444	rs3814058	T	C	.	PASS	AF=0.190092;DESCR=Genotype CC is associated with decreased metabolism of repaglinide in men as compared to genotype TT.
chr3	119823450	rs3732361	A	G	.	PASS	AF=0.582757;DESCR=Allele A is associated with increased concentrations of methotrexate in children with Osteosarcoma as compared to allele G.
chr3	119912967	rs6438552	A	G	.	PASS	AF=0.416955;DESCR=Genotype GG is associated with increased response to lithium in people with Bipolar Disorder.
chr3	120094435	rs334558	A	G	.	PASS	AF=0.402650;DESCR=Genotype GG is associated with increased response to citalopram and fluoxetine in people with Depressive Disorder, Major as compared to allele A.
chr3	120096110	rs3755557	T	A	.	PASS	AF=0.154844;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.
chr3	121928439	rs1143671	C	T	.	PASS	AF=0.393084;DESCR=Genotype TT is associated with decreased dose of warfarin as compared to genotype CC.
chr3	121929321	rs1143672	G	A	.	PASS	AF=0.393372;DESCR=Genotype AA is associated with decreased dose of warfarin as compared to genotype GG.
chr3	122715083	rs10433340	G	A	.	PASS	AF=0.346398;DESCR=Allele A is associated with increased concentrations of 6-hydroxy s-warfarin in people with Atrial Fibrillation, venous thromboembolism or Heart Valve Diseases as compared to allele G.
chr3	124737895	rs1801019	G	C	.	PASS	AF=0.0988473;DESCR=Allele C is not associated with response to fluorouracil in people with Colonic Neoplasms as compared to allele G.
chr3	124740091	rs2291078	T	A	.	PASS	AF=0.0112327;DESCR=Allele A is associated with decreased response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele T.
chr3	124743977	rs3772809	A	G	.	PASS	AF=0.0112392;DESCR=Allele G is associated with decreased response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele A.
chr3	124744112	rs3772810	A	G	.	PASS	AF=0.0112327;DESCR=Allele G is associated with decreased response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele A.
chr3	126146923	rs2886059	C	A	.	PASS	AF=0.153514;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr3	126543249	rs1054097	G	C	.	PASS	AF=0.0123919;DESCR=Allele C is associated with increased response to glibenclamide in people with as compared to allele G.
chr3	128806410	rs4548	C	T	.	PASS	AF=0.0800691;DESCR=Genotype CT is associated with increased exposure to vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma, Hodgkin Disease, Rhabdomyosarcoma, Medulloblastoma or Glioma as compared to genotype CC.
chr3	129796285	rs2811332	G	C	.	PASS	AF=0.367147;DESCR=Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.
chr3	133756878	rs1799852	C	T	.	PASS	AF=0.118224;DESCR=Allele T is associated with increased response to adalimumab in people with Crohn Disease as compared to allele C.
chr3	133822039	rs17376019	C	T	.	PASS	AF=0.148961;DESCR=Genotype CT is associated with decreased concentrations of ethanol in healthy individuals as compared to genotype CC.
chr3	143592418	rs4839603	A	G	.	PASS	AF=0.193836;DESCR=Genotype GG is associated with decreased dose of fentanyl or remifentanil in people with Pain as compared to genotypes AA + AG.
chr3	148697100	rs2125149304;rs2125149307;rs2125149315;rs275651	T	A	.	PASS	AF=0.281844;DESCR=Genotypes AA + AT is associated with decreased response to perindopril in people with Coronary Artery Disease as compared to genotype TT.
chr3	148714582	rs2640543	A	G	.	PASS	AF=0.597174;DESCR=Genotype GG is associated with response to benazepril in women with Hypertension as compared to genotype AA.
chr3	148741608	rs5182	C	T	.	PASS	AF=0.401616;DESCR=Genotypes CC + CT is associated with decreased response to perindopril in people with Coronary Artery Disease as compared to genotype TT.
chr3	148742201	rs5186	A	C	.	PASS	AF=0.322478;DESCR=Genotype AA is associated with decreased response to perindopril in people with Hypertension as compared to genotypes AC + CC.
chr3	149669894	rs3811715	G	A	.	PASS	AF=0.115783;DESCR=Genotype GG is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to genotypes AA + AG.
chr3	151337857	rs16846673	T	C	.	PASS	AF=0.00000;DESCR=Genotype TT is not associated with decreased response to clopidogrel as compared to genotype CC.
chr3	151338810	rs6809699	A	C	.	PASS	AF=0.878963;DESCR=Genotype AA is not associated with response to clopidogrel in people with Carotid Artery Diseases as compared to genotypes AC + CC.
chr3	151338828	rs6785930	G	A	.	PASS	AF=0.195038;DESCR=Genotype GG is associated with decreased response to ticagrelor in healthy individuals as compared to genotype AG.
chr3	151339854	rs2046934	G	A	.	PASS	AF=0.878963;DESCR=Allele G is not associated with response to clopidogrel in people with Acute coronary syndrome as compared to allele A.
chr3	151356835	rs7428575	T	G	.	PASS	AF=0.237176;DESCR=Allele G is not associated with response to clopidogrel in people with Coronary Disease as compared to allele T.
chr3	151357137	rs3732759	A	G	.	PASS	AF=0.242224;DESCR=Genotype GG is associated with decreased response to clopidogrel in people with Coronary Disease as compared to genotypes AA + AG.
chr3	151381953	rs6787801	A	G	.	PASS	AF=0.540657;DESCR=Genotype AG is associated with decreased response to ticagrelor in healthy individuals as compared to genotype AA.
chr3	151827813	rs1803155	G	A	.	PASS	AF=0.832180;DESCR=Genotype GG is associated with decreased exposure to rifampin in people with Tuberculosis as compared to genotypes AA + AG.
chr3	152836568	rs701265	A	G	.	PASS	AF=0.139769;DESCR=Allele G is not associated with response to clopidogrel as compared to allele A.
chr3	160712081	rs7624766	A	G	.	PASS	AF=0.337082;DESCR=Allele G is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.
chr3	165773492	rs1803274	C	T	.	PASS	AF=0.176284;DESCR=Genotype CC is associated with increased response to rivastigmine in people with Alzheimer Disease as compared to genotypes CT + TT.
chr3	165788069	rs1355534	T	C	.	PASS	AF=0.712349;DESCR=Genotype TT is not associated with response to donepezil in people with Alzheimer Disease as compared to genotypes CC + CT.
chr3	171006940	rs1499821	C	G	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased dose-adjusted trough concentrations of tacrolimus in people with lung transplantation as compared to genotypes CT + TT.
chr3	171006940	rs1499821	C	T	.	PASS	AF=0.180636;DESCR=Genotype CC is associated with increased dose-adjusted trough concentrations of tacrolimus in people with lung transplantation as compared to genotypes CT + TT.
chr3	171007094	rs8192675	T	C	.	PASS	AF=0.329677;DESCR=Allele C is associated with increased response to metformin in people with Diabetes Mellitus as compared to allele T.
chr3	171253502	rs2088885	C	A	.	PASS	AF=0.503174;DESCR=Genotype AA is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes AC + CC.
chr3	171262186	rs7627954	T	C	.	PASS	AF=0.503749;DESCR=Genotype CC is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CT + TT.
chr3	172524100	rs12488654	G	A	.	PASS	AF=0.111527;DESCR=Genotype GG is not associated with response to rituximab in people with Lymphoma, Follicular as compared to genotypes AA + AG.
chr3	176534890	rs57449396	C	T	.	PASS	AF=0.0144342;DESCR=Allele T is associated with decreased response to allopurinol as compared to allele C.
chr3	178741877	rs9839376	T	C	.	PASS	AF=0.207205;DESCR=Genotype CC is associated with decreased response to ritodrine as compared to genotypes CT + TT.
chr3	178743983	rs7624046	C	T	.	PASS	AF=0.427582;DESCR=Genotype TT is associated with decreased response to ritodrine as compared to genotypes CC + CT.
chr3	179156079	rs77576241	C	T	.	PASS	AF=0.0737752;DESCR=Allele T is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele C.
chr3	179173633	rs67562832	A	G	.	PASS	AF=0.248558;DESCR=Allele G is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele A.
chr3	183917091	rs1533682	T	C	.	PASS	AF=0.565380;DESCR=Genotype TT is associated with increased clearance of doxorubicin in women with Breast Neoplasms as compared to genotypes CC + CT.
chr3	183917980	rs1000002	C	T	.	PASS	AF=0.432277;DESCR=Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.
chr3	183924515	rs8180093	G	A	.	PASS	AF=0.112327;DESCR=Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.
chr3	183936081	rs2139560	A	G	.	PASS	AF=0.565706;DESCR=Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.
chr3	183942797	rs3749442	G	A	.	PASS	AF=0.125360;DESCR=Allele A is associated with increased response to glibenclamide in people with as compared to allele G.
chr3	183972201	rs3805111	G	A	.	PASS	AF=0.0625360;DESCR=Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.
chr3	183978082	rs3792581	C	A	.	PASS	AF=0.138488;DESCR=Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.
chr3	183982423	rs2293001	C	T	.	PASS	AF=0.413156;DESCR=Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.
chr3	184002711	rs4148572	C	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.
chr3	184002711	rs4148572	C	G	.	PASS	AF=0.0757925;DESCR=Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.
chr3	184015996	rs4148557	A	G	.	PASS	AF=0.544720;DESCR=Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.
chr3	184031943	rs939334	T	C	.	PASS	AF=0.320358;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr3	184036241	rs6792482	T	C	.	PASS	AF=0.584198;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr3	184036506	rs6443930	G	C	.	PASS	AF=0.584775;DESCR=Genotype GG is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes CC + CG.
chr3	184040718	rs7621975	G	A	.	PASS	AF=0.140219;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr3	184055033	rs6808122	G	A	.	PASS	AF=0.748272;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr3	184056974	rs6766410	C	A	.	PASS	AF=0.455069;DESCR=Genotype CC is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes AA + AC.
chr3	184056974	rs6766410	C	T	.	PASS	AF=0.00000;DESCR=Genotype CC is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes AA + AC.
chr3	184060222	rs6807362	G	C	.	PASS	AF=0.611368;DESCR=Genotype GG is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes CC + CG.
chr3	184060510	rs6807670	G	A	.	PASS	AF=0.726067;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr3	184099939	rs6443950	A	T	.	PASS	AF=0.697809;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele T.
chr3	184100628	rs7627615	G	A	.	PASS	AF=0.603866;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr3	184101367	rs7432211	T	C	.	PASS	AF=0.453917;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr3	184102178	rs4912522	G	C	.	PASS	AF=0.433103;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele G.
chr3	185793899	rs4402960	G	C	.	AC0	AF=0.00000;DESCR=Genotypes GT + TT are associated with increased response to repaglinide in people with Diabetes Mellitus, Type 2 as compared to genotype GG.
chr3	185793899	rs4402960	G	T	.	PASS	AF=0.410663;DESCR=Genotypes GT + TT are associated with increased response to repaglinide in people with Diabetes Mellitus, Type 2 as compared to genotype GG.
chr3	185811292	rs1470579	A	C	.	PASS	AF=0.410271;DESCR=Genotypes AC + CC are associated with decreased response to repaglinide in people with Diabetes Mellitus, Type 2 as compared to genotype AA.
chr3	186841636	rs16861194	A	G	.	PASS	AF=0.0662824;DESCR=Genotype AG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.
chr3	186841685	rs266729	C	A	.	PASS	AF=0.00000;DESCR=Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CG + GG.
chr3	186841685	rs266729	C	G	.	PASS	AF=0.282709;DESCR=Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CG + GG.
chr3	186841685	rs266729	C	T	.	PASS	AF=0.00000;DESCR=Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CG + GG.
chr3	186853103	rs2241766	T	C	.	PASS	AF=0.00000;DESCR=Genotype GT is associated with increased response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.
chr3	186853103	rs2241766	T	G	.	PASS	AF=0.206867;DESCR=Genotype GT is associated with increased response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.
chr3	186853334	rs1501299	G	C	.	PASS	AF=0.00000;DESCR=Genotypes GT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.
chr3	186853334	rs1501299	G	T	.	PASS	AF=0.297750;DESCR=Genotypes GT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.
chr3	186853407	rs2241767	A	G	.	PASS	AF=0.202710;DESCR=Genotype AA are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes AG + GG.
chr3	186853697	rs3821799	T	C	.	PASS	AF=0.469723;DESCR=Genotypes CT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype CC.
chr3	186853770	rs3774261	A	G	.	PASS	AF=0.500289;DESCR=Genotypes AG + GG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.
chr3	186856286	rs1063537	C	T	.	PASS	AF=0.202710;DESCR=Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.
chr3	186856375	rs2082940	T	C	.	PASS	AF=0.797750;DESCR=Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.
chr3	186856394	rs1063538	T	C	.	PASS	AF=0.499711;DESCR=Genotypes CC + CT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.
chr3	188227136	rs1975991	A	G	.	PASS	AF=0.689914;DESCR=Allele A is associated with decreased exposure to 2-hydroxyatorvastatin, 4-hydroxyatorvastatin, atorvastatin and atorvastatin lactone in healthy individuals as compared to allele G.
chr3	188227136	rs1975991	A	T	.	AC0	AF=0.00000;DESCR=Allele A is associated with decreased exposure to 2-hydroxyatorvastatin, 4-hydroxyatorvastatin, atorvastatin and atorvastatin lactone in healthy individuals as compared to allele G.
chr4	2904980	rs4961	G	T	.	PASS	AF=0.147262;DESCR=Allele T is not associated with response to hydrochlorothiazide in people with Essential hypertension as compared to allele G.
chr4	2988772	rs2960306	G	A	.	PASS	AF=0.00000;DESCR=Genotype TT is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype GG.
chr4	2988772	rs2960306	G	T	.	PASS	AF=0.282081;DESCR=Genotype TT is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype GG.
chr4	3004316	rs1024323	C	T	.	PASS	AF=0.372549;DESCR=Genotype CC is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype TT.
chr4	3037423	rs1801058	T	C	.	PASS	AF=0.641662;DESCR=Genotype CT is not associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype CC.
chr4	3233253	rs362272	G	A	.	PASS	AF=0.296947;DESCR=Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr4	3233253	rs362272	G	T	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr4	3240373	rs362306	G	A	.	PASS	AF=0.296371;DESCR=Allele A is associated with decreased response to risperidone in people with Schizophrenia as compared to allele G.
chr4	3241491	rs362267	C	T	.	PASS	AF=0.296254;DESCR=Allele T is associated with decreased response to risperidone in people with Schizophrenia as compared to allele C.
chr4	6301627	rs734312	G	A	.	PASS	AF=0.621544;DESCR=Allele G is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele A.
chr4	6301627	rs734312	G	C	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele A.
chr4	7322869	rs73208473	C	A	.	PASS	AF=0.285303;DESCR=Allele A is associated with decreased exposure to atazanavir in women with HIV Infections as compared to allele C.
chr4	7322869	rs73208473	C	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased exposure to atazanavir in women with HIV Infections as compared to allele C.
chr4	9961141	rs11942223	T	C	.	PASS	AF=0.271601;DESCR=Allele T is not associated with dose of allopurinol in people with Gout as compared to allele C.
chr4	10665285	rs13144136	G	T	.	PASS	AF=0.323818;DESCR=Allele G is associated with increased response to Antihypertensives in people with Hypertension as compared to allele T.
chr4	14788854	rs12502866	G	A	.	PASS	AF=0.747259;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr4	15400491	rs10032941	T	C	.	PASS	AF=0.364265;DESCR=Allele C is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.
chr4	15736109	rs28404156	G	A	.	PASS	AF=0.127666;DESCR=Allele A is associated with increased response to Beta blocking agents, selective in people with Hypertension as compared to allele G.
chr4	23864716	rs10213440	T	C	.	PASS	AF=0.239343;DESCR=Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.
chr4	24800212	rs1799895	C	G	.	PASS	AF=0.0138329;DESCR=Allele G is not associated with response to epirubicin, fluorouracil and oxaliplatin in people with Neoplasm Metastasis and Stomach Neoplasms.
chr4	39413373	rs11940694	A	G	.	PASS	AF=0.459942;DESCR=Allele A is associated with decreased dose of ethanol as compared to allele G.
chr4	44919548	rs1390913	G	A	.	PASS	AF=0.375000;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.
chr4	46237987	rs511310	A	G	.	PASS	AF=0.972607;DESCR=Genotype GG is not associated with decreased response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype AA.
chr4	46237987	rs511310	A	T	.	PASS	AF=0.00000;DESCR=Genotype GG is not associated with decreased response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype AA.
chr4	46388848	rs11503014	C	G	.	PASS	AF=0.220300;DESCR=Genotype CC is associated with decreased response to propofol as compared to genotypes CG + GG.
chr4	47227230	rs16860087	C	A	.	PASS	AF=0.129544;DESCR=Allele A is associated with increased dose of antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to allele C.
chr4	47308250	rs4627835	A	T	.	PASS	AF=0.128176;DESCR=Allele T is associated with increased dose of antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to allele A.
chr4	53933078	rs871606	T	C	.	PASS	AF=0.182316;DESCR=Allele T is not associated with response to atenolol in people with Hypertension as compared to allele C.
chr4	53933078	rs871606	T	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to atenolol in people with Hypertension as compared to allele C.
chr4	54227864	rs1800810	C	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.
chr4	54227864	rs1800810	C	G	.	PASS	AF=0.100518;DESCR=Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.
chr4	54228300	rs1800813	G	A	.	PASS	AF=0.0956772;DESCR=Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele A.
chr4	54228462	rs1800812	G	T	.	PASS	AF=0.100576;DESCR=Allele T is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele G.
chr4	54273604	rs35597368	T	C	.	PASS	AF=0.0561636;DESCR=Allele T is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.
chr4	54285873	rs2228230	C	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.
chr4	54285873	rs2228230	C	T	.	PASS	AF=0.0682997;DESCR=Allele T is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.
chr4	55090669	rs7671745	G	A	.	PASS	AF=0.259516;DESCR=Genotype GG is not associated with response to ranibizumab in people with Macular Degeneration as compared to genotype AA.
chr4	55106807	rs1870377	T	A	.	PASS	AF=0.201325;DESCR=Genotypes AA + AT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype TT.
chr4	55113391	rs2305948	C	T	.	PASS	AF=0.0994236;DESCR=Genotypes CT + TT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype CC.
chr4	55125564	rs7667298	T	C	.	PASS	AF=0.495963;DESCR=Genotypes CC + CT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype TT.
chr4	55125564	rs7667298	T	G	.	PASS	AF=0.00000;DESCR=Genotypes CC + CT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype TT.
chr4	55126199	rs2071559	A	G	.	PASS	AF=0.544169;DESCR=Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.
chr4	55435202	rs1801260	A	G	.	PASS	AF=0.236448;DESCR=Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.
chr4	55443825	rs3736544	A	G	.	PASS	AF=0.655620;DESCR=Allele A is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.
chr4	55459198	rs34897046	G	C	.	PASS	AF=0.0141210;DESCR=Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.
chr4	61828999	rs1868790	T	A	.	PASS	AF=0.387190;DESCR=Genotype AA is associated with decreased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AT + TT.
chr4	61873823	rs6551665	G	A	.	PASS	AF=0.649770;DESCR=Genotypes AG + GG are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype AA.
chr4	61878522	rs1947274	C	A	.	PASS	AF=0.651210;DESCR=Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.
chr4	61878827	rs1947275	T	C	.	PASS	AF=0.824207;DESCR=Genotypes CT + TT are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype CC.
chr4	61888602	rs6858066	A	G	.	PASS	AF=0.531142;DESCR=Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.
chr4	61899312	rs2345039	G	C	.	PASS	AF=0.429890;DESCR=Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.
chr4	61903413	rs6813183	G	C	.	PASS	AF=0.660127;DESCR=Genotypes CC + CG are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype GG.
chr4	61914104	rs1355368	A	G	.	PASS	AF=0.656557;DESCR=Genotypes AG + GG are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype AA.
chr4	61935010	rs734644	T	C	.	PASS	AF=0.686778;DESCR=Genotypes CC + CT are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype TT.
chr4	68647129	rs4148269	T	G	.	PASS	AF=0.618140;DESCR=Allele G is associated with increased response to glibenclamide in people with as compared to allele T.
chr4	68670366	rs1902023	A	C	.	PASS	AF=0.453890;DESCR=Allele A is associated with decreased clearance of acetaminophen in healthy individuals as compared to allele C.
chr4	68748341	rs416593	T	A	.	PASS	AF=0.216965;DESCR=Genotypes AA + AT is associated with decreased exposure to clozapine N+ glucuronide as compared to genotype AA.
chr4	68789837	rs1513559	A	G	.	PASS	AF=0.0973502;DESCR=Genotypes AG + GG is associated with decreased exposure to clozapine N+ glucuronide as compared to genotype AA.
chr4	68812655	rs2331559	C	G	.	PASS	AF=0.901848;DESCR=Allele C is not associated with clearance of nicotine as compared to allele G.
chr4	68816218	rs61750900	G	T	.	PASS	AF=0.0652048;DESCR=Allele T is associated with decreased metabolism of nicotine as compared to allele G.
chr4	68817137	rs835309	T	G	.	PASS	AF=0.913144;DESCR=Allele G is not associated with clearance of nicotine as compared to allele T.
chr4	68825803	rs11726322	G	C	.	PASS	AF=0.176945;DESCR=Allele G is not associated with clearance of nicotine as compared to allele C.
chr4	68880929	rs77107237	A	G	.	PASS	AF=0.0648041;DESCR=Allele G is associated with increased concentrations of cotinine in people with Tobacco Use Disorder as compared to allele A.
chr4	69027986	rs4296738	A	G	.	PASS	AF=0.996544;DESCR=Allele A is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele G.
chr4	69028136	rs4235108	G	A	.	PASS	AF=0.683285;DESCR=Allele A is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele G.
chr4	69062829	rs11931604	T	C	.	PASS	AF=0.136023;DESCR=Allele C is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele T.
chr4	69081680	rs4587017	T	G	.	PASS	AF=0.647924;DESCR=Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.
chr4	69095215	rs4455491	A	G	.	PASS	AF=0.511541;DESCR=Allele A is not associated with metabolism of morphine in people with Pain, Postoperative as compared to allele G.
chr4	69095621	rs7438135	G	A	.	PASS	AF=0.511843;DESCR=Genotype AA is associated with increased clinical benefit to cannabinoids in people with Pain as compared to genotypes AG + GG.
chr4	69096194	rs7662029	A	G	.	PASS	AF=0.511521;DESCR=Genotype GG is associated with increased dose-adjusted trough concentrations of mycophenolic acid acyl glucuronide in people with Kidney Transplantation as compared to genotype AG.
chr4	69096360	rs7668258	T	C	.	PASS	AF=0.511816;DESCR=Genotype CC is associated with increased clearance of lamotrigine as compared to genotypes CT + TT.
chr4	69096383	rs73823859	G	A	.	PASS	AF=0.136233;DESCR=Allele G is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.
chr4	69096396	rs7668282	T	C	.	PASS	AF=0.00259217;DESCR=Allele C is not associated with dose of morphine in people with Pain, Postoperative as compared to allele T.
chr4	69096731	rs12233719	G	T	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with increased concentrations of valproic acid in people with Epilepsy as compared to genotype GT.
chr4	69096892	rs28365063	A	G	.	PASS	AF=0.190710;DESCR=Genotype AA is not associated with increased clearance of lamotrigine as compared to genotypes AG + GG.
chr4	69097706	rs62296959	G	A	.	PASS	AF=0.135393;DESCR=Allele A is not associated with metabolism of morphine in children as compared to allele G.
chr4	69097706	rs62296959	G	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with metabolism of morphine in children as compared to allele G.
chr4	69097706	rs62296959	G	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with metabolism of morphine in children as compared to allele G.
chr4	69098070	rs28375964	C	T	.	PASS	AF=0.647924;DESCR=Allele T is not associated with metabolism of morphine in children as compared to allele C.
chr4	69098226	rs62298861	A	G	.	PASS	AF=0.141537;DESCR=Allele G is not associated with concentrations of codeine or morphine as compared to allele A.
chr4	69098553	rs28365062	A	G	.	PASS	AF=0.141537;DESCR=Genotype GG is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotypes AA + AG.
chr4	69098553	rs28365062	A	T	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotypes AA + AG.
chr4	69098619	rs7438284	A	T	.	PASS	AF=0.512160;DESCR=Allele A is associated with increased response to lorazepam and valproic acid in healthy individuals as compared to allele T.
chr4	69098620	rs7439366	T	C	.	PASS	AF=0.511863;DESCR=Allele C is not associated with decreased metabolism of labetalol in healthy individuals as compared to allele T.
chr4	69105219	rs10028494	A	C	.	PASS	AF=0.162435;DESCR=Allele A is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele C.
chr4	69112090	rs10006452	T	A	.	AC0	AF=0.00000;DESCR=Allele C is not associated with metabolism of morphine in children as compared to allele T.
chr4	69112090	rs10006452	T	C	.	PASS	AF=0.648127;DESCR=Allele C is not associated with metabolism of morphine in children as compared to allele T.
chr4	69113032	rs6851533	T	A	.	AC0	AF=0.00000;DESCR=Allele C is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele T.
chr4	69113032	rs6851533	T	C	.	PASS	AF=0.512104;DESCR=Allele C is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele T.
chr4	69123281	rs12645107	G	A	.	PASS	AF=0.172533;DESCR=Allele A is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele G.
chr4	70993476	rs80143932	C	A	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to cytarabine and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele C.
chr4	70993476	rs80143932	C	G	.	PASS	AF=0.0342742;DESCR=Allele G is associated with increased response to cytarabine and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele C.
chr4	70993476	rs80143932	C	T	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to cytarabine and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele C.
chr4	70993635	rs2306744	C	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to cytarabine and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele C.
chr4	70993635	rs2306744	C	G	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to cytarabine and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele C.
chr4	70993635	rs2306744	C	T	.	PASS	AF=0.0342742;DESCR=Allele T is associated with increased response to cytarabine and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele C.
chr4	70996957	rs3775289	T	C	.	PASS	AF=0.961694;DESCR=Genotype CC is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CT + TT.
chr4	71008028	rs12648166	A	G	.	PASS	AF=0.722190;DESCR=Allele A is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele G.
chr4	71028147	rs4694362	C	T	.	PASS	AF=0.735718;DESCR=Allele T is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele C.
chr4	71029543	rs4643786	C	T	.	PASS	AF=0.961694;DESCR=Genotypes CC + CT is associated with decreased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype TT.
chr4	71752617	rs7041	A	C	.	PASS	AF=0.595677;DESCR=Genotype AA is associated with increased response to deferasirox in people with beta-Thalassemia as compared to genotypes AC + CC.
chr4	73740307	rs4073	A	T	.	PASS	AF=0.597695;DESCR=Genotypes AA + AT are associated with decreased response to bevacizumab and cyclophosphamide in women with Ovarian Neoplasms as compared to genotype TT.
chr4	73998833	rs352046	G	A	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to hmg coa reductase inhibitors in people with Acute coronary syndrome as compared to genotypes CG + GG.
chr4	73998833	rs352046	G	C	.	PASS	AF=0.858007;DESCR=Genotype CC is associated with increased response to hmg coa reductase inhibitors in people with Acute coronary syndrome as compared to genotypes CG + GG.
chr4	73998833	rs352046	G	T	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to hmg coa reductase inhibitors in people with Acute coronary syndrome as compared to genotypes CG + GG.
chr4	74384109	rs7687621	T	C	.	PASS	AF=0.815668;DESCR=Genotype CC is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes CT + TT.
chr4	74386633	rs1017733	C	T	.	PASS	AF=0.815638;DESCR=Genotype TT is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes CC + CT.
chr4	74459587	rs2132065	A	T	.	PASS	AF=0.192952;DESCR=Genotype AA is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AT + TT.
chr4	74462391	rs11725706	G	A	.	PASS	AF=0.158790;DESCR=Genotype GG is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.
chr4	74463405	rs1353295	G	A	.	PASS	AF=0.554273;DESCR=Genotype GG is associated with increased response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.
chr4	74471142	rs3913032	A	C	.	PASS	AF=0.332468;DESCR=Genotype CC is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AC.
chr4	74521197	rs6447003	G	C	.	PASS	AF=0.581650;DESCR=Genotype CC is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes CG + GG.
chr4	74529595	rs13104811	G	A	.	PASS	AF=0.488459;DESCR=Genotype GG is associated with increased response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.
chr4	74554070	rs10034692	A	G	.	PASS	AF=0.264706;DESCR=Genotype GG is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.
chr4	74556244	rs9996584	A	G	.	PASS	AF=0.540392;DESCR=Genotype AA is associated with increased response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AG + GG.
chr4	74556361	rs11942466	C	A	.	PASS	AF=0.203458;DESCR=Genotype AA is associated with decreased response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AC + CC.
chr4	76023632	rs56061981	C	T	.	PASS	AF=0.0602305;DESCR=Genotypes CT + TT are associated with increased response to peginterferon alfa-2a or peginterferon alfa-2b in people with Hepatitis C, Chronic as compared to genotype CC.
chr4	78070036	rs4386623	G	A	.	PASS	AF=0.0224784;DESCR=Genotypes AA + AG is associated with increased dose of warfarin in people with heart valve replacement as compared to genotype GG.
chr4	80243569	rs1458038	C	T	.	PASS	AF=0.240623;DESCR=Allele C is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele T.
chr4	88040419	rs2725215	C	T	.	PASS	AF=0.0657439;DESCR=Allele T is associated with decreased response to allopurinol as compared to allele C.
chr4	88099782	rs4148157	G	A	.	PASS	AF=0.0596886;DESCR=Allele A is associated with decreased response to allopurinol as compared to allele G.
chr4	88104089	rs76979899	C	T	.	PASS	AF=0.0596198;DESCR=Allele T is associated with decreased response to allopurinol as compared to allele C.
chr4	88107326	rs2231148	T	A	.	PASS	AF=0.308756;DESCR=Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.
chr4	88107326	rs2231148	T	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.
chr4	88108100	rs2622628	A	C	.	PASS	AF=0.981257;DESCR=Genotype AA is not associated with increased concentrations of lamotrigine in people with Epilepsy as compared to genotype CC.
chr4	88108100	rs2622628	A	G	.	PASS	AF=0.00000;DESCR=Genotype AA is not associated with increased concentrations of lamotrigine in people with Epilepsy as compared to genotype CC.
chr4	88109689	rs12505410	T	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele T.
chr4	88109689	rs12505410	T	G	.	PASS	AF=0.304787;DESCR=Allele G is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele T.
chr4	88109768	rs2622621	C	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr4	88109768	rs2622621	C	G	.	PASS	AF=0.407857;DESCR=Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr4	88112375	rs13120400	T	C	.	PASS	AF=0.173687;DESCR=Genotypes CC + CT is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.
chr4	88117930	rs1481012	A	G	.	PASS	AF=0.0668203;DESCR=Genotypes AG + GG are associated with increased response to rosuvastatin as compared to genotype AA.
chr4	88122482	rs45499402	G	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased response to allopurinol.
chr4	88122482	rs45499402	G	C	.	PASS	AF=0.0668588;DESCR=Allele C is associated with decreased response to allopurinol.
chr4	88122482	rs45499402	G	T	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased response to allopurinol.
chr4	88124179	rs2199936	A	G	.	PASS	AF=0.923343;DESCR=Genotypes AA + AG are associated with increased response to rosuvastatin as compared to genotype GG.
chr4	88129846	rs2725256	A	G	.	PASS	AF=0.416907;DESCR=Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.
chr4	88131171	rs2231142	G	C	.	PASS	AF=0.00000;DESCR=Genotypes GT + TT are associated with increased exposure to rosuvastatin in people with Diabetes Mellitus and Hypercholesterolemia as compared to genotype GG.
chr4	88131171	rs2231142	G	T	.	PASS	AF=0.0668973;DESCR=Genotypes GT + TT are associated with increased exposure to rosuvastatin in people with Diabetes Mellitus and Hypercholesterolemia as compared to genotype GG.
chr4	88133515	rs4148155	A	G	.	PASS	AF=0.0668203;DESCR=Allele G is associated with decreased response to allopurinol as compared to allele A.
chr4	88134227	rs17731538	G	A	.	PASS	AF=0.208766;DESCR=Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele G.
chr4	88139962	rs2231137	C	T	.	PASS	AF=0.102247;DESCR=Allele C is not associated with clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.
chr4	88140113	rs1564481	C	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr4	88140113	rs1564481	C	T	.	PASS	AF=0.397636;DESCR=Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr4	88140758	rs2725252	C	A	.	PASS	AF=0.605886;DESCR=Genotypes AC + CC is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype AA.
chr4	88140758	rs2725252	C	T	.	PASS	AF=0.00000;DESCR=Genotypes AC + CC is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype AA.
chr4	88141361	rs13137622	G	T	.	PASS	AF=0.195677;DESCR=Genotypes GT + TT are associated with increased clearance of methotrexate in people with Osteosarcoma as compared to genotype GG.
chr4	88143429	rs3114018	A	C	.	PASS	AF=0.561060;DESCR=Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.
chr4	88143450	rs3109823	C	T	.	PASS	AF=0.843516;DESCR=Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.
chr4	88144923	rs6857600	C	T	.	PASS	AF=0.298327;DESCR=Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr4	88147303	rs17731799	G	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.
chr4	88147303	rs17731799	G	T	.	PASS	AF=0.493072;DESCR=Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.
chr4	88157772	rs2622604	T	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr4	88157772	rs2622604	T	C	.	PASS	AF=0.852823;DESCR=Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr4	88162514	rs3114020	T	C	.	PASS	AF=0.481257;DESCR=Genotypes CC + CT are associated with increased concentrations of lamotrigine in people with Epilepsy as compared to genotype TT.
chr4	88169725	rs10011796	T	C	.	PASS	AF=0.501155;DESCR=Allele T is not associated with decreased response to allopurinol in people with Gout as compared to allele C.
chr4	89500202	rs1908557	T	C	.	PASS	AF=0.167919;DESCR=Allele C is associated with decreased response to bupropion in people with Depression as compared to allele T.
chr4	93221348	rs1875705	G	A	.	PASS	AF=0.584150;DESCR=Genotype GG is associated with increased response to risperidone in people with as compared to genotypes AA + AG.
chr4	94435177	rs10008257	G	A	.	PASS	AF=0.503462;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.
chr4	94449654	rs2433320	G	A	.	PASS	AF=0.409562;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder.
chr4	94458590	rs2433322	A	G	.	PASS	AF=0.408252;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.
chr4	96767816	rs61692318	G	A	.	PASS	AF=0.185912;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr4	98680790	rs11947402	A	G	.	PASS	AF=0.0706052;DESCR=Allele G is associated with decreased concentrations of serotonin in people with Depressive Disorder as compared to allele A.
chr4	99273820	rs6811453	G	A	.	PASS	AF=0.461982;DESCR=Allele A is associated with increased resistance to cytarabine, fludarabine, gemtuzumab ozogamicin and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele G.
chr4	99280921	rs1229976	C	A	.	AS_VQSR	AF=0.00000;DESCR=Genotype CT is not associated with concentrations of ethanol in healthy individuals as compared to genotype TT.
chr4	99280921	rs1229976	C	T	.	PASS	AF=0.843804;DESCR=Genotype CT is not associated with concentrations of ethanol in healthy individuals as compared to genotype TT.
chr4	99282290	rs2276332	A	C	.	PASS	AF=0.0832373;DESCR=Allele C is associated with metabolism of ethanol.
chr4	99286421	rs1229967	G	C	.	PASS	AF=0.844002;DESCR=Allele C is associated with metabolism of ethanol.
chr4	99286421	rs1229967	G	T	.	PASS	AF=0.00000;DESCR=Allele C is associated with metabolism of ethanol.
chr4	99289690	rs931635	A	G	.	PASS	AF=0.844291;DESCR=Allele A is associated with metabolism of ethanol.
chr4	99296586	rs1826909	C	T	.	PASS	AF=0.452051;DESCR=Allele T is associated with increased resistance to cytarabine, fludarabine, gemtuzumab ozogamicin and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele C.
chr4	99307788	rs17033	T	C	.	PASS	AF=0.0846774;DESCR=Allele C is associated with metabolism of ethanol.
chr4	99307860	rs2066702	G	A	.	PASS	AF=0.00634371;DESCR=Allele A is associated with decreased response to naltrexone in men with Alcoholism as compared to allele G.
chr4	99311721	rs1229985	A	G	.	PASS	AF=0.0432028;DESCR=Allele G is associated with metabolism of ethanol.
chr4	99313983	rs2018417	C	A	.	PASS	AF=0.0115207;DESCR=Allele A is associated with metabolism of ethanol.
chr4	99313983	rs2018417	C	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with metabolism of ethanol.
chr4	99318162	rs1229984	T	C	.	PASS	AF=0.731279;DESCR=Genotypes CC + CT are not associated with concentrations of ethanol in healthy individuals as compared to genotype TT.
chr4	99318162	rs1229984	T	G	.	PASS	AF=0.00000;DESCR=Genotypes CC + CT are not associated with concentrations of ethanol in healthy individuals as compared to genotype TT.
chr4	99338684	rs1662060	T	C	.	PASS	AF=0.272174;DESCR=Allele C is associated with metabolism of ethanol.
chr4	99339632	rs698	T	C	.	PASS	AF=0.272177;DESCR=Allele C is associated with increased response to naltrexone in men with Alcoholism as compared to allele T.
chr4	99344800	rs283411	C	A	.	PASS	AF=0.0942363;DESCR=Allele A is associated with metabolism of ethanol.
chr4	99344800	rs283411	C	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with metabolism of ethanol.
chr4	99350199	rs283416	G	A	.	PASS	AF=0.0945245;DESCR=Allele A is associated with metabolism of ethanol.
chr4	99421745	rs1154461	C	G	.	PASS	AF=0.243080;DESCR=Allele C is associated with metabolism of ethanol.
chr4	99421745	rs1154461	C	T	.	PASS	AF=0.00000;DESCR=Allele C is associated with metabolism of ethanol.
chr4	99574331	rs1800591	G	A	.	PASS	AF=0.00000;DESCR=Genotypes GT + TT are associated with response to pravastatin in men.
chr4	99574331	rs1800591	G	T	.	PASS	AF=0.398618;DESCR=Genotypes GT + TT are associated with response to pravastatin in men.
chr4	101195926	rs3730251	C	T	.	PASS	AF=0.00144259;DESCR=Genotypes CT + TT are not associated with response to tacrolimus in people with Kidney Transplantation as compared to genotype CC.
chr4	102503036	rs3774932	A	G	.	PASS	AF=0.512968;DESCR=Allele G is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele A.
chr4	102560404	rs230504	T	C	.	PASS	AF=0.676386;DESCR=Genotypes CT + TT is associated with increased response to flupenthixol in people with Schizophrenia as compared to genotype CC.
chr4	102565059	rs230493	A	T	.	PASS	AF=0.675691;DESCR=Genotype AT is associated with increased response to flupenthixol in people with Schizophrenia as compared to genotype TT.
chr4	102589957	rs3774959	G	A	.	PASS	AF=0.327765;DESCR=Genotype AG is associated with increased response to flupenthixol in people with Schizophrenia as compared to genotype GG.
chr4	105192914	rs12505746	A	G	.	PASS	AF=0.111751;DESCR=Allele A is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele G.
chr4	105192914	rs12505746	A	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele G.
chr4	105376356	rs2636697	G	A	.	PASS	AF=0.970334;DESCR=Allele G is associated with decreased response to risperidone in people with Schizophrenia as compared to allele A.
chr4	105432212	rs2636719	A	C	.	PASS	AF=0.970334;DESCR=Allele A is associated with decreased response to risperidone in people with Schizophrenia as compared to allele C.
chr4	106752691	rs1364805	T	G	.	PASS	AF=0.622113;DESCR=Allele T is associated with increased response to montelukast in people with Asthma as compared to allele G.
chr4	109737911	rs10033900	T	C	.	PASS	AF=0.509798;DESCR=Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.
chr4	109912954	rs4444903	A	G	.	PASS	AF=0.472350;DESCR=Allele G is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to allele A.
chr4	109962188	rs929446	C	G	.	PASS	AF=0.00000;DESCR=Genotype CC is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes CT + TT.
chr4	109962188	rs929446	C	T	.	PASS	AF=0.484717;DESCR=Genotype CC is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes CT + TT.
chr4	109967851	rs11568972	A	C	.	PASS	AF=0.372334;DESCR=Genotype AA is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AC + CC.
chr4	109967851	rs11568972	A	T	.	PASS	AF=0.00000;DESCR=Genotype AA is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AC + CC.
chr4	109976159	rs11568993	C	T	.	PASS	AF=0.134217;DESCR=Genotype CC is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotype CT.
chr4	109988860	rs2074390	G	A	.	PASS	AF=0.462248;DESCR=Genotype GG is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.
chr4	109989859	rs6850557	G	A	.	PASS	AF=0.340346;DESCR=Genotype GG is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.
chr4	109989859	rs6850557	G	C	.	PASS	AF=0.00000;DESCR=Genotype GG is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.
chr4	109993271	rs4698803	A	T	.	PASS	AF=0.857925;DESCR=Genotype TT is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AT.
chr4	110006407	rs6533485	G	A	.	PASS	AF=0.00000;DESCR=Genotype GG is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes CC + CG.
chr4	110006407	rs6533485	G	C	.	PASS	AF=0.537752;DESCR=Genotype GG is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes CC + CG.
chr4	119320747	rs1799883	T	C	.	PASS	AF=0.729683;DESCR=Genotype TT is not associated with increased dose of valproic acid in people with Epilepsy as compared to genotypes CC + CT.
chr4	122456825	rs2069762	A	C	.	PASS	AF=0.430179;DESCR=Genotype AA is associated with increased dose of opioids in people with Pain and Neoplasms as compared to genotypes AC + CC.
chr4	122588266	rs6822844	G	C	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.
chr4	122588266	rs6822844	G	T	.	PASS	AF=0.0892857;DESCR=Allele G is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.
chr4	122825787	rs308395	C	A	.	PASS	AF=0.00000;DESCR=Genotypes CG + GG is associated with decreased response to lenalidomide or thalidomide in people with Multiple Myeloma as compared to genotype CC.
chr4	122825787	rs308395	C	G	.	PASS	AF=0.215726;DESCR=Genotypes CG + GG is associated with decreased response to lenalidomide or thalidomide in people with Multiple Myeloma as compared to genotype CC.
chr4	122826931	rs1449683	C	T	.	PASS	AF=0.0674352;DESCR=Genotypes CC + CT are associated with decreased response to fluvoxamine in people with Depressive Disorder as compared to genotype TT.
chr4	122861413	rs1960669	C	A	.	PASS	AF=0.0639769;DESCR=Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele C.
chr4	126294163	rs17010902	A	G	.	PASS	AF=0.0783237;DESCR=Allele A is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.
chr4	128287104	rs3733260	G	T	.	PASS	AF=0.188364;DESCR=Genotype TT is not associated with decreased concentrations of 2-hydroxyatorvastatin in healthy individuals as compared to genotypes GG + GT.
chr4	129244309	rs10007051	C	T	.	PASS	AF=0.311995;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr4	129249427	rs11933890	A	G	.	PASS	AF=0.312104;DESCR=Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr4	129253015	rs62319299	A	C	.	PASS	AF=0.312284;DESCR=Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr4	129255324	rs56229625	G	T	.	PASS	AF=0.311816;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr4	129255325	rs55881666	C	T	.	PASS	AF=0.311816;DESCR=Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr4	140101163	rs11100483	G	A	.	PASS	AF=0.196655;DESCR=Allele A is associated with response to perphenazine in people with Schizophrenia.
chr4	147539885	rs5333	T	C	.	PASS	AF=0.298847;DESCR=Genotypes CC + CT is associated with increased resistance to prednisone in children with Nephrotic Syndrome as compared to genotype TT.
chr4	148436323	rs5522	C	T	.	PASS	AF=0.891354;DESCR=Genotype TT is associated with increased response to enalapril in people with Hypertension as compared to genotypes CC + CT.
chr4	148437220	rs2070950	G	C	.	PASS	AF=0.400519;DESCR=Genotype CC is not associated with increased response to enalapril in people with Hypertension as compared to genotypes CG + GG.
chr4	153685974	rs4696480	T	A	.	PASS	AF=0.426555;DESCR=Genotype TT is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotypes AA + AT.
chr4	153688371	rs1816702	T	C	.	PASS	AF=0.832277;DESCR=Genotypes CT + TT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease as compared to genotype CC.
chr4	153700794	rs11938228	C	A	.	PASS	AF=0.399191;DESCR=Genotypes AA + AC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative or Inflammatory Bowel Diseases as compared to genotype CC.
chr4	153700794	rs11938228	C	T	.	PASS	AF=0.00000;DESCR=Genotypes AA + AC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative or Inflammatory Bowel Diseases as compared to genotype CC.
chr4	153703504	rs3804099	T	C	.	PASS	AF=0.444060;DESCR=Genotypes CC + CT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammatory Bowel Diseases as compared to genotype TT.
chr4	153704257	rs3804100	T	C	.	PASS	AF=0.0645905;DESCR=Genotypes CC + CT are associated with decreased dose of morphine in women with Pain, Postoperative as compared to genotype TT.
chr4	157133262	rs17035723	C	T	.	PASS	AF=0.159827;DESCR=Allele T is not associated with response to acamprosate in people with Alcoholism as compared to allele C.
chr4	158680524	rs11559290	C	T	.	PASS	AF=0.876728;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr4	161386160	rs3749598	C	A	.	PASS	AF=0.0631488;DESCR=Genotypes AA + AC is associated with increased concentrations of methotrexate polyglutamate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.
chr4	161386160	rs3749598	C	T	.	PASS	AF=0.00000;DESCR=Genotypes AA + AC is associated with increased concentrations of methotrexate polyglutamate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.
chr4	173328442	rs6832850	A	T	.	PASS	AF=0.602364;DESCR=Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T.
chr4	173336542	rs7686909	T	C	.	PASS	AF=0.0368664;DESCR=Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T.
chr4	176627447	rs1002976	C	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased concentrations of uric acid in people with Hypertension as compared to allele T.
chr4	176627447	rs1002976	C	T	.	PASS	AF=0.334389;DESCR=Allele C is associated with increased concentrations of uric acid in people with Hypertension as compared to allele T.
chr4	176687553	rs7664413	C	T	.	PASS	AF=0.183208;DESCR=Genotypes CT + TT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype CC.
chr4	180916588	rs6848893	C	G	.	AC0	AF=0.00000;DESCR=Genotype CT is not associated with response to oxycodone as compared to genotype TT.
chr4	180916588	rs6848893	C	T	.	PASS	AF=0.975793;DESCR=Genotype CT is not associated with response to oxycodone as compared to genotype TT.
chr4	182892272	rs12507552	C	T	.	PASS	AF=0.0987903;DESCR=Genotype CC is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.
chr4	182894535	rs4742	A	G	.	PASS	AF=0.224078;DESCR=Genotype AA is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG.
chr4	184649399	rs113420705	T	C	.	PASS	AF=0.335352;DESCR=Genotypes CT + TT are associated with decreased response to Immunoglobulins in children with Mucocutaneous Lymph Node Syndrome as compared to genotype CC.
chr4	186082920	rs3775291	C	G	.	PASS	AF=0.00000;DESCR=Genotype CT is associated with decreased response to Measles vaccines as compared to genotype CC.
chr4	186082920	rs3775291	C	T	.	PASS	AF=0.248560;DESCR=Genotype CT is associated with decreased response to Measles vaccines as compared to genotype CC.
chr4	186264957	rs3756009	A	G	.	PASS	AF=0.363899;DESCR=Allele G is not associated with dose of warfarin in people with heart valve replacement as compared to allele A.
chr4	186595501	rs2306987	T	A	.	PASS	AF=0.424452;DESCR=Allele A is not associated with response to aripiprazole in people with Schizophrenia as compared to allele T.
chr4	186595501	rs2306987	T	G	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to aripiprazole in people with Schizophrenia as compared to allele T.
chr4	186597822	rs2306990	C	T	.	PASS	AF=0.389209;DESCR=Allele C is not associated with response to aripiprazole in people with Schizophrenia as compared to allele T.
chr4	186603866	rs2637777	A	C	.	PASS	AF=0.455882;DESCR=Allele A is not associated with response to aripiprazole in people with Schizophrenia as compared to allele C.
chr4	186603866	rs2637777	A	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to aripiprazole in people with Schizophrenia as compared to allele C.
chr4	186604209	rs2304865	C	G	.	PASS	AF=0.382200;DESCR=Allele C is not associated with response to aripiprazole in people with Schizophrenia as compared to allele G.
chr5	609978	rs924607	C	T	.	PASS	AF=0.363977;DESCR=Genotype TT is associated with increased concentrations of methotrexate polyglutamate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes CC + CT.
chr5	1392596	rs3863145	G	A	.	PASS	AF=0.399482;DESCR=Genotype GG is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to genotypes AA + AG.
chr5	1392596	rs3863145	G	C	.	PASS	AF=0.00000;DESCR=Genotype GG is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to genotypes AA + AG.
chr5	1392606	rs10064525	T	G	.	PASS	AF=0.0493080;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr5	1394407	rs27072	C	T	.	PASS	AF=0.157728;DESCR=Allele T is not associated with response to heroin as compared to allele C.
chr5	1394700	rs1042098	A	G	.	PASS	AF=0.413833;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr5	1411297	rs6347	T	C	.	PASS	AF=0.213379;DESCR=Genotype TT is not associated with decreased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CC + CT.
chr5	1432710	rs460000	G	T	.	PASS	AF=0.281304;DESCR=Genotype GG is associated with increased response to amphetamine in healthy individuals as compared to genotypes GT + TT.
chr5	1445501	rs2975226	A	T	.	PASS	AF=0.599826;DESCR=Allele A is associated with increased response to clozapine in people with Schizophrenia as compared to allele T.
chr5	1446274	rs2652511	A	G	.	PASS	AF=0.601269;DESCR=Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.
chr5	1447647	rs11564750	G	C	.	PASS	AF=0.0241935;DESCR=Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.
chr5	1447726	rs2550956	G	A	.	PASS	AF=0.155331;DESCR=Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.
chr5	1447745	rs2652510	C	T	.	PASS	AF=0.592166;DESCR=Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.
chr5	1450329	rs2550948	C	T	.	PASS	AF=0.593084;DESCR=Genotypes CC + CT are associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype TT.
chr5	1461274	rs2292023	C	A	.	PASS	AF=0.128604;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.
chr5	1461274	rs2292023	C	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.
chr5	6720954	rs274717	A	G	.	PASS	AF=0.291570;DESCR=Genotypes AG + GG are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype AA.
chr5	6723447	rs274713	T	C	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes GT + TT.
chr5	6723447	rs274713	T	G	.	PASS	AF=0.687356;DESCR=Genotype GG is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes GT + TT.
chr5	6834054	rs11134178	T	C	.	PASS	AF=0.0576369;DESCR=Allele T is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.
chr5	7634119	rs1544938	G	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased response to antipsychotics in people with Schizophrenia as compared to allele G.
chr5	7634119	rs1544938	G	C	.	PASS	AF=0.276976;DESCR=Allele C is associated with increased response to antipsychotics in people with Schizophrenia as compared to allele G.
chr5	7634119	rs1544938	G	T	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased response to antipsychotics in people with Schizophrenia as compared to allele G.
chr5	7802250	rs2290910	C	T	.	PASS	AF=0.249135;DESCR=Genotypes CC + CT is associated with decreased response to lithium in people with Bipolar Disorder as compared to genotype TT.
chr5	7870860	rs1801394	A	G	.	PASS	AF=0.456196;DESCR=Allele A is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.
chr5	7878066	rs1532268	C	T	.	PASS	AF=0.369364;DESCR=Genotypes CT + TT is associated with increased exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.
chr5	7887365	rs162040	C	A	.	PASS	AF=0.868012;DESCR=Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.
chr5	12968229	rs35661809	A	G	.	PASS	AF=0.371313;DESCR=Allele G is associated with increased response to salbutamol in children with as compared to allele A.
chr5	12978454	rs17834628	G	A	.	PASS	AF=0.370670;DESCR=Allele A is associated with increased response to salbutamol in children with as compared to allele G.
chr5	32278127	rs73069924	A	G	.	PASS	AF=0.0241935;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr5	35874473	rs6897932	C	T	.	PASS	AF=0.231968;DESCR=Allele T is not associated with decreased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele C.
chr5	36689261	rs1529461	A	G	.	PASS	AF=0.755472;DESCR=Genotypes AA + AG is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotype GG.
chr5	37818037	rs2973049	T	C	.	PASS	AF=0.661671;DESCR=Genotypes CT + TT is associated with decreased response to paroxetine in people with Depressive Disorder, Major as compared to genotype CC.
chr5	37828742	rs2216711	G	A	.	PASS	AF=0.767857;DESCR=Genotypes AA + AG is associated with decreased response to paroxetine in women with Depressive Disorder, Major as compared to genotype GG.
chr5	38870806	rs74378198	A	G	.	PASS	AF=0.0322767;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr5	39030605	rs6878291	G	A	.	PASS	AF=0.440600;DESCR=Genotype GG is associated with decreased response to platinum in people with Carcinoma, Non-Small-Cell Lung as compared to genotype AA.
chr5	39045240	rs7703002	A	C	.	PASS	AF=0.970622;DESCR=Genotype AA is associated with decreased response to platinum in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.
chr5	39048733	rs7719775	A	G	.	PASS	AF=0.665323;DESCR=Genotype AA is associated with decreased response to platinum in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.
chr5	40393503	rs10512734	A	G	.	PASS	AF=0.288439;DESCR=Genotype GG is associated with increased response to adalimumab in people with Crohn Disease as compared to genotypes AA + AG.
chr5	40745644	rs11749180	C	A	.	PASS	AF=0.0795848;DESCR=Allele A is associated with decreased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr5	40782137	rs249429	C	T	.	PASS	AF=0.657439;DESCR=Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.
chr5	41142504	rs9200	C	A	.	PASS	AF=0.00000;DESCR=Genotypes CC + CT are associated with decreased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotype TT.
chr5	41142504	rs9200	C	T	.	PASS	AF=0.613191;DESCR=Genotypes CC + CT are associated with decreased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotype TT.
chr5	41158387	rs3805715	A	G	.	PASS	AF=0.0983843;DESCR=Genotype AA is not associated with dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AG + GG.
chr5	41158470	rs6865420	A	C	.	PASS	AF=0.891705;DESCR=Genotype AC is not associated with dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AA + CC.
chr5	41161387	rs3805716	A	G	.	PASS	AF=0.00000;DESCR=Genotype AA is not associated with dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AT + TT.
chr5	41161387	rs3805716	A	T	.	PASS	AF=0.276688;DESCR=Genotype AA is not associated with dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AT + TT.
chr5	41165642	rs10052999	C	T	.	PASS	AF=0.0506912;DESCR=Genotypes CC + TT are associated with decreased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotype CT.
chr5	41198966	rs7443562	A	G	.	PASS	AF=0.592037;DESCR=Genotype AA is not associated with dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AG + GG.
chr5	42194757	rs16872401	T	C	.	PASS	AF=0.445565;DESCR=Allele C is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to allele T.
chr5	43969952	rs62368105	A	G	.	PASS	AF=0.0948127;DESCR=Allele G is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.
chr5	43969952	rs62368105	A	T	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.
chr5	56900777	rs96844	G	A	.	PASS	AF=0.761095;DESCR=Genotypes AG + GG are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype AA.
chr5	59591047	rs295943	T	C	.	PASS	AF=0.908122;DESCR=Allele T is associated with decreased clinical benefit to apremilast in people with Psoriasis as compared to allele C.
chr5	59684120	rs17382202	C	T	.	PASS	AF=0.0829971;DESCR=Allele T is associated with increased response to quetiapine in people with Schizophrenia as compared to allele C.
chr5	59703216	rs17742120	A	G	.	PASS	AF=0.0830450;DESCR=Allele G is associated with increased response to quetiapine in people with Schizophrenia as compared to allele A.
chr5	59715681	rs2164660	G	A	.	PASS	AF=0.0829493;DESCR=Allele A is associated with increased response to quetiapine in people with Schizophrenia as compared to allele G.
chr5	63955024	rs1364043	T	G	.	PASS	AF=0.285138;DESCR=Genotype TT is associated with increased response to fluvoxamine, milnacipran and paroxetine in people with Depressive Disorder, Major as compared to genotypes GG + GT.
chr5	63955835	rs1423691	T	C	.	PASS	AF=0.535159;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr5	63960164	rs878567	A	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr5	63960164	rs878567	A	G	.	PASS	AF=0.535138;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr5	63962738	rs6295	C	G	.	PASS	AF=0.530854;DESCR=Genotype GG is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CC + CG.
chr5	63965502	rs10042486	C	T	.	PASS	AF=0.534602;DESCR=Genotype TT is associated with increased concentrations of quetiapine in men with Schizophrenia as compared to genotype CT.
chr5	73621913	rs929740	G	A	.	PASS	AF=0.453053;DESCR=Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr5	75319196	rs17671591	C	T	.	PASS	AF=0.473775;DESCR=Genotypes CT + TT is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to genotype CC.
chr5	75347030	rs17244841	A	T	.	PASS	AF=0.0472350;DESCR=Allele A is not associated with response to fluvastatin in people with renal transplantation as compared to allele T.
chr5	75355259	rs3846662	A	G	.	PASS	AF=0.515265;DESCR=Genotype AA is associated with decreased response to hmg coa reductase inhibitors in women with familial hypercholesterolemia as compared to allele G.
chr5	75359673	rs17238540	T	G	.	PASS	AF=0.0354671;DESCR=Allele T is not associated with response to fluvastatin in people with renal transplantation as compared to allele G.
chr5	75998585	rs10214163	C	A	.	PASS	AF=0.00000;DESCR=Genotype TT is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes CC + CT.
chr5	75998585	rs10214163	C	T	.	PASS	AF=0.804147;DESCR=Genotype TT is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes CC + CT.
chr5	76104642	rs2134227	C	G	.	PASS	AF=0.699250;DESCR=Genotype GG is not associated with response to quetiapine in people with Schizophrenia as compared to genotypes CC + CG.
chr5	76133778	rs2112865	A	G	.	PASS	AF=0.0986159;DESCR=Genotype AA is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes AG + GG.
chr5	76135874	rs12522597	G	A	.	PASS	AF=0.582804;DESCR=Genotype GG is not associated with response to ziprasidone in people with Schizophrenia as compared to genotypes AA + AG.
chr5	76144530	rs4580760	A	C	.	PASS	AF=0.886233;DESCR=Genotype CC is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes AA + AC.
chr5	76144530	rs4580760	A	T	.	AC0	AF=0.00000;DESCR=Genotype CC is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes AA + AC.
chr5	76181838	rs7732173	A	G	.	PASS	AF=0.822664;DESCR=Genotype AA is not associated with response to risperidone in people with Schizophrenia as compared to genotypes AG + GG.
chr5	76182391	rs10514062	T	A	.	PASS	AF=0.821696;DESCR=Genotype TT is not associated with response to risperidone in people with Schizophrenia as compared to genotypes AA + AT.
chr5	76182391	rs10514062	T	C	.	AC0	AF=0.00000;DESCR=Genotype TT is not associated with response to risperidone in people with Schizophrenia as compared to genotypes AA + AT.
chr5	76183961	rs2358531	G	A	.	PASS	AF=0.821614;DESCR=Genotype GG is not associated with response to risperidone in people with Schizophrenia as compared to genotypes AA + AG.
chr5	76196877	rs12655684	C	T	.	PASS	AF=0.174827;DESCR=Genotype CC is not associated with response to ziprasidone in people with Schizophrenia as compared to genotypes CT + TT.
chr5	76216832	rs1995380	G	C	.	PASS	AF=0.224078;DESCR=Genotype GG is not associated with response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.
chr5	76219161	rs11960832	C	T	.	PASS	AF=0.289914;DESCR=Genotype TT is associated with decreased response to olanzapine in people with Schizophrenia as compared to genotypes CC + CT.
chr5	76268005	rs6882321	A	C	.	PASS	AF=0.191354;DESCR=Genotype AA is not associated with response to risperidone in people with Schizophrenia as compared to genotypes AC + CC.
chr5	76274833	rs1995381	A	G	.	PASS	AF=0.104263;DESCR=Genotype AA is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes AG + GG.
chr5	76274833	rs1995381	A	T	.	PASS	AF=0.00000;DESCR=Genotype AA is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes AG + GG.
chr5	76279030	rs6874435	A	G	.	PASS	AF=0.231968;DESCR=Genotype AA is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes AG + GG.
chr5	76295885	rs2270927	C	A	.	PASS	AF=0.00000;DESCR=Genotype CC is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes CG + GG.
chr5	76295885	rs2270927	C	G	.	PASS	AF=0.209965;DESCR=Genotype CC is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes CG + GG.
chr5	76295885	rs2270927	C	T	.	PASS	AF=0.00000;DESCR=Genotype CC is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes CG + GG.
chr5	76298918	rs31244	G	A	.	PASS	AF=0.104611;DESCR=Genotype GG is not associated with response to quetiapine in people with Schizophrenia as compared to genotypes AA + AG.
chr5	80619201	rs1232027	G	A	.	PASS	AF=0.327855;DESCR=Allele A is associated with increased response to methotrexate in people with Arthritis, Psoriatic as compared to allele G.
chr5	80628972	rs7387	T	A	.	PASS	AF=0.290778;DESCR=Allele A is associated with response to methotrexate in people with Arthritis, Rheumatoid.
chr5	80644324	rs1643650	T	C	.	PASS	AF=0.290899;DESCR=Genotypes CC + CT is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype TT.
chr5	80654962	rs1650697	A	G	.	PASS	AF=0.750577;DESCR=Allele G is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.
chr5	80655314	rs408626	T	C	.	PASS	AF=0.420992;DESCR=Allele C is associated with decreased clinical benefit to methotrexate in people with Crohn Disease as compared to allele T.
chr5	80746456	rs863221	T	G	.	PASS	AF=0.332277;DESCR=Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele T.
chr5	80873118	rs26279	G	A	.	PASS	AF=0.687716;DESCR=Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele A.
chr5	83076846	rs2075685	G	T	.	PASS	AF=0.400000;DESCR=Allele T is associated with decreased response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr5	83081185	rs1478486	G	A	.	PASS	AF=0.353230;DESCR=Allele A is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr5	83177826	rs10040363	A	G	.	PASS	AF=0.392445;DESCR=Allele G is associated with decreased response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele A.
chr5	84941243	rs12518285	C	T	.	PASS	AF=0.243368;DESCR=Allele T is not associated with trough concentration of vancomycin as compared to allele C.
chr5	84944559	rs10085144	A	G	.	PASS	AF=0.242503;DESCR=Allele G is not associated with trough concentration of vancomycin as compared to allele A.
chr5	84944559	rs10085144	A	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with trough concentration of vancomycin as compared to allele A.
chr5	84945793	rs10070381	T	C	.	PASS	AF=0.215522;DESCR=Allele C is not associated with trough concentration of vancomycin as compared to allele T.
chr5	84953148	rs9293392	C	T	.	PASS	AF=0.215811;DESCR=Allele T is not associated with trough concentration of vancomycin as compared to allele C.
chr5	84953973	rs62360865	G	A	.	PASS	AF=0.215975;DESCR=Allele A is not associated with trough concentration of vancomycin as compared to allele G.
chr5	87651774	rs3919583	C	A	.	PASS	AF=0.0400346;DESCR=Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.
chr5	88619764	rs324899	A	G	.	PASS	AF=0.988767;DESCR=Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr5	95466585	rs12657120	G	A	.	PASS	AF=0.00000;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr5	95466585	rs12657120	G	C	.	PASS	AF=0.345643;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr5	95481198	rs4639250	C	G	.	PASS	AF=0.345732;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr5	96766240	rs27524	A	G	.	PASS	AF=0.563076;DESCR=Genotype AA is not associated with response to adalimumab in people with Psoriasis as compared to genotype GG.
chr5	108251082	rs7706429	A	G	.	PASS	AF=0.671569;DESCR=Allele G is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele A.
chr5	108253257	rs4431329	A	T	.	PASS	AF=0.671379;DESCR=Allele T is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele A.
chr5	112865397	rs495794	A	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele A.
chr5	112865397	rs495794	A	G	.	PASS	AF=0.601094;DESCR=Allele G is associated with increased response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele A.
chr5	112900600	rs153549	A	G	.	PASS	AF=0.525967;DESCR=Allele A is associated with increased response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.
chr5	112918680	rs153560	G	A	.	PASS	AF=0.667435;DESCR=Allele G is associated with increased response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele A.
chr5	112918680	rs153560	G	T	.	PASS	AF=0.00172911;DESCR=Allele G is associated with increased response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele A.
chr5	125363546	rs6889896	G	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr5	125363546	rs6889896	G	C	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr5	125363546	rs6889896	G	T	.	PASS	AF=0.582804;DESCR=Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr5	131110726	rs7728773	C	T	.	PASS	AF=0.186167;DESCR=Genotypes CT + TT is associated with increased clinical benefit to daclatasvir null sofosbuvir in people with Hepatitis C, Chronic as compared to genotype CC.
chr5	131160322	rs3852209	C	T	.	PASS	AF=0.162341;DESCR=Genotypes CT + TT are associated with increased response to nicotine in people with Tobacco Use Disorder as compared to genotype CC.
chr5	131161735	rs3864283	T	C	.	PASS	AF=0.275504;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr5	131165058	rs2278060	A	C	.	PASS	AF=0.275982;DESCR=Genotypes AC + CC are not associated with response to nicotine in people with Tobacco Use Disorder as compared to genotype AA.
chr5	131165149	rs4696	A	G	.	PASS	AF=0.0881844;DESCR=Genotype AA is not associated with increased clinical benefit to daclatasvir null sofosbuvir in people with Hepatitis C, Chronic as compared to genotypes AG + GG.
chr5	132059422	rs181781	G	A	.	PASS	AF=0.139401;DESCR=Genotype AA is associated with increased exposure to tacrolimus in people with Kidney Transplantation as compared to genotypes AG + GG.
chr5	132094425	rs657075	G	A	.	PASS	AF=0.131776;DESCR=Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.
chr5	132327369	rs272893	T	C	.	PASS	AF=0.590490;DESCR=Allele T is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr5	132327369	rs272893	T	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr5	132340627	rs1050152	C	T	.	PASS	AF=0.395389;DESCR=Genotype CC is not associated with clearance of busulfan in children with Transplantation as compared to genotype TT.
chr5	132367886	rs2631372	G	C	.	PASS	AF=0.307205;DESCR=Genotypes CG + GG are associated with increased response to imatinib in people with Gastrointestinal Stromal Tumors as compared to genotype CC.
chr5	132368084	rs2631370	T	A	.	AC0	AF=0.00000;DESCR=Allele C is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele T.
chr5	132368084	rs2631370	T	C	.	PASS	AF=0.415802;DESCR=Allele C is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele T.
chr5	132369766	rs2631367	C	G	.	PASS	AF=0.494240;DESCR=Genotypes CG + GG are associated with increased response to imatinib in people with Gastrointestinal Stromal Tumors as compared to genotype CC.
chr5	132448701	rs12521868	G	T	.	PASS	AF=0.391869;DESCR=Allele G is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele T.
chr5	132544224	rs2069812	A	G	.	PASS	AF=0.648789;DESCR=Genotypes AA + AG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotype GG.
chr5	132567707	rs2299014	A	C	.	PASS	AF=0.402882;DESCR=Genotypes AA + AC is associated with increased resistance to cytarabine and daunorubicin in people with Leukemia, Myeloid, Acute as compared to genotype CC.
chr5	132660151	rs1295686	T	C	.	PASS	AF=0.731391;DESCR=Allele T is associated with decreased response to Hepatitis vaccines as compared to allele C.
chr5	132660808	rs848	A	C	.	PASS	AF=0.748127;DESCR=Genotypes AA + AC is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotype CC.
chr5	135892476	rs2069885	G	A	.	PASS	AF=0.157728;DESCR=Genotypes AA + AG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotype GG.
chr5	135964588	rs2107506	C	G	.	PASS	AF=0.497695;DESCR=Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.
chr5	140118020	rs2013169	T	A	.	PASS	AF=0.206628;DESCR=Allele T is associated with decreased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr5	140633331	rs2569190	A	G	.	PASS	AF=0.528547;DESCR=Genotypes AA + AG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotype GG.
chr5	140633331	rs2569190	A	T	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotype GG.
chr5	141152584	rs17844444	G	A	.	PASS	AF=0.175115;DESCR=Allele A is associated with decreased clinical benefit to verapamil in people with Migraine NOS as compared to allele G.
chr5	141178947	rs3733694	A	G	.	PASS	AF=0.165581;DESCR=Allele G is associated with decreased clinical benefit to verapamil in people with Migraine NOS as compared to allele A.
chr5	143277248	rs258747	A	G	.	PASS	AF=0.475490;DESCR=Genotype AA is not associated with decreased concentrations of 2-hydroxyatorvastatin in healthy individuals as compared to genotypes AG + GG.
chr5	143278056	rs6198	T	C	.	PASS	AF=0.230548;DESCR=Genotype CC is associated with increased time to response to dexamethasone in people with COVID-19 as compared to genotypes CT + TT.
chr5	143281925	rs6196	A	G	.	PASS	AF=0.0654556;DESCR=Allele G is associated with decreased resistance to prednisone in people with Nephrotic Syndrome as compared to allele A.
chr5	143282715	rs258751	G	A	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased resistance to prednisone in people with Nephrotic Syndrome as compared to allele G.
chr5	143317730	rs33388	A	T	.	PASS	AF=0.525375;DESCR=Genotype AA is associated with increased time to response to dexamethasone in people with COVID-19 as compared to genotypes AT + TT.
chr5	143320934	rs33389	C	G	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with increased time to response to dexamethasone in people with COVID-19 as compared to genotypes CC + CT.
chr5	143320934	rs33389	C	T	.	PASS	AF=0.0622837;DESCR=Genotype TT is associated with increased time to response to dexamethasone in people with COVID-19 as compared to genotypes CC + CT.
chr5	143399010	rs41423247	G	C	.	PASS	AF=0.243952;DESCR=Genotype GG is associated with decreased clinical benefit to antiepileptics in children with Epilepsy as compared to genotypes CC + CG.
chr5	143407136	rs10052957	G	A	.	PASS	AF=0.293710;DESCR=Allele A is associated with decreased resistance to prednisone in people with Nephrotic Syndrome as compared to allele G.
chr5	148120328	rs2303070	G	A	.	AC0	AF=0.00000;DESCR=Allele T is associated with increased response to glibenclamide in people with as compared to allele G.
chr5	148120328	rs2303070	G	C	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to glibenclamide in people with as compared to allele G.
chr5	148120328	rs2303070	G	T	.	PASS	AF=0.183103;DESCR=Allele T is associated with increased response to glibenclamide in people with as compared to allele G.
chr5	148166889	rs9285669	T	A	.	PASS	AF=0.631412;DESCR=Allele A is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele T.
chr5	148452493	rs1971431	C	A	.	PASS	AF=0.00000;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr5	148452493	rs1971431	C	T	.	PASS	AF=0.218606;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr5	148494993	rs4264931	G	A	.	PASS	AF=0.306181;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr5	148627450	rs2068190	G	A	.	PASS	AF=0.449597;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr5	148650501	rs1862342	C	T	.	PASS	AF=0.453837;DESCR=Allele T is not associated with dose of opioids in people with Pain as compared to allele C.
chr5	148825809	rs2053044	A	C	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG is associated with increased response to ramipril in people with Hypertension as compared to genotype GG.
chr5	148825809	rs2053044	A	G	.	PASS	AF=0.615340;DESCR=Genotypes AA + AG is associated with increased response to ramipril in people with Hypertension as compared to genotype GG.
chr5	148825809	rs2053044	A	T	.	AC0	AF=0.00000;DESCR=Genotypes AA + AG is associated with increased response to ramipril in people with Hypertension as compared to genotype GG.
chr5	148826785	rs1042711	C	T	.	PASS	AF=0.627304;DESCR=Allele T is not associated with response to atenolol in people with Essential hypertension.
chr5	148826877	rs1042713	G	A	.	PASS	AF=0.429971;DESCR=Allele G is not associated with response to hydrochlorothiazide in people with Essential hypertension as compared to allele A.
chr5	148826910	rs1042714	G	C	.	PASS	AF=0.628456;DESCR=Genotype CC is associated with increased response to atenolol or metoprolol in people with Tachycardia as compared to genotypes CG + GG.
chr5	148827354	rs1042718	C	A	.	PASS	AF=0.153314;DESCR=Genotype AC is associated with increased response to fentanyl in healthy individuals as compared to genotype CC.
chr5	148827354	rs1042718	C	T	.	AS_VQSR	AF=0.00000;DESCR=Genotype AC is associated with increased response to fentanyl in healthy individuals as compared to genotype CC.
chr5	148827884	rs1042719	G	C	.	PASS	AF=0.276848;DESCR=Genotype CC is not associated with dose of ephedrine or phenylephrine in people with Hypotension as compared to genotype GG.
chr5	148848933	rs11959113	G	A	.	PASS	AF=0.198962;DESCR=Genotype AA is associated with increased dose of fentanyl in people with Pain, Postoperative as compared to genotypes AG + GG.
chr5	149280101	rs1438692	G	A	.	PASS	AF=0.292964;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr5	149723081	rs73277969	G	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased discontinuation of infliximab in people with Crohn Disease as compared to allele G.
chr5	149723081	rs73277969	G	T	.	PASS	AF=0.124279;DESCR=Allele T is associated with increased discontinuation of infliximab in people with Crohn Disease as compared to allele G.
chr5	153488877	rs548294	T	C	.	PASS	AF=0.568667;DESCR=Allele C is not associated with response to almotriptan, eletriptan, frovatriptan, rizatriptan, sumatriptan or zolmitriptan in people with Migraine without Aura as compared to allele T.
chr5	153491449	rs2195450	G	A	.	PASS	AF=0.254755;DESCR=Allele A is not associated with response to almotriptan, eletriptan, frovatriptan, rizatriptan, sumatriptan or zolmitriptan in people with Migraine without Aura as compared to allele G.
chr5	154063336	rs34767465	A	T	.	PASS	AF=0.200924;DESCR=Allele T is not associated with response to adalimumab, certolizumab pegol or infliximab in people with Inflammatory Bowel Diseases as compared to allele A.
chr5	158411534	rs4551053	G	A	.	PASS	AF=0.405242;DESCR=Allele G is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele A.
chr5	159315942	rs3212227	T	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to methotrexate in people with Psoriasis as compared to allele T.
chr5	159315942	rs3212227	T	G	.	PASS	AF=0.166859;DESCR=Allele G is not associated with response to methotrexate in people with Psoriasis as compared to allele T.
chr5	159323761	rs3213094	C	G	.	PASS	AF=0.00000;DESCR=Genotype CT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype CC.
chr5	159323761	rs3213094	C	T	.	PASS	AF=0.166667;DESCR=Genotype CT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype CC.
chr5	159328122	rs3212217	C	G	.	PASS	AF=0.170317;DESCR=Genotype GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammatory Bowel Diseases as compared to genotype CC.
chr5	159332892	rs2546890	A	G	.	PASS	AF=0.525648;DESCR=Genotypes AG + GG are associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype AA.
chr5	159937991	rs10515807	G	A	.	PASS	AF=0.164265;DESCR=Allele G is associated with decreased dose of doxazosin or phenoxybenzamine in people with Pheochromocytoma or Paraganglioma as compared to allele A.
chr5	160452971	rs2431697	T	C	.	PASS	AF=0.500000;DESCR=Genotypes CC + CT is associated with decreased response to etanercept in people with Psoriasis as compared to genotype TT.
chr5	161684168	rs1992647	G	A	.	PASS	AF=0.634549;DESCR=Genotype AA is associated with decreased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotype GG.
chr5	161842777	rs6892782	T	C	.	PASS	AF=0.112233;DESCR=Genotype CC is not associated with response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype TT.
chr5	161851332	rs6883877	C	T	.	PASS	AF=0.0155620;DESCR=Genotype CT is not associated with increased response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype CC.
chr5	161860841	rs10068980	G	A	.	PASS	AF=0.218497;DESCR=Genotype AA is not associated with response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype GG.
chr5	161892308	rs1157122	T	C	.	PASS	AF=0.112745;DESCR=Genotype CC is not associated with response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype TT.
chr5	161895883	rs2279020	G	A	.	PASS	AF=0.646601;DESCR=Genotype GG is associated with increased response to propofol as compared to genotypes AA + AG.
chr5	161897892	rs2290732	A	G	.	PASS	AF=0.588998;DESCR=Genotypes AA + AG are associated with increased response to carbamazepine in people with Epilepsy as compared to genotype GG.
chr5	163162852	rs4376293	T	C	.	PASS	AF=0.419169;DESCR=Allele T is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.
chr5	163162852	rs4376293	T	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.
chr5	166918083	rs13169373	C	T	.	PASS	AF=0.198211;DESCR=Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.
chr5	168491921	rs244898	T	A	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with increased response to cisplatin in people with Urinary Bladder Neoplasms as compared to genotypes CC + CT.
chr5	168491921	rs244898	T	C	.	PASS	AF=0.495951;DESCR=Genotype TT is associated with increased response to cisplatin in people with Urinary Bladder Neoplasms as compared to genotypes CC + CT.
chr5	170382398	rs703505	A	G	.	PASS	AF=0.437716;DESCR=Genotypes AA + AG is associated with decreased clinical benefit to tocilizumab in people with Rheumatoid arthritis as compared to genotype GG.
chr5	170383792	rs11739136	C	T	.	PASS	AF=0.183756;DESCR=Genotypes CC + CT is associated with increased response to dexmedetomidine in people with surgery as compared to genotype TT.
chr5	170788634	rs10036156	T	C	.	PASS	AF=0.0493080;DESCR=Genotypes CC + CT are associated with increased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotype TT.
chr5	172771552	rs881152	G	A	.	PASS	AF=0.136023;DESCR=Allele G is not associated with increased response to salbutamol in people with Asthma as compared to allele A.
chr5	174642665	rs11749255	A	G	.	PASS	AF=0.332661;DESCR=Allele A is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele G.
chr5	175336319	rs966775	A	G	.	PASS	AF=0.231567;DESCR=Genotypes AG + GG is associated with increased concentrations of fentanyl in people with Pain, Postoperative as compared to genotype AA.
chr5	175435417	rs265976	G	T	.	PASS	AF=0.153203;DESCR=Genotype GT is associated with decreased response to clozapine in people with Schizophrenia as compared to genotypes GG + TT.
chr5	175440896	rs4867798	T	C	.	PASS	AF=0.388249;DESCR=Genotypes CC + CT is associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotype TT.
chr5	175441697	rs686	G	A	.	PASS	AF=0.680507;DESCR=Allele A is not associated with response to clozapine in people with Schizophrenia as compared to allele G.
chr5	175443147	rs4532	C	T	.	PASS	AF=0.684150;DESCR=Genotype CC is not associated with dose of methadone in people with Substance-Related Disorders as compared to genotypes CT + TT.
chr5	175443193	rs5326	C	T	.	PASS	AF=0.141417;DESCR=Genotypes CC + TT are not associated with response to antipsychotics in people with Schizophrenia as compared to genotype CC.
chr5	175443899	rs265981	A	G	.	PASS	AF=0.684544;DESCR=Allele A is not associated with response to clozapine in people with Schizophrenia as compared to allele G.
chr5	175443899	rs265981	A	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to clozapine in people with Schizophrenia as compared to allele G.
chr5	178981601	rs17078853	T	G	.	PASS	AF=0.0620312;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr5	178983150	rs2071247	C	T	.	PASS	AF=0.167339;DESCR=Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr5	178983212	rs17078877	T	C	.	PASS	AF=0.0619954;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr5	178986946	rs11746675	T	C	.	PASS	AF=0.608871;DESCR=Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr5	178988936	rs2067011	A	G	.	PASS	AF=0.483862;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr5	180601717	rs307822	T	C	.	PASS	AF=0.856279;DESCR=Genotypes CT + TT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype CC.
chr5	180602471	rs6877011	C	G	.	PASS	AF=0.118664;DESCR=Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.
chr5	180650487	rs307805	T	C	.	PASS	AF=0.148127;DESCR=Genotypes CC + CT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype TT.
chr6	3010156	rs1143684	C	T	.	PASS	AF=0.711527;DESCR=Allele C is not associated with response to cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to allele T.
chr6	3887105	rs9328202	C	A	.	PASS	AF=0.0617070;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.
chr6	6318562	rs5985	C	A	.	PASS	AF=0.169648;DESCR=Genotypes AA + AC are associated with decreased response to photodynamic therapy in people with Choroidal Neovascularization as compared to genotype CC.
chr6	12296022	rs5370	G	T	.	PASS	AF=0.210663;DESCR=Genotype GT is associated with increased response to atenolol and irbesartan in men with Essential hypertension as compared to genotype GG.
chr6	12903725	rs9349379	A	G	.	PASS	AF=0.414747;DESCR=Allele G is not associated with response to Selective serotonin (5HT1) agonists in people with Migraine without Aura as compared to allele A.
chr6	13070841	rs4615376	A	G	.	PASS	AF=0.331027;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr6	15572843	rs742105	C	T	.	PASS	AF=0.365130;DESCR=Genotypes CT + TT are associated with increased response to clozapine in people with Schizophrenia as compared to genotype CC.
chr6	15627871	rs3213207	T	C	.	PASS	AF=0.0666474;DESCR=Allele C is not associated with response to aripiprazole in people with Schizophrenia as compared to allele T.
chr6	15633201	rs1011313	T	C	.	PASS	AF=0.955069;DESCR=Allele C is not associated with response to aripiprazole in people with Schizophrenia as compared to allele T.
chr6	15650571	rs2005976	C	T	.	PASS	AF=0.161188;DESCR=Allele C is not associated with response to aripiprazole in people with Schizophrenia as compared to allele T.
chr6	15650901	rs760761	G	A	.	PASS	AF=0.163878;DESCR=Allele A is associated with increased response to citalopram in people with Depressive Disorder, Major as compared to allele G.
chr6	15653418	rs2619522	A	C	.	PASS	AF=0.161002;DESCR=Allele C is not associated with response to aripiprazole in people with Schizophrenia as compared to allele A.
chr6	15660640	rs909706	T	C	.	PASS	AF=0.701037;DESCR=Genotype CT is associated with increased response to haloperidol in people with Schizophrenia as compared to genotype CC.
chr6	16145094	rs9370867	A	G	.	PASS	AF=0.516724;DESCR=Genotype AA is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to genotypes AG + GG.
chr6	17505713	rs910039	A	G	.	PASS	AF=0.535817;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr6	17505713	rs910039	A	T	.	AC0	AF=0.00000;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr6	18123271	rs12199316	C	G	.	PASS	AF=0.386521;DESCR=Allele G is associated with increased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.
chr6	18130687	rs1142345	T	C	.	PASS	AF=0.0190202;DESCR=Genotype TT is not associated with dose of mercaptopurine or methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes CC + CT.
chr6	18138997	rs1800460	C	T	.	PASS	AF=0.0181452;DESCR=Genotype CT is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.
chr6	20661019	rs7754840	G	A	.	AC0	AF=0.00000;DESCR=Genotype CG is associated with increased response to sitagliptin in people with Diabetes Mellitus, Type 2.
chr6	20661019	rs7754840	G	C	.	PASS	AF=0.345533;DESCR=Genotype CG is associated with increased response to sitagliptin in people with Diabetes Mellitus, Type 2.
chr6	20661019	rs7754840	G	T	.	PASS	AF=0.00000;DESCR=Genotype CG is associated with increased response to sitagliptin in people with Diabetes Mellitus, Type 2.
chr6	20679478	rs7756992	A	G	.	PASS	AF=0.316138;DESCR=Allele G is associated with increased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus as compared to allele A.
chr6	20728500	rs6908425	T	A	.	AC0	AF=0.00000;DESCR=Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.
chr6	20728500	rs6908425	T	C	.	PASS	AF=0.790202;DESCR=Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.
chr6	23548122	rs2066911	G	A	.	PASS	AF=0.268300;DESCR=Allele A is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele G.
chr6	24503362	rs2760118	C	T	.	PASS	AF=0.244380;DESCR=Genotypes CT + TT is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to genotype CC.
chr6	25177280	rs6942227	A	G	.	PASS	AF=0.103399;DESCR=Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr6	25776721	rs11754288	G	A	.	PASS	AF=0.509516;DESCR=Allele A is associated with increased concentrations of losartan and losartan E-3174 in healthy individuals as compared to allele G.
chr6	25823216	rs1183201	A	T	.	PASS	AF=0.451297;DESCR=Allele T is not associated with dose of allopurinol in people with Gout as compared to allele A.
chr6	26090951	rs1799945	C	G	.	PASS	AF=0.120819;DESCR=Allele G is associated with decreased dose of epoetin alfa in people with hemodialysis treatment as compared to allele C.
chr6	26091108	rs2071303	T	C	.	PASS	AF=0.341302;DESCR=Genotypes CC + CT are associated with increased response to adalimumab in people with Crohn Disease as compared to genotype TT.
chr6	26092913	rs1800562	G	A	.	PASS	AF=0.0138329;DESCR=Allele A is associated with decreased dose of epoetin alfa in people with hemodialysis treatment as compared to allele G.
chr6	29783228	rs1611255	C	A	.	PASS	AF=0.359180;DESCR=Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.
chr6	29783976	rs1611259	C	T	.	PASS	AF=0.494230;DESCR=Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.
chr6	29830833	rs1707	C	T	.	PASS	AF=0.902481;DESCR=Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CT + TT.
chr6	29830840	rs1710	G	C	.	PASS	AF=0.644053;DESCR=Genotype GG is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CC + CG.
chr6	29830857	rs17179101	C	A	.	PASS	AF=0.0567723;DESCR=Genotype AC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.
chr6	29830865	rs17179108	C	T	.	PASS	AF=0.134294;DESCR=Genotype CT is associated with increased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.
chr6	29830972	rs1063320	C	G	.	PASS	AF=0.644957;DESCR=Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CG + GG.
chr6	29831017	rs9380142	A	G	.	PASS	AF=0.197118;DESCR=Genotype GG is associated with decreased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes AA + AG.
chr6	29831026	rs1610696	C	G	.	PASS	AF=0.400000;DESCR=Genotypes CG + GG are not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.
chr6	30490287	rs1264457	G	A	.	PASS	AF=0.543113;DESCR=Genotype AA is associated with increased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in women with Arthritis, Rheumatoid as compared to genotypes AG + GG.
chr6	30490287	rs1264457	G	T	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with increased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in women with Arthritis, Rheumatoid as compared to genotypes AG + GG.
chr6	31139584	rs2233945	C	A	.	PASS	AF=0.0919839;DESCR=Allele A is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.
chr6	31261561	rs9366772	G	A	.	PASS	AF=0.0844380;DESCR=Allele A is associated with increased response to allopurinol as compared to allele G.
chr6	31285148	rs12191877	C	T	.	PASS	AF=0.309689;DESCR=Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.
chr6	31298313	rs4406273	G	A	.	PASS	AF=0.100923;DESCR=Genotype AA is not associated with response to ustekinumab in people with Psoriasis as compared to genotype GG.
chr6	31387342	rs13437088	C	T	.	PASS	AF=0.565092;DESCR=Genotype TT is associated with decreased response to etanercept in people with Psoriasis as compared to genotypes CC + CT.
chr6	31411200	rs1051792	G	A	.	PASS	AF=0.467435;DESCR=Genotype AA is associated with decreased clinical benefit to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylarthropathy as compared to genotypes AG + GG.
chr6	31498018	rs3828913	C	A	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes AA + AC.
chr6	31572536	rs909253	A	G	.	PASS	AF=0.241329;DESCR=Genotype AA is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.
chr6	31572536	rs909253	A	T	.	PASS	AF=0.00000;DESCR=Genotype AA is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.
chr6	31573007	rs1041981	C	A	.	PASS	AF=0.241349;DESCR=Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.
chr6	31574531	rs1799964	T	C	.	PASS	AF=0.219364;DESCR=Genotype TT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CC + CT.
chr6	31574699	rs1800630	C	A	.	PASS	AF=0.148041;DESCR=Genotype AA is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AC + CC.
chr6	31574705	rs1799724	C	T	.	PASS	AF=0.255472;DESCR=Genotype CC is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CT + TT.
chr6	31574756	rs4248158	C	T	.	PASS	AF=0.00951009;DESCR=Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.
chr6	31575186	rs1800750	G	A	.	PASS	AF=0.0227797;DESCR=Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.
chr6	31575254	rs1800629	G	A	.	PASS	AF=0.0838617;DESCR=Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.
chr6	31575324	rs361525	G	A	.	PASS	AF=0.0700288;DESCR=Genotype AG is not associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotype GG.
chr6	31576050	rs1800610	G	A	.	PASS	AF=0.255331;DESCR=Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.
chr6	31588804	rs1052248	T	A	.	PASS	AF=0.356484;DESCR=Genotypes AT + TT is associated with increased clinical benefit to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype AA.
chr6	31936027	rs9332739	G	C	.	PASS	AF=0.0250576;DESCR=Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.
chr6	31946403	rs641153	G	A	.	PASS	AF=0.0574149;DESCR=Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.
chr6	31962685	rs429608	G	A	.	PASS	AF=0.0963091;DESCR=Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.
chr6	32622994	rs2097432	T	C	.	PASS	AF=0.306555;DESCR=Genotypes CC + CT is associated with decreased response to infliximab in people with Crohn Disease as compared to genotype TT.
chr6	32956807	rs209474	A	G	.	PASS	AF=0.482997;DESCR=Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr6	32973038	rs17220479	C	T	.	PASS	AF=0.0106567;DESCR=Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.
chr6	32982440	rs16871297	A	G	.	PASS	AF=0.0106567;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr6	33065245	rs3077	A	G	.	PASS	AF=0.168779;DESCR=Genotype GG is associated with increased response to peginterferon alfa-2b in people with Hepatitis B, Chronic as compared to genotypes AA + AG.
chr6	35385746	rs6922548	A	G	.	PASS	AF=0.185624;DESCR=Allele G is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele A.
chr6	35394748	rs7769719	G	A	.	PASS	AF=0.148782;DESCR=Allele G is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele A.
chr6	35402029	rs1883322	C	T	.	PASS	AF=0.570687;DESCR=Allele C is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele T.
chr6	35411001	rs2016520	C	T	.	PASS	AF=0.621972;DESCR=Allele C is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele T.
chr6	35427233	rs3734254	C	T	.	PASS	AF=0.580357;DESCR=Allele T is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele C.
chr6	35574699	rs3800373	C	A	.	PASS	AF=0.713668;DESCR=Genotypes AC + CC are associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotype AA.
chr6	35639794	rs1360780	T	C	.	PASS	AF=0.728950;DESCR=Genotype CC is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.
chr6	35654144	rs17614642	T	C	.	PASS	AF=0.0250576;DESCR=Genotype TT is associated with decreased response to bupropion in people with Depressive Disorder, Major as compared to genotype CT.
chr6	35702206	rs4713916	A	G	.	PASS	AF=0.794524;DESCR=Genotype AA is associated with increased response to antidepressants in people with Depressive Disorder as compared to genotypes AG + GG.
chr6	36039221	rs3804454	T	C	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele T.
chr6	36039221	rs3804454	T	G	.	PASS	AF=0.376009;DESCR=Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele T.
chr6	37381257	rs2284922	G	A	.	PASS	AF=0.432853;DESCR=Allele A is associated with increased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms.
chr6	39048860	rs10305420	C	T	.	PASS	AF=0.368588;DESCR=Allele T is not associated with decreased clinical benefit to albiglutide, dulaglutide or Glucagon-like peptide-1 (GLP-1) analogues in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr6	39065819	rs3765467	G	A	.	PASS	AF=0.00230415;DESCR=Genotype AG is associated with increased response to sitagliptin in people with Diabetes Mellitus, Type 2.
chr6	39066296	rs6923761	G	A	.	PASS	AF=0.244233;DESCR=Genotype AA is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.
chr6	39066296	rs6923761	G	C	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.
chr6	39079095	rs761386	C	T	.	PASS	AF=0.0536023;DESCR=Genotypes CT + TT is associated with increased response to exenatide in people with Diabetes Mellitus, Type 2 as compared to genotype CC.
chr6	39340966	rs9471077	A	G	.	PASS	AF=0.368376;DESCR=Genotypes AG + GG are associated with increased response to atorvastatin or pravastatin.
chr6	39348016	rs9462535	C	A	.	PASS	AF=0.368224;DESCR=Genotypes AA + AC are associated with increased response to atorvastatin or pravastatin.
chr6	39348016	rs9462535	C	T	.	PASS	AF=0.00000;DESCR=Genotypes AA + AC are associated with increased response to atorvastatin or pravastatin.
chr6	39357302	rs20455	A	G	.	PASS	AF=0.338710;DESCR=Genotypes AG + GG are associated with increased response to pravastatin in people with Myocardial Infarction as compared to genotype AA.
chr6	41232816	rs9369266	A	G	.	PASS	AF=0.404844;DESCR=Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr6	41237497	rs13204353	G	A	.	PASS	AF=0.363531;DESCR=Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr6	41661988	rs6458232	C	A	.	PASS	AF=0.409458;DESCR=Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele A.
chr6	43764117	rs833058	C	T	.	PASS	AF=0.434620;DESCR=Allele T is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele C.
chr6	43764932	rs699946	A	G	.	PASS	AF=0.268588;DESCR=Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.
chr6	43768652	rs699947	A	C	.	PASS	AF=0.537154;DESCR=Genotypes AC + CC are associated with increased response to ranibizumab in people with Macular Degeneration as compared to genotype AA.
chr6	43768652	rs699947	A	T	.	PASS	AF=0.00000;DESCR=Genotypes AC + CC are associated with increased response to ranibizumab in people with Macular Degeneration as compared to genotype AA.
chr6	43769749	rs833061	C	G	.	AC0	AF=0.00000;DESCR=Allele C is not associated with response to bevacizumab, capecitabine, fluorouracil, irinotecan, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to allele T.
chr6	43769749	rs833061	C	T	.	PASS	AF=0.535138;DESCR=Allele C is not associated with response to bevacizumab, capecitabine, fluorouracil, irinotecan, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to allele T.
chr6	43770093	rs1570360	A	G	.	PASS	AF=0.701501;DESCR=Genotypes AA + AG are not associated with increased response to ranibizumab in people with Macular Degeneration as compared to genotype GG.
chr6	43770613	rs2010963	C	G	.	PASS	AF=0.589049;DESCR=Allele G is not associated with response to bevacizumab, capecitabine, fluorouracil, irinotecan, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to allele C.
chr6	43770613	rs2010963	C	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to bevacizumab, capecitabine, fluorouracil, irinotecan, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to allele C.
chr6	43771240	rs25648	C	T	.	PASS	AF=0.154467;DESCR=Allele T is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.
chr6	43774790	rs833068	G	A	.	PASS	AF=0.414986;DESCR=Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.
chr6	43774842	rs833069	T	C	.	PASS	AF=0.425403;DESCR=Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.
chr6	43774842	rs833069	T	G	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.
chr6	43777358	rs2146323	C	A	.	PASS	AF=0.304611;DESCR=Genotype CC is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotypes AA + AC.
chr6	43778432	rs3025000	C	T	.	PASS	AF=0.363767;DESCR=Genotypes CT + TT are associated with increased response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to genotype CC.
chr6	43782850	rs3025030	G	C	.	PASS	AF=0.130334;DESCR=Allele C is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele G.
chr6	43783338	rs3025033	A	G	.	PASS	AF=0.166571;DESCR=Allele G is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele A.
chr6	43784799	rs3025039	C	T	.	PASS	AF=0.132217;DESCR=Genotype CC is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype TT.
chr6	43785475	rs10434	A	G	.	PASS	AF=0.561201;DESCR=Genotypes AA + AG are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype GG.
chr6	43794385	rs9369421	T	C	.	PASS	AF=0.0936599;DESCR=Genotypes CC + CT are associated with increased response to carboplatin and taxanes in women with as compared to genotype TT.
chr6	44221463	rs3778504	G	A	.	PASS	AF=0.00605187;DESCR=Genotypes AA + AG are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype GG.
chr6	44226608	rs747199	G	C	.	PASS	AF=0.160323;DESCR=Genotype GG is not associated with metabolism of gemcitabine as compared to genotypes CC + CG.
chr6	44228255	rs9394992	C	T	.	PASS	AF=0.366935;DESCR=Genotype CC is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.
chr6	44228841	rs324148	T	C	.	PASS	AF=0.744092;DESCR=Genotype CC is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.
chr6	44233216	rs760370	A	G	.	PASS	AF=0.377304;DESCR=Genotype GG is associated with decreased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AA + AG.
chr6	44233997	rs3734703	C	A	.	PASS	AF=0.000576369;DESCR=Allele A is associated with increased response to cytarabine in people with Leukemia, Myeloid, Acute as compared to allele C.
chr6	44386904	rs992160	C	T	.	PASS	AF=0.0141292;DESCR=Genotypes CT + TT are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype CC.
chr6	52185988	rs3819024	A	G	.	PASS	AF=0.336217;DESCR=Genotypes AG + GG is associated with decreased clinical benefit to budesonide, fluticasone/salmeterol, formoterol or omalizumab in children with Asthma as compared to genotype AA.
chr6	52186235	rs2275913	G	A	.	PASS	AF=0.292964;DESCR=Genotypes AA + AG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative and Inflammatory Bowel Diseases as compared to genotype GG.
chr6	52236941	rs763780	T	C	.	PASS	AF=0.0493080;DESCR=Allele T is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele C.
chr6	52803872	rs3957356	T	C	.	PASS	AF=0.568090;DESCR=Allele T is associated with decreased clearance of busulfan in children with hematopoietic stem cell transplantation as compared to allele C.
chr6	52803889	rs3957357	A	G	.	PASS	AF=0.567341;DESCR=Genotype AA is associated with increased clearance of busulfan in children with Transplantation as compared to genotypes AG + GG.
chr6	52843999	rs4715354	G	A	.	PASS	AF=0.403621;DESCR=Allele G is not associated with decreased clearance of busulfan in people with Neoplasms as compared to allele A.
chr6	52849339	rs7746993	C	A	.	PASS	AF=0.0262248;DESCR=Allele C is not associated with decreased clearance of busulfan in people with Neoplasms as compared to allele A.
chr6	55774230	rs41271330	G	A	.	PASS	AF=0.107741;DESCR=Allele A is associated with decreased response to escitalopram in people with Depressive Disorder, Major as compared to allele G.
chr6	77460345	rs9361233	T	C	.	PASS	AF=0.514121;DESCR=Genotypes CC + TT is associated with increased response to fluoxetine in children with Depressive Disorder, Major as compared to genotype CT.
chr6	77461407	rs13212041	C	T	.	PASS	AF=0.866282;DESCR=Genotype TT is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to genotypes CC + CT.
chr6	77462543	rs6296	C	G	.	PASS	AF=0.252450;DESCR=Allele G is not associated with response to rizatriptan in people with Migraine without Aura as compared to allele C.
chr6	77463564	rs130058	T	A	.	PASS	AF=0.329493;DESCR=Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele T.
chr6	77463564	rs130058	T	G	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele T.
chr6	77463665	rs11568817	A	C	.	PASS	AF=0.534274;DESCR=Allele C is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to allele A.
chr6	77464492	rs1778258	T	C	.	PASS	AF=0.960807;DESCR=Allele T is associated with increased response to citalopram, clomipramine, escitalopram, fluoxetine, fluvoxamine, paroxetine or sertraline in people with Obsessive-Compulsive Disorder as compared to allele C.
chr6	77466125	rs9361235	C	T	.	PASS	AF=0.525952;DESCR=Genotypes CC + TT is associated with increased response to fluoxetine in children with Depressive Disorder, Major as compared to genotype CT.
chr6	83799353	rs1081848	G	A	.	PASS	AF=0.227457;DESCR=Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.
chr6	83799353	rs1081848	G	C	.	AC0	AF=0.00000;DESCR=Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.
chr6	88140381	rs806368	T	C	.	PASS	AF=0.298038;DESCR=Genotypes CT + TT are associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.
chr6	88141462	rs12720071	T	C	.	PASS	AF=0.112039;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr6	88143916	rs1049353	C	T	.	PASS	AF=0.180219;DESCR=Genotypes CT + TT is associated with increased clinical benefit to liraglutide in people with Diabetes Mellitus, Type 2 and Obesity as compared to genotype CC.
chr6	88154934	rs806380	A	G	.	PASS	AF=0.267147;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr6	98829991	rs1869641	C	T	.	PASS	AF=0.314228;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr6	98830552	rs2444933	T	C	.	PASS	AF=0.411527;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr6	98831573	rs1883306	A	C	.	PASS	AF=0.0406106;DESCR=Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr6	98833933	rs195862	C	A	.	PASS	AF=0.741349;DESCR=Allele C is not associated with response to platinum in people with Lung Neoplasms as compared to allele A.
chr6	98836656	rs3823036	T	C	.	PASS	AF=0.227771;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.
chr6	98841599	rs195854	T	A	.	PASS	AF=0.517691;DESCR=Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele A.
chr6	106120159	rs548234	C	T	.	PASS	AF=0.676945;DESCR=Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.
chr6	106207742	rs9373839	T	C	.	PASS	AF=0.158213;DESCR=Genotype CT is associated with decreased clinical benefit to tildrakizumab in people with Psoriasis as compared to genotypes CC + TT.
chr6	106326155	rs510432	T	C	.	PASS	AF=0.427995;DESCR=Genotypes CT + TT are associated with increased response to adalimumab in people with Inflammatory Bowel Diseases as compared to genotype CC.
chr6	110438805	rs12210538	A	G	.	PASS	AF=0.267147;DESCR=Allele G is not associated with response to cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to allele A.
chr6	110442672	rs723685	A	G	.	PASS	AF=0.122767;DESCR=Allele G is not associated with response to cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to allele A.
chr6	110456759	rs6907567	A	G	.	PASS	AF=0.313725;DESCR=Allele G is not associated with response to cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to allele A.
chr6	111299555	rs465646	G	A	.	PASS	AF=0.851873;DESCR=Genotypes AG + GG are not associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype AA.
chr6	111307423	rs3204953	C	T	.	PASS	AF=0.167532;DESCR=Genotypes CT + TT are not associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype CC.
chr6	111352511	rs240993	T	C	.	PASS	AF=0.623055;DESCR=Genotype TT is not associated with response to adalimumab in people with Psoriasis as compared to genotype CC.
chr6	111374684	rs462779	G	A	.	PASS	AF=0.786455;DESCR=Genotypes AG + GG are associated with decreased response to cisplatin in people with Osteosarcoma as compared to genotype AA.
chr6	111592059	rs33980500	C	T	.	PASS	AF=0.129320;DESCR=Allele T is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.
chr6	111674463	rs3730353	A	G	.	PASS	AF=0.108420;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.
chr6	111720156	rs706895	T	C	.	PASS	AF=0.318732;DESCR=Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.
chr6	112346991	rs9384825	C	T	.	PASS	AF=0.0827089;DESCR=Allele T is associated with decreased metabolism of tramadol as compared to allele C.
chr6	116279647	rs3828743	G	A	.	PASS	AF=0.241787;DESCR=Genotypes AG + GG is associated with increased clearance of cyclosporine in men with Kidney Transplantation as compared to genotype AA.
chr6	117755821	rs7750468	G	A	.	PASS	AF=0.100288;DESCR=Allele G is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele A.
chr6	117755821	rs7750468	G	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele A.
chr6	131570680	rs2781659	A	G	.	PASS	AF=0.409274;DESCR=Allele A is associated with increased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele G.
chr6	132571367	rs7772821	T	C	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with increased response to corticosteroids in people with Asthma as compared to genotypes GT + TT.
chr6	132571367	rs7772821	T	G	.	PASS	AF=0.164747;DESCR=Genotype GG is associated with increased response to corticosteroids in people with Asthma as compared to genotypes GT + TT.
chr6	132572626	rs4305746	G	A	.	PASS	AF=0.468858;DESCR=Genotypes AA + AG are associated with increased response to aripiprazole in people with Schizophrenia as compared to genotype GG.
chr6	133291776	rs17301249	G	C	.	PASS	AF=0.120104;DESCR=Allele C is associated with decreased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr6	136781227	rs9376230	C	A	.	PASS	AF=0.655908;DESCR=Genotype CC is associated with increased clinical benefit to hydroxyurea in people with Beta-thalassemia and related diseases.
chr6	136784262	rs9483947	C	T	.	PASS	AF=0.659458;DESCR=Genotype CC is associated with increased clinical benefit to hydroxyurea in people with Beta-thalassemia and related diseases.
chr6	137219383	rs2234711	A	G	.	PASS	AF=0.500865;DESCR=Genotype AG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotype AA.
chr6	137681038	rs2113433517;rs6927172	C	A	.	PASS	AF=0.00000;DESCR=Genotypes CG + GG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative and Inflammatory Bowel Diseases as compared to genotype CC.
chr6	137681038	rs2113433513;rs2113433517;rs2113433532;rs6927172	C	G	.	PASS	AF=0.147465;DESCR=Genotypes CG + GG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative and Inflammatory Bowel Diseases as compared to genotype CC.
chr6	137681500	rs10499194;rs2113433583;rs2113433587;rs2113433596	C	T	.	PASS	AF=0.355825;DESCR=Allele T is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.
chr6	137685367	rs6920220	G	A	.	PASS	AF=0.147262;DESCR=Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.
chr6	137874929	rs2230926	T	G	.	PASS	AF=0.0440668;DESCR=Allele T is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele G.
chr6	137878280	rs610604	G	T	.	PASS	AF=0.610375;DESCR=Genotype GG is associated with decreased clinical benefit to tildrakizumab in people with Psoriasis as compared to genotypes GT + TT.
chr6	138928988	rs17068112	C	G	.	PASS	AF=0.0377522;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.
chr6	143957125	rs2247408	T	C	.	PASS	AF=0.691931;DESCR=Allele C is associated with response to olanzapine in people with Schizophrenia.
chr6	143959392	rs3819811	A	G	.	PASS	AF=0.664257;DESCR=Allele A is associated with response to olanzapine in people with Schizophrenia.
chr6	145701395	rs1415744	T	C	.	PASS	AF=0.609636;DESCR=Allele C is associated with increased response to chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone or trifluoperazine in people with Schizophrenia as compared to allele T.
chr6	149400554	rs237025	G	A	.	PASS	AF=0.466840;DESCR=Genotype AA is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AG + GG.
chr6	149400554	rs237025	G	T	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AG + GG.
chr6	151807942	rs2077647	T	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to glibenclamide in people with as compared to allele C.
chr6	151807942	rs2077647	T	C	.	PASS	AF=0.510951;DESCR=Allele T is associated with increased response to glibenclamide in people with as compared to allele C.
chr6	151842149	rs4986936	A	G	.	PASS	AF=0.0198962;DESCR=Allele G is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.
chr6	151842200	rs2234693	T	C	.	PASS	AF=0.457061;DESCR=Allele C is not associated with dose of morphine in people with Pain, Postoperative as compared to allele T.
chr6	151842246	rs9340799	A	G	.	PASS	AF=0.386324;DESCR=Allele A is not associated with response to raloxifene in women Menopause and Schizophrenia as compared to allele G.
chr6	151944387	rs1801132	G	A	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to raloxifene in women Menopause and Schizophrenia as compared to allele G.
chr6	151944387	rs1801132	G	C	.	PASS	AF=0.798099;DESCR=Allele C is not associated with response to raloxifene in women Menopause and Schizophrenia as compared to allele G.
chr6	152992697	rs766127	G	A	.	PASS	AF=0.627813;DESCR=Allele G is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele A.
chr6	152994560	rs3192723	C	T	.	PASS	AF=0.137623;DESCR=Genotype CC is associated with decreased response to methadone in people with Heroin Dependence as compared to genotypes CT + TT.
chr6	153024050	rs672170	A	G	.	PASS	AF=0.581892;DESCR=Allele A is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele G.
chr6	153704004	rs73568641	T	C	.	PASS	AF=0.161383;DESCR=Allele C is associated with decreased dose of methadone in women with Opioid-Related Disorders as compared to allele T.
chr6	154010049	rs1319339	T	C	.	PASS	AF=0.117935;DESCR=Allele C is not associated with dose of morphine in people with Pain, Postoperative as compared to allele T.
chr6	154014538	rs1294092	A	G	.	PASS	AF=0.204441;DESCR=Allele G is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele A.
chr6	154027470	rs7776341	A	C	.	PASS	AF=0.00892857;DESCR=Allele C is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.
chr6	154027674	rs1074287	A	G	.	PASS	AF=0.221774;DESCR=Allele G is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele A.
chr6	154037798	rs12205732	G	A	.	PASS	AF=0.00894919;DESCR=Allele A is not associated with dose of heroin in people with Heroin Dependence as compared to allele G.
chr6	154038226	rs17174629	A	G	.	PASS	AF=0.00000;DESCR=Allele G is not associated with dose of morphine in people with Pain as compared to allele A.
chr6	154039373	rs6912029	G	T	.	PASS	AF=0.00893887;DESCR=Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele G.
chr6	154039561	rs1799972	C	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with dose of morphine in people with Pain as compared to allele C.
chr6	154039561	rs1799972	C	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with dose of morphine in people with Pain as compared to allele C.
chr6	154039561	rs1799972	C	T	.	PASS	AF=0.0112392;DESCR=Allele T is not associated with dose of morphine in people with Pain as compared to allele C.
chr6	154039662	rs1799971	A	G	.	PASS	AF=0.175808;DESCR=Allele G is not associated with response to modafinil in people with methamphetamine dependence as compared to allele A.
chr6	154039913	rs12209447	C	T	.	PASS	AF=0.00892857;DESCR=Allele T is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele C.
chr6	154040884	rs510769	C	T	.	PASS	AF=0.210329;DESCR=Allele T is not associated with dose of ethanol as compared to allele C.
chr6	154043004	rs3798676	C	T	.	PASS	AF=0.00893887;DESCR=Allele T is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele C.
chr6	154043682	rs553202	C	T	.	PASS	AF=0.214245;DESCR=Allele T is associated with increased response to ethanol as compared to allele C.
chr6	154047412	rs511435	C	T	.	PASS	AF=0.211438;DESCR=Allele T is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele C.
chr6	154051557	rs499796	A	G	.	PASS	AF=0.213668;DESCR=Allele G is not associated with concentrations of cotinine in people with Heroin Dependence as compared to allele A.
chr6	154053957	rs524731	C	A	.	PASS	AF=0.212680;DESCR=Allele A is associated with increased response to ethanol as compared to allele C.
chr6	154058017	rs3823010	G	A	.	PASS	AF=0.127592;DESCR=Allele A is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele G.
chr6	154059015	rs7748401	T	G	.	PASS	AF=0.00892857;DESCR=Allele G is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele T.
chr6	154059877	rs3778148	G	T	.	PASS	AF=0.116561;DESCR=Allele T is associated with increased response to ethanol as compared to allele G.
chr6	154061407	rs495491	A	G	.	PASS	AF=0.222926;DESCR=Allele G is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele A.
chr6	154062523	rs3778150	T	C	.	PASS	AF=0.126082;DESCR=Genotypes CC + CT are associated with decreased response to ethanol as compared to genotype TT.
chr6	154069938	rs10457090	A	G	.	PASS	AF=0.00892857;DESCR=Allele G is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele A.
chr6	154069938	rs10457090	A	T	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele A.
chr6	154070234	rs1461773	G	A	.	PASS	AF=0.124784;DESCR=Allele A is associated with increased response to ethanol as compared to allele G.
chr6	154072003	rs589046	C	T	.	PASS	AF=0.227220;DESCR=Allele T is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele C.
chr6	154072123	rs1381376	C	A	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele C.
chr6	154072123	rs1381376	C	T	.	PASS	AF=0.119446;DESCR=Allele A is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele C.
chr6	154072696	rs3778152	A	G	.	PASS	AF=0.00892857;DESCR=Allele G is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele A.
chr6	154074792	rs506247	A	C	.	PASS	AF=0.0855908;DESCR=Allele C is not associated with response to ethanol as compared to allele A.
chr6	154086832	rs563649	C	T	.	PASS	AF=0.0943451;DESCR=Allele T is not associated with response to ethanol as compared to allele C.
chr6	154090209	rs9479757	G	A	.	PASS	AF=0.112968;DESCR=Genotype AG is associated with increased dose of heroin in people with Heroin Dependence as compared to genotype GG.
chr6	154090869	rs2075572	G	C	.	PASS	AF=0.595910;DESCR=Allele G is associated with increased response to ethanol as compared to allele C.
chr6	154092120	rs10485057	A	G	.	PASS	AF=0.118088;DESCR=Allele G is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele A.
chr6	154093311	rs540825	A	C	.	PASS	AF=0.00000;DESCR=Allele T is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.
chr6	154093311	rs540825	A	T	.	PASS	AF=0.789171;DESCR=Allele T is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.
chr6	154093428	rs675026	A	G	.	PASS	AF=0.687356;DESCR=Allele G is not associated with response to methadone in people with Heroin Dependence as compared to allele A.
chr6	154093438	rs562859	C	T	.	PASS	AF=0.687536;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr6	154097012	rs548646	T	C	.	PASS	AF=0.689049;DESCR=Allele T is associated with increased response to ethanol as compared to allele C.
chr6	154099922	rs9384179	G	A	.	PASS	AF=0.689645;DESCR=Genotype AA is associated with increased dose of fentanyl in people with Pain, Postoperative as compared to genotypes AG + GG.
chr6	154099922	rs9384179	G	T	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with increased dose of fentanyl in people with Pain, Postoperative as compared to genotypes AG + GG.
chr6	154100709	rs1323042	G	T	.	PASS	AF=0.564125;DESCR=Allele G is not associated with dose of opioids in people with Pain as compared to allele T.
chr6	154101476	rs648007	A	G	.	PASS	AF=0.688940;DESCR=Allele A is associated with increased response to ethanol as compared to allele G.
chr6	154103186	rs9322447	A	G	.	PASS	AF=0.564014;DESCR=Allele G is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele A.
chr6	154103535	rs618207	A	G	.	PASS	AF=0.689337;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr6	154103535	rs618207	A	T	.	PASS	AF=0.00000;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr6	154106606	rs681243	T	C	.	PASS	AF=0.688761;DESCR=Allele T is associated with increased response to ethanol as compared to allele C.
chr6	154107531	rs677830	C	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with dose of morphine in people with Pain, Postoperative as compared to allele C.
chr6	154107531	rs677830	C	T	.	PASS	AF=0.196542;DESCR=Allele T is not associated with dose of morphine in people with Pain, Postoperative as compared to allele C.
chr6	154109880	rs609148	G	A	.	PASS	AF=0.196882;DESCR=Allele A is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele G.
chr6	154115579	rs639855	C	A	.	PASS	AF=0.196943;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele A.
chr6	154115579	rs639855	C	G	.	PASS	AF=0.00000;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele A.
chr6	154117494	rs648893	A	G	.	PASS	AF=0.196830;DESCR=Allele G is not associated with response to ethanol as compared to allele A.
chr6	154119607	rs671531	A	C	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with decreased response to highly active antiretroviral therapy (haart) in people with HIV Infections as compared to genotypes AA + AG.
chr6	154119607	rs671531	A	G	.	PASS	AF=0.688761;DESCR=Genotype GG is associated with decreased response to highly active antiretroviral therapy (haart) in people with HIV Infections as compared to genotypes AA + AG.
chr6	154120830	rs558025	A	G	.	PASS	AF=0.196078;DESCR=Genotypes AG + GG are associated with decreased dose of methadone in people with Heroin Dependence as compared to genotype AA.
chr6	154121377	rs497976	G	T	.	PASS	AF=0.196943;DESCR=Allele G is not associated with dose of opioids in people with Pain as compared to allele T.
chr6	154121541	rs642489	G	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to ethanol as compared to allele G.
chr6	154121541	rs642489	G	T	.	PASS	AF=0.196717;DESCR=Allele T is not associated with response to ethanol as compared to allele G.
chr6	154124080	rs10485058	A	G	.	PASS	AF=0.0749712;DESCR=Allele G is not associated with dose of methadone in people with Opioid-Related Disorders as compared to allele A.
chr6	154157305	rs2236256	C	A	.	PASS	AF=0.712680;DESCR=Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele A.
chr6	154157305	rs2236256	C	T	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele A.
chr6	154157432	rs2236257	G	C	.	PASS	AF=0.276688;DESCR=Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele G.
chr6	154157569	rs2236258	C	T	.	PASS	AF=0.714574;DESCR=Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.
chr6	154157758	rs2236259	T	C	.	PASS	AF=0.714862;DESCR=Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.
chr6	154157868	rs6902403	T	C	.	PASS	AF=0.714862;DESCR=Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.
chr6	154247041	rs9322453	G	C	.	PASS	AF=0.553057;DESCR=Allele C is not associated with dose of heroin in people with Heroin Dependence as compared to allele G.
chr6	154400423	rs6917661	C	T	.	PASS	AF=0.176471;DESCR=Allele C is not associated with response to lithium in people with Bipolar Disorder.
chr6	154962860	rs2273897	T	C	.	PASS	AF=0.401498;DESCR=Genotype TT is associated with increased concentrations of emtricitabine in people with HIV Infections and Pregnancy as compared to genotypes CC + CT.
chr6	157939659	rs2364349	G	A	.	PASS	AF=0.172822;DESCR=Allele A is associated with decreased response to atenolol or metoprolol in people with Hypertension as compared to allele G.
chr6	159061489	rs394581	C	T	.	PASS	AF=0.681949;DESCR=Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.
chr6	159692840	rs4880	A	G	.	PASS	AF=0.519331;DESCR=Allele G is not associated with response to clozapine in people with Schizophrenia as compared to allele A.
chr6	160120141	rs6935207	G	A	.	PASS	AF=0.137673;DESCR=Allele A is not associated with clearance of metformin in healthy individuals as compared to allele G.
chr6	160122091	rs1867351	T	C	.	PASS	AF=0.136888;DESCR=Allele C is not associated with exposure to metformin as compared to allele T.
chr6	160122116	rs12208357	C	T	.	PASS	AF=0.0953341;DESCR=Allele T is associated with decreased response to Antiemetics And Antinauseants as compared to allele C.
chr6	160129897	rs9457841	T	C	.	PASS	AF=0.228637;DESCR=Allele C is associated with increased concentrations of n-desmethyltramadol and o-desmethyltramadol in people with Death as compared to allele T.
chr6	160130172	rs683369	G	C	.	PASS	AF=0.840542;DESCR=Genotype CC is associated with decreased dose-adjusted trough concentrations of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes CG + GG.
chr6	160132274	rs34134157	C	T	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with decreased concentrations of n-desmethyltramadol and o-desmethyltramadol in people with Death as compared to genotype CT.
chr6	160134722	rs594709	G	A	.	PASS	AF=0.665994;DESCR=Genotypes AA + AG are associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to genotype GG.
chr6	160136611	rs2282143	C	G	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased clearance of metformin in healthy individuals as compared to genotypes CT + TT.
chr6	160136611	rs2282143	C	T	.	PASS	AF=0.000288184;DESCR=Genotype CC is associated with increased clearance of metformin in healthy individuals as compared to genotypes CT + TT.
chr6	160136672	rs35235578	C	T	.	PASS	AF=0.00000;DESCR=Genotype CT is associated with increased concentrations of n-desmethyltramadol and o-desmethyltramadol in people with Death as compared to genotype CC.
chr6	160139813	rs628031	A	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with increased resistance to efavirenz, lamivudine, lopinavir, nevirapine, ritonavir and zidovudine in people with HIV Infections as compared to allele G.
chr6	160139813	rs628031	A	G	.	PASS	AF=0.664553;DESCR=Allele A is not associated with increased resistance to efavirenz, lamivudine, lopinavir, nevirapine, ritonavir and zidovudine in people with HIV Infections as compared to allele G.
chr6	160151834	rs622342	C	A	.	PASS	AF=0.755043;DESCR=Genotype AA is not associated with response to metformin in people with genetic variation at rs2289669.
chr6	160155979	rs41267797	G	A	.	PASS	AF=0.0112457;DESCR=Genotype AG is associated with increased concentrations of n-desmethyltramadol and o-desmethyltramadol in people with Death as compared to genotype GG.
chr6	160231826	rs315978	T	C	.	PASS	AF=0.846198;DESCR=Allele T is not associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr6	160249250	rs316019	A	C	.	PASS	AF=0.853602;DESCR=Genotype CC is associated with increased clearance of metformin in healthy individuals as compared to genotype AC.
chr6	160254732	rs316009	T	C	.	PASS	AF=0.859781;DESCR=Genotype TT is associated with increased response to metformin in people with Diabetes Mellitus as compared to genotypes CC + CT.
chr6	160254732	rs316009	T	G	.	PASS	AF=0.00000;DESCR=Genotype TT is associated with increased response to metformin in people with Diabetes Mellitus as compared to genotypes CC + CT.
chr6	160275887	rs662301	C	T	.	PASS	AF=0.130698;DESCR=Allele T is not associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr6	160451754	rs2076828	C	G	.	PASS	AF=0.573241;DESCR=Allele G is associated with decreased response to metformin in healthy individuals as compared to allele C.
chr6	160471209	rs3127602	C	T	.	PASS	AF=0.287032;DESCR=Allele T is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr6	160589086	rs10455872	A	G	.	PASS	AF=0.0299539;DESCR=Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to allele A.
chr6	166165782	rs2305089	C	T	.	PASS	AF=0.561383;DESCR=Genotype TT is associated with increased response to flunisolide in people with Asthma as compared to genotypes CC + CT.
chr7	96804	rs6973474	C	T	.	PASS	AF=0.467147;DESCR=Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.
chr7	5335911	rs10234709	C	A	.	PASS	AF=0.369515;DESCR=Allele A is associated with decreased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr7	7967878	rs37972	T	A	.	AC0	AF=0.00000;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr7	7967878	rs37972	T	C	.	PASS	AF=0.643433;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr7	7968245	rs37973	G	A	.	PASS	AF=0.631700;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	7975326	rs37976	C	T	.	PASS	AF=0.640715;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr7	7978850	rs7792118	A	G	.	PASS	AF=0.00720461;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	7980303	rs715377	A	G	.	PASS	AF=0.0769009;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	7981939	rs12537880	A	G	.	PASS	AF=0.0512673;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	7985680	rs7800750	T	C	.	PASS	AF=0.00662824;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr7	7987543	rs37990	A	C	.	PASS	AF=0.693772;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr7	8002758	rs38010	C	T	.	PASS	AF=0.556196;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr7	8004853	rs2041362	G	T	.	PASS	AF=0.0501441;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr7	8016034	rs17141876	C	T	.	PASS	AF=0.0337176;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr7	8020426	rs1476823	C	T	.	PASS	AF=0.651096;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr7	8022100	rs10229643	T	A	.	PASS	AF=0.521889;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr7	8022863	rs13239966	C	T	.	PASS	AF=0.000576369;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr7	8022960	rs10243846	G	A	.	PASS	AF=0.525072;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr7	8034978	rs13245462	C	T	.	PASS	AF=0.113479;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr7	8037729	rs10435183	G	A	.	PASS	AF=0.00403226;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr7	8040851	rs7801924	A	G	.	PASS	AF=0.584824;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr7	8040851	rs7801924	A	T	.	AC0	AF=0.00000;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr7	8047009	rs4725061	A	G	.	PASS	AF=0.554468;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8047009	rs4725061	A	T	.	AC0	AF=0.00000;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8048764	rs10226865	G	A	.	PASS	AF=0.647806;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8057258	rs13222222	A	C	.	PASS	AF=0.00432526;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8057991	rs6969971	T	C	.	PASS	AF=0.00720046;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr7	8058510	rs9648623	G	A	.	PASS	AF=0.104913;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr7	8059188	rs13242904	C	T	.	PASS	AF=0.00144175;DESCR=Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr7	8061469	rs11978165	G	A	.	PASS	AF=0.591171;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8061469	rs11978165	G	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8062135	rs6463755	C	T	.	PASS	AF=0.704323;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr7	8070767	rs16872488	A	C	.	PASS	AF=0.0619240;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8072384	rs2191318	C	T	.	PASS	AF=0.629908;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr7	8073682	rs11976862	A	C	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8073682	rs11976862	A	G	.	PASS	AF=0.552799;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8074121	rs4236406	T	C	.	PASS	AF=0.508656;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr7	8075646	rs17142716	A	G	.	PASS	AF=0.0576037;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8075646	rs17142716	A	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8076164	rs17142727	A	G	.	PASS	AF=0.118444;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8076349	rs10253260	G	A	.	PASS	AF=0.693595;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.
chr7	8077302	rs10952084	C	A	.	PASS	AF=0.0649163;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr7	8077302	rs10952084	C	G	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr7	8077318	rs6964558	G	A	.	PASS	AF=0.0606586;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr7	8077868	rs6956039	T	G	.	PASS	AF=0.00778098;DESCR=Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr7	8082683	rs1468594	A	C	.	PASS	AF=0.796424;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr7	8083797	rs10257285	C	T	.	PASS	AF=0.683573;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr7	8085639	rs12668352	C	A	.	PASS	AF=0.0619954;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.
chr7	8086334	rs929509	C	T	.	PASS	AF=0.708309;DESCR=Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.
chr7	8088080	rs4725068	G	A	.	PASS	AF=0.499423;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr7	8090098	rs6967565	G	A	.	PASS	AF=0.185196;DESCR=Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.
chr7	9648479	rs4236420	A	G	.	PASS	AF=0.595898;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr7	13597906	rs1568885	T	A	.	PASS	AF=0.168400;DESCR=Allele A is associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid.
chr7	17565446	rs1448673	A	G	.	PASS	AF=0.638537;DESCR=Allele G is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele A.
chr7	20643261	rs17143212	C	T	.	PASS	AF=0.0123848;DESCR=Allele T is not associated with clearance of talinolol in healthy individuals as compared to allele C.
chr7	22105466	rs16873129	T	C	.	PASS	AF=0.0449309;DESCR=Allele C is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr7	22693220	rs2097677	G	A	.	PASS	AF=0.322376;DESCR=Allele A is associated with increased response to alogliptin, linagliptin, sitagliptin, teneligliptin or vildagliptin in people with Diabetes Mellitus, Type 2 as compared to allele G.
chr7	22720869	rs10499563	T	C	.	PASS	AF=0.178777;DESCR=Genotypes CC + CT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative and Inflammatory Bowel Diseases as compared to genotype TT.
chr7	22726602	rs1800797	A	G	.	PASS	AF=0.742224;DESCR=Allele G is associated with decreased response to peginterferon alfa-2a in people with Hepatitis C, Chronic as compared to allele A.
chr7	22726627	rs1800796	G	C	.	PASS	AF=0.0812212;DESCR=Allele G is associated with increased response to alogliptin, linagliptin, sitagliptin, teneligliptin or vildagliptin in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr7	22727026	rs1800795	C	G	.	PASS	AF=0.737039;DESCR=Allele G is associated with decreased response to peginterferon alfa-2a in people with Hepatitis C, Chronic as compared to allele C.
chr7	22728600	rs1524107	C	T	.	PASS	AF=0.0769009;DESCR=Allele C is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation.
chr7	22728630	rs2066992	G	T	.	PASS	AF=0.0769009;DESCR=Genotype GT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotype GG.
chr7	22728953	rs2069840	C	G	.	PASS	AF=0.261521;DESCR=Genotype CC is associated with decreased clinical benefit to tocilizumab in people with Rheumatoid arthritis as compared to genotype CG.
chr7	22734612	rs10242595	G	A	.	PASS	AF=0.518166;DESCR=Genotype AA is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes AG + GG.
chr7	27200863	rs3807598	C	G	.	PASS	AF=0.461627;DESCR=Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.
chr7	27202740	rs1859168	A	C	.	PASS	AF=0.961249;DESCR=Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele C.
chr7	27202740	rs1859168	A	G	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele C.
chr7	27202740	rs1859168	A	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele C.
chr7	30660356	rs2270007	G	C	.	PASS	AF=0.848991;DESCR=Genotypes CC + CG are associated with decreased response to citalopram in people with Depressive Disorder, Major as compared to genotype GG.
chr7	30661980	rs73294475	T	C	.	PASS	AF=0.00000;DESCR=Genotype CT is associated with increased response to salbutamol in children with Asthma as compared to genotype TT.
chr7	30676471	rs2267715	G	A	.	PASS	AF=0.704441;DESCR=Allele G is associated with decreased response to salbutamol in people with Asthma as compared to allele A.
chr7	30678487	rs2284220	G	A	.	PASS	AF=0.884438;DESCR=Allele G is not associated with decreased response to salbutamol in people with Asthma as compared to allele A.
chr7	30687161	rs7793837	A	T	.	PASS	AF=0.222447;DESCR=Allele T is associated with decreased response to salbutamol and selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele A.
chr7	30689292	rs255100	A	T	.	PASS	AF=0.650058;DESCR=Allele A is not associated with decreased response to salbutamol in people with Asthma as compared to allele T.
chr7	30922175	rs28362731	G	A	.	PASS	AF=0.103111;DESCR=Genotype AG is not associated with response to cisplatin in people with Mesothelioma as compared to genotype GG.
chr7	30924207	rs1049305	G	C	.	PASS	AF=0.404090;DESCR=Genotypes CC + CG are not associated with response to cisplatin in people with Mesothelioma as compared to genotype GG.
chr7	31032854	rs34548976	C	T	.	PASS	AF=0.329008;DESCR=Allele T is associated with decreased response to adrenergics, inhalants in children with Asthma as compared to allele C.
chr7	33021334	rs3750117	A	G	.	PASS	AF=0.559654;DESCR=Genotype AA is associated with increased clearance of gemcitabine in people with Neoplasms as compared to genotype GG.
chr7	33021334	rs3750117	A	T	.	AC0	AF=0.00000;DESCR=Genotype AA is associated with increased clearance of gemcitabine in people with Neoplasms as compared to genotype GG.
chr7	33043495	rs6946062	T	C	.	PASS	AF=0.309510;DESCR=Genotype TT is not associated with metabolism of gemcitabine as compared to genotypes CC + CT.
chr7	33120302	rs2392165	A	G	.	PASS	AF=0.368224;DESCR=Genotypes AG + GG are associated with increased response to budesonide in children with Asthma as compared to genotype AA.
chr7	40301030	rs17171676	A	C	.	PASS	AF=0.0216263;DESCR=Allele C is associated with response to hmg coa reductase inhibitors as compared to allele A.
chr7	41691455	rs2237435	A	C	.	PASS	AF=0.632217;DESCR=Allele A is not associated with response to bevacizumab and ranibizumab in people with as compared to allele C.
chr7	44539581	rs2072183	G	C	.	PASS	AF=0.221165;DESCR=Allele G is associated with decreased response to hmg coa reductase inhibitors in people with Cardiovascular Diseases and Hypercholesterolemia as compared to allele C.
chr7	45607253	rs1521470	A	G	.	PASS	AF=0.870392;DESCR=Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.
chr7	50458521	rs11575553	G	A	.	PASS	AF=0.0545297;DESCR=Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr7	50567279	rs12666409;rs2115080663;rs2115080668;rs2115080677	T	A	.	PASS	AF=0.221165;DESCR=Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr7	54239886	rs4351379	G	C	.	PASS	AF=0.0938940;DESCR=Genotypes CC + CG is associated with decreased response to VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors in people with Macular Degeneration as compared to genotype GG.
chr7	54239886	rs4351379	G	T	.	PASS	AF=0.00000;DESCR=Genotypes CC + CG is associated with decreased response to VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors in people with Macular Degeneration as compared to genotype GG.
chr7	55019062	rs712829	G	C	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to allele G.
chr7	55019062	rs712829	G	T	.	PASS	AF=0.424032;DESCR=Allele T is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to allele G.
chr7	55161562	rs2227983	G	A	.	PASS	AF=0.329493;DESCR=Allele A is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to allele G.
chr7	55201223	rs2293347	C	T	.	PASS	AF=0.0725806;DESCR=Genotype CC is associated with decreased response to fluorouracil in people with Stomach Neoplasms as compared to genotypes CT + TT.
chr7	65908864	rs4072879	A	G	.	PASS	AF=0.0170422;DESCR=Genotype AA is associated with decreased dose of warfarin as compared to genotypes AG + GG.
chr7	65911469	rs10950022	C	T	.	PASS	AF=0.395617;DESCR=Genotypes CC + CT is associated with decreased dose of warfarin as compared to genotype TT.
chr7	66125934	rs1976200	G	A	.	PASS	AF=0.526683;DESCR=Allele A is not associated with response to erenumab, fremanezumab or galcanezumab in people with Migraine without Aura or Migraine with Aura as compared to allele G.
chr7	71273743	rs7794356	G	A	.	PASS	AF=0.366647;DESCR=Allele A is associated with increased response to montelukast in people with Asthma as compared to allele G.
chr7	75960585	rs2868177	A	G	.	PASS	AF=0.444988;DESCR=Allele A is not associated with dose of acenocoumarol in people with Atrial Fibrillation, heart valve replacement and Thromboembolism as compared to allele G.
chr7	75979668	rs10239977	C	T	.	PASS	AF=0.244521;DESCR=Genotypes CT + TT is not associated with dose of warfarin as compared to genotype CC.
chr7	75981831	rs10954732	G	A	.	PASS	AF=0.685121;DESCR=Genotype GG is associated with increased concentrations of voriconazole as compared to genotype AA.
chr7	75982438	rs3815455	C	T	.	PASS	AF=0.285303;DESCR=Genotypes CT + TT is not associated with dose of warfarin as compared to genotype CC.
chr7	75983485	rs41301394	C	T	.	PASS	AF=0.280403;DESCR=Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.
chr7	75985688	rs1057868	C	T	.	PASS	AF=0.257061;DESCR=Allele T is associated with increased metabolism of tacrolimus in people with Kidney Transplantation as compared to allele C.
chr7	81508392	rs73151902	A	G	.	PASS	AF=0.0989043;DESCR=Allele A is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G.
chr7	86679790	rs2299214	C	T	.	PASS	AF=0.313187;DESCR=Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes CT + TT.
chr7	86696058	rs724226	A	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to risperidone in people with Schizophrenia.
chr7	86696058	rs724226	A	G	.	PASS	AF=0.697110;DESCR=Allele G is associated with increased response to risperidone in people with Schizophrenia.
chr7	86774159	rs6465084	A	G	.	PASS	AF=0.283815;DESCR=Genotype AA is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes AG + GG.
chr7	86804135	rs1468412	A	T	.	PASS	AF=0.362824;DESCR=Genotypes AA + AT is associated with decreased response to antipsychotics in people with Schizophrenia.
chr7	87499549	rs6946119	T	C	.	PASS	AF=0.343732;DESCR=Allele T is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele C.
chr7	87504050	rs3842	T	C	.	PASS	AF=0.192085;DESCR=Allele C is associated with metabolism of efavirenz in people with HIV Infections as compared to allele T.
chr7	87509195	rs2235048	G	A	.	PASS	AF=0.646194;DESCR=Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.
chr7	87509329	rs1045642	A	G	.	PASS	AF=0.653203;DESCR=Allele G is not associated with concentrations of atazanavir in people with HIV Infections as compared to allele A.
chr7	87510000	rs4437575	A	G	.	PASS	AF=0.615762;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr7	87511492	rs10808071	A	G	.	PASS	AF=0.213134;DESCR=Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.
chr7	87512498	rs6949448	T	C	.	PASS	AF=0.689049;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr7	87519012	rs28401781	C	T	.	PASS	AF=0.147059;DESCR=Allele T is associated with increased response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele C.
chr7	87520606	rs2235067	C	T	.	PASS	AF=0.144585;DESCR=Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr7	87522787	rs4148740	A	G	.	PASS	AF=0.149942;DESCR=Genotype AG is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to genotype AA.
chr7	87524269	rs10280101	A	C	.	PASS	AF=0.150144;DESCR=Allele C is not associated with exposure to olanzapine in healthy individuals as compared to allele A.
chr7	87524269	rs10280101	A	G	.	PASS	AF=0.00000;DESCR=Allele C is not associated with exposure to olanzapine in healthy individuals as compared to allele A.
chr7	87527735	rs7787082	G	A	.	PASS	AF=0.210496;DESCR=Allele A is not associated with exposure to olanzapine in healthy individuals as compared to allele G.
chr7	87528267	rs2373586	A	C	.	PASS	AF=0.654467;DESCR=Genotypes AC + CC are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.
chr7	87531245	rs2032583	A	G	.	PASS	AF=0.149856;DESCR=Genotype AG is not associated with concentrations of desmethylcitalopram or escitalopram in people with Depressive Disorder, Major as compared to genotypes AA + GG.
chr7	87531302	rs2032582	A	C	.	PASS	AF=0.628242;DESCR=Genotype AT is not associated with dose of tacrolimus in people with Kidney Transplantation as compared to allele C.
chr7	87531302	rs2032582	A	T	.	PASS	AF=0.0262248;DESCR=Genotype AT is not associated with dose of tacrolimus in people with Kidney Transplantation as compared to allele C.
chr7	87531733	rs4148739	T	C	.	PASS	AF=0.150231;DESCR=Genotype TT is associated with decreased metabolism of carbamazepine in people with Epilepsy as compared to genotype CT.
chr7	87532204	rs11983225	T	C	.	PASS	AF=0.150058;DESCR=Allele C is not associated with exposure to olanzapine in healthy individuals as compared to allele T.
chr7	87533733	rs4148738	C	T	.	PASS	AF=0.623126;DESCR=Genotype CC is not associated with trough concentration of apixaban, dabigatran, edoxaban or rivaroxaban in people with Thromboembolism as compared to genotypes CT + TT.
chr7	87535033	rs117937072	A	C	.	PASS	AF=0.0282421;DESCR=Allele G is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele A.
chr7	87535033	rs117937072	A	G	.	PASS	AF=0.00000;DESCR=Allele G is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele A.
chr7	87535576	rs10234411	T	A	.	PASS	AF=0.627236;DESCR=Allele A is not associated with concentrations of carbamazepine in people with Epilepsy as compared to allele T.
chr7	87535576	rs10234411	T	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with concentrations of carbamazepine in people with Epilepsy as compared to allele T.
chr7	87535576	rs10234411	T	G	.	PASS	AF=0.00000;DESCR=Allele A is not associated with concentrations of carbamazepine in people with Epilepsy as compared to allele T.
chr7	87535670	rs10248420	A	G	.	PASS	AF=0.209919;DESCR=Allele G is not associated with exposure to olanzapine in healthy individuals as compared to allele A.
chr7	87536434	rs2235040	C	T	.	PASS	AF=0.150144;DESCR=Genotypes CC + CT are not associated with concentrations of desmethylcitalopram or escitalopram in people with Depressive Disorder, Major as compared to genotype TT.
chr7	87540040	rs12720067	C	T	.	PASS	AF=0.148127;DESCR=Allele T is not associated with exposure to olanzapine in healthy individuals as compared to allele C.
chr7	87540386	rs12720066	A	C	.	PASS	AF=0.0398153;DESCR=Genotypes AC + CC are associated with decreased exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.
chr7	87541836	rs4148737	T	C	.	PASS	AF=0.468318;DESCR=Allele C is not associated with exposure to olanzapine in healthy individuals as compared to allele T.
chr7	87542820	rs6961419	T	C	.	PASS	AF=0.468281;DESCR=Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.
chr7	87544351	rs1922242	A	T	.	PASS	AF=0.467975;DESCR=Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr7	87549310	rs2235013	C	T	.	PASS	AF=0.551873;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr7	87549770	rs2235035	G	A	.	PASS	AF=0.382930;DESCR=Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele G.
chr7	87549827	rs2235033	A	G	.	PASS	AF=0.551297;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr7	87550285	rs1128503	A	G	.	PASS	AF=0.633718;DESCR=Genotypes AG + GG are not associated with concentrations of desmethylcitalopram or escitalopram in people with Depressive Disorder, Major as compared to genotype AA.
chr7	87550493	rs2229109	C	T	.	PASS	AF=0.0279539;DESCR=Genotype CT is associated with increased resistance to doxorubicin, methotrexate, prednisolone and vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.
chr7	87550882	rs10276036	C	T	.	PASS	AF=0.633429;DESCR=Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.
chr7	87552102	rs6961665	C	A	.	PASS	AF=0.551873;DESCR=Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr7	87552102	rs6961665	C	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr7	87560614	rs868755	T	G	.	PASS	AF=0.668588;DESCR=Allele T is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele G.
chr7	87565790	rs1202170	C	T	.	PASS	AF=0.452450;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele T.
chr7	87570248	rs2235015	C	A	.	PASS	AF=0.222607;DESCR=Genotype AA is not associated with concentrations of desmethylcitalopram or escitalopram in people with Depressive Disorder, Major as compared to genotype CC.
chr7	87571770	rs2520464	C	T	.	PASS	AF=0.366935;DESCR=Genotype TT is not associated with dose of methadone in people with Heroin Dependence as compared to genotypes CC + CT.
chr7	87573299	rs10264990	C	T	.	PASS	AF=0.628028;DESCR=Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.
chr7	87581729	rs1202171	T	A	.	PASS	AF=0.666763;DESCR=Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr7	87589031	rs7802773	A	G	.	PASS	AF=0.441720;DESCR=Allele A is not associated with dose of opioids in people with Pain as compared to allele G.
chr7	87590165	rs13229143	G	C	.	PASS	AF=0.420369;DESCR=Allele C is not associated with dose of opioids in people with Pain as compared to allele G.
chr7	87591018	rs12535512	T	A	.	PASS	AF=0.00000;DESCR=Genotypes CC + CT are not associated with response to risperidone in people with Schizophrenia as compared to genotype TT.
chr7	87591018	rs12535512	T	C	.	PASS	AF=0.360150;DESCR=Genotypes CC + CT are not associated with response to risperidone in people with Schizophrenia as compared to genotype TT.
chr7	87591570	rs3789243	A	G	.	PASS	AF=0.423832;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr7	87600124	rs9282564	T	A	.	AC0	AF=0.00000;DESCR=Allele C is associated with decreased concentrations of methadone in people with Opioid-Related Disorders as compared to allele T.
chr7	87600124	rs9282564	T	C	.	PASS	AF=0.0178571;DESCR=Allele C is associated with decreased concentrations of methadone in people with Opioid-Related Disorders as compared to allele T.
chr7	87600877	rs3213619	A	G	.	PASS	AF=0.0219273;DESCR=Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.
chr7	87604286	rs4728709	G	A	.	PASS	AF=0.0603349;DESCR=Allele G is not associated with exposure to olanzapine in healthy individuals as compared to allele A.
chr7	87615644	rs13233308	C	T	.	PASS	AF=0.425894;DESCR=Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.
chr7	87649444	rs10267099	G	A	.	PASS	AF=0.779954;DESCR=Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.
chr7	87713270	rs3747802	A	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.
chr7	87713270	rs3747802	A	G	.	PASS	AF=0.000288351;DESCR=Allele A is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.
chr7	87714706	rs28656907	T	C	.	PASS	AF=0.418303;DESCR=Genotype TT is associated with increased dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes CC + CT.
chr7	92113414	rs7793861	C	G	.	PASS	AF=0.542701;DESCR=Allele G is associated with increased response to glibenclamide in people with as compared to allele C.
chr7	93375669	rs12672399	T	C	.	PASS	AF=0.148586;DESCR=Allele C is not associated with response to erenumab, fremanezumab or galcanezumab in people with Migraine without Aura or Migraine with Aura as compared to allele T.
chr7	93394909	rs4470942	A	G	.	PASS	AF=0.140427;DESCR=Allele G is not associated with response to erenumab, fremanezumab or galcanezumab in people with Migraine without Aura or Migraine with Aura as compared to allele A.
chr7	93502080	rs75252614	C	G	.	PASS	AF=0.0251010;DESCR=Allele G is not associated with response to erenumab, fremanezumab or galcanezumab in people with Migraine without Aura or Migraine with Aura as compared to allele C.
chr7	93502080	rs75252614	C	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to erenumab, fremanezumab or galcanezumab in people with Migraine without Aura or Migraine with Aura as compared to allele C.
chr7	95294544	rs854547	G	A	.	PASS	AF=0.595334;DESCR=Allele A is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr7	95308134	rs662	T	C	.	PASS	AF=0.322478;DESCR=Genotype CC is not associated with response to clopidogrel in people with Coronary Artery Disease as compared to genotype TT.
chr7	95316772	rs854560	A	T	.	PASS	AF=0.397288;DESCR=Allele A is not associated with response to clopidogrel as compared to allele T.
chr7	95432609	rs2299267	A	G	.	PASS	AF=0.159366;DESCR=Allele G is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele A.
chr7	98850871	rs1203844	C	T	.	PASS	AF=0.802480;DESCR=Allele C is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele T.
chr7	99647390	rs4646458	T	G	.	PASS	AF=0.0386167;DESCR=Allele G is associated with dose of tacrolimus in people with Kidney Transplantation as compared to allele T.
chr7	99647457	rs4646457	A	C	.	PASS	AF=0.0829971;DESCR=Allele C is associated with dose of tacrolimus in people with Kidney Transplantation as compared to allele A.
chr7	99648291	rs15524	A	G	.	PASS	AF=0.0781430;DESCR=Genotypes AG + GG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype AA.
chr7	99662739	rs4646453	C	A	.	PASS	AF=0.0386167;DESCR=Genotypes AA + AC is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype CC.
chr7	99665212	rs10264272	C	T	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele C.
chr7	99668695	rs4646450	G	A	.	PASS	AF=0.165418;DESCR=Genotype GG is associated with increased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AA + AG.
chr7	99668820	rs4646449	C	T	.	PASS	AF=0.0386390;DESCR=Genotype CC is associated with increased concentrations of tacrolimus in people with Kidney Transplantation as compared to genotypes CT + TT.
chr7	99669165	rs3800959	A	G	.	PASS	AF=0.000288018;DESCR=Allele A is not associated with dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to allele G.
chr7	99735325	rs45446698	T	G	.	PASS	AF=0.0288517;DESCR=Allele G is associated with increased metabolism of atorvastatin as compared to allele T.
chr7	99756491	rs12333983	T	A	.	PASS	AF=0.115562;DESCR=Allele A is associated with dose of tacrolimus in people with Kidney Transplantation as compared to allele T.
chr7	99758352	rs3735451	T	C	.	PASS	AF=0.115829;DESCR=Genotype CC is associated with decreased concentrations of hydroxychloroquine in people with Arthritis, Rheumatoid or Lupus Erythematosus, Systemic as compared to genotypes CT + TT.
chr7	99758352	rs3735451	T	G	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with decreased concentrations of hydroxychloroquine in people with Arthritis, Rheumatoid or Lupus Erythematosus, Systemic as compared to genotypes CT + TT.
chr7	99763247	rs4646440	G	A	.	PASS	AF=0.0115207;DESCR=Allele A is not associated with concentrations of carbamazepine in people with Epilepsy as compared to allele G.
chr7	99763843	rs2242480	C	T	.	PASS	AF=0.107493;DESCR=Allele T is not associated with metabolism of methadone in men with Heroin Dependence as compared to allele C.
chr7	99767460	rs4646437	G	A	.	PASS	AF=0.115407;DESCR=Genotypes AA + AG is not associated with increased dose-adjusted trough concentrations of voriconazole in children as compared to genotype GG.
chr7	99768096	rs2246709	A	G	.	PASS	AF=0.280277;DESCR=Genotypes AG + GG are associated with increased response to amlodipine in people with Hypertension as compared to genotype AA.
chr7	99768320	rs2687116	C	A	.	PASS	AF=0.948991;DESCR=Allele C is associated with increased response to carbamazepine, lamotrigine, phenytoin, primidone or valproic acid in children with Epilepsy as compared to allele A.
chr7	99768693	rs35599367	G	A	.	PASS	AF=0.0582133;DESCR=Genotype GG is associated with increased metabolism of tacrolimus in people with Kidney Transplantation as compared to genotypes AA + AG.
chr7	99784473	rs2740574	C	T	.	PASS	AF=0.953549;DESCR=Allele C is associated with decreased concentrations of cyclosporine or tacrolimus in people with Kidney Transplantation as compared to allele T.
chr7	99823462	rs62471956	G	A	.	PASS	AF=0.0591119;DESCR=Allele G is associated with decreased concentrations of ticagrelor in people with Acute coronary syndrome as compared to allele A.
chr7	99832220	rs651430	A	G	.	PASS	AF=0.491922;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr7	99857481	rs12535293	G	A	.	PASS	AF=0.00316820;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr7	99859982	rs680055	C	G	.	PASS	AF=0.0535714;DESCR=Genotype CG is associated with increased response to antipsychotics, aripiprazole, clozapine, haloperidol, olanzapine, quetiapine or risperidone in people with schizoaffective disorder or Schizophrenia as compared to genotype CC.
chr7	99862484	rs472660	G	A	.	PASS	AF=0.143516;DESCR=Genotype AA is associated with increased clearance of olanzapine in people with Schizophrenia as compared to genotypes AG + GG.
chr7	99862822	rs17161981	G	A	.	PASS	AF=0.00317003;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr7	99866195	rs17161983	A	G	.	PASS	AF=0.00462428;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr7	99876804	rs2572023	A	G	.	PASS	AF=0.445759;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr7	99879803	rs2527927	G	A	.	PASS	AF=0.382353;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr7	99941218	rs2527894	A	G	.	PASS	AF=0.511233;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr7	99953331	rs2527887	T	A	.	PASS	AF=0.337853;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.
chr7	99953331	rs2527887	T	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.
chr7	99980576	rs2525557	A	G	.	PASS	AF=0.972638;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr7	99985596	rs6960542	C	G	.	AC0	AF=0.00000;DESCR=Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.
chr7	99985596	rs6960542	C	T	.	PASS	AF=0.972062;DESCR=Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.
chr7	99986027	rs4729562	G	A	.	PASS	AF=0.729948;DESCR=Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.
chr7	100719675	rs1617640	C	A	.	PASS	AF=0.712846;DESCR=Genotype AA is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotypes AC + CC.
chr7	100892018	rs2571598	C	T	.	PASS	AF=0.432198;DESCR=Genotype TT is associated with increased response to rivastigmine in people with Alzheimer Disease as compared to genotypes CC + CT.
chr7	101126257	rs2227631	A	G	.	PASS	AF=0.453890;DESCR=Allele G is associated with decreased response to citalopram and fluoxetine in people with Depressive Disorder, Major as compared to allele A.
chr7	101252199	rs6942609	G	A	.	PASS	AF=0.138408;DESCR=Allele A is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele G.
chr7	103513015	rs3808035	A	C	.	PASS	AF=0.634737;DESCR=Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele A.
chr7	103513015	rs3808035	A	T	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele A.
chr7	103545430	rs362719	C	A	.	PASS	AF=0.203458;DESCR=Allele A is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele C.
chr7	103552085	rs2535764	C	T	.	PASS	AF=0.360358;DESCR=Allele T is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele C.
chr7	103566787	rs362726	T	C	.	PASS	AF=0.358627;DESCR=Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr7	103568581	rs362731	T	C	.	PASS	AF=0.467109;DESCR=Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr7	103574673	rs362814	T	A	.	PASS	AF=0.731369;DESCR=Allele A is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr7	103576772	rs362626	A	C	.	PASS	AF=0.719597;DESCR=Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele A.
chr7	103576772	rs362626	A	G	.	AC0	AF=0.00000;DESCR=Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele A.
chr7	103576772	rs362626	A	T	.	PASS	AF=0.0144009;DESCR=Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele A.
chr7	103581859	rs2237628	T	C	.	PASS	AF=0.486713;DESCR=Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr7	103756635	rs3819479	T	A	.	PASS	AF=0.249856;DESCR=Allele A is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr7	103764368	rs7341475	G	A	.	PASS	AF=0.211073;DESCR=Allele A is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele G.
chr7	103819488	rs39339	T	G	.	PASS	AF=0.214657;DESCR=Allele G is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr7	103936441	rs12705169	T	C	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr7	103936441	rs12705169	T	G	.	PASS	AF=0.233122;DESCR=Allele G is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.
chr7	105107452	rs117986340	G	T	.	PASS	AF=0.0288351;DESCR=Genotype GG is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotype GT.
chr7	106283804	rs3801266	T	C	.	PASS	AF=0.251009;DESCR=Allele C is not associated with response to Antihypertensives in women with Pregnancy as compared to allele T.
chr7	106285307	rs1319501	C	T	.	PASS	AF=0.768012;DESCR=Allele C is not associated with response to Antihypertensives in women with Pregnancy as compared to allele T.
chr7	110448995	rs11543791	T	C	.	PASS	AF=0.00605187;DESCR=Genotype CC is associated with decreased response to raloxifene in women Menopause and Schizophrenia as compared to genotypes CT + TT.
chr7	121985055	rs12154537	A	G	.	PASS	AF=0.507497;DESCR=Allele G is associated with increased response to escitalopram in people with Depressive Disorder, Major as compared to allele A.
chr7	127524904	rs6467136	A	G	.	PASS	AF=0.324394;DESCR=Genotypes AA + AG are not associated with response to repaglinide in people with Diabetes Mellitus, Type 2 as compared to genotype GG.
chr7	127606849	rs10229583	G	A	.	PASS	AF=0.174063;DESCR=Genotypes AA + AG are not associated with response to repaglinide or rosiglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype GG.
chr7	127606849	rs10229583	G	T	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG are not associated with response to repaglinide or rosiglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype GG.
chr7	128238730	rs7799039	G	A	.	PASS	AF=0.418203;DESCR=Allele A is not associated with exposure to olanzapine in healthy individuals as compared to allele G.
chr7	128238730	rs7799039	G	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with exposure to olanzapine in healthy individuals as compared to allele G.
chr7	128401285	rs4731448	A	G	.	PASS	AF=0.772046;DESCR=Genotype GG is associated with increased concentrations of methotrexate polyglutamate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AG.
chr7	128748594	rs2290228	G	A	.	PASS	AF=0.238754;DESCR=Genotype AA is associated with decreased dose of warfarin as compared to genotype GG.
chr7	128754552	rs2307040	C	T	.	PASS	AF=0.379608;DESCR=Genotype CT is not associated with increased dose of warfarin as compared to genotype CC.
chr7	128759170	rs339097	A	G	.	PASS	AF=0.00201729;DESCR=Allele G is associated with increased dose of warfarin.
chr7	128769171	rs1043550	A	G	.	PASS	AF=0.394297;DESCR=Genotype AA is not associated with increased dose of phenprocoumon as compared to genotypes AG + GG.
chr7	128769526	rs11653	T	A	.	PASS	AF=0.394297;DESCR=Allele T is not associated with dose of warfarin.
chr7	130496266	rs3807348	G	A	.	PASS	AF=0.538927;DESCR=Genotypes AA + AG is associated with increased response to cisplatin in people with Mesothelioma as compared to genotype GG.
chr7	137016561	rs8191992	T	A	.	PASS	AF=0.562284;DESCR=Allele A is associated with response to fluticasone/salmeterol in people with Asthma as compared to allele T.
chr7	137017188	rs6962027	T	A	.	PASS	AF=0.576457;DESCR=Allele A is associated with response to fluticasone/salmeterol in people with Asthma as compared to allele T.
chr7	137017188	rs6962027	T	G	.	PASS	AF=0.00000;DESCR=Allele A is associated with response to fluticasone/salmeterol in people with Asthma as compared to allele T.
chr7	139014844	rs7802493	T	C	.	PASS	AF=0.0210253;DESCR=Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.
chr7	147247997	rs11763492	G	A	.	PASS	AF=0.119446;DESCR=Allele A is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.
chr7	147252273	rs13223171	C	T	.	PASS	AF=0.121536;DESCR=Allele T is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.
chr7	150634289	rs34940374	G	A	.	PASS	AF=0.193836;DESCR=Allele A is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G.
chr7	150861278	rs12539	C	T	.	PASS	AF=0.157349;DESCR=Genotypes CT + TT are associated with increased response to cannabidiol in people with Epilepsy as compared to genotype CC.
chr7	150951110	rs1137617	A	G	.	PASS	AF=0.617579;DESCR=Genotype GG is not associated with response to candesartan, imidapril or irbesartan in people with Essential hypertension as compared to genotypes AA + AG.
chr7	150992991	rs2070744	C	T	.	PASS	AF=0.645245;DESCR=Genotype TT is not associated with response to salbutamol in healthy individuals as compared to genotypes CC + CT.
chr7	150999023	rs1799983	T	A	.	PASS	AF=0.00000;DESCR=Genotype GG is not associated with response to salbutamol in healthy individuals as compared to genotypes GT + TT.
chr7	150999023	rs1799983	T	G	.	PASS	AF=0.806582;DESCR=Genotype GG is not associated with response to salbutamol in healthy individuals as compared to genotypes GT + TT.
chr7	151717955	rs10224002	A	G	.	PASS	AF=0.395208;DESCR=Allele A is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to allele G.
chr7	151803293	rs4725434	C	T	.	PASS	AF=0.323343;DESCR=Allele T is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr7	151807373	rs13224758	G	A	.	PASS	AF=0.131048;DESCR=Allele G is associated with increased response to rivaroxaban in people with Atrial Fibrillation as compared to allele A.
chr7	151807412	rs12703159	C	T	.	PASS	AF=0.138249;DESCR=Allele C is associated with increased response to rivaroxaban in people with Atrial Fibrillation as compared to allele T.
chr7	154385759	rs887929	C	T	.	PASS	AF=0.0630760;DESCR=Genotype TT is not associated with concentrations of deferasirox in people with beta-Thalassemia as compared to genotypes CT + TT.
chr7	156182007	rs6961071	A	G	.	PASS	AF=0.524235;DESCR=Genotype GG is associated with increased response to fentanyl in people with Pain, Postoperative as compared to genotypes AA + AG.
chr7	157087704	rs6966038	A	G	.	PASS	AF=0.192795;DESCR=Allele G is associated with increased response to citalopram in people with Depressive Disorder, Major as compared to allele A.
chr7	157539478	rs221253	T	C	.	PASS	AF=0.971486;DESCR=Allele C is associated with response to olanzapine in people with Schizophrenia.
chr7	158532811	rs4909237	C	T	.	PASS	AF=0.148875;DESCR=Genotype TT are not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma.
chr7	158733764	rs1061735	G	A	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr7	158733764	rs1061735	G	T	.	PASS	AF=0.227063;DESCR=Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr8	2952059	rs11993031	T	A	.	PASS	AF=0.415611;DESCR=Allele T is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele A.
chr8	3045498	rs7387065	A	G	.	PASS	AF=0.343606;DESCR=Allele A is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele G.
chr8	3045498	rs7387065	A	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele G.
chr8	3217516	rs6981827	C	T	.	PASS	AF=0.0677233;DESCR=Allele T is associated with decreased response to anastrozole in women with Breast Neoplasms as compared to allele C.
chr8	3269991	rs6990851	A	G	.	PASS	AF=0.188184;DESCR=Allele G is associated with increased response to anastrozole in women with Breast Neoplasms as compared to allele A.
chr8	3912168	rs2954625	C	G	.	PASS	AF=0.00000;DESCR=Genotypes CT + TT are associated with decreased response to metformin in people with Diabetes Mellitus as compared to genotype CC.
chr8	3912168	rs2954625	C	T	.	PASS	AF=0.195389;DESCR=Genotypes CT + TT are associated with decreased response to metformin in people with Diabetes Mellitus as compared to genotype CC.
chr8	4606687	rs2617102	A	C	.	PASS	AF=0.0961982;DESCR=Genotypes AC + CC is associated with decreased response to metformin in people with Diabetes Mellitus as compared to genotype AA.
chr8	4606687	rs2617102	A	G	.	PASS	AF=0.00000;DESCR=Genotypes AC + CC is associated with decreased response to metformin in people with Diabetes Mellitus as compared to genotype AA.
chr8	4610006	rs17070785	A	G	.	PASS	AF=0.157439;DESCR=Allele A is associated with response to olanzapine in people with Schizophrenia.
chr8	6507401	rs2515409	T	C	.	PASS	AF=0.100518;DESCR=Allele C is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele T.
chr8	6516544	rs10102851	A	G	.	PASS	AF=0.0204729;DESCR=Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.
chr8	6526078	rs2515462	A	G	.	PASS	AF=0.723859;DESCR=Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.
chr8	6538388	rs11989215	G	A	.	PASS	AF=0.644380;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr8	6538388	rs11989215	G	C	.	AC0	AF=0.00000;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr8	6538388	rs11989215	G	T	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr8	6539242	rs13269021	G	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.
chr8	6539242	rs13269021	G	T	.	PASS	AF=0.308069;DESCR=Allele T is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.
chr8	6539349	rs1375668	G	A	.	PASS	AF=0.669262;DESCR=Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.
chr8	6539349	rs1375668	G	C	.	PASS	AF=0.000288351;DESCR=Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.
chr8	6644838	rs17570753	T	A	.	PASS	AF=0.123343;DESCR=Allele A is associated with response to perphenazine in people with Schizophrenia.
chr8	6646795	rs11774231	C	T	.	PASS	AF=0.119528;DESCR=Allele C is associated with response to perphenazine in people with Schizophrenia.
chr8	11486464	rs2736340	C	T	.	PASS	AF=0.143804;DESCR=Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.
chr8	11742061	rs10090884	A	C	.	PASS	AF=0.0685879;DESCR=Genotype AA is not associated with dose of warfarin as compared to genotypes AC + CC.
chr8	11749887	rs3735814	G	A	.	PASS	AF=0.336023;DESCR=Genotypes AG + GG are not associated with decreased dose of phenprocoumon as compared to genotype AA.
chr8	11751907	rs2645400	T	G	.	PASS	AF=0.361432;DESCR=Genotype TT is associated with increased dose of warfarin as compared to genotypes GG + GT.
chr8	11754872	rs13273672	T	C	.	PASS	AF=0.213214;DESCR=Genotype CC is associated with decreased clinical benefit to Drugs used in alcohol dependence in people with Alcoholism as compared to genotypes CT + TT.
chr8	11756716	rs4841588	G	T	.	PASS	AF=0.122984;DESCR=Genotype TT is associated with increased dose of warfarin as compared to genotypes GG + GT.
chr8	18214398	rs13253389	A	G	.	PASS	AF=0.658790;DESCR=Genotypes AG + GG is associated with increased concentrations of cotinine in children as compared to genotype AA.
chr8	18214398	rs13253389	A	T	.	AC0	AF=0.00000;DESCR=Genotypes AG + GG is associated with increased concentrations of cotinine in children as compared to genotype AA.
chr8	18390208	rs4646244	T	A	.	PASS	AF=0.315167;DESCR=Genotype AT is associated with decreased clearance of isoniazid in people with Tuberculosis as compared to genotype TT.
chr8	18400593	rs1799930	G	A	.	PASS	AF=0.361512;DESCR=Genotype AA is associated with decreased clearance of isoniazid in people with Tuberculosis as compared to genotype GG.
chr8	18400593	rs1799930	G	C	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with decreased clearance of isoniazid in people with Tuberculosis as compared to genotype GG.
chr8	18415371	rs1495741	G	A	.	PASS	AF=0.831892;DESCR=Genotypes AG + GG is associated with decreased clinical benefit to iguratimod in people with Arthritis, Rheumatoid as compared to genotype AA.
chr8	19948197	rs1801177	G	A	.	PASS	AF=0.00489914;DESCR=Allele A is not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to allele G.
chr8	19948197	rs1801177	G	C	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to allele G.
chr8	19948197	rs1801177	G	T	.	AC0	AF=0.00000;DESCR=Allele A is not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to allele G.
chr8	19961566	rs320	T	G	.	PASS	AF=0.377810;DESCR=Genotype GG is associated with decreased response to fenofibrate in people with Hypertriglyceridemia as compared to genotypes GT + TT.
chr8	19962213	rs328	C	G	.	PASS	AF=0.105248;DESCR=Genotype GG is associated with increased response to pravastatin as compared to genotypes CC + CG.
chr8	21693288	rs1128397	A	T	.	PASS	AF=0.424251;DESCR=Allele A is associated with decreased response to clozapine in people with Schizophrenia as compared to allele T.
chr8	21718897	rs13250096	C	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with decreased response to clozapine in people with Schizophrenia as compared to allele G.
chr8	21718897	rs13250096	C	G	.	AS_VQSR	AF=0.114697;DESCR=Allele C is associated with decreased response to clozapine in people with Schizophrenia as compared to allele G.
chr8	21722498	rs4567028	G	A	.	PASS	AF=0.727666;DESCR=Allele G is associated with decreased response to clozapine in people with Schizophrenia as compared to allele A.
chr8	22371315	rs17060812	C	T	.	PASS	AF=0.0386390;DESCR=Allele C is associated with increased response to nortriptyline in people with Depression as compared to allele T.
chr8	22927888	rs17685420	C	G	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr8	22927888	rs17685420	C	T	.	PASS	AF=0.278386;DESCR=Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr8	23191779	rs2230229	C	T	.	PASS	AF=0.888697;DESCR=Genotype TT is not associated with response to rituximab in people with Lymphoma, Follicular as compared to genotypes CC + CT.
chr8	23200707	rs20576	T	G	.	PASS	AF=0.203982;DESCR=Genotype TT is not associated with response to rituximab in people with Lymphoma, Follicular as compared to genotypes GG + GT.
chr8	23201811	rs20575	C	G	.	PASS	AF=0.493952;DESCR=Genotype GG is not associated with response to rituximab in people with Lymphoma, Follicular as compared to genotypes CC + CG.
chr8	23512505	rs11782370	C	T	.	PASS	AF=0.276399;DESCR=Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.
chr8	23760950	rs310279	A	G	.	PASS	AF=0.205357;DESCR=Genotypes AG + GG is associated with increased dose of warfarin in people with heart valve replacement as compared to genotype AA.
chr8	26770511	rs1048101	A	G	.	PASS	AF=0.492507;DESCR=Genotypes AA + AG are associated with increased response to nifedipine in people with Hypertension as compared to genotype GG.
chr8	27470994	rs2472553	G	A	.	PASS	AF=0.0550432;DESCR=Allele A is not associated with response to bupropion, nicotine or varenicline in people with Tobacco Use Disorder as compared to allele G.
chr8	27470994	rs2472553	G	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to bupropion, nicotine or varenicline in people with Tobacco Use Disorder as compared to allele G.
chr8	27567179	rs59724122	C	T	.	PASS	AF=0.184620;DESCR=Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.
chr8	31034997	rs2725335	G	A	.	PASS	AF=0.0279700;DESCR=Allele A is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.
chr8	31167138	rs1346044	T	C	.	PASS	AF=0.200865;DESCR=Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele T.
chr8	31622107	rs10954808	A	G	.	PASS	AF=0.228662;DESCR=Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chr8	32460401	rs17716295	C	A	.	PASS	AF=0.285920;DESCR=Allele A is associated with decreased response to antipsychotics in people with Schizophrenia as compared to allele C.
chr8	32535292	rs13250975	A	G	.	PASS	AF=0.229971;DESCR=Allele G is associated with increased response to antipsychotics in people with Schizophrenia as compared to allele A.
chr8	40544855	rs1367094	C	T	.	PASS	AF=1.00000;DESCR=Allele T is associated with increased response to atenolol or metoprolol in people with Hypertension as compared to allele C.
chr8	42695355	rs6474412	C	T	.	PASS	AF=0.705357;DESCR=Allele C is not associated with concentrations of 3-hydroxycotinine, cotinine or nicotine in people with Tobacco Use Disorder as compared to allele T.
chr8	42695921	rs6474413	C	T	.	PASS	AF=0.706001;DESCR=Allele T is not associated with response to bupropion, nicotine or varenicline in people with Tobacco Use Disorder as compared to allele C.
chr8	42697490	rs4950	G	A	.	PASS	AF=0.703693;DESCR=Allele G is associated with increased response to nicotine in smokers as compared to allele A.
chr8	42704443	rs13280604	G	A	.	PASS	AF=0.702656;DESCR=Allele G is associated with increased response to nicotine in smokers as compared to allele A.
chr8	42751043	rs9298629	G	A	.	PASS	AF=0.000866051;DESCR=Allele T is not associated with response to nicotine in women as compared to allele G.
chr8	42751043	rs9298629	G	T	.	PASS	AF=0.221098;DESCR=Allele T is not associated with response to nicotine in women as compared to allele G.
chr8	42753056	rs2304297	G	C	.	PASS	AF=0.278098;DESCR=Allele C is not associated with response to nicotine in women as compared to allele G.
chr8	42763303	rs2217732	A	G	.	PASS	AF=0.226932;DESCR=Allele G is not associated with response to nicotine in women as compared to allele A.
chr8	42764858	rs1072003	C	G	.	PASS	AF=0.211073;DESCR=Allele G is not associated with response to nicotine in women as compared to allele C.
chr8	53226264	rs16918842	C	A	.	PASS	AF=0.00000;DESCR=Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele C.
chr8	53226264	rs16918842	C	T	.	PASS	AF=0.148906;DESCR=Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele C.
chr8	53228388	rs3802279	C	T	.	PASS	AF=0.180403;DESCR=Genotype CC is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes CT + TT.
chr8	53228603	rs3802281	T	C	.	PASS	AF=0.201441;DESCR=Genotype TT is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes CC + CT.
chr8	53229264	rs963549	C	T	.	PASS	AF=0.192684;DESCR=Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele C.
chr8	53229594	rs16918875	G	A	.	PASS	AF=0.0201729;DESCR=Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.
chr8	53229597	rs702764	T	C	.	PASS	AF=0.192441;DESCR=Genotype CC is associated with increased response to butorphanol in healthy individuals as compared to genotypes CT + TT.
chr8	53229597	rs702764	T	G	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to butorphanol in healthy individuals as compared to genotypes CT + TT.
chr8	53237474	rs16918909	A	G	.	PASS	AF=0.252598;DESCR=Allele G is not associated with response to heroin as compared to allele A.
chr8	53239818	rs997917	T	C	.	PASS	AF=0.486751;DESCR=Allele C is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele T.
chr8	53240422	rs6473797	T	C	.	PASS	AF=0.466571;DESCR=Allele C is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele T.
chr8	53240563	rs6473799	A	G	.	PASS	AF=0.466571;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr8	53244114	rs7813478	T	C	.	PASS	AF=0.109636;DESCR=Allele C is not associated with response to heroin as compared to allele T.
chr8	53248142	rs16918941	A	G	.	PASS	AF=0.0807848;DESCR=Allele A is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele G.
chr8	53248556	rs6985606	T	C	.	PASS	AF=0.639931;DESCR=Allele T is not associated with response to heroin as compared to allele C.
chr8	53251002	rs1051660	C	A	.	PASS	AF=0.109798;DESCR=Allele A is not associated with response to butorphanol in healthy individuals as compared to allele C.
chr8	53251002	rs1051660	C	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to butorphanol in healthy individuals as compared to allele C.
chr8	53252242	rs3808627	C	T	.	PASS	AF=0.147904;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr8	54638367	rs374527	G	T	.	PASS	AF=0.229058;DESCR=Allele G is not associated with response to efavirenz in people with HIV Infections as compared to allele T.
chr8	55911999	rs1546519	G	A	.	PASS	AF=0.640922;DESCR=Allele G is associated with response to ziprasidone in people with Schizophrenia.
chr8	58500365	rs3808607	G	T	.	PASS	AF=0.653780;DESCR=Genotype GG is not associated with response to atorvastatin as compared to genotype TT.
chr8	63015187	rs17279558	T	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr8	63015187	rs17279558	T	C	.	PASS	AF=0.122120;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr8	63026205	rs11545078	G	A	.	PASS	AF=0.122261;DESCR=Genotypes AA + AG is associated with increased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.
chr8	63029783	rs12681874	C	T	.	PASS	AF=0.206221;DESCR=Allele T is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.
chr8	63038678	rs11545077	C	T	.	PASS	AF=0.256344;DESCR=Genotypes CC + CT are associated with increased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype TT.
chr8	63038753	rs1800909	A	G	.	PASS	AF=0.279123;DESCR=Allele G is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.
chr8	63038892	rs11545076	A	C	.	PASS	AF=0.278291;DESCR=Genotypes AC + CC are associated with increased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.
chr8	63039122	rs719235	C	A	.	PASS	AF=0.212270;DESCR=Allele A is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.
chr8	63039122	rs719235	C	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.
chr8	63039169	rs3758149	G	A	.	PASS	AF=0.278963;DESCR=Genotypes AA + AG are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.
chr8	63040622	rs10464903	C	T	.	PASS	AF=0.0838617;DESCR=Allele T is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.
chr8	63999464	rs3850736	C	G	.	PASS	AF=0.466763;DESCR=Allele G is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.
chr8	64044325	rs2356369	T	A	.	AC0;AS_VQSR	AF=0.00000;DESCR=Allele C is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.
chr8	64044325	rs2356369	T	C	.	PASS	AF=0.467227;DESCR=Allele C is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.
chr8	64044325	rs2356369	T	G	.	AC0	AF=0.00000;DESCR=Allele C is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.
chr8	64069102	rs7841320	G	A	.	PASS	AF=0.467398;DESCR=Allele A is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G.
chr8	66280144	rs4737771	T	C	.	PASS	AF=0.0682604;DESCR=Allele C is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr8	67747912	rs2162145	T	C	.	PASS	AF=0.720622;DESCR=Allele T is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.
chr8	68961217	rs16935279	T	C	.	PASS	AF=0.0265283;DESCR=Genotypes CC + CT are associated with decreased metabolism of antiepileptics in people with Bipolar Disorder and Psychotic Disorders as compared to genotype TT.
chr8	73989727	rs11465996	C	G	.	PASS	AF=0.131852;DESCR=Genotypes CG + GG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.
chr8	74560988	rs2891356	A	G	.	PASS	AF=0.669067;DESCR=Allele G is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele A.
chr8	74562294	rs746460	C	T	.	PASS	AF=0.669164;DESCR=Allele T is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele C.
chr8	74566177	rs4476990	T	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele C.
chr8	74566177	rs4476990	T	C	.	PASS	AF=0.669355;DESCR=Allele G is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele C.
chr8	74566177	rs4476990	T	G	.	PASS	AF=0.00000;DESCR=Allele G is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele C.
chr8	74567389	rs13260300	C	T	.	PASS	AF=0.669937;DESCR=Allele T is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele C.
chr8	74602319	rs4735715	G	A	.	PASS	AF=0.757209;DESCR=Allele A is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele G.
chr8	74603964	rs3802201	G	C	.	PASS	AF=0.756912;DESCR=Allele C is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele G.
chr8	78800763	rs16906115	G	A	.	PASS	AF=0.0817972;DESCR=Genotype AA is associated with decreased clinical benefit to atezolizumab and bevacizumab in people with Carcinoma, Hepatocellular as compared to genotypes AG + GG.
chr8	79644265	rs113889867	G	A	.	PASS	AF=0.0974063;DESCR=Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.
chr8	88535703	rs10504861	C	T	.	PASS	AF=0.175995;DESCR=Allele C is associated with increased response to Angiotensin II Antagonists in people with Migraine with Aura or Migraine without Aura as compared to allele T.
chr8	97154685	rs1835740	T	C	.	PASS	AF=0.766417;DESCR=Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele T.
chr8	102187808	rs1265138	A	G	.	PASS	AF=0.0971742;DESCR=Genotype AA is associated with increased response to cladribine and cytarabine in children with Leukemia, Myeloid, Acute as compared to genotypes AG + GG.
chr8	102226603	rs2607658	G	C	.	PASS	AF=0.00000;DESCR=Genotypes GG + GT is associated with increased concentrations of telbivudine in people with Hepatitis B, Chronic as compared to genotype TT.
chr8	102226603	rs2607658	G	T	.	PASS	AF=0.499711;DESCR=Genotypes GG + GT is associated with increased concentrations of telbivudine in people with Hepatitis B, Chronic as compared to genotype TT.
chr8	107371097	rs2445365	G	A	.	PASS	AF=0.282584;DESCR=Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.
chr8	112812829	rs2432742	A	G	.	PASS	AF=0.258213;DESCR=Allele A is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.
chr8	117172544	rs13266634	C	A	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to metformin in people with high risk of developing diabetes as compared to allele T.
chr8	117172544	rs13266634	C	T	.	PASS	AF=0.262824;DESCR=Allele C is not associated with response to metformin in people with high risk of developing diabetes as compared to allele T.
chr8	119580575	rs7832704	G	A	.	PASS	AF=0.152425;DESCR=Genotype AA is associated with increased dose of opioids in people with Pain, Postoperative as compared to genotypes AG + GG.
chr8	119593412	rs2249015	G	A	.	PASS	AF=0.141869;DESCR=Genotype AA is associated with increased dose of opioids in people with Pain, Postoperative as compared to genotypes AG + GG.
chr8	121927683	rs11995962	C	T	.	PASS	AF=0.0452710;DESCR=Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.
chr8	122883055	rs17289471	T	C	.	PASS	AF=0.605825;DESCR=Allele C is associated with increased response to peginterferon alfa-2a in people with Hepatitis B virus infection as compared to allele T.
chr8	127401060	rs6983267	G	T	.	PASS	AF=0.506336;DESCR=Allele T is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele G.
chr8	127402647	rs7013278	T	C	.	PASS	AF=0.636809;DESCR=Allele T is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele C.
chr8	127412547	rs7014346	A	G	.	PASS	AF=0.637097;DESCR=Allele A is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele G.
chr8	127735225	rs4645943	C	T	.	PASS	AF=0.0576701;DESCR=Genotypes CT + TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotype CC.
chr8	127739080	rs4645962	T	C	.	PASS	AF=0.00000;DESCR=Genotype CT is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype TT.
chr8	127742443	rs4645974	C	G	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CT + TT.
chr8	127742443	rs4645974	C	T	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CT + TT.
chr8	128008933	rs2114358	G	A	.	PASS	AF=0.584824;DESCR=Allele A is associated with increased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele G.
chr8	135413336	rs72732317	G	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with decreased metabolism of tramadol as compared to allele G.
chr8	135413336	rs72732317	G	T	.	PASS	AF=0.00201962;DESCR=Allele T is associated with decreased metabolism of tramadol as compared to allele G.
chr8	142918184	rs1799998	A	G	.	PASS	AF=0.541811;DESCR=Genotypes AA + AG are associated with increased response to benazepril or imidapril in people with Essential hypertension as compared to genotype GG.
chr8	142918184	rs1799998	A	T	.	PASS	AF=0.00000;DESCR=Genotypes AA + AG are associated with increased response to benazepril or imidapril in people with Essential hypertension as compared to genotype GG.
chr9	5074189	rs12343867	T	C	.	PASS	AF=0.255184;DESCR=Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotype TT.
chr9	6556839	rs10975641	C	G	.	PASS	AF=0.288184;DESCR=Allele G is associated with increased response to citalopram and escitalopram in people with Depressive Disorder, Major as compared to allele C.
chr9	8176226	rs10739150	T	G	.	PASS	AF=0.858871;DESCR=Genotypes GG + GT are associated with increased response to atenolol in people with Hypertension as compared to genotype TT.
chr9	8879118	rs17584499	C	T	.	PASS	AF=0.152362;DESCR=Genotype CC is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotypes CT + TT.
chr9	9059545	rs324498	G	A	.	PASS	AF=0.811636;DESCR=Allele G is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele A.
chr9	9687487	rs4742610	C	G	.	PASS	AF=0.00000;DESCR=Allele T is associated with resistance to trandolapril and verapamil in people with Hypertension as compared to allele C.
chr9	9687487	rs4742610	C	T	.	PASS	AF=0.382234;DESCR=Allele T is associated with resistance to trandolapril and verapamil in people with Hypertension as compared to allele C.
chr9	11018077	rs12346562	C	A	.	PASS	AF=0.378893;DESCR=Genotypes AA + AC is associated with increased response to atenolol in people with Hypertension as compared to genotype CC.
chr9	11028275	rs1104514	A	G	.	PASS	AF=0.601729;DESCR=Genotypes AA + AG are associated with increased response to atenolol in people with Hypertension as compared to genotype GG.
chr9	14087770	rs7858	C	T	.	PASS	AF=0.165513;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr9	14163908	rs28379954	T	C	.	PASS	AF=0.0331795;DESCR=Allele C is not associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to allele T.
chr9	20405632	rs10964552	C	A	.	PASS	AF=0.163112;DESCR=Genotypes AA + AC are associated with decreased response to cisplatin in people with Urinary Bladder Neoplasms as compared to genotype CC.
chr9	20497144	rs6475448	G	A	.	PASS	AF=0.619446;DESCR=Genotype AA is associated with increased response to montelukast in people with Asthma as compared to genotype GG.
chr9	21077717	rs1051922	G	A	.	PASS	AF=0.314697;DESCR=Allele G is not associated with decreased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele A.
chr9	22003368	rs1063192	G	A	.	PASS	AF=0.715482;DESCR=Allele G is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele A.
chr9	22056500	rs10120688	G	A	.	PASS	AF=0.612009;DESCR=Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.
chr9	22125504	rs1333049	G	C	.	PASS	AF=0.577233;DESCR=Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.
chr9	27561051	rs774359	T	C	.	PASS	AF=0.205187;DESCR=Genotypes CC + CT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype TT.
chr9	34710263	rs2812378	G	A	.	PASS	AF=0.728374;DESCR=Allele A is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.
chr9	35704153	rs10814270	C	T	.	PASS	AF=0.0467128;DESCR=Allele T is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele C.
chr9	35712006	rs2295795	G	A	.	PASS	AF=0.288639;DESCR=Allele A is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele G.
chr9	38643999	rs1890109	A	G	.	PASS	AF=0.218984;DESCR=Genotypes AG + GG is associated with increased dose of warfarin in people with heart valve replacement as compared to genotype AA.
chr9	71336039	rs2043144	T	C	.	PASS	AF=0.992800;DESCR=Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.
chr9	72930966	rs13959	G	A	.	PASS	AF=0.447550;DESCR=Genotypes AG + GG is associated with increased clinical benefit to cyclophosphamide, doxorubicin, FEC100 or fluorouracil in people with Breast Neoplasms.
chr9	76389297	rs11144870	C	T	.	PASS	AF=0.227378;DESCR=Allele T is associated with decreased response to citalopram or escitalopram in people with Depressive Disorder, Major as compared to allele C.
chr9	80329287	rs17180299	A	G	.	PASS	AF=0.0731567;DESCR=Genotypes AG + GG are associated with increased concentrations of methadone in people with Opioid-Related Disorders as compared to genotype AA.
chr9	84284969	rs4877831	C	A	.	PASS	AF=0.00000;DESCR=Genotype GG is not associated with metabolism of gemcitabine as compared to genotypes CC + CG.
chr9	84284969	rs4877831	C	G	.	PASS	AF=0.277810;DESCR=Genotype GG is not associated with metabolism of gemcitabine as compared to genotypes CC + CG.
chr9	84286011	rs7853758	G	A	.	PASS	AF=0.222190;DESCR=Genotype GG is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AA + AG.
chr9	84302386	rs10868138	T	C	.	PASS	AF=0.0662824;DESCR=Genotype TT is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CT.
chr9	84305321	rs7867504	T	C	.	PASS	AF=0.362248;DESCR=Genotype CC is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.
chr9	84331158	rs17343066	G	A	.	PASS	AF=0.551555;DESCR=Genotype AA is associated with increased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotypes AG + GG.
chr9	84671000	rs1187326	C	G	.	AC0	AF=0.00000;DESCR=Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.
chr9	84671000	rs1187326	C	T	.	PASS	AF=0.769452;DESCR=Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.
chr9	84673278	rs1439050	G	A	.	PASS	AF=0.00000;DESCR=Allele G is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr9	84673278	rs1439050	G	T	.	PASS	AF=0.334968;DESCR=Allele G is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr9	84673625	rs1187327	T	C	.	PASS	AF=0.562248;DESCR=Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.
chr9	84678542	rs1187352	T	A	.	AC0	AF=0.00000;DESCR=Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr9	84678542	rs1187352	T	C	.	PASS	AF=0.650058;DESCR=Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr9	84707625	rs1778929	T	C	.	PASS	AF=0.500865;DESCR=Genotype TT is associated with decreased response to clozapine in people with Schizophrenia as compared to genotypes CC + CT.
chr9	84709496	rs1778933	C	G	.	AC0;AS_VQSR	AF=0.00000;DESCR=Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr9	84709496	rs1778933	C	T	.	PASS	AF=0.647229;DESCR=Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr9	84777667	rs10465180	C	T	.	PASS	AF=0.658501;DESCR=Genotype CC is associated with decreased response to clozapine in people with Schizophrenia as compared to genotypes CT + TT.
chr9	84841436	rs2120266	G	A	.	PASS	AF=0.155133;DESCR=Genotype AA is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes AG + GG.
chr9	84948455	rs2289658	T	C	.	PASS	AF=0.0250576;DESCR=Genotypes CC + CT are associated with increased dose of methadone in people with Heroin Dependence as compared to genotype TT.
chr9	84948545	rs2289657	C	A	.	PASS	AF=0.0210496;DESCR=Allele A is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele C.
chr9	84948545	rs2289657	C	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele C.
chr9	84948647	rs2289656	G	A	.	PASS	AF=0.247839;DESCR=Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.
chr9	84955089	rs3824519	C	T	.	PASS	AF=0.0273775;DESCR=Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.
chr9	84986054	rs4358872	T	G	.	PASS	AF=0.548127;DESCR=Genotype GG is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes GT + TT.
chr9	85001342	rs1948308	G	A	.	PASS	AF=0.537464;DESCR=Genotype GG is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes AA + AG.
chr9	85001342	rs1948308	G	T	.	PASS	AF=0.00000;DESCR=Genotype GG is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes AA + AG.
chr9	85002156	rs1565445	G	A	.	PASS	AF=0.744085;DESCR=Genotype AA is not associated with response to lithium or valproic acid in people with Bipolar Disorder as compared to genotypes AG + GG.
chr9	85004508	rs2378676	A	C	.	PASS	AF=0.534006;DESCR=Genotype AA is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes AC + CC.
chr9	85017403	rs4877900	C	T	.	PASS	AF=0.569204;DESCR=Genotype CC is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes CT + TT.
chr9	85025721	rs1387923	A	G	.	PASS	AF=0.557604;DESCR=Genotype AA is associated with increased response to lithium in people with Bipolar Disorder.
chr9	85297756	rs2769605	C	T	.	PASS	AF=0.536599;DESCR=Genotype CC is associated with decreased response to lithium or valproic acid in people with Bipolar Disorder as compared to genotypes CT + TT.
chr9	86348093	rs17461620	C	T	.	PASS	AF=0.341878;DESCR=Allele C is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele T.
chr9	87620879	rs11141915	A	C	.	PASS	AF=0.166186;DESCR=Allele A is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele C.
chr9	95956391	rs689979	T	C	.	PASS	AF=0.551933;DESCR=Allele T is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.
chr9	96023994	rs238	A	G	.	PASS	AF=0.544983;DESCR=Allele A is associated with decreased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.
chr9	97697296	rs1800975	T	C	.	PASS	AF=0.631912;DESCR=Genotype CC is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CT + TT.
chr9	100301363	rs10123866	G	A	.	PASS	AF=0.504611;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr9	100301363	rs10123866	G	C	.	AC0	AF=0.00000;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr9	100302248	rs7472	G	A	.	PASS	AF=0.497111;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr9	100302983	rs10124893	G	A	.	PASS	AF=0.496241;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr9	100302983	rs10124893	G	C	.	PASS	AF=0.00000;DESCR=Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr9	100309102	rs7035619	A	T	.	PASS	AF=0.503749;DESCR=Allele A is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.
chr9	100311309	rs6479008	C	A	.	PASS	AF=0.503753;DESCR=Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.
chr9	100349683	rs10989064	C	T	.	PASS	AF=0.503746;DESCR=Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr9	101570213	rs7030238	A	C	.	PASS	AF=0.214862;DESCR=Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr9	101570761	rs1983812	T	C	.	PASS	AF=0.472062;DESCR=Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr9	101670591	rs942142	T	C	.	PASS	AF=0.00000;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr9	101670591	rs942142	T	G	.	PASS	AF=0.434582;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.
chr9	101670752	rs10512285	A	G	.	PASS	AF=0.434582;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr9	101733129	rs3983721	C	T	.	PASS	AF=0.415850;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr9	104800523	rs2230808	T	C	.	PASS	AF=0.746398;DESCR=Genotype CC is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.
chr9	104858586	rs2230806	C	T	.	PASS	AF=0.276369;DESCR=Allele T is associated with decreased response to atorvastatin, rosuvastatin or simvastatin as compared to allele C.
chr9	104883196	rs12003906	G	T	.	PASS	AF=0.0769452;DESCR=Allele C is associated with decreased response to atorvastatin, pravastatin or simvastatin in people with Hyperlipidemias as compared to allele G.
chr9	104941653	rs2487032	G	A	.	PASS	AF=0.620531;DESCR=Allele A is associated with decreased response to clopidogrel in people with Coronary Artery Disease as compared to allele G.
chr9	107487224	rs2236599	C	T	.	PASS	AF=0.247836;DESCR=Allele C is associated with increased response to hydroxyurea in people with Anemia, Sickle Cell and beta-Thalassemia as compared to allele T.
chr9	108212718	rs10512361	T	C	.	PASS	AF=0.149482;DESCR=Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.
chr9	114341693	rs2250242	A	G	.	PASS	AF=0.393703;DESCR=Genotype AA is associated with increased clearance of docetaxel in men with Prostatic Neoplasms as compared to genotypes AG + GG.
chr9	116490350	rs6478241	A	G	.	PASS	AF=0.631932;DESCR=Allele A is not associated with response to Selective serotonin (5HT1) agonists in people with Migraine without Aura as compared to allele G.
chr9	117194009	rs7858836	T	C	.	PASS	AF=0.663495;DESCR=Genotypes CT + TT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype CC.
chr9	117196574	rs958804	T	C	.	PASS	AF=0.270029;DESCR=Genotypes CC + CT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype TT.
chr9	117700861	rs2770150	A	G	.	PASS	AF=0.242354;DESCR=Genotype GG is associated with decreased response to Pertussis vaccines in children as compared to genotype AG.
chr9	117710486	rs1927907	C	T	.	PASS	AF=0.153668;DESCR=Allele T is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele C.
chr9	117712004	rs5030728	G	A	.	PASS	AF=0.244515;DESCR=Genotypes AA + AG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammatory Bowel Diseases as compared to genotype GG.
chr9	117713024	rs4986790	A	G	.	PASS	AF=0.0697005;DESCR=Genotype AA is associated with increased response to Pertussis vaccines in children as compared to genotypes AG + GG.
chr9	117713024	rs4986790	A	T	.	PASS	AF=0.00000;DESCR=Genotype AA is associated with increased response to Pertussis vaccines in children as compared to genotypes AG + GG.
chr9	117713324	rs4986791	C	T	.	PASS	AF=0.0513264;DESCR=Allele T is associated with decreased clinical benefit to prednisolone in children with Thrombocytopenia as compared to allele C.
chr9	117718534	rs1554973	T	C	.	PASS	AF=0.311924;DESCR=Genotypes CC + CT is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammatory Bowel Diseases as compared to genotype TT.
chr9	120927961	rs3761847	G	A	.	PASS	AF=0.663306;DESCR=Allele G is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele A.
chr9	122370243	rs10306114	A	G	.	PASS	AF=0.0700288;DESCR=Genotype AG is associated with decreased response to latanoprost in people with Glaucoma, Open-Angle as compared to genotype AA.
chr9	122371228	rs3842787	C	T	.	PASS	AF=0.0688364;DESCR=Allele T is not associated with response to aspirin as compared to allele C.
chr9	122375416	rs10306135	A	T	.	PASS	AF=0.140058;DESCR=Genotype AA is not associated with response to ketoprofen in people with Pain, Postoperative as compared to genotypes AT + TT.
chr9	122399591	rs12353214	C	T	.	PASS	AF=0.0724596;DESCR=Genotype CC is not associated with response to ketoprofen in people with Pain, Postoperative as compared to genotype CT.
chr9	123104493	rs9032	C	G	.	PASS	AF=0.846398;DESCR=Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.
chr9	125238840	rs430397	C	T	.	PASS	AF=0.104551;DESCR=Genotype TT is associated with increased resistance to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.
chr9	125274966	rs10819043	C	T	.	PASS	AF=0.450375;DESCR=Allele T is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele C.
chr9	125366503	rs2291858	A	G	.	PASS	AF=0.447581;DESCR=Allele G is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele A.
chr9	125370928	rs10760397	T	C	.	PASS	AF=0.459101;DESCR=Allele C is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele T.
chr9	127800446	rs1544105	C	T	.	PASS	AF=0.394464;DESCR=Genotypes CT + TT are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.
chr9	127804260	rs7856096	A	G	.	PASS	AF=0.00633641;DESCR=Allele G is associated with decreased dose of warfarin as compared to allele A.
chr9	127824342	rs1800956	C	G	.	PASS	AF=0.00259516;DESCR=Allele G is associated with decreased clearance of methotrexate in children with Acute lymphoblastic leukemia as compared to allele C.
chr9	130483269	rs10901080	G	A	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to hydroxyurea in people with Anemia, Sickle Cell and beta-Thalassemia as compared to allele G.
chr9	130483269	rs10901080	G	C	.	PASS	AF=0.00000;DESCR=Allele T is associated with increased response to hydroxyurea in people with Anemia, Sickle Cell and beta-Thalassemia as compared to allele G.
chr9	130483269	rs10901080	G	T	.	PASS	AF=0.122620;DESCR=Allele T is associated with increased response to hydroxyurea in people with Anemia, Sickle Cell and beta-Thalassemia as compared to allele G.
chr9	130502523	rs10793902	C	T	.	PASS	AF=0.675130;DESCR=Allele T is associated with increased response to hydroxyurea in people with Anemia, Sickle Cell and beta-Thalassemia as compared to allele C.
chr9	133533736	rs756770	C	A	.	PASS	AF=0.0305828;DESCR=Allele A is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.
chr9	133533736	rs756770	C	T	.	PASS	AF=0.00000;DESCR=Allele A is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.
chr9	133635081	rs1611114	C	T	.	PASS	AF=0.341302;DESCR=Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.
chr9	133635393	rs1611115	T	C	.	PASS	AF=0.764859;DESCR=Genotypes CT + TT are associated with increased response to levodopa in people with Cocaine-Related Disorders as compared to genotype CC.
chr9	133635393	rs1611115	T	G	.	AC0	AF=0.00000;DESCR=Genotypes CT + TT are associated with increased response to levodopa in people with Cocaine-Related Disorders as compared to genotype CC.
chr9	133640522	rs2873804	T	A	.	PASS	AF=0.00000;DESCR=Genotype CC is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CT + TT.
chr9	133640522	rs2873804	T	C	.	PASS	AF=0.435409;DESCR=Genotype CC is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CT + TT.
chr9	133642351	rs5320	G	A	.	PASS	AF=0.0770340;DESCR=Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.
chr9	133652975	rs77905	A	G	.	PASS	AF=0.469994;DESCR=Genotype GG is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AG.
chr9	133658547	rs129882	C	T	.	PASS	AF=0.189228;DESCR=Allele T is not associated with response to heroin as compared to allele C.
chr9	133659796	rs129915	A	G	.	PASS	AF=0.290081;DESCR=Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.
chr9	134041883	rs467387	G	A	.	PASS	AF=0.339481;DESCR=Genotype AA is associated with increased response to rivaroxaban in healthy individuals as compared to genotypes AG + GG.
chr9	134436440	rs1805343	G	A	.	PASS	AF=0.636311;DESCR=Allele A is associated with increased exposure to rosuvastatin in healthy individuals.
chr9	134441072	rs3132291	G	A	.	PASS	AF=0.740922;DESCR=Allele A is associated with increased metabolism of docetaxel in people with Nasopharyngeal Neoplasms as compared to allele G.
chr9	134441602	rs4842198	A	G	.	PASS	AF=0.779446;DESCR=Allele G is associated with increased metabolism of docetaxel in people with Nasopharyngeal Neoplasms.
chr9	134448667	rs9409929	G	A	.	PASS	AF=0.297578;DESCR=Allele A is associated with increased metabolism of vitamin d and analogues in people with Adenoma as compared to allele G.
chr9	134882699	rs3124955	T	C	.	PASS	AF=0.442008;DESCR=Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.
chr9	134883293	rs3128624	A	G	.	PASS	AF=0.465130;DESCR=Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.
chr9	135703102	rs546120	G	A	.	PASS	AF=0.674928;DESCR=Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.
chr9	135705128	rs496503	G	A	.	PASS	AF=0.847350;DESCR=Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.
chr9	135711894	rs487750	C	T	.	PASS	AF=0.307493;DESCR=Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.
chr9	135714078	rs1165016	C	T	.	PASS	AF=0.727666;DESCR=Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.
chr9	135715705	rs498974	A	T	.	PASS	AF=0.188473;DESCR=Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.
chr9	135724120	rs498618	A	G	.	PASS	AF=0.487032;DESCR=Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.
chr9	135725457	rs1537416	T	C	.	PASS	AF=0.592454;DESCR=Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.
chr9	135725655	rs7855716	G	C	.	PASS	AF=0.510381;DESCR=Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.
chr9	135725655	rs7855716	G	T	.	PASS	AF=0.00000;DESCR=Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.
chr9	135739808	rs755722	C	T	.	PASS	AF=0.344669;DESCR=Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.
chr9	135752357	rs10735239	T	C	.	PASS	AF=0.425894;DESCR=Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.
chr9	135756318	rs11103167	T	C	.	PASS	AF=0.0976945;DESCR=Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.
chr9	135761806	rs10118746	A	G	.	PASS	AF=0.260669;DESCR=Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.
chr9	135771950	rs11103182	G	T	.	PASS	AF=0.553283;DESCR=Allele G is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.
chr9	135776227	rs1318383	A	G	.	PASS	AF=0.623848;DESCR=Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.
chr9	135778130	rs10776845	C	A	.	PASS	AF=0.173487;DESCR=Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele C.
chr9	135785692	rs10776850	T	A	.	PASS	AF=0.184074;DESCR=Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.
chr9	135789055	rs10858173	T	C	.	PASS	AF=0.198931;DESCR=Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.
chr9	137011907	rs2271862	G	A	.	PASS	AF=0.708646;DESCR=Allele G is associated with increased clearance of fluorouracil in people with Colorectal Neoplasms as compared to allele A.
chr9	137138632	rs11146020	G	C	.	PASS	AF=0.0777650;DESCR=Genotypes CC + CG are not associated with increased response to clozapine in people with Schizophrenia as compared to genotype GG.
chr9	138116189	rs2739258	A	G	.	PASS	AF=0.443772;DESCR=Genotypes AG + GG is associated with increased clinical benefit to nicardipine or nimodipine in people with Bipolar Disorder as compared to genotype AA.
chr9	138117612	rs2739260	A	G	.	PASS	AF=0.447869;DESCR=Genotypes AG + GG is associated with increased clinical benefit to nicardipine or nimodipine in people with Bipolar Disorder as compared to genotype AA.
chr9	138122079	rs2229949	C	T	.	PASS	AF=0.920795;DESCR=Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype TT.
chrX	9373808	rs715171	C	A	.	PASS	AF=0.00000;DESCR=Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chrX	9373808	rs715171	C	T	.	PASS	AF=0.354556;DESCR=Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chrX	9967804	rs5934731	C	T	.	InbreedingCoeff	AF=0.488177;DESCR=Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chrX	12885540	rs179008	A	T	.	PASS	AF=0.168688;DESCR=Allele A is not associated with response to interferon alfa-2a, recombinant in people with Hepatitis C, Chronic as compared to allele T.
chrX	15599938	rs2106809	A	G	.	PASS	AF=0.269406;DESCR=Genotype GG is associated with increased response to captopril in women with Hypertension as compared to genotypes AA + AG.
chrX	23356860	rs7051085	A	T	.	InbreedingCoeff	AF=0.832261;DESCR=Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.
chrX	43742116	rs979605	A	G	.	InbreedingCoeff	AF=0.700722;DESCR=Genotype AA is associated with decreased clinical benefit to antidepressants in people with Depressive Disorder, Major as compared to allele A.
chrX	43744144	rs1137070	T	C	.	InbreedingCoeff	AF=0.713146;DESCR=Allele C is not associated with response to rizatriptan in people with Migraine without Aura as compared to allele T.
chrX	43768752	rs1799836	T	C	.	PASS	AF=0.420450;DESCR=Allele T is associated with increased concentrations of 5-hydroxyindole-3-acetic acid and serotonin in men with Depressive Disorder, Major as compared to allele C.
chrX	45781104	rs5906072	T	C	.	PASS	AF=0.129008;DESCR=Allele T is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele C.
chrX	114583809	rs3813928	G	A	.	PASS	AF=0.147592;DESCR=Allele A is associated with decreased response to risperidone in children with Autistic Disorder as compared to genotype GG.
chrX	114584047	rs3813929	C	G	.	PASS	AF=0.00000;DESCR=Allele T is not associated with exposure to olanzapine in healthy individuals as compared to allele C.
chrX	114584047	rs3813929	C	T	.	PASS	AF=0.146157;DESCR=Allele T is not associated with exposure to olanzapine in healthy individuals as compared to allele C.
chrX	114903581	rs1414334	C	G	.	InbreedingCoeff	AF=0.814773;DESCR=Allele G is not associated with exposure to olanzapine in healthy individuals as compared to allele C.
chrX	123182584	rs3761555	T	C	.	PASS	AF=0.336006;DESCR=Genotype TT is associated with decreased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotypes CC + CT.
chrX	123183391	rs3761554	T	C	.	PASS	AF=0.0491679;DESCR=Genotype TT is associated with decreased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotypes CC + CT.
chrX	123403426	rs502434	T	C	.	InbreedingCoeff	AF=0.644055;DESCR=Genotype CC is associated with decreased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotypes CT + TT.
chrX	136648396	rs1126535	T	C	.	PASS	AF=0.149526;DESCR=Allele T is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.
chrX	151969707	rs1139916	A	C	.	InbreedingCoeff	AF=0.598476;DESCR=Allele A is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele C.
chrX	151969707	rs1139916	A	T	.	PASS	AF=0.00000;DESCR=Allele A is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele C.
chrX	152247402	rs6627221	T	C	.	PASS	AF=0.171786;DESCR=Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele T.
chrX	152321843	rs2201169	A	G	.	PASS	AF=0.166025;DESCR=Allele G is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele A.
chrX	152413524	rs4828696	T	C	.	PASS	AF=0.569301;DESCR=Genotype TT is not associated with increased response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype CC.
chrX	152437532	rs1112122	G	C	.	AS_VQSR	AF=0.00000;DESCR=Genotype GG is not associated with response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype TT.
chrX	152437532	rs1112122	G	T	.	PASS	AF=0.501144;DESCR=Genotype GG is not associated with response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype TT.
chrX	154046529	rs17435	T	A	.	InbreedingCoeff	AF=0.737304;DESCR=Allele A is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chrX	154046529	rs17435	T	C	.	AC0	AF=0.00000;DESCR=Allele A is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chrX	154059995	rs1734787	A	C	.	PASS	AF=0.216762;DESCR=Allele A is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele C.
chrX	154065469	rs1734791	A	G	.	PASS	AF=0.00000;DESCR=Allele A is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chrX	154065469	rs1734791	A	T	.	PASS	AF=0.219614;DESCR=Allele A is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.
chrX	154536002	rs1050828	C	T	.	PASS	AF=0.00000;DESCR=Allele T is not associated with response to artemisinin and derivatives in people with Malaria, Falciparum as compared to allele C.
